cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
78997,"Cassie, ext.",289-655-3,89958-31-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1396,H411:1287;H317:1396;H318:60;H315:108;H319:7;H412:1
78998,Pimelonitrile,211-469-8,646-20-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H312:38;H301:39;H319:1;H315:1
78999,"Naphthalenesulfonic acid, dibutyl-, Me derivs., sodium salts",272-717-9,68909-84-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H302:90;H319:90;H315:90
79004,Indazole,205-978-4,271-44-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;Not classified:1
79008,3-bromo-4-fluorobenzonitrile,279-200-7,79630-23-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:46;H335:45;H312:45;H302:45;H332:45;H315:46;H311:2;H331:2;H301:2
79009,"1-(1,1-dimethylethoxy)-2-methylpropane",251-347-1,33021-02-2,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,85,H318:84;H411:84;H315:85;H225:85;H319:1;H335:1;H412:1
79010,"β-Alanine, N-(2-carboxyethyl)-, N-tallow alkyl derivs., disodium salts",263-190-6,61791-56-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,478,H318:441;H315:445;Not classified:33;H319:4
79013,3-methylisothiazol-5-ylamine hydrochloride,257-997-2,52547-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
79014,Octyl (R)-2-(4-chloro-2-methylphenoxy)propionate,266-358-7,66423-13-0,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,5,H302:5;H317:4;H411:1;H318:1;H410:3;H400:3
79018,"Benzenesulfonamide, N-[2-(3,4-dihydro-4-oxo-2-quinazolinyl)phenyl]-4-methyl-",608-785-7,32787-68-1,Not Classified,Notified C&L,1,Not classified:1
79021,butan-2-ol,201-158-5,78-92-2,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H319:0;H226:0;H335:0;H336:0
79025,"(5α,6α)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride",245-549-9,23277-43-2,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Lact.,REACH registration C&L,59,H302:21;H362:3;H318:3;H336:4;H300:38;H310:38;H330:38;H317:16;H312:16;H334:16;H332:18
79027,"2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-butenal",265-455-1,65114-02-5,Not Classified,Notified C&L,1,Not classified:1
79028,"2,2-dimethyl-3-oxopropyl dodecanoate",468-880-2,102985-93-3,Aquatic Chronic 3,REACH registration C&L,49,H412:3;Not classified:46
79030,4-chlorophenylacetyl chloride,246-571-1,25026-34-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,46,H302:45;H317:41;H314:46;H290:1;H318:1
79041,Diheptyl succinate,239-996-9,15872-89-6,Not Classified,REACH registration C&L,2,Not classified:2
79044,"methyl (2,3-dichlorophenoxy)acetate",606-285-3,1928-56-9,Acute Tox. 4,REACH registration C&L,91,H302:91
79047,3-methyl-2-phenyl-8-(1-propenyl)-4-benzopyrone,222-424-7,3468-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79048,"4-Acetoxy-3,5-dimethoxybenzaldehyde",611-030-4,53669-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
79049,5-bromo-2-pyridylamine,214-019-9,1072-97-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,139,H319:138;H335:137;H315:138;H301:130;H312:4;H302:4;H332:4;H311:1;H331:1
79050,3-(m-hydroxyphenyl)propionic acid,210-692-8,621-54-5,,Notified C&L,6,H319:6;H335:6;H315:6
79052,"Benzenesulfonic acid, mono-C9-17-branched alkyl derivs., compds. with 2-propanamine",272-018-9,68649-00-3,Not Classified,Notified C&L,234,Not classified:179;H302:55;H319:34;H411:54;H315:35;H335:20;H318:21;H314:20
79055,"4-hydroxy-2-quinolone, monosodium salt",224-828-9,4510-76-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H312:38;H302:38;H332:38;H315:38
79057,Zirconium(4+) acetate,224-179-1,4229-34-9,Aquatic Chronic 4,Notified C&L,4,H413:2;H319:2;H315:2
79058,"(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one hydrochloride",607-864-3,26116-57-4,Skin Sens. 1,Notified C&L,2,H317:2;H334:1
79059,Trilithium hexafluoroaluminate,237-509-4,13821-20-0,Acute Tox. 4;Acute Tox. 3;Lact.;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,3,H372:2;H412:2;H362:2;H331:2;H302:3;H332:1;H373:1
79062,"4'-Ethyl-2,3-difluorbiphenyl",929-069-3,,Not Classified,REACH registration C&L,2,Not classified:2
79063,Tetrahydro-2-furancarboxylic acid,605-530-1,16874-33-2,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,125,H302:118;H290:3;H318:5;H314:125;Not classified:2;H332:1;H312:1
79064,"Bis(1,3-dimethylbutyl) 2-butenedioate",267-946-6,67953-19-9,Not Classified,REACH registration C&L,16,Not classified:16
79066,Triphenylsilanol,212-339-3,791-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H319:46;H335:44;H315:46;Not classified:26
79067,"1H-Imidazole-1-ethanol, 4,5-dihydro, 2-(C11-17 and C17 unsatd. alkyl) derivs.",930-778-5,1334421-89-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,87,H318:87;H400:87;H302:87;H410:87;H314:87
79070,Methyl oct-2-ynoate,203-836-6,111-12-6,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1757,H412:42;H317:1711;H400:43;H302:1715;H315:46;H410:38;H319:6;H335:4;H336:1;H411:1
79071,(butylamino)acetonitrile,221-132-7,3010-04-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H312:38;H302:38;H332:38;H315:38
79074,"1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one",245-833-2,23696-85-7,Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 2,Notified C&L,1940,H317:1938;H411:1936;H315:1354;H225:2;H302:1;H412:1
79075,Tetrasodium N-(3-carboxylato-1-oxo-2-sulphonatopropyl)-N-octadecyl-L-aspartate,222-273-7,3401-73-8,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,75,H319:38;H413:38;H411:37
79077,"Lycium barbarum, ext.",285-375-0,85085-46-7,Not Classified,Notified C&L,1,Not classified:1
79079,Iproniazid phosphate,206-164-1,305-33-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:38;H331:38;H301:38;H302:1
79082,4-bromo-2-nitrophenol,231-707-4,7693-52-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:44;H335:43;H302:39;H332:39;H315:44;H341:1
79085,Acetanilide,203-150-7,103-84-4,Acute Tox. 4,Notified C&L,1619,H302:1617;H319:45;H335:44;H315:52;Not classified:12;H311:8;H331:8;H400:8;H332:9;H312:1
79086,"(15α)-3-Methoxy-17-oxoandrosta-3,5-dien-15-yl acetate",604-156-6,139667-09-7,Skin Sens. 1B;STOT RE 2;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H401:2;H373:2;H411:2;H317:2
79089,hydrocarbon resin,618-501-3,9017-27-0,Not Classified,Notified C&L,94,Not classified:93;H319:1;H335:1;H315:1
79090,"2-Propenoic acid, polymer with sodium phosphinate",615-245-4,71050-62-9,Met. Corr. 1;Skin Corr. 1B,Notified C&L,181,H290:102;H314:84;Not classified:79;H412:17
79091,"Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate",222-811-0,3618-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:39;H335:38;H315:39;Not classified:10;H332:1
79092,N-ethylformamide,211-001-2,627-45-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
79093,1-(3-methoxyphenyl)piperazine dihydrochloride,230-189-7,6968-76-9,,Notified C&L,5,H319:5;H335:5;H315:5
79095,Fluoren-9-one hydrazone,237-116-8,13629-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
79099,"Naphthenic acids, compds. with triethanolamine",270-084-3,68410-61-7,,Notified C&L,34,Not classified:33;H319:1;H315:1
79101,"1H-Inden-1-one, 2,3-dihydro-2,6-dimethyl-",619-799-8,66309-83-9,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,129,H412:129;H318:116;H314:129
79105,Ethyl 2-cyanocinnamate,217-972-9,2025-40-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H332:1;H315:1
79109,C11 Ketones,615-495-4,71808-49-6,STOT SE 3;Aquatic Chronic 2,Notified C&L,154,H411:90;H336:90;Not classified:44;H319:20;H315:20;H335:2
79112,"2,6-dichlorophenol",201-761-3,87-65-0,Skin Corr. 1B,Notified C&L,55,H314:49;H312:6;H411:8;H319:5;H315:5;Not classified:3;H318:2;H311:2
79113,Trimethylsulphonium tetrafluoroborate(1-),211-632-3,676-88-0,Skin Corr. 1B,Notified C&L,42,H314:42
79114,Pterostilbene,611-041-4,537-42-8,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,39,H411:39;H318:39
79115,3-ethyl-6-methylpyridin-2-amine,255-614-3,41995-31-7,,Notified C&L,5,H319:4;H312:4;H302:5;H332:4;H315:5;H318:1;H335:1
79119,2-hydroxy-6-methylpyridine-3-carboxylic acid,253-784-3,38116-61-9,Eye Irrit. 2,Notified C&L,42,H319:41;Not classified:1;H335:2;H315:3
79120,3-methyl-2-naphthol,241-346-4,17324-04-8,,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
79125,"1,4-dihydro-5,7-dinitrobenzofurazan-4-ol 3-oxide, potassium salt",249-543-7,29267-75-2,Unst. Expl.,REACH registration C&L,4,H200:2;H302:2;H319:2;H201:2;H315:2
79127,"Estra-5(10),9(11)-dien-3-one, 17-(acetyloxy)-17-(1-oxopropyl)-, cyclic 3-(1,2-ethanediyl acetal), (17b)-",604-899-6,153363-57-6,Repr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H360:1;H411:1;H373:1
79134,2-octylthiophene,212-913-3,880-36-4,Not Classified,Notified C&L,1,Not classified:1
79135,"Sodium (6R-trans)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",248-278-4,27164-46-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,62,H317:60;H334:61;H302:1;H341:1
79136,Dioxobis(stearato)trilead,235-702-8,12578-12-0,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H372:5;H362:4;H360:6;H400:6;H302:6;H351:5;H332:6;H410:6;H373:1
79137,"Octahydro-4,7-methano-1H-indenedimethyl diisocyanate",249-247-8,28807-72-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,34,H319:34;H335:34;H317:34;H334:34;H330:34;H315:34
79142,"Chromate(1-), bis[[]3-(hydroxy-[?]O)-4-[[]2-[[]2-(hydroxy-[?]O)-3,5-dinitrophenyl]diazenyl-[?]N1]-N-phenyl-2-naphthalenecarboxamidato(2-)]-, hydrogen (1:1)",617-547-1,84179-66-8,Not Classified,Notified C&L,4,Not classified:4
79143,"Tetrasodium 3,3'-[carbonylbis[imino(5-methoxy-2-methyl-4,1-phenylene)azo]]bis(naphthalene-1,5-disulphonate)",229-158-0,6420-33-3,Skin Sens. 1B;STOT RE 2,REACH registration C&L,9,H373:8;H317:8;Not classified:1
79145,3-(2-thienyl)acrylonitrile,227-928-0,6041-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
79146,"Copper, diazotized 3-amino-4-methoxybenzenesulfonic acid-diazotized 4-nitro-1,3-benzenediamine-resorcinol coupling products ammonium sodium complexes",308-952-1,99148-46-6,,Notified C&L,33,Not classified:33
79148,2-chloroethyltriphenylphosphonium bromide,250-527-7,31238-20-7,,Notified C&L,4,H319:4;H335:4;H315:4
79149,Fuel gases;Petroleum gas;[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.],270-667-2,68476-26-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
79151,"Triethylenetetramine, ethoxylated and propoxylated",500-178-4,67939-72-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,85,H319:84;H315:59;H335:25;Not classified:1
79153,"2,4-difluorobenzoyl chloride",276-690-4,72482-64-5,Skin Corr. 1B;STOT SE 3,Notified C&L,47,H335:41;H314:47;H290:1;H318:1;H319:2
79155,3-[tris(1-methylethoxy)silyl]propyl methacrylate,279-538-5,80750-05-6,Not Classified,Notified C&L,26,Not classified:26
79161,"Oligomerisation products of But-2-yne-1,4-diol and methyloxirane",612-177-7,61596-96-1,Acute Tox. 3;Skin Sens. 1B;STOT RE 2,REACH registration C&L,84,H373:84;H317:84;H301:84
79165,"2,4-dimethylpenta-1,3-diene",213-677-4,1000-86-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H225:39
79167,Pigment Yellow FC 26290,411-080-5,,Not Classified,Notified C&L,1,Not classified:1
79169,"Benzene-1,2,4-tricarboxylic acid, compound with 2-phenyl-1H-imidazole-1-propiononitrile (1:1)",268-383-9,68083-35-2,Not Classified,Notified C&L,25,Not classified:25
79180,"5-[5-(hexahydro-4,6-dioxo-2-thioxopyrimidin-5-yl)-2,4-pentadienylidene]dihydro-2-thioxo-1H,5H-pyrimidine-4,6-dione",264-470-0,63811-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79181,"reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;dihexadecyl 9-nonyl-10-octylnonadecandioate;1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;dioctadecyl 9-nonyl-10-octylnonadecandioate",432-910-2,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
79187,Hexacosanoic acid,208-040-2,506-46-7,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
79188,"1,2-Difluor-4-{2-(4-trans-pentyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl}-benzene",600-804-7,107215-67-8,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
79191,"3,6-dihydro-4-methoxy-2H-pyran",241-348-5,17327-22-9,Flam. Liq. 3,Notified C&L,38,H226:38
79192,(Z)-docos-13-enamide,204-009-2,112-84-5,Not Classified,REACH registration C&L,682,Not classified:417;H319:264;H335:264;H315:264;H302:2
79195,Chlorazanil,207-904-6,500-42-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
79199,"9-α-fluoro-11-β,21-dihydroxy-16-α,17-α-isopropylidenedioxypregna-1,4-diene-3,20-dione",200-948-7,76-25-5,Repr. 1B,Notified C&L,53,H360:44;H361:7;H372:5;H302:5;H373:3;Not classified:1;H319:1;H335:1;H315:1;H412:1;H362:1;H334:1
79201,"Naphthenic acids, zinc salts, basic",282-762-6,84418-50-8,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,26,H412:6;H317:6;H319:17;H411:18;H315:18;Not classified:2
79202,"Xanthylium, 3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethyl-, molybdatephosphate",269-695-8,68310-07-6,Not Classified,Notified C&L,116,Not classified:116
79203,2-chloro-5-nitropyridine,224-908-3,4548-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47;H302:5;H312:1;H332:1
79208,"N,N-dioctadecylcarbamoyl chloride",255-311-6,41319-54-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,39,H319:39;H412:38;H335:39;H315:39
79212,"Cimicifuga racemosa, ext.",283-951-6,84776-26-1,Not Classified,Notified C&L,2,Not classified:1;H226:1
79213,"4,6-dihydro-4-hydroxy-2H-furo[3,2-c]pyran-2-one",205-735-2,149-29-1,Acute Tox. 2;Skin Irrit. 2,Notified C&L,44,H300:41;H315:39;H301:3;H351:2;H310:2;H330:2
79217,Trichromium heptacarbide,235-701-2,12552-55-5,Not Classified,Notified C&L,1,Not classified:1
79222,3-hydroxybenzaldehyde,202-892-9,100-83-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,58,H302:3;H319:56;H412:3;H335:51;H315:53;H317:1;Not classified:1
79226,"4'-Bromo-(1,1'-biphenyl)-4-ol",608-376-3,29558-77-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
79227,"(E)-4-Ethoxy-1,1,1-trifluoro-3-buten-2-one (stabilized with BHT)",475-900-3,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;STOT RE 1;Aquatic Chronic 3,Notified C&L,2,H319:1;H317:2;H372:2;H412:2;H330:2;H302:2;H226:2;H315:1;H318:1;H314:1
79229,"Alcohols, C9-11-branched and linear, C10-rich",298-696-6,93821-11-5,Not Classified,Notified C&L,88,Not classified:59;H319:29;H315:29
79230,o-chlorophenyl dichlorophosphate,239-129-4,15074-54-1,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
79232,"Urtica urens, ext.",290-397-9,90131-83-2,Repr. 1B,Notified C&L,1286,H360:1286
79233,4-propylcyclohexanone,406-810-4,40649-36-3,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0
79234,Dihexyl azelate,203-664-1,109-31-9,Not Classified,Notified C&L,16,Not classified:16
79235,Anise Oil Pure,616-914-3,8007-70-3,Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,231,H351:139;H341:139;H411:139;H317:231;H412:2;H226:1
79237,"1,2-dibromo-3,3-dimethylbutane",613-415-2,640-21-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,39,H319:39;H335:39;H320:1;H312:39;H302:39;H332:39;H315:39
79240,"2,3-dimethylcyclohexylamine",255-704-2,42195-92-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H226:39;H314:39
79242,Dibarium hexacyanoferrate,237-507-3,13821-06-2,,Notified C&L,4,H302:4;H332:4
79243,"9,10-phenanthrenequinone",201-515-5,84-11-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,177,H319:130;H315:172;H335:41;H341:4;H400:6;Not classified:1
79244,2-(hydroxypropyl)-1H-benzimidazole,219-290-7,2403-66-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
79246,1-methyl-4-(1-methylvinyl)cyclohexan-1-ol,205-342-6,138-87-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,145,H319:90;H315:90;Not classified:55
79250,Sodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzene-1-sulphonamidato(2-)]chromate(1-),277-511-2,73507-68-3,Not Classified,Notified C&L,2,Not classified:2
79252,6-ethoxy-2-methylquinoline,229-609-1,6628-28-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
79254,"Oxirane, 2-methyl-, polymer with oxirane, di-(9Z)-9-octadecenoate",614-025-5,67167-17-3,Aquatic Chronic 3,Notified C&L,446,H412:446
79255,Phenyl-2-thiourea,203-151-2,103-85-5,Acute Tox. 1;Skin Sens. 1,Notified C&L,76,H300:72;H317:68;Not classified:3;H319:1;H335:1;H311:1;H331:1;H301:1;H315:1
79259,"4,4'-oxydiphthalic anhydride",412-830-4,1823-59-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
79261,"1,1,2,2-tetrachloro-1-fluoroethane",206-546-8,354-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79262,"2-[3-[4-(3-chlorophenyl)piperazin-1-y]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one hydrochloride",246-855-5,25332-39-2,Acute Tox. 4;Carc. 2,Notified C&L,53,H302:53;H351:41;H361:2;H318:1;H400:1
79265,"Cyclohex-1,2-ylenediaminetetra(acetic acid)",207-582-7,482-54-2,Not Classified,Notified C&L,65,Not classified:63;H302:2
79266,Ethyl salicylate,204-265-5,118-61-6,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,1678,H302:1678;H315:80;H319:44;H335:5;H411:1
79267,"Decanoic acid, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol octanoate",234-392-1,11138-60-6,Not Classified,Notified C&L,109,Not classified:109
79268,"Magnolia grandiflora, ext.",285-376-6,85085-47-8,Not Classified,Notified C&L,36,Not classified:36
79269,"Glycerides, palm-oil mono-, di- and tri-, hydrogenated, citrates, sodium salts",294-635-2,91744-70-6,Not Classified,Notified C&L,1,Not classified:1
79273,"2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione",422-650-8,148935-94-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
79276,"N-phenyl-4-[[4-(phenylamino)phenyl][4-(phenylimino)cyclohexa-2,5-dien-1-ylidene]methyl]aniline monohydrochloride",218-441-4,2152-64-9,Not Classified,REACH registration C&L,2,Not classified:2
79279,C.I. Disperse Violet 93:1,602-785-0,122463-28-9,Not Classified,Notified C&L,4,Not classified:3;H317:1
79280,"Trimethylhexa-1,6-diyl diisocyanate",249-151-6,28679-16-5,Not Classified,Notified C&L,15,Not classified:14;H317:1;H311:1;H331:1;H334:1;H301:1
79284,"2-(11H-dibenzo[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione",616-149-5,74860-00-7,,REACH registration C&L,1,Not classified:1
79287,hydrazine-trinitromethane,414-850-9,4682-01-3,Expl. 1.1;Self-react. A;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B,Harmonised C&L,0,H317:0;H201:0;H331:0;H240:0;H301:0;H350:0
79290,Cyclohexylpropionyl chloride,254-289-5,39098-75-4,Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1
79292,"2,3 dihydrothieno (3,4-b) -1 4 dioxine",603-128-0,126213-50-1,Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2,Notified C&L,50,H302:50;H319:42;H311:41;H412:9;H312:8;H331:1
79293,Phenylsulphonyl isocyanate,220-640-6,2845-62-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,Notified C&L,43,H319:43;H317:38;H334:43;H302:42;H332:38;H315:43;H335:5;H331:5;H301:1
79296,"Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;Refinery gas;[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-781-2,68477-98-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
79297,Methyl cyclohexanecarboxylate,225-050-2,4630-82-4,Flam. Liq. 3,Notified C&L,131,H226:121;Not classified:10
79298,"Ethanol, 2-amino-, reaction products with ammonia, ethylenediamine fraction, distn. residues",296-389-1,92623-59-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H319:21;H315:21
79299,"Oxalic acid, potassium salt",233-137-1,10043-22-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,24,H302:24;H312:23;H371:1
79303,4-iodotoluene,210-841-7,624-31-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,19,H302:7;H319:17;H303:2;H335:8;H315:15;H332:2;H312:2
79304,ethyl methacrylate,202-597-5,97-63-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H317:0;H225:0;H315:0
79308,reaction mass of: esters of C,413-750-2,171090-93-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
79309,7-methyl-8-nitroquinoline,231-268-9,7471-63-8,,Notified C&L,5,H341:4;H319:1;H315:1
79310,"methyl (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate",600-422-0,103335-41-7,Repr. 2;Aquatic Chronic 3,REACH registration C&L,37,H412:1;H361:36;H302:1;H341:1
79311,Pyridine-2-thiol N-oxide,214-329-4,1121-31-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H301:42;H312:1;H302:2;H332:1
79316,"Manganese, 3-hydroxy-4-[(1-sulfo-2-naphthalenyl)azo]-2-naphthalenecarboxylic acid complex",252-525-1,35355-77-2,Not Classified,REACH registration C&L,140,Not classified:140
79319,cobalt sulfate,233-334-2,10124-43-3,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B;Repr. 1B,Harmonised C&L,0,H317:0;H341:0;H334:0;H360:0;H400:0;H302:0;H410:0;H350:0
79324,6-methylbenzotriazole,205-265-8,136-85-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,93,H318:1;H314:1;H302:91;H319:47;H335:48;H315:47;H332:3;H312:4;Not classified:1
79325,"2,7-Naphthalenedisulfonic acid, 3-amino-4-[[4-[[4-fluoro-6-[methyl[[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy",620-145-9,680204-51-7,Eye Dam. 1,Notified C&L,1,H318:1
79327,Caesium iodide,232-145-2,7789-17-5,Repr. 2;Aquatic Acute 1,REACH registration C&L,79,H361:5;H400:5;H317:39;H319:44;H335:43;H315:44;Not classified:30;H302:6;H373:1
79328,"Fatty acids, C14-18 and C16-18-unsatd., Me esters, mixed with lard oil, sulfurized",306-516-5,97281-17-9,Not Classified,Notified C&L,1,Not classified:1
79331,Nitrosyl chloride,220-273-1,2696-92-6,Ox. Gas 1;Press. Gas (Comp.);Skin Corr. 1A;Acute Tox. 1,Notified C&L,111,H280:111;H270:111;H314:111;H330:111
79332,Zinc hexafluorosilicate,240-894-1,16871-71-9,Acute Tox. 4,REACH registration C&L,43,H302:40;H318:3;H311:3;H331:3;H400:12;H301:3;H410:38;H314:3
79336,"Poly (hydroxyphenylenemethylene-1,4-phenylenemethylene)",608-005-5,26834-02-6,Muta. 1A;Repr. 1A;STOT SE 2;STOT RE 2,Notified C&L,3,H360:2;H340:2;H371:2;H373:2;Not classified:1
79337,Titanium disulphide,234-883-0,12039-13-3,Self-heat. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,237,H319:212;H252:208;H335:212;H315:212;Not classified:25;H261:4
79339,"Benzoic acid, 2,6-bis((4,6-dimethoxy-2-pyrimidinyl)oxy)-, sodium salt",603-066-4,125401-92-5,Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,160,H373:89;H411:122;H317:122;H319:38
79341,Ethyl 2-methyl-2-butenoate,259-688-8,55514-48-2,Flam. Liq. 3,Notified C&L,1,H226:1
79342,"cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole",265-846-7,65621-78-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79343,Dipotassium clorazepate,260-565-6,57109-90-7,Acute Tox. 4;Repr. 2,Notified C&L,42,H302:42;H361:40;H336:3;H314:2;H362:1
79344,Lysine hydrochloride,211-519-9,657-27-2,Not Classified,REACH registration C&L,312,Not classified:312
79348,"(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride",402-200-7,103430-24-6,Aquatic Chronic 3,Harmonised C&L,0,H412:0
79350,Triisopropyl borate,226-529-9,5419-55-6,Flam. Liq. 3;Eye Irrit. 2,REACH registration C&L,127,H319:69;H225:119;H226:8;H335:3;H315:2;Not classified:2;H411:1
79352,"2,3,6aα,8,9,9aα-hexahydro-4-methoxycyclopenta[c]furo[2',3':4,5]furo[2,3-h]chromene-1,11-dione",230-618-8,7220-81-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,3,H300:3;H350:3;H310:3;H330:3
79353,Isobutylcyclohexane,216-839-2,1678-98-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H302:38;H319:38;H410:38;H400:38;H226:5;Not classified:3
79357,(±)-2-methyl-1-nitrosoindoline,287-218-1,85440-79-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H301:1
79360,Ethyl 1-piperidineacetate,607-278-8,23853-10-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
79361,Dibromoacetonitrile,221-843-2,3252-43-5,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,113,H319:107;H400:72;H301:79;H335:36;H312:34;H302:34;H332:34;H315:36;H351:20;H411:13;H410:14;H226:9;H314:6;H311:3;H330:3;H318:1;H350:1
79362,1-aminofluoren-9-one,228-748-5,6344-62-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
79363,Trimethylsilyl [(trimethylsilyl)oxy]acetate,251-580-9,33581-77-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H226:38;H335:38;H315:38
79365,Reaction products of (1 mole) Pentaerythritol ethoxylated and propoxylated (4:1) with 2-propenoic acid (4 moles),604-394-0,144086-02-2,Eye Irrit. 2,Notified C&L,96,H319:96;H411:22
79366,Tyrosine,200-460-4,60-18-4,Not Classified,REACH registration C&L,241,Not classified:214;H319:25;H335:24;H315:25;H302:1;H361:1
79369,"(2-(1,3-Dioxolan-2-yl)ethyl)triphenylphosphonium bromide",617-894-9,86608-70-0,Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,38,H302:38;H373:38;H412:38;H318:38
79371,propyl formate,203-798-0,110-74-7,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H319:0;H336:0;H335:0;H225:0
79372,"N'-(3-aminopropyl)-N,N-dimethylpropane-1,3-diamine",234-148-4,10563-29-8,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,316,H302:316;H318:132;H317:278;H314:316;H312:260
79373,"1,2-dihydropyridazine-3,6-dione, potassium salt",257-261-0,51542-52-0,Not Classified,Notified C&L,1,Not classified:1
79375,Silicium dioxide (Silicium dioxide/Kieselguhr),612-383-7,61790-53-2,Not Classified,Notified C&L,785,Not classified:585;H302:116;H319:168;H335:168;H373:36;H351:4;H315:1;H372:1
79376,"1H-Imidazole-1-propanoic acid, 2-methyl-5-nitro-",617-353-7,82553-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
79377,"Oxidase, sarcosine",232-850-5,9029-22-5,Resp. Sens. 1,Notified C&L,1,H334:1
79380,"Coke (petroleum), calcined",265-210-9,64743-05-1,Not Classified,Notified C&L,41,Not classified:41
79381,"1,1,1,2,2,4,5,5,5-NONAFLUORO-4-(TRIFLUOROMETHYL)-3-PENTANONE",616-243-6,756-13-8,Aquatic Chronic 3,Notified C&L,4,H412:4
79384,"Fatty acids, tall-oil, triesters with trimethylolpropane",305-507-3,94581-09-6,Aquatic Chronic 4,Notified C&L,4,H413:2;Not classified:2
79390,[3-[(ethylimidocarbonyl)amino]propyl]trimethylammonium iodide,245-095-1,22572-40-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H335:42;H312:38;H302:43;H332:38;H315:43
79392,"1,6-bis(2,3-epoxypropoxy)hexane",240-260-4,16096-31-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,599,H317:597;H319:597;H412:574;H315:597;Not classified:2;H400:1;H410:1
79396,Propiononitrile,203-464-4,107-12-0,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,68,H300:66;H319:64;H310:65;H225:68;H332:58;H311:3;Not classified:2;H331:2;H301:2;H373:1;H402:1
79397,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium hydrogen oxalate",286-171-4,85187-83-3,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H318:2;H400:2;H301:2
79399,2-oxovaleric acid,217-340-2,1821-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
79401,4-cyclohexyl-2-methyl-2-butanol,420-630-3,83926-73-2,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
79402,"Naphthalenesulfonic acid, sodium salt, isopropylated",270-475-9,68442-09-1,Not Classified,Notified C&L,98,Not classified:68;H302:30;H373:30;H318:30;H331:29;H330:1
79408,"1-(4-Hydrazinobenzyl)-1H-1,2,4-triazole Dihydrochloride",606-727-5,212248-62-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H373:1;H341:1;H331:1;H301:1;H351:1
79411,1-phenylhexan-3-one,249-937-9,29898-25-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
79414,toluidinium chloride,208-740-8,540-23-8,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H319:0;H317:0;H311:0;H331:0;H400:0;H301:0;H351:0
79415,Tridecanenitrile,211-097-6,629-60-7,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,39,H302:38;H413:38;H311:1;H331:1;H301:1
79419,Undecenal,215-656-5,1337-83-3,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1531,H317:1335;H319:1337;H315:1496;H412:1299;H411:206;H410:25;H400:35
79421,"1,7-dihydro-6H-purine-6-selone",226-088-2,5270-30-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H331:38;H400:38;H301:38;H410:38
79424,"Chromate(2-), [5-chloro-3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulfonato(3-)][4-[(3,5-dichloro-2-hydroxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, disodium",263-582-7,62524-44-1,Aquatic Chronic 2,Notified C&L,38,H411:37;Not classified:1
79425,Trimanganese tetraoxide,215-266-5,1317-35-7,Repr. 2,REACH registration C&L,333,H361:166;H319:60;H335:60;H315:60;Not classified:87;H373:20;H312:1;H332:1
79429,"Trisodium 1-amino-4-[3-[[4-chloro-6-[3(or4)-sulphonatoanilino]-1,3,5-triazin-2-yl]amino]-2,4,6-trimethyl-5-sulphonatoanilino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",305-380-4,94481-53-5,,Notified C&L,1,H412:1
79431,"Trisodium 4-[[4-[[(2,3-dichloro-6-quinoxalinyl)carbonyl]amino]-2-sulphonatophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",278-108-4,75199-00-7,Skin Sens. 1B,REACH registration C&L,23,H317:23
79432,4-methoxybutan-2-one,620-150-6,6975-85-5,,Notified C&L,2,H226:2;H319:1;H335:1;H315:1
79434,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with 4-methyl-1,3-benzenediamine and m-phenylenediamine, sodium salt",286-256-6,85203-66-3,Eye Irrit. 2,Notified C&L,1,H319:1
79436,Cyclohex-1-ene-1-methylamine,251-293-9,32917-19-4,,Notified C&L,1,H319:1;H335:1;H315:1
79441,"2,4-dimethylpentane",203-548-0,108-08-7,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H225:0;H336:0;H304:0;H400:0;H410:0;H315:0
79443,diethylmercury,211-000-7,627-44-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H373:0;H310:0;H330:0;H400:0;H410:0
79447,Sodium 2-(4-(3-methyl-4-(phenylsulphonyloxy)phenylazo)phenylimino)-5-nitrobenzenesulphonate,227-490-0,5858-39-9,Not Classified,Notified C&L,1,Not classified:1
79449,"isazofos (ISO);O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate",255-863-8,42509-80-8,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H317:0;H311:0;H330:0;H400:0;H301:0;H410:0
79450,Nimodipine,266-127-0,66085-59-4,STOT RE 2,Notified C&L,67,H373:39;H361:25;H315:24;Not classified:1;H332:1;H312:1;H302:1
79459,"(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate",433-520-5,82911-69-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H317:0
79460,Cinnamaldehyde azine,216-371-9,1568-11-2,Acute Tox. 4,Notified C&L,38,H302:38
79462,Methylphosphonous dichloride,211-631-8,676-83-5,Pyr. Liq. 1;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,43,H302:1;H332:1;H250:43;H314:43;H311:38;H331:38;H301:38;H226:42;H252:4
79471,Indoprofen,250-833-0,31842-01-0,Acute Tox. 3;Carc. 2,Notified C&L,38,H351:38;H301:38
79474,Methyl β-D-glucoside,211-909-9,709-50-2,Not Classified,Notified C&L,2,Not classified:2
79475,Triphosphoric acid,233-840-3,10380-08-2,Not Classified,Notified C&L,19,Not classified:18;H290:1;H314:1
79481,p-pentylphenyl p-pentylbenzoate,277-812-9,74305-48-9,Aquatic Chronic 4,Notified C&L,39,H413:39;Not classified:1
79482,C.I. Direct Black 155,615-684-1,71902-06-2,Not Classified,Notified C&L,1,Not classified:1
79483,2-hydrazinoethanol,203-711-6,109-84-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,45,H319:44;H335:43;H311:40;H331:40;H301:45;H351:39;H315:44
79484,"5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran",415-360-8,41107-56-6,Muta. 2,Harmonised C&L,0,H341:0
79486,"disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);C.I. Direct Red 28",209-358-4,573-58-0,Carc. 1B;Repr. 2,Harmonised C&L,0,H361:0;H350:0
79487,"1,3-bis(hydroxymethyl)cyclohexane",223-594-5,3971-28-6,Eye Dam. 1,Notified C&L,100,H318:55;H319:40;H335:40;H315:40;Not classified:5
79488,3-mercaptobutan-2-one,255-082-2,40789-98-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1456,H319:1456;H226:169;H335:1445;H315:1446;H302:1287;H332:1287
79490,"2,3,4,6-tetra-O-acetyl-1-C-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-a-D-glucopyranose",921-285-6,1071929-02-6,Not Classified,Notified C&L,1,Not classified:1
79493,Lithium amide,231-968-4,7782-89-0,Self-heat. 1;Water-react. 2;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,76,H318:2;H261:46;H412:2;H251:2;H314:71;Not classified:5
79497,[No public or meaningful name is available],472-070-4,,Not Classified,Notified C&L,83,Not classified:83
79499,4-fluoroglutamic acid,220-302-8,2708-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
79502,(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate,247-162-0,25646-77-9,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H317:0;H400:0;H301:0;H410:0
79504,"Cola acuminata, ext.",289-720-6,89997-82-0,Not Classified,Notified C&L,51,Not classified:26;H226:25
79508,Tetradecyl stearate,241-640-2,17661-50-6,Not Classified,REACH registration C&L,35,Not classified:35
79511,"1-(2,4-dichlorophenyl)cyclopropanecarbonitrile",275-494-6,71463-55-3,Acute Tox. 3;Acute Tox. 3,Notified C&L,157,H311:157;H301:157
79513,"(8α,9R)-10,11-dihydrocinchonan-9-ol",207-620-2,485-64-3,Acute Tox. 4;Skin Sens. 1A,Notified C&L,1,H302:1;H317:1
79516,N-tert-butyl-2-methylacrylamide,229-482-2,6554-73-0,Acute Tox. 4,Notified C&L,1,H302:1
79519,3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid,222-425-2,3468-01-7,,Notified C&L,8,H319:7;H335:6;H315:6;H302:2
79524,2-aminobenzothiazole-6-sulphonic acid,244-676-7,21951-32-6,,Notified C&L,1,H302:1
79531,Methyl 4-[4-(4-methoxybenzoylamino)-3-nitrophenyl]-3-methyl-4-oxo-butyrate,426-290-2,,Aquatic Chronic 4,Notified C&L,2,H413:1;Not classified:1
79533,nickel barium titanium primrose priderite;C.I. Pigment Yellow 157;C.I. 77900,271-853-6,68610-24-2,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H372:0;H317:0;H350:0
79541,Heptamethylenediamine,211-468-2,646-19-5,Skin Corr. 1B,Notified C&L,44,H314:44;H318:2;H335:1;H312:1;H302:1
79547,2-phenylisobutyric acid,212-556-3,826-55-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,19,H319:18;H315:18;Not classified:1;H335:1
79552,"Fatty acids, C12-18 and C18-22-unsatd., monoesters with sorbitan",296-265-7,92456-86-5,Not Classified,Notified C&L,1,Not classified:1
79555,SOLVENT ORANGE 11,612-349-1,61725-76-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,188,H410:179;H317:179;H400:188;H413:9
79557,Allyl Methyl Carbonate,468-750-5,35466-83-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H226:2;H315:2;H335:1
79558,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(2-methyl-4-sulphophenyl)azo]naphthalene-2-sulphonic] acid",251-348-7,33025-12-6,Not Classified,Notified C&L,9,Not classified:9
79560,"Amines, N-tallow alkyldipropylenetri-",263-191-1,61791-57-9,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H302:9;H400:9;H410:8;H314:9;H373:1;H318:1
79564,"6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo[3,4-b]pyrazin-5-one",256-139-4,43200-81-3,Eye Irrit. 2,REACH registration C&L,9,H319:6;H302:3;H332:1;H312:1
79565,Dihexylamine,205-588-4,143-16-8,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1,Notified C&L,127,H300:87;H318:84;H310:88;H330:83;H400:121;H314:126;H302:39;H311:38;Not classified:1
79567,1-[2-chloro-4-(4-chlorophenoxy)phenyl]ethanone,601-639-3,119851-28-4,Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,192,H410:190;H317:34;H400:189;H319:2;H335:1;H315:2
79570,"2-(2,4-diaminophenoxy)ethanol dihydrochloride",266-357-1,66422-95-5,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,145,H302:144;H318:8;H411:85;H317:140;H319:94;H335:8;H332:3;H315:4
79571,(2-aminoethyl)({2-[[](2-aminoethyl)amino]ethyl})amine hydrate,608-500-6,305808-21-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,38,H412:38;H312:38;H317:38;H314:38
79576,2-[1-(2-hydroxy-5-sulphophenyl)-3-phenyl-5-formazano]benzoic acid,205-197-9,135-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
79577,"Sodium 2,4-diamino-5-(2-hydroxy-5-nitrophenylazo)benzenesulphonate",222-810-5,3618-62-0,Skin Sens. 1;Eye Dam. 1;Muta. 2,REACH registration C&L,19,H318:4;H341:4;H317:4;Not classified:15
79578,p-menth-8-en-2-ol,210-575-1,619-01-2,Skin Irrit. 2,Notified C&L,217,H315:129;Not classified:88;H319:2;H335:2
79580,(1-naphthylmethyl)triphenylphosphonium chloride,245-548-3,23277-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
79581,"Terphenyl, hydrogenated",262-967-7,61788-32-7,Aquatic Chronic 2,REACH registration C&L,669,H411:45;H413:603;Not classified:15;H410:6;H400:4
79582,"2-Naphthalenesulfonic acid, 5(or 8)-amino-, coupled with diazotized aniline, diazotized, coupled with diazotized 4-aminobenzenesulfonic acid and m-phenylenediamine",305-478-7,94552-32-6,Not Classified,REACH registration C&L,27,Not classified:23;H410:4;H411:3;H317:4
79584,"2-methyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-butenal",265-454-6,65114-01-4,Not Classified,REACH registration C&L,29,Not classified:29
79585,"Glycerides, coco mono-",263-027-9,61789-05-7,Not Classified,Notified C&L,14,Not classified:14
79590,2-amino-5-nitrothiobenzamide,246-572-7,25026-97-5,,Notified C&L,4,H302:4;H319:4;H335:4;H315:4
79596,4-nitroanilinium chloride,239-997-4,15873-51-5,Acute Tox. 4;Repr. 2;STOT SE 1;STOT RE 1;Aquatic Chronic 3,Notified C&L,1,H372:1;H361:1;H412:1;H302:1;H370:1
79602,N-allylsalicylamide,204-266-0,118-62-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
79605,Thiazolidinane,204-660-2,123-90-0,Skin Corr. 1B,Notified C&L,47,H314:47;H226:2;H335:2;H302:1;H318:1
79608,"Paraffin oils (petroleum), catalytic dewaxed light;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-176-5,64742-71-8,Carc. 1B,Harmonised C&L,0,H350:0
79610,Dichlorofluoroacetic acid,206-547-3,354-19-8,Skin Corr. 1B,Notified C&L,2,H314:2
79612,"2,3,4,5-tetrachlorobenzoylchloride",406-760-3,42221-52-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0;H314:0
79614,"3-(diethylamino)propane-1,2-diol",210-693-3,621-56-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67,H319:61;H335:39;H315:61;H314:6;H318:1
79617,"7 alpha-Bromo-5,6 beta-epoxy-15 beta,16 beta-methylene-3 beta-pivaloyloxy-5 beta-androstan-17-one",617-834-1,863329-69-5,Aquatic Chronic 4,REACH registration C&L,2,H413:2
79618,"Maleic acid, potassium salt",233-569-0,10237-70-4,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,Notified C&L,17,H317:14;H318:14;H315:17;H319:3;H335:3
79619,"6-oxa-3-thiabicyclo[3.1.0]hexane 3,3-dioxide",224-827-3,4509-11-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:39;H312:39;H302:39;H332:39;H315:39
79620,"Naphthalene-2,3-dicarboxylic acid",218-517-7,2169-87-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
79621,1-[17beta-(acetyloxy)-3alpha-hydroxy-2beta-(4-morpholinyl)-5alpha-androstan-16beta-yl]-1-(2propenyl)pyrrolidinium bromide,601-597-6,119302-91-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 3,Notified C&L,24,H302:18;H312:18;H331:17;Not classified:3;H330:2;H300:1;H310:1;H301:1;H319:1;H372:1
79622,"Cashew, ext.",289-654-8,89958-30-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
79623,C.I. Acid Green 115,616-547-9,77907-15-4,Not Classified,Notified C&L,1,Not classified:1
79625,"N-tricyclo[3.3.1.13,7]dec-1-ylacetamide",212-914-9,880-52-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,44,H302:40;H332:40;H312:40;H319:4;H335:4;H315:4
79627,"Naphthalenesulfonic acid, butyl-, Me derivs., sodium salts",272-716-3,68909-83-1,Eye Irrit. 2,Notified C&L,2,H319:2;H335:1;H315:1
79632,Piperidine-1-acetonitrile,221-131-1,3010-03-5,Acute Tox. 3,Notified C&L,43,H301:39;H319:5;H335:4;H312:4;H302:4;H332:4;H315:5;H311:1;H331:1
79635,1-bromo-2-methoxynaphthalene,222-272-1,3401-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
79636,[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium methyl sulphate,287-462-9,85508-38-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,7,H317:7;H319:7;H315:7
79639,"Benzenemethanamine, 3-bromo-4-fluoro-, hydrochloride (1:1)",606-495-5,202865-68-7,,Notified C&L,5,H319:5;H335:5;H315:5
79649,butanone;ethyl methyl ketone,201-159-0,78-93-3,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H336:0;H225:0
79653,"3,7-dimethyloct-6-enal oxime",245-011-3,22457-25-6,Not Classified,REACH registration C&L,85,Not classified:2;H319:83;H411:83
79659,Dehydroabietylamine acetate,217-973-4,2026-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H319:39;H335:39;H315:39;H400:38
79660,"2-Imidazolidinone, 4,5-dihydroxy-, methylated",291-481-8,90412-01-4,Not Classified,Notified C&L,1,Not classified:1
79661,CERIUM AND IRON OXIDE ISOSTEARATE.,442-240-2,,Not Classified,Notified C&L,1,Not classified:1
79663,"β,ε-carotene-3,3'-diol",204-840-0,127-40-2,Not Classified,Notified C&L,136,Not classified:129;H413:6;H319:1;H315:1
79664,"9,10-Anthracenedione, 1,4-bis(pentylamino)-, branched and linear",294-181-5,91696-26-3,Not Classified,Notified C&L,32,Not classified:32
79668,"Tris(dipentyldithiocarbamato-S,S')antimony",240-028-2,15890-25-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1035,H302:461;H332:460;H411:462;Not classified:447;H413:126;H312:1
79672,benzyl-2-hydroxydodecyldimethylammonium benzoate,402-610-6,113694-52-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H410:0;H314:0
79673,"pyrogallol;1,2,3-trihydroxybenzene",201-762-9,87-66-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;Aquatic Chronic 3,Harmonised C&L,0,H341:0;H312:0;H412:0;H302:0;H332:0
79674,"Reaction Product of Fatty acids, soya, 2-(2-aminoethoxyethanol) and boric acid",925-592-6,,Not Classified,Notified C&L,6,Not classified:6
79675,"3,5-dimethylpyridin-2-amine",255-613-8,41995-30-6,Acute Tox. 4,Notified C&L,38,H302:38
79678,"Plumeria alba, ext.",305-220-3,94350-02-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,5,H411:4;H317:5;H319:1;H412:1;H371:1
79679,Tryptic Enzymatic Digest Hydrolysate of Casein (Bovine),927-711-7,,Not Classified,Notified C&L,1,Not classified:1
79691,N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]stearamide monoacetate,267-947-1,67953-23-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,15,H318:8;H315:8;Not classified:7
79696,"Gold, chloro isooctyl mercaptoacetate complexes",307-272-2,97592-75-1,Not Classified,Notified C&L,36,Not classified:36
79697,Methyl octanoate,203-835-0,111-11-5,Not Classified,REACH registration C&L,1805,Not classified:190;H317:1602;H315:12;H319:6;H411:1
79699,2-methoxyethyl 2-[(3-nitrophenyl)methylene]acetoacetate,254-511-0,39562-22-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:2;H317:2;H400:2;H319:1;H330:1
79702,"Glyoxal, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol",500-177-9,67939-70-2,Not Classified,Notified C&L,17,Not classified:17
79703,"Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]",269-439-5,68239-26-9,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H300:0;H412:0;H330:0
79705,"2,5-dichlorophenylhydrazine",206-163-6,305-15-7,Acute Tox. 3;Eye Irrit. 2,Notified C&L,43,H319:43;H301:38;H302:5;H335:4;H315:5
79707,SCH 530348-HB,478-680-7,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
79708,(Z)-hex-3-enal,229-854-4,6789-80-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1590,H302:1590;H226:1552;H319:38
79711,Feldspar-group minerals,270-666-7,68476-25-5,Eye Irrit. 2;STOT SE 3,Notified C&L,633,H319:463;H335:463;Not classified:103;H373:38;H372:29
79713,"Heptane, branched and linear",295-413-8,92045-32-4,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H225:16;H336:16;H304:16;H400:16;H410:16;H315:16
79715,Magnesium octadecylbenzenesulphonate,250-528-2,31242-17-8,Not Classified,Notified C&L,1,Not classified:1
79716,"1,2-Dibromo-3,5-difluorobenzene",604-114-7,139215-43-3,Acute Tox. 3,Notified C&L,43,H301:38;H319:5;H335:4;H315:5
79719,"Gases (petroleum), hydrogen-rich;Refinery gas;[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]",270-780-7,68477-97-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
79723,Chitosan,618-480-0,9012-76-4,Not Classified,Notified C&L,59,Not classified:54;H319:5;H335:5;H315:5
79724,2-methyl-1-naphthol,231-265-2,7469-77-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,76,H318:40;H335:40;H315:40;Not classified:36;H317:1;H411:1;H302:1
79725,Isoconazole,248-508-3,27523-40-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34,H410:34;H400:34
79727,Imibenconazole,617-888-6,86598-92-7,Skin Sens. 1;Repr. 2;STOT SE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H317:1;H261:1;H361:1;H371:1;H400:1;H410:1
79730,Phenoxathiin,205-975-8,262-20-4,,Notified C&L,4,H319:4;H335:4;H315:4
79732,"Ammonium [R-(R*,R*)]-tartrate",238-245-2,14307-43-8,Not Classified,Notified C&L,1,Not classified:1
79734,Boron nitride,233-136-6,10043-11-5,Not Classified,Notified C&L,481,Not classified:424;H319:55;H413:37;H335:51;H220:4;H336:4;H315:2;H360:1
79736,Tetraethylammonium periodate,226-824-2,5492-69-3,Flam. Sol. 1,Notified C&L,38,H228:38
79740,"Hexasodium 2,2'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-morpholino-1,3,5-triazine-4,2-diyl]imino]]bis(benzene-1,4-disulphonate)",257-827-7,52301-70-9,Not Classified,REACH registration C&L,146,Not classified:59;H319:87
79743,N-(5-nitro-2-thiazolyl)benzamide,264-868-4,64398-84-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
79744,Galantamine hydrobromide,217-780-5,1953-04-4,Acute Tox. 3,Notified C&L,212,H301:210;H319:7;H373:7;H317:10;H331:11;H400:8;H410:8;H315:9;H311:1;Not classified:1;H300:1
79750,"Iron, 4-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]-3-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonate sodium complexes",308-009-4,97808-87-2,Not Classified,Notified C&L,20,Not classified:18;H412:2
79751,"13-ethyl-17α-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one butyrate",289-270-0,86679-33-6,Carc. 2;Repr. 1B;Lact.;Aquatic Chronic 2,Notified C&L,1,H351:1;H360:1;H411:1;H362:1
79759,"Phenol, 4-ethenyl-, acetate, polymer with 1-(1,1-dimethylethyl)-4-ethenylbenzene, tert-Bu 2,2-dimethylpropaneperoxoate-initiated, hydrolyzed, 1-(2-cyclohexylethoxy) ethyl ether",454-080-0,,Aquatic Chronic 4,Notified C&L,1,H413:1
79761,Bupivacaine hydrochloride,241-917-8,18010-40-7,Acute Tox. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,94,H300:93;H319:88;H412:87;H335:3;H311:5;H315:4;H331:1;H301:1;H370:1;H310:2;H330:3
79762,CAMPHOR OIL,616-922-7,8008-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,181,H319:85;H335:47;H315:180;H226:70;H317:95;H410:94;H304:31;H400:58
79766,Phenethyl formate,203-220-7,104-62-1,Not Classified,Notified C&L,1599,Not classified:1561;H317:38
79767,"Carbamic chloride, 1,6-hexanediylbis[methyl-",619-403-3,99191-71-6,Skin Corr. 1B,Notified C&L,83,H314:83
79770,"Tantalum oxide (Ta2O5), hydrate",602-932-9,12337-18-7,Not Classified,Notified C&L,1,Not classified:1
79772,cadmium sulphate,233-331-6,10124-36-4,Acute Tox. 3;Acute Tox. 2;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H372:0;H330:0;H360:0;H400:0;H301:0;H410:0;H340:0;H350:0
79774,Dipotassium hydrogen citrate,222-775-6,3609-96-9,Eye Irrit. 2,REACH registration C&L,61,H319:57;H335:55;H315:55;Not classified:4
79775,"4,4'-bis(dimethylamino)thiobenzophenone",214-962-6,1226-46-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H319:42;H315:42;H335:1
79779,"6-chloro-1,2-dihydro-2,2,4-trimethylquinoline",229-937-5,6848-16-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H335:38;H317:38;H400:38;H302:38;H410:38;H315:38
79784,"Disodium 2(or 5)-butyl-5(or 2)-[[4-[(4-butylsulphonatophenyl)amino]-9,10-dihydro-5,8-dihydroxy-9,10-dioxo-1-anthryl]amino]benzenesulphonate",276-184-3,71927-89-4,,Notified C&L,19,H319:8;Not classified:6;H412:5
79785,dipentene;limonene,205-341-0,138-86-3,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H226:0;H410:0;H315:0
79793,Vinyl octanoate,212-452-8,818-44-0,,Notified C&L,1,H319:1;H335:1;H315:1
79794,"Hexanedioic acid, 2-amino-, (2S)-",601-134-8,1118-90-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79795,ethyl (Z)-2-amino-α-(hydroxyimino)thiazol-4-acetate,264-910-1,64485-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:38;H315:39;H412:1;H317:1
79799,"3,4-diethoxybenzaldehyde",217-979-7,2029-94-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79802,"Oils, fish, sulfated, compds. with ethanolamine",307-666-4,97675-92-8,Not Classified,Notified C&L,2,Not classified:1;H315:1
79803,C.I. Solvent Yellow 88,612-762-7,61931-55-3,Not Classified,Notified C&L,5,Not classified:5
79807,"Coconut oil, Me ester, glycerol-free",309-428-5,100298-75-7,Not Classified,Notified C&L,1,Not classified:1
79810,Titanium Niobium Aluminium Carbide,925-641-1,,Not Classified,Notified C&L,1,Not classified:1
79812,"5,7-dimethyl-1,8-naphthyridin-2-ylamine",254-516-8,39565-07-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H335:2;H312:1;H302:2;H332:1;H315:2
79816,4-phenylbutyric acid,217-341-8,1821-12-1,Eye Irrit. 2,REACH registration C&L,11,H319:11;H335:8;H315:9
79817,"10,11-dihydro-N,N,β-trimethyl-5H-dibenz[b,f]azepine-5-propylamine monomethanesulphonate",246-852-9,25332-13-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,10,H319:9;H335:9;H361:9;H302:10;H315:9;H411:1;H317:1
79818,"5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile",421-240-6,120068-79-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
79826,"Sodium 3,5,6-trichloropyridin-2-olate",253-506-0,37439-34-2,Acute Tox. 4,REACH registration C&L,57,H302:56;H319:1;H335:1;H315:1
79834,"4,4'-bis(2,3-epoxypropoxy)biphenyl",219-556-2,2461-46-3,Skin Irrit. 2;Skin Sens. 1;Muta. 2,Notified C&L,3,H317:3;H341:3;H315:2;H319:1
79837,"Sodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]cobaltate(1-)",277-510-7,73507-67-2,Not Classified,Notified C&L,2,Not classified:2
79839,"1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-2-oxo-N-(2-phenylethyl)-",607-424-0,247098-18-6,Not Classified,Notified C&L,1,Not classified:1
79840,"reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers",423-600-8,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
79844,"Fatty acids, C14-18 and C16-18-unsatd., isodecyl esters",305-754-7,95009-27-1,Not Classified,Notified C&L,1,Not classified:1
79853,2-ethoxyethyl acetate;ethylglycol acetate,203-839-2,111-15-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H312:0;H360:0;H332:0;H302:0;H226:0
79854,Propylcyclohexane,216-836-6,1678-92-8,Flam. Liq. 3,Notified C&L,39,H226:39;H304:1
79855,"1,8-diaminobromo-4,5-dihydroxyanthraquinone",248-624-4,27733-08-0,Not Classified,Notified C&L,9,Not classified:9
79856,"Oxydiethane-1,2-diyl distearate",203-663-6,109-30-8,Not Classified,Notified C&L,13,Not classified:13
79857,3-hydroxypropionaldehyde,218-365-1,2134-29-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
79860,"2-(1,3-Benzodioxol-5-yl)-4,6-bis(trichloromethyl)-1,3,5-triazine",615-269-5,71255-78-2,Skin Sens. 1,Notified C&L,3,H317:2;H319:1;H341:1;H315:1
79862,"2H-1,5-Benzodioxepin-3(4H)-one, 7-(1,1-dimethylethyl)-",606-333-3,195251-91-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,74,H302:37;H312:37;H317:37;Not classified:37
79863,"Dimer fatty acids, C18-unsatd., reaction productswith diethylenetriamine and maleic anhydride",614-014-5,670241-71-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
79865,"2,5-FURANDIONE, DIHYDRO-, POLYBUTENYL DERIVS., REACTION PRODUCTS WITH TETRAETHYLENEPENTAMINE",614-621-5,68583-75-5,Aquatic Chronic 4,Notified C&L,6,H413:6
79868,"α,3,3-trimethylcyclohexylmethyl formate",246-735-2,25225-08-5,Aquatic Chronic 2,Notified C&L,1633,H411:1381;Not classified:252
79870,"2-Imidazolidinone, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-, reaction products with diethylene glycol",600-368-8,102923-00-2,Not Classified,Notified C&L,85,Not classified:84;H318:1;H315:1
79876,4-methoxy-N-phenyl-o-toluidine,255-310-0,41317-15-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H319:3;H412:2;H315:3
79877,Indium iodide,237-746-3,13966-94-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,48,H319:40;H335:40;H334:42;H302:42;H315:40;H314:5;H361:3;H317:3
79878,2-chloro-4'-phenylbenzophenone,252-160-8,34701-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
79879,"Octadecanoic acid, ester with 1,2,3-propanetriol 2-hydroxypropanoate",215-659-1,1338-10-9,Not Classified,Notified C&L,6,Not classified:6
79880,"Undec-10-enoic acid, compound with 2-aminoethanol (1:1)",260-247-7,56532-40-2,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1
79884,7-ethyl-2-methylundecan-4-ol,203-088-0,103-20-8,Aquatic Chronic 4,Notified C&L,38,H413:38
79886,1-vinylimidazole,214-012-0,1072-63-5,Repr. 1B,Harmonised C&L,0,H360:0
79893,o-Anisidine Hydrochloride,603-807-1,134-29-2,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Muta. 2;Carc. 2;STOT SE 2;STOT RE 2,Notified C&L,1,H319:1;H373:1;H341:1;H311:1;H331:1;H371:1;H301:1;H351:1
79896,"2-(chloromethyl)-1,3-difluorobenzene",615-010-6,697-73-4,Skin Corr. 1B,REACH registration C&L,48,H314:48;H302:1;H290:1;H318:1;H319:1;H335:1
79898,2-pyridylmethanol,209-592-7,586-98-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,55,H302:48;H319:54;H335:46;H315:55;H312:1;H332:1
79899,"Dihydro-3-tetradecylfuran-2,5-dione",256-300-9,47165-57-1,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H319:39;H413:38;H315:1
79903,2-aminoethyl(ethyl)amine,203-795-4,110-72-5,Flam. Liq. 2;Skin Corr. 1B;Resp. Sens. 1,Notified C&L,77,H314:44;H225:39;H334:38;Not classified:33;H226:6;H318:2
79905,"Fatty acids, tallow, Me esters, epoxidized",293-146-1,91051-90-0,Not Classified,Notified C&L,22,Not classified:22
79907,5-methyloctan-2-one,261-382-4,58654-67-4,Flam. Liq. 3,Notified C&L,1,H226:1
79908,"3-methyl-1,2,4-trithiane",256-056-3,43040-01-3,Acute Tox. 4,Notified C&L,37,H302:37
79909,"(S)Ammonium-(2E,4E)-11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate",926-381-1,,Not Classified,REACH registration C&L,2,Not classified:2
79912,"2,5-diaminoanisole",226-161-9,5307-02-8,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H317:1;H312:1;H334:1;H302:1;H332:1
79913,Erbium tribromide,236-895-1,13536-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
79915,"A mixture of: (9-cis,12-cis)-2-hydroxy-3-(octadeca-9,12-dienoylamino)propyl hexadecanoate; (9-cis)-2-hydroxy-3-(octadeca-9-enoylamino)propylhexadecanoate ethyl hexadecanoate;",453-200-9,,Not Classified,Notified C&L,1,Not classified:1
79919,Dichlorobis(propan-2-olato)titanium,212-106-6,762-99-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
79920,Iron disulphide,235-106-8,12068-85-8,Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,67,H410:38;H317:38;H400:38;H334:38;Not classified:28;H319:1;H335:1;H315:1
79921,Methyl nitroacetate,219-622-0,2483-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:39;H315:46
79925,"2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]anilino]ethyl benzoate",253-586-7,37672-70-1,Not Classified,Notified C&L,1,Not classified:1
79927,6-methylheptan-3-one,210-844-3,624-42-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H226:1;H335:1;H315:1
79929,"Acetic acid, chloro-, sodium salt, reaction products with 4,5-dihydro-1H-imidazole-1-ethanol 2-norcoco alkyl derivs. and sodium hydroxide",271-793-0,68608-65-1,Eye Irrit. 2,Notified C&L,505,H319:499;H315:17;H318:6
79934,"Formaldehyde, oligomeric reaction products with 4-heptylphenol, calcium salts",500-622-7,161278-31-5,Not Classified,Notified C&L,441,Not classified:441
79936,"Oxybispropanediol, ethoxylated, esters with stearic acid",500-254-7,72828-11-6,Not Classified,Notified C&L,33,Not classified:33
79937,"5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride",410-490-1,138451-65-7,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H317:0;H318:0;H411:0;H302:0
79938,"N,N-dichlorotoluene-4-sulphonamide",207-462-4,473-34-7,Ox. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H335:49;H271:50;H315:50
79939,"2,4,5-Trifluorobenzonitrile",619-339-6,98349-22-5,,Notified C&L,8,H319:8;H335:5;H312:5;H302:5;H332:5;H315:8;H311:2;H330:1;H301:3;H331:1
79944,"N-ethyl-2,4-dinitroaniline",223-345-0,3846-50-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
79946,"trans-2-methyl-4-propyl-1,3-oxathiane",261-700-1,59324-17-3,Flam. Liq. 3,Notified C&L,137,H226:92;H319:25;H412:43;Not classified:2
79948,Butyl diphenyl phosphate,220-398-1,2752-95-6,,Notified C&L,40,Not classified:40
79951,Palladium dinitrate,233-265-8,10102-05-3,Ox. Sol. 1;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,153,H271:98;H318:102;H400:101;H302:103;H410:104;H290:102;H314:149;H272:49;H301:3;H319:2;H335:2;H315:2;Not classified:1
79954,Benzyl salicylate,204-262-9,118-58-1,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2138,H319:1680;H412:1456;H317:1960;H411:425;H335:167;H315:169;H371:83;Not classified:10;H400:3;H302:1;H330:1;H314:1;H410:1
79955,"1,2-dicyclohexylethane",222-032-6,3321-50-4,Acute Tox. 4,Notified C&L,38,H302:38
79960,(S)-α-amino-3-hydroxy-4-oxo-1(4H)-pyridylpropionic acid,207-905-1,500-44-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
79962,Methyl dichlorophosphate,211-639-1,677-24-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
79964,"Disodium 5-(acetylamino)-3-[(dimethylphenyl)azo]-4-hydroxynaphthalene-2,7-disulphonate",235-329-0,12167-45-2,,Notified C&L,1,H315:1
79965,N-(tert-butoxycarbonyl)-L-histidine,241-768-9,17791-52-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
79966,"α-(3,4-dimethoxyphenyl)-6,7-dimethoxyisoquinoline-1-methanol",207-585-3,482-76-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
79971,"4,4'-[(isopropylidene)bis(p-phenyleneoxy)]diphthalic dianhydride",253-781-7,38103-06-9,Not Classified,REACH registration C&L,42,Not classified:41;H319:1;H315:1
79972,"Butanedioic acid, polyisobutenyl derivs., reaction products with tetraethylenepentamine, zinc salts",617-678-4,85137-07-1,Not Classified,Notified C&L,6,Not classified:6
79974,2-phenylpiperidine,222-422-6,3466-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:40;H315:42;H302:1
79978,"Oleic acid, compound with N-octadec-9-enylpropane-1,3-diamine (2:1)",303-459-8,94199-84-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,26,H302:26;H312:25;H314:26;H411:25;H400:1
79981,"trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate",423-970-0,182926-43-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
79985,"1,1,1-trimethyl-N,N-bis(trimethylsilyl)silylamine",216-445-0,1586-73-8,Skin Corr. 1B,Notified C&L,42,H314:42
79989,Methyl α-methylpiperidine-1-propionate hydrochloride,246-573-2,25027-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
79994,Titanium tungsten carbide,254-435-8,39377-63-4,Not Classified,REACH registration C&L,3,Not classified:3
79998,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with ethylenediamine",500-253-1,72480-18-3,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,156,H318:4;H317:5;H400:4;H302:5;H410:4;H314:5;Not classified:151;H312:1;H334:1;H226:1
80001,"1,1´-(methylenedi-p-phenylene)bis-,Polymer with 4,4´-methylenebis(benzenamine)",607-872-7,26140-67-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
80003,"α,β,2,2,3-pentamethylcyclopent-3-ene-1-butanol",265-453-0,65113-99-7,Aquatic Chronic 2,Notified C&L,1772,H411:1687;H319:237;H410:85;H400:45;H332:25;H373:1
80004,"3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide",619-682-1,224049-04-1,Skin Sens. 1B,Notified C&L,129,H317:90;H302:39;H319:39;H334:39
80008,"4-trans-Propoxy-4-trans-propyl-[1,1-bicyclohexyl]",619-337-5,98321-58-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
80011,Isopentylbenzene,218-075-5,2049-94-7,Not Classified,Notified C&L,26,Not classified:25;H319:1;H227:1;H335:1;H315:1
80012,"2,3,6-trimethylphenol",219-330-3,2416-94-6,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,275,H317:74;H318:223;H315:186;H314:89;H335:29
80014,"Benzoic acid, compound with 2-aminoethanol (1:1)",224-387-2,4337-66-0,Not Classified,Notified C&L,149,Not classified:148;H318:1
80019,"1H-Pyrrole-2,5-dione, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-",603-702-0,133052-90-1,Acute Tox. 4,Notified C&L,38,H302:38
80023,Perfluoropentane-1-sulphonic acid,220-301-2,2706-91-4,Acute Tox. 4;Skin Corr. 1;STOT SE 3,Notified C&L,1,H302:1;H335:1;H314:1
80028,"[1,2,3,4,8,9,10,11,15,16,17,18,22,23,24,25-hexadecachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",238-897-8,14832-14-5,Not Classified,Notified C&L,4,Not classified:4
80032,"6-(1-methylcyclohexyl)-2,4-xylenol",201-042-4,77-61-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,13,H317:13;H319:13;H411:13;H315:13
80036,Methyl 3-(p-methoxyphenyl)-3-oxopropionate,244-732-0,22027-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
80039,"Fatty acids, tallow, reaction products with diethylenetriamine, di-Me sulfate-quaternized",293-147-7,91051-91-1,Not Classified,Notified C&L,1,Not classified:1
80041,"Fatty acids, C16-22 and C16-22-unsatd., Me esters, sulfonated, sodium salts",307-020-1,97488-82-9,Not Classified,Notified C&L,2,Not classified:2
80043,diethyl ether,200-467-2,60-29-7,Flam. Liq. 1;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H302:0;H224:0;H336:0
80045,"1,2,2-trichloro-1,1-difluoroethane",206-548-9,354-21-2,Flam. Liq. 3;Ozone 1,Notified C&L,2,H226:2;H420:2
80046,"Isooctadecanoic acid, monoester with glycerol",266-124-4,66085-00-5,Not Classified,REACH registration C&L,164,Not classified:164
80051,Choline hydrogen tartrate,201-763-4,87-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:45;H335:45;H315:45;Not classified:4
80056,"β-D-Glucopyranose, 4,6-O-ethylidene-1-O-(trimethylsilyl)-, bis(dichloroacetate)",604-683-1,149312-24-3,Not Classified,REACH registration C&L,2,Not classified:2
80058,"Gelatins, hydrolyzates",270-082-2,68410-45-7,Not Classified,Notified C&L,29,Not classified:29
80062,"3,4-dimethylbenzoic acid",210-576-7,619-04-5,,Notified C&L,8,H319:7;H335:6;H315:7;H302:1;Not classified:1
80063,2-Methyl-indan-1-one,605-746-6,17496-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H312:1;H302:1;H332:1;H303:1
80066,2-(4-Isobutylphenyl) propionic acid lysinate,611-545-4,57469-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H302:135;H319:83;H335:83;H315:83;H361:52
80067,N-[5-[bis(2-methoxyethyl)amino]-2-[(2-cyano-4-nitrophenyl)azo]phenyl]acetamide,257-999-3,52549-57-2,Not Classified,Notified C&L,10,Not classified:10
80068,N-[4-bromo-2-(2-fluorobenzoyl)phenyl]-2-chloroacetamide,287-461-3,85508-36-7,Aquatic Chronic 4,Notified C&L,1,H413:1
80069,"5'-chloro-3-hydroxy-2',4'-dimethoxy-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]azo]naphthalene-2-carboxanilide",243-886-6,20568-80-3,Not Classified,Notified C&L,1,Not classified:1
80070,3-amino-N-ethylpiperidine,229-857-0,6789-94-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H312:1;H302:1;H332:1
80081,Nitrosyl hydroxide,231-963-7,7782-77-6,Skin Corr. 1A;Eye Dam. 1,Notified C&L,2,H318:2;H314:2;H300:1;H400:1
80083,"[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15, 16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate hydrate",611-316-9,55812-90-3,Repr. 2;Lact.;STOT RE 2,Notified C&L,1,H373:1;H361:1;H362:1
80084,"1,3-dimethylcyclohexane",209-707-0,591-21-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:46;H335:46;H315:46;H225:47;H411:8;H304:5;H224:4;H336:4
80089,5-nitrobenzotriazole,219-047-5,2338-12-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1
80097,"Nonanoic acid, compound with 2,2'-iminodiethanol (1:1)",241-593-8,17618-32-5,Aquatic Chronic 3,Notified C&L,442,H412:442
80098,4-methylpentan-1-ol,210-969-3,626-89-1,Flam. Liq. 3,Notified C&L,49,H226:49;H302:11;H311:10;H331:10
80101,sec-butyl 2-(2-hydroxyethyl)piperidine-1- carboxylate/Icaridine (Icaridine),423-210-8,119515-38-7,Eye Irrit. 2,Notified C&L,1,H319:1
80104,"[2-Chloro-1,2,2-trifluoro-1-(trifluoromethyl)ethoxy] difluoroacetyl fluoride",917-631-0,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3,Notified C&L,1,H318:1;H311:1;H331:1;H301:1;H314:1
80108,"9-Octadecenoic acid (Z)-, zinc salt, basic",291-759-9,90480-27-6,Not Classified,REACH registration C&L,444,Not classified:444
80110,"reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine",401-940-8,,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H319:0;H411:0
80113,"Fatty acids, olive-oil, potassium salts",268-921-2,68154-77-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:7;H315:7;Not classified:1
80114,"1,2,3,6-tetrahydro-3-methylphthalic anhydride",226-247-6,5333-84-6,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0
80115,4-(4-hydroxyphenyl)but-3-en-2-one,221-607-9,3160-35-8,,Notified C&L,4,H319:4;H335:4;H315:4
80118,"Octanoic acid, compound with dicyclohexylamine (1:1)",239-914-1,15816-71-4,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,7,H302:7;H311:1;H411:1;H317:1;H318:6;H315:6
80119,Iodoform,200-874-5,75-47-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1359,H319:1357;H335:1357;H312:1348;H302:1358;H332:1348;H315:1357;H311:10;H331:10;H411:6;Not classified:1
80122,"Ethyl 2,4,7-decatrienoate",422-590-2,78417-28-4,Skin Sens. 1B,Notified C&L,24,H317:24
80124,"Oxygenase, lip-",232-853-1,9029-60-1,Not Classified,Notified C&L,3,Not classified:2;H334:1
80126,"Proteins, soy, phthalated",615-737-9,72245-15-9,Not Classified,Notified C&L,7,Not classified:7
80128,Ionone,232-396-8,8013-90-9,Aquatic Chronic 2,Notified C&L,1642,H411:1641;H319:7;H315:1
80130,"(1S, 5R) – (-)- 2-oxabicyclo(3.3.0.) oct-6-en-3-one",610-106-4,43119-28-4,Not Classified,REACH registration C&L,2,Not classified:2
80139,"Potassium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptane-1-sulphonate",262-135-3,60270-55-5,Acute Tox. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H319:69;H335:69;H301:69
80142,Indoramin,248-041-5,26844-12-2,Acute Tox. 4,Notified C&L,2,H302:2
80145,Stearoyl chloride,204-004-5,112-76-5,Met. Corr. 1;Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,156,H317:95;H290:85;H315:95;H314:61;H261:4;H335:1;H318:1;H302:1
80149,1-methoxy-3-(3-methoxypropoxy)propane,601-045-4,111109-77-4,Eye Irrit. 2,Notified C&L,1040,H319:707;Not classified:333;H335:55;H315:79
80151,Diammonium maleate,245-835-3,23705-99-9,Not Classified,Notified C&L,7,Not classified:7
80154,nitrosodipropylamine,210-698-0,621-64-7,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H350:0
80155,"Amidation product of dimer fatty acids, tall oil and triethylene tetramine",922-085-1,,Not Classified,Notified C&L,71,Not classified:71
80171,"2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-, (5Z)-",603-959-9,136401-69-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H312:2;H302:1
80173,"2-methylcyclohexane-1,3-dione",214-773-9,1193-55-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
80174,"Octanoic acid, ester with 1,2,3-propanetriol",234-398-4,11140-04-8,Not Classified,REACH registration C&L,11,Not classified:11
80175,Trimethadione,204-845-8,127-48-0,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,44,H332:39;H360:44;H312:39;H336:1
80178,Benzyltripropylammonium chloride,625-674-9,5197-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
80180,Diyttrium trisulphide,234-887-2,12039-19-9,,Notified C&L,4,H319:4;H335:4;H315:4;H261:4
80181,"3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)dipropanol",241-916-2,18001-97-3,Not Classified,Notified C&L,5,Not classified:5
80183,"4-[(2,6-dichlorophenyl)(4-imino-3,5-dimethylcyclohexa-2,5-dien-1-ylidene)methyl]-2,6-xylidine phosphate (1:1)",277-929-5,74578-10-2,Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55,H410:54;H373:55;H318:55;H400:54
80185,"2-[2-[4-[(2-cyanoethyl)ethylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",258-948-8,54060-94-5,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
80186,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12-pentacosafluoro-14-iodotetradecane",250-014-8,30046-31-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
80188,o-mercaptophenol,214-326-8,1121-24-0,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H318:40;H314:46;H301:47;H311:2;H331:1;H319:1;H330:1;H315:1
80191,Pyridinium bromide,242-600-7,18820-82-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,52,H319:49;H335:46;H315:50;H312:40;H302:46;H332:40
80194,"2,2'-[[5-acetamido-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]imino]diethyl diacetate",222-813-1,3618-72-2,Not Classified,REACH registration C&L,81,Not classified:41;H412:39;H413:1
80195,"2,3-dihydro-6-methyl-2-thioxo-(1H,8H)-pteridine-4,7-dione",302-099-9,94088-97-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
80197,"Dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)",277-749-7,74181-84-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,89,H302:4;H319:2;H315:2;Not classified:85
80200,Ethyl 4-methyl-2-oxocyclohexanecarboxylate,236-910-1,13537-82-1,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1
80205,"Tetrabutylammonium, salt with chromic acid (2:1)",260-315-6,56660-19-6,Ox. Sol. 2;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H317:38;H272:39;H400:38;H410:38;H350:39;H319:1;H311:1;H331:1;H301:1;H315:1
80213,"Alcohols, C10-16, ethoxylated, sulfates, ammonium salts",500-172-1,67762-19-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,416,H319:338;H315:382;H318:77;H412:65;Not classified:34;H302:1
80220,"(3,3-dimethoxypropen-1-yl)benzene",224-454-6,4364-06-1,Not Classified,Notified C&L,234,Not classified:234
80222,"diflufenican (ISO);N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide",617-446-2,83164-33-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
80225,"5H-1,3-dioxolo[4,5-f]indole",205-976-3,267-48-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
80226,"7-(2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyloxy)-2,3-dihydro-4',5,7-trihydroxyflavone",233-566-4,10236-47-2,Not Classified,REACH registration C&L,185,Not classified:141;H319:44;H335:44;H315:44
80227,"4,4'-bis[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo][1,1'-biphenyl]-2,2'-disulphonic acid",253-622-1,37678-92-5,Not Classified,Notified C&L,1,Not classified:1
80228,"Potassium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate",249-616-3,29420-49-3,Eye Dam. 1,REACH registration C&L,112,H318:46;H319:63;H335:62;H315:64;Not classified:3
80231,"Amidase, aryl acyl-",232-787-3,9025-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H334:1
80232,17β-hydroxy-1α-methylandrost-4-ene-3-one,210-063-8,604-26-2,Repr. 2;Aquatic Chronic 2,REACH registration C&L,1,H361:1;H411:1
80235,2-methyl-8-nitroquinoline,212-919-6,881-07-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:38;H318:38;H335:38;H315:39;H341:4;H319:1
80239,"1-Propanaminium, 3-amino-N-(2-hydroxyethyl)-N,N-dimethyl-, N-mink-oil acyl derivs., chlorides",273-222-0,68953-64-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,33,H302:15;H411:15;H318:15;H400:15;H319:18;H410:13
80241,"(+/-) trans-3,3-Dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)pent-4-en-2-ol",600-853-4,107898-54-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,246,H410:221;H315:246;H400:218;H319:35
80243,Titanium disilicide,234-904-3,12039-83-7,,Notified C&L,6,H319:4;H335:4;H315:4;H228:4;Not classified:2
80245,Itaconic acid,202-599-6,97-65-4,Eye Dam. 1,REACH registration C&L,535,H318:357;H335:141;H319:77;H315:79;Not classified:36;H310:3;H410:1;H400:1;H302:1
80251,[2-(ethylphenylamino)ethyl][2-hydroxypropyl]dimethylammonium hydrogen sulphate,280-629-7,83732-78-9,Eye Irrit. 2,Notified C&L,1,H319:1
80254,Dihydrostreptomycin sulphate,226-823-7,5490-27-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1A,Notified C&L,172,H302:96;H332:56;H360:56;H312:56;H372:36;Not classified:34;H317:3;H361:5;H319:2;H335:2;H315:1
80255,"Amines, polyethylenepoly-, reaction products with succinic anhydride polyisobutenyl derivs., borated",603-861-6,134758-95-5,Not Classified,Notified C&L,888,Not classified:491;H319:397
80257,Aluminium sulphate,233-135-0,10043-01-3,Met. Corr. 1;Eye Dam. 1,REACH registration C&L,833,H290:217;H318:737;H302:96;Not classified:50;H319:48;H335:47;H412:25;H315:45;H410:17;H400:17;H411:18;H314:3;H272:1
80258,"Titanium, diethylene glycol propylene glycol triethanolamine complexes",272-250-0,68784-48-5,Not Classified,REACH registration C&L,54,Not classified:1;H319:53;H315:53
80259,"acibenzolar-S-methyl;benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester",420-050-0,135158-54-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H335:0;H317:0;H400:0;H410:0;H315:0
80263,"α,α,α,β,β,β-hexafluoro-m-xylene",206-939-4,402-31-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:94;H226:94;H335:72;H315:94;H411:23;Not classified:5
80266,"Senna, Cassia tora, ext.",297-202-6,93348-59-5,Not Classified,Notified C&L,1,Not classified:1
80269,Coriander oil (Coriandrum sativum L.),616-923-2,8008-52-4,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,191,H317:148;H304:145;H411:147;H315:181;H319:52;Not classified:10;H335:3;H412:1
80270,"1-amino-9,10-dihydro-4-[[4-[[methyl[(4-methylphenyl)sulphonyl]amino]methyl]phenyl]amino]-9,10-dioxoanthracene-2-sulphonic acid",241-918-3,18013-23-5,,Notified C&L,33,Not classified:33
80275,Sodium N-chlorobenzenesulphonamide,204-847-9,127-52-6,Acute Tox. 4;Skin Corr. 1B;Resp. Sens. 1,Notified C&L,42,H302:40;H314:39;H334:40;H319:2;H335:1;H317:1;H400:1;H315:2;H272:1;Not classified:1
80283,Calcium nitrate,233-332-1,10124-37-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,904,H319:605;H315:562;H302:312;H318:201;H272:244;H271:94;Not classified:4;H335:2;H312:1;H332:1;H334:1;H400:1
80287,C.I. Acid Brown 188,601-987-6,12219-57-7,Not Classified,Notified C&L,4,Not classified:4
80294,"Benzenesulfonamide, 4-hydroxy-3-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-N-(3-methoxypropyl)-",601-288-6,113950-51-9,Not Classified,Notified C&L,2037,Not classified:2037
80300,Sodium 4-hydroxymercuriobenzoate,205-340-5,138-85-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H373:38;H310:38;H330:38;H400:38;H410:38
80303,"Formaldehyde, reaction products with cyclohexanone",305-639-1,94891-38-0,Not Classified,Notified C&L,1,Not classified:1
80304,m-(o-toluidino)phenol,228-428-5,6264-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40;H302:2
80307,Onion oil,616-802-4,8002-72-0,Not Classified,Notified C&L,155,Not classified:90;H319:39;H335:39;H302:39;H226:40;H315:64
80311,Butylcyclohexane,216-837-1,1678-93-9,Flam. Liq. 3,Notified C&L,43,H226:43
80315,Methyl pent-3-enoate,212-453-3,818-58-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,39,H302:38;H226:39
80326,"Hexadecanoic acid, ester with 1,2,3-propanetriol 2-hydroxypropanoate",215-658-6,1338-09-6,Not Classified,Notified C&L,2,Not classified:2
80331,Dimethyl adipimidate dihydrochloride,238-660-9,14620-72-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
80338,[(naphthyloxy)methyl]oxirane,219-555-7,2461-42-9,Skin Sens. 1;Muta. 2;Carc. 2,REACH registration C&L,5,H351:4;H341:4;H317:4;H302:2;H319:1;H335:1
80339,"1,2-dimethyl-5-nitro-1H-imidazole monohydrochloride",246-853-4,25332-20-1,,Notified C&L,1,H319:1;H335:1;H315:1
80343,tert-butyl formate,212-105-0,762-75-4,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H225:0
80346,"Naphtha (petroleum), catalytic dewaxed;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-170-2,64742-66-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
80348,Fater Recycled Superabsorbent (FRS),921-143-3,,Eye Irrit. 2,Notified C&L,1,H319:1
80351,"Naphthenic acids, zirconium salts, basic",294-505-5,91723-01-2,Skin Irrit. 2,Notified C&L,1,H315:1
80353,"Tetrasodium 7,16-dichloro-6,15-dihydroanthrazine-5,9,14,18-tetrayl tetrakis(sulphate)",219-744-4,2519-28-0,Not Classified,Notified C&L,1,Not classified:1
80354,"Fatty acids, tall-oil, reaction products with formaldehyde and (Z)-N-9-octadecenyl-1,3-propanediamine",272-789-1,68911-83-1,Skin Sens. 1;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,4,H373:2;H411:4;H317:2;H331:2;H319:2;H332:2
80355,DL-3-(methylthio)butanone,258-576-6,53475-15-3,Flam. Liq. 3,Notified C&L,1413,H226:1413
80356,"13-phenyl-1,4,7,10-tetraoxa-13-azacyclopentadecane",266-470-6,66750-10-5,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1
80365,2-methylbutyl acetat,210-843-8,624-41-9,Flam. Liq. 3,Harmonised C&L,0,H226:0
80366,heptanoic acid,203-838-7,111-14-8,Skin Corr. 1B,Harmonised C&L,0,H314:0
80368,Branched hexatriacontane,417-070-7,151006-62-1,Aquatic Chronic 4,Notified C&L,912,H413:910;H304:2
80374,"4-[2,4-bis(tert-pentyl)phenoxy]-N-(4-chloro-3-nitrophenyl)butyramide",263-918-2,63134-29-2,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
80375,"Acetic acid, chloro-, reaction products with 2-heptyl-4,5-dihydro-1H-imidazole-1-ethanol and sodium hydroxide",271-792-5,68608-64-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,37,H319:33;H315:33;Not classified:4
80383,"Ylang-ylang, Cananga odorata macrophylla, ext.",297-681-1,93686-30-7,Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1390,H319:1383;H317:1386;H341:1287;H304:1361;H411:1359;H351:1287;H361:24;H412:26;H315:25;Not classified:4
80384,"Propane-1,2,3-triyl tris[(Z)-docos-13-enoate]",220-399-7,2752-99-0,Not Classified,Notified C&L,18,Not classified:18
80386,"2,5-diphenyloxazole",202-181-3,92-71-7,Not Classified,REACH registration C&L,48,Not classified:4;H302:44;H319:44;H413:43
80388,5-methylisoxazol-3-ylamine,214-013-6,1072-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:4;H315:5
80391,Natriummetasilicat Pentahydrat,600-279-4,10213-79-3,Met. Corr. 1;Skin Corr. 1B;STOT SE 3,Notified C&L,332,H335:325;H290:149;H314:326;H302:43;H318:41;H315:16;Not classified:6
80393,Iodic acid,231-962-1,7782-68-5,Ox. Liq. 2;Met. Corr. 1;Skin Corr. 1A,REACH registration C&L,50,H290:3;H314:50;H272:50;Not classified:1
80395,"Hexachlorobuta-1,3-diene",201-765-5,87-68-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,28,H317:13;H312:16;H400:21;H302:13;H332:13;H315:22;H319:8;H310:9;H371:4;H330:5;H301:13;H410:8;H361:4;H351:5;Not classified:2;H318:1;H311:1;H350:1;H314:1
80399,Nitrosobenzene,209-591-1,586-96-9,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:43;H312:43;H301:44;H319:1;H311:1;H331:1;H315:1
80403,"Fatty acids, linseed-oil, potassium salts",293-068-8,91051-18-2,Eye Irrit. 2,Notified C&L,13,H319:13
80405,2-Bromo-4-nitrophenol,611-662-0,5847-59-6,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H302:41;H400:39;H319:2;H411:2;H315:2
80407,"1,1-bis(4-hydroxy-2,5-dimethylphenyl)acetone",433-650-2,,Aquatic Chronic 4,Notified C&L,1,H413:1
80408,"N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide",407-970-8,75511-91-0,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
80409,"2-(2-hydroxyethoxy)ethyl 2-hydroxypropyl 3,4,5,6-tetrabromophthalate",243-885-0,20566-35-2,Aquatic Chronic 3,Notified C&L,97,H412:81;Not classified:16
80411,"2,4,5-Trifluorobenzoic Acid",610-198-6,446-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
80412,phenmedipham (ISO);methyl 3-(3-methylcarbaniloyloxy)carbanilate,237-199-0,13684-63-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
80413,Lanthanum tribromide,236-896-7,13536-79-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
80415,(S)-(+)-3-Amino-1-Boc-piperidine,613-056-1,625471-18-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H302:40;H319:41;H335:40;H315:41;H314:6;H318:2;H312:1;H332:1
80420,Dialuminium titanium pentaoxide,234-456-9,12004-39-6,Not Classified,Notified C&L,39,Not classified:35;H335:4
80422,"Neodecanoic acid, reaction products with 4,4-methylenebis [N, N-bis (2,3-epoxypropyl) aniline",620-171-0,1179991-51-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1;H315:1
80425,Methyl D-prolinate,256-057-9,43041-12-9,Acute Tox. 4,Notified C&L,234,H302:234;H318:1;H335:1;H315:1
80436,"Phenol, 4-chloro-3-iodo-",606-512-6,202982-72-7,Acute Tox. 3;Eye Dam. 1,Notified C&L,42,H318:38;H301:38;H302:4;H319:4;H335:4;H315:4
80437,Lithium chromate,238-244-7,14307-35-8,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,67,H410:41;H317:67;H400:66;H350:67;H372:26;H312:26;H334:26;H330:26;H360:26;H413:25;H301:26;H340:26;H411:1
80441,Oxacycloheptadecan-2-one,203-662-0,109-29-5,Not Classified,REACH registration C&L,313,Not classified:270;H315:43;H319:5
80442,"Graphite, acid-treated",291-367-8,90387-90-9,Not Classified,REACH registration C&L,7,Not classified:7
80446,2-chloro-4-nitrobenzyl alcohol,257-828-2,52301-88-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H335:1;H315:1;H411:1
80453,N-N-bis(2-hydroxyethyl)formamide,246-734-7,25209-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
80455,Methyl 3-amino-4-methyl-2-thenoate,285-060-8,85006-31-1,Aquatic Chronic 3,REACH registration C&L,69,H412:15;H319:53;H335:52;H315:53;H302:1
80456,Ammonium laurate,219-439-6,2437-23-2,,Notified C&L,49,H319:26;Not classified:23
80457,"2-Oxepanone, homopolymer, 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester",600-970-0,110489-05-9,Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,86,H319:78;H335:48;H317:53;H315:29;Not classified:5;H318:3;H372:3;H302:4;H332:3;H312:2
80458,"Fatty acids, tall-oil, dimers",500-255-2,73138-53-1,Not Classified,Notified C&L,1,Not classified:1
80459,1-Bromo-3-methoxypropane,609-300-1,36865-41-5,Flam. Liq. 3,Notified C&L,6,H226:4;Not classified:2;H319:2;H315:2;H335:1
80460,"2-benzotriazol-2-yl-4,6-di-tert-butylphenol",223-346-6,3846-71-7,Carc. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,112,H351:92;H373:110;H412:111;Not classified:1
80465,2-bromo-1-cyclopentyl-ethanone,610-836-3,52423-62-8,Skin Sens. 1B;STOT RE 2,Notified C&L,1,H373:1;H317:1
80466,Triethoxy(3-thiocyanatopropyl)silane,252-161-3,34708-08-2,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39,H302:37;H412:36;H319:2;H335:2;H311:1;H331:1;H301:1;H315:3;H312:1;H332:1;Not classified:1
80470,2-ethylhexyl salicylate,204-263-4,118-60-5,Not Classified,REACH registration C&L,1532,Not classified:68;H315:1463;H413:11;H319:2
80473,Benzo[b]thiophene-4-ol,222-776-1,3610-02-4,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
80479,tert-butylmagnesium chloride,211-638-6,677-22-5,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,71,H260:67;H314:71;H318:2;H225:32;H250:39;H261:4;H335:1
80481,"1,2-dichloro-1,1,2-trifluoroethane",206-549-4,354-23-4,Not Classified,Notified C&L,3,Not classified:3
80483,"Aloysia triphylla, ext.",285-515-0,85116-63-8,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,318,H317:317;H304:212;H315:317;H411:132;H410:1;H319:1;Not classified:1
80484,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol,618-944-2,93413-69-5,Acute Tox. 4,Notified C&L,3,H302:3;H319:1;H362:1;H360:1;H411:1
80487,mancozeb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt,616-995-5,8018-01-7,Skin Sens. 1;Aquatic Acute 1;Repr. 2,Harmonised C&L,0,H361:0;H317:0;H400:0
80489,[2-(1-ethoxyethoxy)ethyl]benzene,219-868-9,2556-10-7,Aquatic Chronic 2,REACH registration C&L,1551,H411:29;Not classified:1522
80493,"2,3-Difluorobenzeneboronic acid",601-759-6,121219-16-7,,Notified C&L,9,H319:8;H335:7;H315:8;H302:1;Not classified:1
80508,"1,4-diisobutyl hydrogen (Z)-N-(3-carboxylatoacryloyl)-N-octadecyl-L-aspartate",272-670-4,68906-34-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,6,H318:4;H410:5;H315:6;H400:5;H319:1;H412:1
80511,5-chloro-o-cresol,226-160-3,5306-98-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:43;H319:41;H335:44;H315:45;H318:4;H312:4;H400:4;H332:4;H311:1;H331:1;H301:1
80512,Methyl α-methyl-4-morpholinepropionate hydrochloride,246-574-8,25027-56-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
80516,"3,3'-[carbonylbis[imino(5-methoxy-2-methyl-p-phenylene)azo]]bis(naphthalene-1,5-disulphonic) acid, lithium sodium salt",278-106-3,75198-98-0,Not Classified,Notified C&L,31,Not classified:31
80518,"3,4-diaminobenzoic acid",210-577-2,619-05-6,Not Classified,Notified C&L,2085,Not classified:2039;H319:46;H335:45;H315:46
80519,"6-(2,2,3-trimethylcyclopent-3-en-1-yl)hex-4-en-3-one",265-452-5,65113-96-4,Not Classified,Notified C&L,897,Not classified:897
80522,"N,N,β-trimethyl-10H-phenothiazine-10-propylamine 5,5-dioxide monohydrochloride",225-330-4,4784-40-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,2,H302:2;H317:2;H332:1;H312:1
80524,"Poly[oxy(methyl-1,2-ethanediyl)], α,α'-(1,6-dioxo-1,6-hexanediyl)bis[ω-(tetradecyloxy)-",607-156-4,227755-70-6,Not Classified,Notified C&L,1,Not classified:1
80526,"5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-",608-350-1,29331-92-8,Aquatic Chronic 2,Notified C&L,59,H411:38;H302:19;H317:19;H334:19;Not classified:1;H361:1;H301:1
80531,tert-pentylbenzene,218-076-0,2049-95-8,Flam. Liq. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,7,H226:7;H411:6;H317:5;H221:1
80535,"3-(1,1-dimethylethyl)[1,1'-biphenyl]-2-ol",219-331-9,2416-98-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,35,H410:35;H317:35;H400:35
80536,Dibismuth triselenide,235-104-7,12068-69-8,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H331:42;H400:42;H301:42;H410:42
80537,(25S)-5β-spirostan-3β-ol,204-776-3,126-19-2,Not Classified,Notified C&L,2,Not classified:2
80538,Copper(1+) acetate,209-938-7,598-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
80540,Perfluorovaleric acid,220-300-7,2706-90-3,Skin Corr. 1B,Notified C&L,50,H314:50;H290:1;H318:1
80545,1-Chloroethyl Isopropyl Carbonate,619-334-9,98298-66-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,3,H319:1;H335:1;H317:2;H341:1;H226:2;H315:1;H318:1;H314:1
80550,1-bromo-4-methylpentane,210-968-8,626-88-0,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:40;H319:39;H226:41;H312:1;H332:1;H335:1;H315:1
80551,"4-Cyclopentene-1,3-diol, 1-acetate, (1R,3S)-",611-973-1,60410-16-4,,Notified C&L,1,Not classified:1
80556,"4H-1-Benzopyran-4-one, 7-hydroxy-3-phenyl-",603-427-6,13057-72-2,Acute Tox. 4,Notified C&L,38,H302:38
80557,"N-(2,5-dimethoxyphenyl)acetamide",222-423-1,3467-59-2,Acute Tox. 4,REACH registration C&L,33,H302:33
80558,"Phosphoric acid, silver(1+) sodium zirconium(4+) salt",607-956-3,265647-11-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,446,H410:441;H400:441;Not classified:5
80559,2-imino-1-methylimidazolidin-4-one,200-466-7,60-27-5,Not Classified,REACH registration C&L,9,Not classified:7;H319:2;H335:2;H315:2
80563,Ethyl iminobenzoate hydrochloride,226-248-1,5333-86-8,,Notified C&L,9,H319:9;H335:9;H315:9
80571,"Phenazine-2,3-diyldiamine",211-512-0,655-86-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H302:40;H319:39;H335:39;H315:39;Not classified:33;H312:1;H332:1
80573,3-hydroxy-2-naphthoic acid,202-180-8,92-70-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,199,H302:198;H412:140;H318:154;H319:45;H335:21;H315:7;Not classified:1;H341:1
80574,"Aluminum oxide, basic",254-434-2,39377-45-2,Not Classified,Notified C&L,1,Not classified:1
80579,"Dinonylphenol, branched",284-702-4,84962-08-3,Not Classified,Notified C&L,100,Not classified:100
80580,"Fatty acids, tall-oil, magnesium salts, basic",271-979-1,68648-08-8,Not Classified,Notified C&L,5,Not classified:5
80582,"(2,4,6-Trimethyl-phenyl)-acetyl chloride",610-879-8,52629-46-6,Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,44,H412:33;H317:33;H314:44;H226:11;H290:2
80583,"Phosphoric acid, C16-18-alkyl esters, ammonium salts",291-874-4,90506-16-4,Not Classified,Notified C&L,3,Not classified:2;H318:1;H315:1
80586,"1-(3,3-dimethylbicyclo[2.2.1]hept-2-yl)ethan-1-one",255-779-1,42370-07-0,Eye Irrit. 2,Notified C&L,151,H319:54;H302:38;Not classified:59
80596,Hexyl benzoate,229-856-5,6789-88-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1707,H410:27;H400:27;Not classified:1546;H315:133;H319:5;H411:1;H335:1
80597,Sodium iodoacetate,206-165-7,305-53-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:40;H335:40;H315:40;H301:40
80600,Pent-2-enenitrile,236-297-0,13284-42-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H226:39;H311:39;H331:39;H301:39;H319:1;H315:1
80602,ammonium N-methyldithiocarbamate,609-738-3,39680-90-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H317:1;H400:1;H302:1;H290:1;H314:1
80603,Di-p-tolyl disulphide,203-087-5,103-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129,H319:129;H335:128;H315:129
80604,Octan-2-one,203-837-1,111-13-7,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1848,H302:10;H319:41;H226:1829;H412:27;H312:50;H315:30;Not classified:17;H335:5;H332:1
80605,Pentafluoropropionic anhydride,206-604-2,356-42-3,,Notified C&L,11,H314:11;H318:1;H335:1;H332:2
80606,"5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride",417-220-1,37441-29-5,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
80608,3-bromophenol,209-706-5,591-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H319:49;H335:48;H315:49;H312:5;H302:8
80609,p-tolyl 4-chlorobenzoate,411-530-0,15024-10-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
80610,Potassium trifluoromethanesulphinate,255-556-9,41804-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
80617,Methyl propyl trisulphide,241-594-3,17619-36-2,Acute Tox. 4,Notified C&L,1438,H302:1364;H319:141;H335:141;H315:141;Not classified:11
80622,Indan-2-ylammonium chloride,219-048-0,2338-18-3,Acute Tox. 4,Notified C&L,47,H302:47;H319:1;H335:1;H332:1;H315:1
80625,"(1α,2α,5α)-4,5-dimethyl-2-(2-methylpropen-1-yl)cyclohex-3-ene-1-carbaldehyde",255-861-7,42507-58-4,Not Classified,Notified C&L,1,Not classified:1
80626,"Fatty acids, tall-oil, calcium salts",268-922-8,68154-86-9,Not Classified,Notified C&L,18,Not classified:18
80631,Lead titanium trioxide,235-038-9,12060-00-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,44,H373:44;H360:44;H302:44;H332:44;H410:44;H400:42
80635,chlorotoluene,246-698-2,25168-05-2,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H411:0
80636,"Dehydrogenase, phenylalanine",614-961-4,69403-12-9,Resp. Sens. 1,Notified C&L,2,H334:2
80637,"3-carboxy-2,2,5,5-tetramethylpyrrolidin-1-yloxy",218-448-2,2154-68-9,,Notified C&L,6,H319:5;H335:4;H315:5;Not classified:1
80638,"Oligomerisation products of but-2-yne-1,4-diol and ethylene oxide",608-711-3,32167-31-0,Acute Tox. 4;Skin Sens. 1B;STOT RE 2,REACH registration C&L,85,H302:85;H373:85;H317:85
80640,2-methylpyridin-3-ol,214-327-3,1121-25-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H302:40;H318:39;H335:45;H315:46;H319:7;H332:1
80642,Fusel oil,232-395-2,8013-75-0,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1748,H318:1458;H315:1483;H225:1484;H319:45;H336:1371;H335:1496;H226:215;H332:173;H302:116;H331:10;H317:1;H412:1;H350:1
80645,Mefexamide,214-963-1,1227-61-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H300:38;H310:38;H330:38
80647,"2',5-dichloro-2-hydroxybenzophenone",262-965-6,61785-35-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
80654,N-[3-(dimethylamino)propyl]docosanamide,262-134-8,60270-33-9,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,80,H412:17;H318:61;H315:46;H319:18;H302:2
80657,"2-Propyl-heptanol, ethoxylated, propoxylated",605-450-7,166736-08-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,464,H302:455;H318:456;H412:211;H315:234;Not classified:7;H319:1
80660,2-phenylthio-5-trifluoromethylbenzoic acid,257-998-8,52548-96-6,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H335:1;H315:1
80662,trans-2-tert-butylcyclohexan-1-ol,226-670-6,5448-22-6,Not Classified,Notified C&L,114,Not classified:113;H319:1;H335:1;H315:1
80663,"2,2-dimethylpentan-3-ol",223-592-4,3970-62-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H226:42;H335:38;H315:38
80667,Methylcarbamoyl chloride,229-253-7,6452-47-7,Acute Tox. 4,Notified C&L,39,H302:39
80668,"1-[2-[[2-[[2-[[2-[3-(icosenyl)-2,5-dioxo-1-pyrrolidinyl]ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-3-(tetracosenyl)pyrrolidine-2,5-dione",264-634-1,64051-44-1,,Notified C&L,1,Not classified:1
80670,4-(phenylazo)-o-cresol,210-699-6,621-66-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H335:38;H318:38;H411:38;H302:38;H315:38
80673,"3,5-dibromo-2-methylthiophene",249-617-9,29421-73-6,,Notified C&L,1,H319:1;H335:1;H315:1
80676,3-Hydroxybenzoic Acid Sodium Salt,616-442-8,7720-19-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
80681,"tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{}{6-[4-(2-aminoethyl)piperazin-1-yl]}}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)",420-350-1,172277-97-3,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
80682,propan-2-yl 2-methoxyacetate,605-774-9,17640-21-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H226:2;H335:2;H315:2
80687,"1-Propanamine, 3-(C12-15-alkyloxy) derivs.",271-855-7,68610-26-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,23,H302:23;H410:23;H314:23
80691,"3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one",204-846-3,127-51-5,Aquatic Chronic 2,REACH registration C&L,1959,H411:1719;H317:1743;H319:1405;H315:1544;H412:202;Not classified:36
80694,4-methyl-1-phenylpent-1-en-3-one,221-606-3,3160-32-5,Acute Tox. 4,Notified C&L,38,H302:38
80695,"7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole",417-140-7,79185-77-6,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
80698,"Oxidase, ascorbate",232-852-6,9029-44-1,Resp. Sens. 1,Notified C&L,6,H334:5;Not classified:1
80699,"1-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium thiocyanate",281-873-7,84051-84-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H302:2;H319:2;H411:2
80707,"Reaction mass of Benzene, 1-[2-[3,5-dimethoxy-4-(1-methylpropoxy)phenyl]ethenyl]-4-[2-(3,5-dimethoxy-4-propoxyphenyl)ethenyl]- ; Benzene, 1,4-bis[2-[3,5-dimethoxy-4-(1-methylpropoxy)phenyl]ethenyl]- ; and Benzene, 1,4-bis[2-[3,5-dimethoxy-4-propoxyphenyl)ethenyl]-",487-101-7,,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
80709,2-bromodecanoic acid,220-086-5,2623-95-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
80713,Digadolinium(3+) trisulphate,237-115-2,13628-54-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
80714,"[hexane-1,6-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid",245-781-0,23605-74-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:3;H318:1;H290:1
80715,"1,1'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[3,4-dimethylbenzene]",265-687-3,65294-20-4,Not Classified,Notified C&L,1,Not classified:1
80719,"3,3',5,5'-Tetramethylbiphenyl-4,4'-diol",607-334-1,2417-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
80723,2-((1-((2-ethylhexyl)poly-oxy)poly-propan-2-yl)oxy)ethanol,613-582-1,64366-70-7,Aquatic Chronic 3,Notified C&L,262,H412:199;H332:64;H319:27;H318:4;H411:1;H315:1
80727,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and fatty acids, linseed-oil",500-171-6,67746-09-2,Not Classified,Notified C&L,62,Not classified:61;H317:1;H319:1;H411:1;H315:1
80728,Quinoline-4-carbaldehyde,224-453-0,4363-93-3,Skin Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:7
80731,Carboxypeptidase B,232-788-9,9025-24-5,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H334:38
80741,Phenethyl octanoate,226-718-6,5457-70-5,Not Classified,Notified C&L,93,Not classified:93
80742,Vanadium tribromide,236-736-6,13470-26-3,Skin Corr. 1B,Notified C&L,42,H314:42;H332:4
80743,Calcium bis(dihydrogenorthophosphate) monohydrate,600-059-8,10031-30-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,131,H319:90;H335:90;H315:90;H318:40;Not classified:1
80748,"Tetrahydro-1,3,4,6-tetrakis[(2-hydroxyethoxy)methyl]imidazo[4,5-d]imidazole-2,5(1H,3H)-dione",267-376-8,67846-63-3,Aquatic Chronic 3,Notified C&L,18,H412:18
80749,"1,2,4-Benzenetricarboxylic acid, tri-C7-9-branched and linear alkyl esters",271-101-7,68515-60-6,Not Classified,Notified C&L,26,Not classified:26
80751,N-carbamoylmethyliminodi(acetic acid),247-530-0,26239-55-4,Acute Tox. 4,REACH registration C&L,49,H302:8;Not classified:41
80752,"10H-pyrido[3,2-b](1,4)benzothiazine",205-973-7,261-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H319:41;H335:40;H315:41;Not classified:1
80753,"2-Propenoic acid, C16-18-alkyl esters",292-060-1,90530-21-5,,Notified C&L,39,H319:39;H335:39;H315:39;H411:39
80754,tert-Butylarsine,610-051-6,4262-43-5,Pyr. Liq. 1;Water-react. 2;Acute Tox. 2,Notified C&L,39,H330:39;H250:39;H261:38;H412:1
80759,"Hydroxyacetic acid, compound with 4,4'-[m-phenylenebis(azo)]bis(benzene-1,3-diamine) acetate formate",268-386-5,68083-37-4,Not Classified,Notified C&L,1,Not classified:1
80760,Biotinamidocaproyl hydrazine,600-909-8,109276-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
80763,2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)benzoic acid,424-110-7,,Not Classified,Notified C&L,1,Not classified:1
80764,Piperidine-3-carboxamide,223-962-5,4138-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:38;H315:40
80766,"Fatty acids, tall-oil, C11-18-alkyl esters",268-923-3,68154-87-0,Not Classified,Notified C&L,2,Not classified:2
80772,"Disodium 7-anilino-3-[[4-[(2,4-dimethyl-6-sulphonatophenyl)azo]-6-methoxy-m-tolyl]azo]-4-hydroxynaphthalene-2-sulphonate",226-822-1,5489-77-0,Not Classified,Notified C&L,22,Not classified:19;H319:3;H413:1
80775,"N,N'-(iminodiethylene)bis(octadec-9-enamide) monoacetate",299-940-4,93918-61-7,Skin Corr. 1C;Eye Dam. 1,Notified C&L,83,H318:83;H314:83
80780,Decenoic acid,247-698-5,26446-27-5,Skin Irrit. 2,Notified C&L,1286,H315:1286
80782,3-hydroxybutyronitrile,224-457-2,4368-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
80783,Sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate,205-738-9,149-39-3,Eye Irrit. 2,Notified C&L,14,H319:14
80787,trans-4-methylcyclohexanamine acetate,611-103-0,54160-74-6,Acute Tox. 4,REACH registration C&L,2,H302:2
80788,"Benzene, 1-bromo-2-methyl-4-(phenylmethoxy)-",605-779-6,17671-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H312:1;H302:1;H332:1
80793,Dichlorobis(triphenylphosphine)palladium,237-744-2,13965-03-2,Aquatic Chronic 4,REACH registration C&L,170,H413:92;H317:123;H302:44;H319:46;H315:46;Not classified:34;H312:2;H332:3;H335:5
80794,"3-Quinolinecarboxylic acid, 7-chloro-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-, ethyl ester",600-496-4,103877-51-6,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,3,H411:2;H301:2;Not classified:1
80796,4'-chlorobutyrophenone,225-631-0,4981-63-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
80801,1-chloro-5-iodopentane,262-137-4,60274-60-4,,Notified C&L,4,H319:4;H335:4;H315:4
80806,3-phenylpropyl formate,203-222-8,104-64-3,Not Classified,Notified C&L,233,Not classified:233
80807,ethyl 2-(1-cyanocyclohexyl)acetate,415-970-4,133481-10-4,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H373:0;H412:0
80812,"(9Z,12Z)-octadeca-9,12-dienoic acid, monoester with glycerol",247-788-4,26545-74-4,Not Classified,Notified C&L,1,Not classified:1
80819,Tridecanoic acid,211-341-1,638-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,155,H319:153;H335:152;H315:153;Not classified:2
80820,"2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid",424-870-1,27624-67-5,Expl. 1.1;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H201:0;H412:0;H318:0
80821,"5-methylpyridine-2,3-dicarboxylic acid",611-023-6,53636-65-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
80826,"4-[Difluor(3,4,5-trifluorphenoxy)methyl]-3,5-difluor-4'-propyl-1,1'-biphenyl",608-462-0,303186-20-1,Repr. 1B,REACH registration C&L,3,H360:3
80829,"Formaldehyde, polymer with phenol and urea",607-549-0,25104-55-6,Skin Sens. 1B,Notified C&L,18,H317:15;Not classified:3
80831,Rhodium acetate,255-707-9,42204-14-8,Eye Irrit. 2;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,11,H319:10;H341:2;H410:2;H400:2;H335:5;Not classified:1
80833,isobutyl formate,208-818-1,542-55-2,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H225:0
80835,"[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]ammonium acetate",229-939-6,6850-28-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:3;H335:3;H315:3;Not classified:2
80836,"1-Naphthalenesulfonic acid, 5-[(1,3-dioxobutyl)amino]-, potassium salt (1:1)",604-574-9,147152-82-7,Not Classified,Notified C&L,31,Not classified:31
80842,"Disodium [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]ferrate(2-)",243-136-8,19529-38-5,Not Classified,REACH registration C&L,97,Not classified:97
80850,Alfaprostol,277-746-0,74176-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,1,H319:1;H361:1;H335:1;H315:1
80853,"(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate",412-670-5,54275-93-3,Resp. Sens. 1,Harmonised C&L,0,H334:0
80856,"Oils, fish, sulfated, potassium salts",307-668-5,97675-93-9,Not Classified,Notified C&L,443,Not classified:442;H319:1
80857,"Oxirane, reaction products with ammonia, distn. residues",273-224-1,68953-70-8,Not Classified,Notified C&L,100,Not classified:98;H319:2;H315:2
80858,p-menth-1-en-8-yl formate,218-444-0,2153-26-6,Aquatic Chronic 3,Notified C&L,1617,H412:1286;Not classified:293;H319:38;H335:38;H315:38
80861,"2,7-dichloroquinoline",612-138-4,613-77-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
80862,"5-benzyl N-[(1,1-dimethylethoxy)carbonyl]-L-glutamate",237-007-5,13574-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
80868,"reaction mass of: pentasodium 5-amino-3-(5-{}{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{}{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;tetrasodium 5-amino-3-[5-{}{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate",424-320-9,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
80871,[(dodecyloxy)methyl]oxirane,219-554-1,2461-18-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,79,H318:78;H413:78;H315:79;H335:18;H317:18;H319:1
80872,"Acetic acid, copper salt",224-051-5,4180-12-5,Acute Tox. 4,Notified C&L,170,H302:170
80873,Tripotassium hydrogen (1-hydroxyethylidene)bisphosphonate,262-203-2,60376-08-1,Not Classified,Notified C&L,40,Not classified:26;H302:13;H319:1;H315:1
80874,Homosalate,204-260-8,118-56-9,Not Classified,REACH registration C&L,160,Not classified:111;H319:38;H335:38;H315:38;H413:11
80875,"ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate",427-110-5,,Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H302:0;H413:0;H373:0
80879,"1,1'-isopropylidenebis[4-(allyloxy)-3,5-dibromobenzene]",246-850-8,25327-89-3,Not Classified,REACH registration C&L,37,Not classified:18;H413:16;H319:3
80881,Dichloro(methyl)silane,200-877-1,75-54-7,Flam. Liq. 2;Water-react. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,Notified C&L,2263,H261:2199;H225:2262;H331:2186;H301:2186;H314:2207;H318:16;H335:13;H260:8;H332:6;H330:2;Not classified:1
80890,[2-[(4-nitrophenyl)amino]ethyl]urea,410-700-1,27080-42-8,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
80891,"Fatty acids, C14-18 and C16-18-unsatd., decyl esters",297-363-2,93455-77-7,Not Classified,Notified C&L,5,Not classified:5
80892,Dialuminium strontium tetraoxide,234-455-3,12004-37-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,194,H319:184;H335:184;H315:184;Not classified:10
80894,2-(hex-3-enyl)cyclopentan-1-one,268-701-6,68133-74-4,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H315:1
80897,Polythiazide,206-468-4,346-18-9,Acute Tox. 4,Notified C&L,38,H302:38
80903,N-(2-aminoethyl)-N'-[3-(trimethoxysilyl)propyl]ethylenediamine,252-390-9,35141-30-1,Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,127,H318:47;H317:85;H332:7;H411:40;H312:38;H314:38;H319:37;Not classified:5;H412:1;H315:1
80905,"Benzene, mono C10-13-alkyl derivs., fractionation bottoms, heavy ends, sulfonated, sodium salts",604-638-6,148520-82-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,20,H318:20;H413:2;H411:2;H302:20;H315:20;H335:18
80910,Calcium dichromate,238-243-1,14307-33-6,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Chronic 1,Notified C&L,94,H302:92;H410:94;H317:94;H350:94;H400:3
80911,Foots oil (petroleum);[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C,265-171-8,64742-67-2,Carc. 1B,Harmonised C&L,0,H350:0
80916,N-[3-(dimethylamino)propyl]oleamide,203-661-5,109-28-4,Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,586,H318:533;H317:117;H400:101;H410:93;H314:89;H315:490;H319:52;H412:31;H302:2;H335:1
80920,2-phenyl-2-ethyl-2-cyanoacetic acid methyl ester,607-327-3,24131-07-5,Repr. 2,REACH registration C&L,1,H361:1
80926,Ethiodized Oil,616-924-8,8008-53-5,Not Classified,Notified C&L,1,Not classified:1
80928,"1,1',1''-(1,1,3,5-tetramethylpentane-1,3,5-triyl)tris(cyclohexane)",264-085-8,63302-75-0,Not Classified,Notified C&L,8,Not classified:8
80931,"Ginseng, Panax quinquefolium coreense, ext.",296-193-6,92347-06-3,Not Classified,Notified C&L,2,Not classified:2
80932,"3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-3-en-2-one",265-450-4,65113-95-3,Not Classified,Notified C&L,479,Not classified:478;H411:1
80933,"β-Alanine, N-coco alkyl derivs., sodium salts",271-795-1,68608-68-4,Not Classified,Notified C&L,10,Not classified:5;H319:5
80937,3-ethylaniline,209-594-8,587-02-0,,Notified C&L,39,Not classified:38;H319:1;H311:1;H331:1;H302:1;H315:1
80938,N-isopropylpyridine-2-methylamine,261-384-5,58669-30-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
80942,"1,3,4-thiadiazole-2,5-dithiol",214-014-1,1072-71-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,543,H302:497;H411:14;H318:464;H412:443;H319:79;H335:45;H315:46
80943,"Nelumbo nucifera, ext.",285-379-2,85085-51-4,Not Classified,Notified C&L,39,Not classified:39
80945,L-alanine hydrochloride,227-849-1,6003-05-0,Not Classified,Notified C&L,62,Not classified:62
80947,1-naphthohydrazide,256-054-2,43038-45-5,,Notified C&L,6,H319:6;H335:5;H315:6
80948,"[R-(R*,R*)]-1,4-dimercaptobutane-2,3-diol",240-263-0,16096-97-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H312:38;H302:38;H315:39
80951,"4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-ol",244-735-7,22029-76-1,Not Classified,Notified C&L,234,Not classified:224;H332:10;H400:10
80952,Praseodymium tribromide,236-893-0,13536-53-3,Eye Irrit. 2,Notified C&L,43,H319:43;H335:5;H315:5
80953,"trans,trans-4'-Butylbicyclohexyl-4-carboxylic Acid",618-242-6,89111-63-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,Not classified:1;H410:1;H400:1;H319:1;H315:1
80956,Bromo[thiobis[methane]]copper,259-292-5,54678-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
80958,1-butyl (sulphooxy)-9-octadecenoate,254-044-2,38621-44-2,Not Classified,Notified C&L,1,Not classified:1
80959,Allyltrimethylsilane,212-104-5,762-72-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H225:46;H312:1;H302:1;H332:1;H411:1
80960,"N,N'-dimethylethylenediamine",203-793-3,110-70-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,70,H226:69;H314:59;H319:11;H335:11;H315:11;H318:3;Not classified:1;H312:1;H302:1;H332:1
80961,Methyl oxirane-2-carboxylate,610-247-1,4538-50-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H226:1;H335:1;H315:1
80969,2-(4-methoxyphenyl)acetamide,228-745-9,6343-93-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
80970,"o-(p-hydroxybenzoyl)benzoic acid, compound with 1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]piperidine (1:1)",253-584-6,37671-82-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H335:1;H312:1;H302:2;H332:1
80971,4-imidazoleacetic acid hydrochloride,221-840-6,3251-69-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
80974,Mercury telluride,235-108-9,12068-90-5,,Notified C&L,4,H300:4;H373:4;H310:4;H330:4;H400:4;H410:4
80979,Zinc telluride,215-260-2,1315-11-3,Acute Tox. 2,Notified C&L,97,H330:90;H302:5;H332:5;Not classified:2;H413:1
80983,"β,4-dimethylcyclohex-3-ene-1-ethanol",242-366-6,18479-68-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,88,H317:88;H410:88;H315:88;H400:52
80985,Calcium bis[didodecylbenzenesulphonate],249-547-9,29299-35-2,Not Classified,Notified C&L,1,Not classified:1
80987,"Iron, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycine sodium complexes",309-303-5,100208-96-6,Not Classified,Notified C&L,85,Not classified:85
80992,Ethylene bis(hydroxyacetate),258-165-1,52767-61-0,Not Classified,Notified C&L,5,Not classified:5
80993,trans-2-methoxycinnamic acid,228-047-4,6099-03-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,126,H319:126;H335:126;H315:126
80996,2-bromoundecane,254-514-7,39563-54-7,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
80997,"3,3,3-trifluoropropene",211-637-0,677-21-4,Flam. Gas 1;Press. Gas (Comp.);STOT SE 3;STOT RE 2,REACH registration C&L,51,H280:44;H220:6;H373:4;H336:4;Not classified:6;H224:1;H221:1
80998,(+)-tartaric acid,201-766-0,87-69-4,Eye Dam. 1,REACH registration C&L,4598,H318:1776;H319:2770;H335:2601;H317:2037;H302:2038;H315:2593;Not classified:46;H412:3;H314:3;H312:1
81000,"Oils, lard, sulfonated",296-303-2,92457-22-2,,Notified C&L,2,Not classified:2
81002,Benzothiazol-2-ylamine,205-268-4,136-95-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,93,H302:90;H319:76;H410:14;H400:14;Not classified:3;H315:1
81004,nickel(II) selenite,233-263-7,10101-96-9,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H372:0;H334:0;H400:0;H410:0;H350:0
81005,5-tert-butyl-2-methoxybenzaldehyde,445-500-3,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
81007,"Alcohols, C11-15-secondary, ethoxylated",614-295-4,68131-40-8,Aquatic Chronic 3,REACH registration C&L,2579,H412:95;H318:2198;H315:1253;H411:195;H317:148;H319:157;H302:276;H332:252;H312:69;Not classified:14;H373:7;H341:7;H350:7;H400:6
81013,Dineodymium trisulphate,233-262-1,10101-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
81018,Ethyl 2-bromoheptanoate,226-249-7,5333-88-0,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H314:38
81019,Lead zirconium trioxide,235-039-4,12060-01-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H373:43;H360:43;H400:43;H302:43;H332:43;H410:43
81020,"1,4-bis[(2-ethylhexyl)amino]anthraquinone",249-931-6,29887-08-9,Not Classified,Notified C&L,623,Not classified:583;H319:40;H315:40
81023,4-bromobutyric acid,220-083-9,2623-87-2,Skin Corr. 1B,Notified C&L,51,H314:51;H290:1;H318:2;H302:1
81024,Sodium 5-[[4-acetamido-2-(trifluoromethyl)phenyl]azo]-6-amino-4-hydroxynaphthalene-2-sulphonate,278-103-7,75198-93-5,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H317:4
81025,"Amines, polyethylenepoly-, reaction products with succinic anhydride polyisobutenyl derivatives",617-593-2,84605-20-9,Not Classified,Notified C&L,677,Not classified:477;H319:159;H302:36;H312:36;H317:37;H315:35;H412:3;H413:1
81026,5-pentylresorcinol,207-908-8,500-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
81027,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium acetate,281-876-3,84051-87-6,Eye Irrit. 2,REACH registration C&L,10,H319:4;H412:4;Not classified:2
81028,"Acetyltransferase, phosphate",232-855-2,9029-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
81030,o-(or p)-toluenesulphonamide,232-394-7,8013-74-9,Not Classified,Notified C&L,1,Not classified:1
81031,Thiazolidine-2-thione,202-512-1,96-53-7,Acute Tox. 3,Notified C&L,61,H301:61;Not classified:2
81034,"1-(3,3-dimethylbicyclo[2.2.1]hept-5-en-2-yl)ethan-1-one",255-778-6,42370-06-9,Not Classified,Notified C&L,88,Not classified:88
81037,Methylurea,209-935-0,598-50-5,Not Classified,REACH registration C&L,89,Not classified:88;H302:1
81040,3-bromopropiononitrile,219-332-4,2417-90-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,45,H319:45;H335:44;H311:40;H331:40;H301:40;H315:45;H300:5;H310:1;H330:1
81043,Methyl 2-oxo-2H-pyran-3-carboxylate,247-397-9,25991-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81044,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulpho-2-naphthyl)azo]naphthalene-2-sulphonic] acid, sodium salt, compound with 2-aminoethanol",289-057-2,85959-62-2,Not Classified,Notified C&L,84,Not classified:83;H317:1
81046,"Glycerides, palm-oil mono- and di-",293-228-7,91052-66-3,Not Classified,Notified C&L,7,Not classified:7
81049,"1H-Imidazolium, 1,3-diethyl-, octanoate (1:1)",620-242-6,1040916-85-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,83,H318:83;H314:83
81051,Elaidic acid,204-006-6,112-79-8,,Notified C&L,8,H319:7;H335:6;H315:7;Not classified:1
81053,"Phenol, polymer with formaldehyde, sulfonated, sodium salt",615-283-1,71342-95-5,Not Classified,Notified C&L,56,Not classified:36;H411:20;H318:18;H319:2;H315:2
81057,"Kerosine (petroleum), solvent-refined sweetened;Kerosine - unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 °C to 260 °C (302 °F to 500 °F).]",295-416-4,92045-36-8,Asp. Tox. 1,Harmonised C&L,0,H304:0
81058,2-chloro-3-nitrotoluene,223-591-9,3970-40-9,Acute Tox. 4;Aquatic Acute 1,Notified C&L,40,H302:38;H400:38;H319:1;H311:2;H331:2;H301:2;H315:1
81062,"Fatty acids, wheat germ-oil, Et esters",293-149-8,91051-93-3,Not Classified,Notified C&L,1,Not classified:1
81063,butyraldehyde oxime,203-792-8,110-69-0,Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0;H311:0
81068,Tomatidine,201-040-3,77-59-8,Acute Tox. 4,Notified C&L,2,H302:1;H331:1;H301:1
81071,(DHQ)2PHAL,604-211-4,140924-50-1,Skin Sens. 1,Notified C&L,39,H317:38;Not classified:1
81073,"α,3,3-trimethylcyclohexylmethyl acetate",246-737-3,25225-10-9,Eye Irrit. 2,Notified C&L,1555,H319:1286;Not classified:269
81074,Methylsilanetriyl triacetate,224-221-9,4253-34-3,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,545,H302:400;H318:118;H314:463;H319:114;H335:76;H315:115;Not classified:5;H317:1;H320:1;H334:1
81082,"Hydrogen [29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-)",249-300-5,28901-96-4,Eye Dam. 1,REACH registration C&L,300,H318:102;Not classified:197;H319:1
81084,ethynyl cyclopropane,425-430-1,6746-94-7,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0;H315:0;H225:0
81091,"Acetic acid, anhydride, reaction products with 1,5,10-trimethyl-1,5,9-cyclododecatriene",482-330-9,144020-22-4,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,16,H410:14;H317:14;H400:14;H411:3;H315:2
81092,"Hexanoic acid, ester with 1,2,3-propanetriol",234-396-3,11139-91-6,Skin Irrit. 2,Notified C&L,1,H315:1
81093,"Phosphoric acid, isotridecyl ester, compd. with 2,2'-iminobis[ethanol]",287-146-0,85409-75-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
81094,"Ethanol, 2-[(2-aminoethyl)amino]-, reaction products with epichlorohydrin, ethylenediamine and 1H-imidazole",291-259-0,90367-12-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H312:1;H400:1;H302:1;H332:1;H410:1
81096,Scandium trichloride,233-799-1,10361-84-9,Not Classified,Notified C&L,4,Not classified:3;H319:1
81097,3-methylbenzyl alcohol,209-595-3,587-03-1,,Notified C&L,6,H319:6;H315:6;H335:1
81099,"Fatty acids, coco, polymers with adipic acid and propylene glycol",614-586-6,68551-87-1,Not Classified,Notified C&L,1,Not classified:1
81100,"4-((1R,2R,4R)-born-2-yl)cyclohexanol",266-122-3,66072-32-0,,Notified C&L,389,H411:389;H315:389
81103,Pentadecyl methacrylate,228-126-3,6140-74-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,448,H317:447;H319:447;H335:447;H315:447;Not classified:1
81104,"Phosphoric acid, C8-16-alkyl esters, compds. with diethanolamine",291-877-0,90506-18-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:7;H315:8
81106,"1,2,4-triazin-3-ylamine",214-324-7,1120-99-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
81107,(2-fluorophenyl)urea,211-513-6,656-31-5,Acute Tox. 3,Notified C&L,38,H301:38
81109,2-chloro-4-nitrophenol,210-578-8,619-08-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,50,H302:50;H319:49;H312:43;H315:49;H335:42;H332:39
81111,Dihexadecyldimethylammonium bromide,274-849-2,70755-47-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
81112,Biomass residue ex B2,920-031-1,,Not Classified,REACH registration C&L,1,Not classified:1
81119,7-(diethylamino)-2-benzopyrone,243-888-7,20571-42-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:39;Not classified:1
81120,"p,p',p''-tris(dimethylamino)tritylium m-[(p-anilinophenyl)azo]benzenesulphonate",265-686-8,65294-17-9,Eye Dam. 1,Notified C&L,121,H318:84;Not classified:37
81122,"1-Fluor-4-[2-(4-trans-propyl-[1,1-bicyclohexyl]-4-trans-yl )-ethyl]-benzene",619-304-5,97941-21-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
81123,"Siloxanes and Silicones, C24-54-branched and linear alkyl Me",606-176-0,189378-12-9,Not Classified,Notified C&L,1,Not classified:1
81125,"Methyl 4-cyano-5-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-3-methyl-2-thenoate",277-146-9,72968-71-9,Not Classified,REACH registration C&L,158,Not classified:75;H413:83
81127,tetrabutylammonium 2-amino-6-iodopurinate,424-710-9,156126-48-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H318:0;H317:0;H312:0;H411:0;H302:0;H315:0
81132,"1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrochloride",285-680-9,85118-27-0,Acute Tox. 4,Notified C&L,4,H302:3;Not classified:1;H332:1;H312:1
81139,2-decyltetradecanol,261-385-0,58670-89-6,Not Classified,REACH registration C&L,42,Not classified:41;H319:1
81141,"Ethyl 2,4,5-trifluorobenzoylacetate",619-340-1,98349-24-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H314:1
81146,ammonia;5-ethyl-2-(4-isopropyl-4-methyl-5-oxo-1H-imidazol-2-yl)pyridine-3-carboxylic acid,600-249-0,101917-66-2,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,205,H319:89;H400:89;Not classified:83;H332:33
81147,Decaglycerol,232-921-0,9041-07-0,Not Classified,Notified C&L,12,Not classified:12
81154,"2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo-[d,g][1,3,2]dioxaphosphocin 6-oxide, lithium salt",458-880-0,,Not Classified,Notified C&L,1,Not classified:1
81156,"Soybean oil, maleated, 2-(2-butoxyethoxy)ethyl esters",609-161-7,356789-51-0,,Notified C&L,71,Not classified:71
81159,Zinc tartrate,208-998-1,551-64-4,Not Classified,Notified C&L,1,Not classified:1
81163,3-Amino-4-methoxycarbonyl-benzylammonium hydrogensulfate,917-276-1,,,Notified C&L,31,Not classified:31
81164,VP-LS204,411-610-5,,Not Classified,Notified C&L,1,Not classified:1
81165,nitromethane,200-876-6,75-52-5,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H302:0;H226:0
81168,4-chloro-2-fluoroaniline,261-034-1,57946-56-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H335:40;H312:40;H302:43;H332:44;H315:45;H373:6;H311:5;H301:2;H330:1
81169,C.I. Reactive Red 141,612-761-1,61931-52-0,Not Classified,Notified C&L,3,Not classified:3
81174,Methyl hexahydro-α-methyl-1H-azepine-1-propionate hydrochloride,246-575-3,25027-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
81180,[No public or meaningful name is available],930-615-8,54068-28-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H373:1;H317:1;H312:1;H412:1;H302:1;H315:1
81181,Undecan-6-ol,245-837-4,23708-56-7,Flam. Sol. 2,Notified C&L,1,H228:1
81182,"2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium tetrachlorozincate (2:1)",238-779-6,14726-58-0,Flam. Sol. 2,Notified C&L,1,H302:1;H332:1;H312:1;H228:1
81184,N-(hydroxymethyl)nicotinamide,222-668-4,3569-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
81187,Pentyl benzoate,218-077-6,2049-96-9,Not Classified,Notified C&L,274,Not classified:235;H411:38;H319:1;H315:1
81189,"L-Proline, 1,1'-[dithiobis[(2S)-2-methyl-1-oxo-3,1-propanediyl]]bis-",613-693-5,64806-05-9,,Notified C&L,1,H361:1;H318:1
81192,4-diazobenzenesulphonic acid,206-168-3,305-80-6,Skin Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H315:41
81195,"1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione",431-220-9,158574-65-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
81201,Ethyl 2-amino-5-ethyl-3-thenoate,224-824-7,4507-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81203,N-cyclopropyl-4-[(2-methoxybenzoyl)sulfamoyl]benzamide,485-320-2,,Not Classified,Notified C&L,1,Not classified:1
81205,"ethylenediamine;1,2-diaminoethane",203-468-6,107-15-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H312:0;H334:0;H302:0;H226:0;H314:0
81206,"1-(2,6,6-trimethyl-1-cyclohexen-1-yl)pent-1-en-3-one",204-843-7,127-43-5,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1618,H411:1617;H317:1401;H315:257;H319:35;H334:20;H412:1
81208,Cinnamyl formate,203-223-3,104-65-4,Not Classified,REACH registration C&L,1522,Not classified:236;H317:1286
81214,Pentadecane-8-one,212-450-7,818-23-5,Aquatic Chronic 4,Notified C&L,38,H413:38
81219,Methoxydimethyloctylsilane,298-404-7,93804-29-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1;H315:1
81220,p-toluohydrazide,222-815-2,3619-22-5,Acute Tox. 4,Notified C&L,44,H302:38;H319:6;H335:5;H315:6
81224,(S)-2-hydroxyvaleric acid,255-175-8,41014-93-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H318:1;H335:2;H315:2;H319:1
81225,Guanidine formiate,613-307-5,63656-95-1,Not Classified,Notified C&L,2,Not classified:1;H302:1
81226,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium methyl sulphate",258-946-7,54060-92-3,Acute Tox. 3;Acute Tox. 4;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,83,H318:70;H312:19;H330:11;H400:16;H301:55;H410:55;H302:21;H412:18;Not classified:5;H319:7;H315:4;H411:1
81228,4-nitro-N-(4-nitrophenyl)aniline,217-343-9,1821-27-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
81234,"Isophthalic acid, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phthalic anhydride",500-174-2,67846-32-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,15,H302:14;H317:14;H318:14;H315:14;Not classified:1
81239,3-chlorobenzophenone,213-809-0,1016-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
81243,"Ornithine, 2-(difluoromethyl)-, monohydrochloride, monohydrate",619-187-0,96020-91-6,Not Classified,Notified C&L,1,Not classified:1
81244,Lysozyme,232-620-4,9001-63-2,Resp. Sens. 1,Notified C&L,42,H334:41;H319:2;H317:3
81246,Ormetoprim,230-246-6,6981-18-6,,Notified C&L,1,H302:1
81247,Iron citrate,219-045-4,2338-05-8,Not Classified,Notified C&L,3,Not classified:3
81249,1-(benzylamino)propan-2-ol,248-274-2,27159-32-6,,Notified C&L,5,H319:4;H335:5;H315:5;H318:1
81251,2-chloro-6-nitrophenol,210-061-7,603-86-1,Eye Irrit. 2,Notified C&L,44,H319:44;H302:5;H335:4;H315:5
81253,2-methyl-1-nitronaphthalene,212-917-5,881-03-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
81257,1-pentanol,200-752-1,71-41-0,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H226:0;H335:0;H315:0;H332:0
81259,muscalure;cis-tricos-9-ene,248-505-7,27519-02-4,Skin Sens. 1B,Harmonised C&L,0,H317:0
81260,"1,1-dimethoxynonane",242-603-3,18824-63-0,Not Classified,Notified C&L,88,Not classified:88
81269,"m-(4,5-dihydro-5-imino-3-methyl-1H-pyrazol-1-yl)benzenesulphonic acid",268-387-0,68083-38-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,42,H319:40;H315:40;Not classified:2;H335:38
81274,"Fatty acids, tall-oil, compds. with diethylamine",268-924-9,68154-89-2,Not Classified,Notified C&L,35,Not classified:35
81277,Canrenoic acid,223-963-0,4138-96-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
81280,"Glycerides, C14-18 di-",271-027-5,68514-25-0,Not Classified,Notified C&L,1,Not classified:1
81282,4'-bromobutyrophenone,225-632-6,4981-64-0,Acute Tox. 4,Notified C&L,38,H302:38
81288,Sodium hydroxymethanesulphinate,205-739-4,149-44-0,Muta. 2;Repr. 2,REACH registration C&L,498,H341:285;H361:179;Not classified:198;H319:15;H335:13;H315:15;H334:1;H412:1
81292,But-3-yn-2-ol,217-978-1,2028-63-9,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 3;Self-react. G,REACH registration C&L,134,H300:131;H310:93;H225:86;H318:85;Not classified:85;H412:89;H330:89;H315:134;H319:49;H301:3;H226:48;H335:6
81296,2-amino-3-nitrophenol,210-060-1,603-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:5;H312:1;H332:1
81297,Keracyanin,242-528-6,18719-76-1,Not Classified,Notified C&L,2,Not classified:2
81300,DL-homocysteine thiolactone hydrochloride,227-923-3,6038-19-3,Not Classified,REACH registration C&L,162,Not classified:160;H319:2;H335:2;H315:2
81301,Manganese lactate,257-492-7,51877-53-3,Not Classified,Notified C&L,2,Not classified:1;H412:1
81307,2-benzylaminoethanol,203-221-2,104-63-2,Skin Corr. 1A,REACH registration C&L,12,H314:5;H319:7;H315:7;H335:1
81310,"Fatty acids, linseed-oil, Me esters",293-066-7,91051-16-0,Not Classified,Notified C&L,8,Not classified:8
81311,"2-Naphthalenesulfonic acid, 5(or 8)-amino-, reaction products with 4-aminophenol and sodium sulfide (Na2(Sx))",309-304-0,100208-97-7,Not Classified,REACH registration C&L,40,Not classified:40
81313,"Butanedioic acid, sulfo-, C-(2-coco amido-1-methylethyl) esters, disodium salts",271-102-2,68515-65-1,Not Classified,Notified C&L,2,Not classified:1;H318:1;H315:1
81314,4'-Ethyl-3-fluorbiphenyl-4-boronic acid,618-440-2,900796-46-5,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H373:2;H400:2
81318,2-bromobenzohydrazide,249-614-2,29418-67-5,Acute Tox. 4,Notified C&L,44,H302:39;H319:6;H335:5;H315:6
81319,Dibenzo-p-dioxin,205-974-2,262-12-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,39,H302:39;H411:38
81320,2-(trifluoromethyl)benzylic alcohol,206-467-9,346-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:43;H315:45
81324,Glucuronic acid,229-486-4,6556-12-3,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
81328,"Octahydro-4,7-methano-1H-inden-5-yl acetate",264-598-7,64001-15-6,Not Classified,REACH registration C&L,1537,Not classified:251;H319:1286;H412:1286
81334,Sodium 6-N-butylbenzotriazole,601-554-1,118685-34-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1;H317:1;H314:1
81336,"5-{}{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt",418-340-7,157707-94-3,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
81338,"Dodecenylsuccinic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",264-867-9,64396-12-9,Eye Irrit. 2,REACH registration C&L,4,H319:3;H315:2;Not classified:1
81343,"1,2,3,4-tetrafluorobenzene",208-997-6,551-62-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H225:45
81347,1-methyl-1-(4-methyl-3-cyclohexen-1-yl)ethyl butyrate,218-445-6,2153-28-8,Not Classified,Notified C&L,138,Not classified:137;H413:1
81353,Butyl 2-bromopropionate,255-241-6,41145-84-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
81356,(±)-2-methylbutan-1-ol,252-163-4,34713-94-5,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,39,H226:39;H318:38;H315:38;H335:1;H332:1
81359,"L-lysine, compound with S-(carboxymethyl)-L-cysteine (1:1)",256-425-9,49673-81-6,Not Classified,REACH registration C&L,3,Not classified:3
81365,(E)-anethole,224-052-0,4180-23-8,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,1752,H412:104;H317:1652;Not classified:57;H411:94;H410:2;H319:1;H315:2;H312:1;H331:1;H302:1;H314:1;H318:1
81371,"2-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro-3H-indol-3-one",207-586-9,482-89-3,STOT RE 2,REACH registration C&L,67,H373:52;Not classified:11;H319:4;H335:3;H315:4
81373,isobutyl nitrite,208-819-7,542-56-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Muta. 2;Carc. 1B,Harmonised C&L,0,H225:0;H341:0;H302:0;H332:0;H350:0
81375,[[(2-ethylhexyl)oxy]methyl]oxirane,219-553-6,2461-15-6,Skin Irrit. 2;Skin Sens. 1A,REACH registration C&L,1428,H317:916;H315:1370;H319:801;H335:503;H411:97;H412:108;Not classified:23;H341:1
81376,Acetaminosalol,204-261-3,118-57-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38
81377,"2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile",429-180-2,157362-53-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
81380,4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile,244-530-2,21690-43-7,Not Classified,Notified C&L,88,Not classified:88
81382,"Tar, coal, storage residues;Coal Tar Solids Residue;[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]",293-764-1,91082-50-7,Carc. 1B,Harmonised C&L,0,H350:0
81383,"4-methyl-2,6-bis(methyloxy)-8-nitro-5-{[3-(trifluoromethyl)phenyl]oxy}quinoline",606-188-6,189746-15-4,Skin Sens. 1,Notified C&L,1,H317:1
81386,"8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo[2,3-b:2',3'-m]triphenodioxazine",259-444-0,55034-80-5,Not Classified,Notified C&L,5,Not classified:5
81392,1-bromo-3-iodobenzene,209-703-9,591-18-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:43;H315:49
81393,"Micrococcus tetragenus, lysate",295-793-5,92128-93-3,Not Classified,Notified C&L,1,Not classified:1
81395,"1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo-, ester with phenyl(2,3,4-trihydroxyphenyl)methanone",270-931-7,68510-93-0,Flam. Sol. 2;Self-react. D;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,60,H412:5;H242:5;H315:5;H228:5;Not classified:55;H351:1
81399,Bis(4-chlorobenzoic) anhydride,212-335-1,790-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81401,2-chloro-5-nitrophenol,210-579-3,619-10-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
81404,"Naphthenic oils (petroleum), catalytic dewaxed heavy;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-172-3,64742-68-3,Carc. 1B,Harmonised C&L,0,H350:0
81405,"Geranium macrorrhizum, ext.",296-192-0,92347-05-2,Asp. Tox. 1,Notified C&L,76,H304:74;Not classified:2;H317:1
81408,"Fatty acids, C18-unsatd., dimers, polymers with piperazine and polypropylene glycol monoacrylate ether with glycerol (3:1)",600-302-8,1023312-83-5,Not Classified,Notified C&L,22,Not classified:22
81414,Diiron magnesium tetraoxide,235-107-3,12068-86-9,Not Classified,REACH registration C&L,49,Not classified:49
81424,"N,N-dichlorobenzenesulphonamide",207-461-9,473-29-0,Not Classified,Notified C&L,5,Not classified:3;H319:1;H271:1;H315:2;H302:1
81426,"Alcohols, C6-12, ethoxylated propoxylated",614-825-4,68937-66-6,Not Classified,Notified C&L,172,Not classified:127;H318:34;H411:20;H400:20;H302:30;H315:20;H319:11
81429,"Acetic acid, chloro-, sodium salt, reaction products with 4,5-dihydro-2-undecyl-1H-imidazole-1-ethanol and sodium hydroxide",271-794-6,68608-66-2,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,584,H319:543;H412:12;Not classified:41
81430,"α,α,4-trimethylcyclohexene-1-methanol",242-365-0,18479-65-7,Skin Irrit. 2,Notified C&L,10,H315:10
81431,2-(4-methylthiazol-5-yl)ethyl acetate,211-515-7,656-53-1,Acute Tox. 4,Notified C&L,1421,H332:1286;Not classified:89;H319:45;H335:45;H315:46;H317:1
81433,4-thiacyclohexanone,214-015-7,1072-72-6,,Notified C&L,11,H319:10;H335:5;H315:5;Not classified:1
81436,L-arabinopyranose,201-767-6,87-72-9,Not Classified,Notified C&L,4,Not classified:4
81438,1-propylbutylamine,240-814-5,16751-59-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,4,H226:3;H314:4;H225:1;H318:1
81440,"4,7-Methano-1H-indene-2-carboxaldehyde, octahydro-5-methoxy-",617-923-5,86803-90-9,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,316,H319:194;H411:316;H317:316
81441,fluorosulphonic acid,232-149-4,7789-21-1,Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H332:0;H314:0
81443,Methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate,262-204-8,60376-73-0,Not Classified,Notified C&L,1,Not classified:1
81446,"Phosphoric acid, ammonium salt",233-330-0,10124-31-9,Not Classified,Notified C&L,3,Not classified:3
81449,(Z)-3-hexenyl cinnamate,268-702-1,68133-75-5,Not Classified,Notified C&L,89,Not classified:89
81451,Deuterium bromide,236-894-6,13536-59-9,Skin Corr. 1A;Acute Tox. 3;STOT SE 3,Notified C&L,42,H335:42;H314:42;H331:38
81455,"1,2-dimethoxyethane;ethylene glycol dimethyl ether;EGDME",203-794-9,110-71-4,Flam. Liq. 2;Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H332:0;H360:0;H225:0
81456,"9,10-Anthracenedione, 1-[(2-ethylhexyl)amino]-4-(pentylamino)-, branched and linear",294-185-7,91696-30-9,Not Classified,Notified C&L,33,Not classified:33
81460,dialuminium nickel tetraoxide,234-454-8,12004-35-2,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H372:0;H317:0;H350:0
81463,"Fatty acids, C6-16",305-753-1,95009-26-0,Not Classified,Notified C&L,1,Not classified:1
81471,2-mercaptoethanol,200-464-6,60-24-2,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,746,H373:265;H317:346;H318:427;H310:310;H361:108;H331:375;H411:412;H400:374;H301:380;H315:397;H311:431;H302:361;H332:220;H314:255;H410:252;H319:59;H336:47;H330:49;H371:25;H335:30;Not classified:8
81472,"Kerosine (petroleum), straight-run wide-cut;Straight run kerosine;[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 °C to 220 °C (158 °F to 428 °F).]",295-418-5,92045-37-9,Asp. Tox. 1,Harmonised C&L,0,H304:0
81476,"Propanedioic acid, 1,3-diethyl ester, polymer with 1,3-benzenedimethanamine, 2-(chloromethyl)oxirane and 4,4'-(1-methylethylidene)bis[phenol], reaction products with glycidyl tolyl ether and isocyanatobenzene",613-745-7,651031-40-2,Not Classified,Notified C&L,71,Not classified:71
81477,"Myo-Inositol, hexakis(dihydrogen phosphate), sodium salt",238-242-6,14306-25-3,Acute Tox. 4,REACH registration C&L,33,H302:30;Not classified:8;H319:12;H335:12;H315:12
81484,3-chloro-5-fluorophenol,606-511-0,202982-70-5,,Notified C&L,8,H302:6;H312:6;H314:6;H411:6;H319:2;H335:2;H315:2
81486,Ethylcyclohexane,216-835-0,1678-91-7,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,235,H225:229;H336:138;H304:202;H411:9;H400:8;H334:8;H410:8;Not classified:6
81487,"2-(tricyclo(3.3.1.1'3,7)dec-1-yl)ethanol",228-353-8,6240-11-5,,Notified C&L,1,H319:1;H335:1;H315:1
81498,Ethyl(2-naphthyl)amine,219-437-5,2437-03-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,38,H302:38;H319:38;H411:38
81500,"α,3,3-trimethylcyclohexanemethanol",246-736-8,25225-09-6,Not Classified,Notified C&L,234,Not classified:234
81503,6-bromohexanoic acid,224-176-5,4224-70-8,Skin Corr. 1B,Notified C&L,49,H314:49;H290:1;H318:1;H302:1;H332:1;H312:1
81505,Methylphosphonothioic dichloride,211-636-5,676-98-2,Skin Corr. 1B,Notified C&L,38,H314:38
81508,pentyl formate,211-340-6,638-49-3,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H226:0;H335:0
81509,(5S)-5-(hydroxymethyl)pyrrolidin-2-one,605-678-7,17342-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
81510,"4,5,6,7-tetrahydro-1H-benzotriazole",229-858-6,6789-99-7,Eye Dam. 1,REACH registration C&L,88,H318:87;H302:1;H319:1;H335:1;H315:1
81514,"3-[[4-[benzylmethylamino]phenyl]azo]dimethyl-1H-1,2,4-triazolium trichlorozincate(1-)",258-166-7,52769-39-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,10,H302:7;H412:8;H318:9;Not classified:1;H411:1
81516,2-(2-aminoethyl)-5-methoxyindole,222-778-2,3610-36-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,3,H317:3;H314:3;H318:1
81522,p-nitrophenyl-2-aminothiazol-5-ylsulphone,254-515-2,39565-05-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
81524,"Hexasodium 4,4'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-morpholino-1,3,5-triazine-4,2-diyl]imino]]bis[5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate]",241-769-4,17791-81-0,Not Classified,REACH registration C&L,140,Not classified:138;H335:1;H317:2;H334:1
81525,Thiophene-2-carbaldehyde oxime,249-778-5,29683-84-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
81528,"Formaldehyde polymer with 1,3-benzenediol and ethenylbenzene",603-888-3,135020-80-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
81530,Glycollonitrile,203-469-1,107-16-4,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1,Notified C&L,94,H300:94;H310:94;H330:94
81534,2-chloro-6-fluorobenzamide,266-123-9,66073-54-9,,Notified C&L,5,H319:5;H335:5;H315:5
81538,1-methylpyrrole,202-513-7,96-54-8,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,1521,H302:1368;H335:1502;H315:1521;H225:132;H319:85;Not classified:2
81540,1-bromobut-2-ene,225-332-5,4784-77-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H225:1
81541,"Sugar, invert",232-393-1,8013-17-0,Not Classified,REACH registration C&L,133,Not classified:133
81542,"Benzenesulfonic acid, 2-methyl-5-nitro-, alkaline condition products, diethanolamine salt",280-199-0,83155-77-5,Not Classified,Notified C&L,9,Not classified:9
81543,"Ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate",606-885-5,2199-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81545,"2-[[4-(diethylamino)-2-methylphenyl]azo]-5-methylbenzene-1,3-dicarbonitrile",278-104-2,75198-96-8,,Notified C&L,36,Not classified:36
81546,"Oils, lard, sulfated, ammonium salts",293-391-4,91079-06-0,Eye Dam. 1,REACH registration C&L,6,H318:2;Not classified:4
81548,"Tetrasodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate",219-746-5,2519-30-4,Not Classified,REACH registration C&L,17,Not classified:16;H319:1;H410:1;H315:1;H400:1
81550,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (CAS: 101-68-8) and Octylamine (111-86-4)",924-173-5,,Not Classified,Notified C&L,1,Not classified:1
81554,Oleoyl chloride,204-005-0,112-77-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,63,H302:3;H290:4;H314:63;H318:1;H332:2
81557,Nitrosylsulphuric acid,231-964-2,7782-78-7,Skin Corr. 1A,REACH registration C&L,163,H314:163;H271:106;H272:51;H311:38;H331:38;H301:39;H318:3;H330:1;H290:1
81558,N-(tert-Butoxycarbonyl)-4-cyano-L-phenylalanine,603-503-9,131724-45-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H332:1;H315:1
81560,Succinimido (4-nitrophenyl)acetate,268-551-1,68123-33-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
81561,Sodium 2-[methyl(1-oxododecyl)amino]ethanesulphonate,224-388-8,4337-75-1,Eye Irrit. 2,REACH registration C&L,3,H319:3
81562,"Enzymatic Hydrolysate of Soy, Papain",919-030-9,,Not Classified,Notified C&L,1,Not classified:1
81564,cyclohexyldimethoxymethylsilane,402-140-1,17865-32-6,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
81567,Butonate,204-778-4,126-22-7,Acute Tox. 4,Notified C&L,38,H302:38
81570,2-chloro-3-nitrobenzoic acid,223-590-3,3970-35-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
81571,Benzylhydrazine dihydrochloride,243-887-1,20570-96-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,46,H302:4;H319:46;H317:3;H315:46;H335:42;H301:2
81572,butan-1-ol;n-butanol,200-751-6,71-36-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,Harmonised C&L,0,H335:0;H318:0;H336:0;H302:0;H226:0;H315:0
81574,"3-(4,7,7-trimethylbicyclo[4.1.0]hept-3-ylidene)propiononitrile",272-321-6,68804-02-4,Acute Tox. 4,Notified C&L,1,H302:1
81576,2-methyl-5-nitro-1H-imidazole-1-ethyl benzoate,236-131-7,13182-89-3,Not Classified,Notified C&L,59,Not classified:52;H319:1;H335:1;H315:1;H350:2;H302:3;H332:2;H373:1;H312:2;H351:2;H341:2
81581,3-tert-butylcyclohexyl acetate,250-837-2,31846-06-7,Skin Irrit. 2,Notified C&L,1401,H315:1401
81582,Ethylenediamine sulphate (1:1),244-733-6,22029-36-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,4,H317:3;H319:4;H315:4;H311:2
81585,"Sulfurous acid, sodium salt (1:1), polymer with 2-butene-1,4-diol and 2-methyloxirane",616-264-0,75790-77-1,Not Classified,Notified C&L,25,Not classified:25
81586,"2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulphonyl]ethyl hydrogen sulphate",258-042-2,52610-09-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3
81587,"2-(1,3-benzodioxol-5-ylamino)ethanol hydrochloride",303-085-5,94158-14-2,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,45,H319:7;H373:42;H317:42;H411:42;H302:9
81588,1-(1H-pyrrol-2-yl)ethan-1-one,214-016-2,1072-83-9,Skin Irrit. 2,Notified C&L,1438,H315:1413;H302:42;H335:59;Not classified:25;H319:20
81590,2-butoxy-1-methylethyl acetate,287-147-6,85409-76-3,Not Classified,Notified C&L,1,Not classified:1
81592,Quinuclidin-3-one hydrochloride,214-776-5,1193-65-3,Aquatic Chronic 2,REACH registration C&L,97,H411:93;H319:2;H335:2;H315:2;H302:1;H332:1;H312:1;Not classified:1
81596,[No public or meaningful name is available],458-430-3,,Skin Irrit. 2,REACH registration C&L,2,H315:2
81597,1-bromo-4-(methylsulphonyl)benzene,222-421-0,3466-32-8,,Notified C&L,8,H319:8;H335:7;H315:8
81602,"4-PIPERIDINOL,1-HYDROXY-2,2,6,6-TETRAMETHYL-",609-238-5,3637-10-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,3,H302:3;H412:2;H373:1;H318:1
81604,"2,4,6-tris(nonadecafluorononyl)-1,3,5-triazine",260-560-9,57101-59-4,Acute Tox. 4,Notified C&L,40,H332:39;H319:1;H335:1;H315:1;H302:1;H312:1
81608,"Octadecanoic acid, reaction products with diethylenetriamine, formates",284-700-3,84962-06-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
81609,"Magnesium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']magnesate(2-)",254-436-3,39377-66-7,Not Classified,Notified C&L,1,Not classified:1
81610,Methyl-2-thiourea,209-936-6,598-52-7,Acute Tox. 2,Notified C&L,47,H300:45;H361:5;H301:2;H330:1;H411:1
81612,Dienestrol,201-519-7,84-17-3,Carc. 1B;Repr. 2,Notified C&L,39,H361:38;H350:39
81614,"(2,4-difluorophenyl)acetonitrile",211-514-1,656-35-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:46;H335:45;H312:45;H302:45;H332:45;H315:46;H311:2;H330:1;H301:2;H331:1;H227:1
81617,p-nitrobenzyl thiocyanate,236-299-1,13287-49-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
81620,"Xanthylium, 3,6-bis(ethylamino)-9-[2-(methoxycarbonyl)phenyl]-2,7-dimethyl-, molybdatetungstatephosphate",289-056-7,85959-61-1,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,105,H410:18;H400:18;H301:1;H319:83;H412:83;Not classified:4
81621,Methyl 4-oxovalerate,210-846-4,624-45-3,Not Classified,Notified C&L,122,Not classified:89;H319:33;H335:33;H315:33
81628,Ethyl 3-(dimethylamino)butyrate,285-681-4,85118-28-1,,Notified C&L,2,H319:1;H335:2;H315:1;H227:1;H314:1
81632,reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II),424-270-8,,Eye Dam. 1,Harmonised C&L,0,H318:0
81636,(DHQD)2PHAL sulfate,604-213-5,140924-51-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H317:38;H319:38;H335:38;H315:38;H302:1;H332:1;H410:1;H312:1
81639,"Reaction products of 3-aminomethyl-3,5,5-trimethylcyclohexylamine with 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane",614-657-1,68609-08-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,114,H302:13;H411:36;H317:18;Not classified:54;H318:19;H314:24
81640,Retinyl propionate,230-363-2,7069-42-3,Repr. 1B;Aquatic Chronic 4,Notified C&L,193,H413:157;H360:157;Not classified:36;H372:35;H315:1
81642,(R)-(-)-1-Benzyl-3-hydroxypiperidine,618-772-8,91599-81-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H301:38
81645,D-gluconic acid 6-(dihydrogen phosphate),213-069-9,921-62-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H332:38;H311:1;H331:1;H301:1
81646,Dibutylthioxostannane,224-220-3,4253-22-9,Acute Tox. 3,Notified C&L,101,H301:86;H335:20;H317:20;H318:20;H341:21;H372:21;H360:21;H400:21;H370:20;H410:21;H315:34;H319:14;H373:14;H312:15;H411:14;H302:15;H330:4;H311:4
81648,3-bromoaniline,209-704-4,591-19-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:45;H335:39;H312:40;H302:45;H315:46;H373:6;H311:7;H332:6;H331:1;H301:2;H330:1
81652,Trimethylsilyl trimethylsilylcarbamate,252-520-4,35342-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
81654,tri-methylamine ;tri-methylamine ... %,200-875-0,75-50-3,,,0,H335:0;H318:0;Not classified:0;H220:0;H332:0;H315:0
81656,"2,5-di-tert-butyl-p-benzoquinone",219-552-0,2460-77-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,REACH registration C&L,81,H302:1;H317:1;H400:1;H319:80;H335:79;H315:80
81657,"Tetradecanoic acid, ester with 1,2,3-propanetriol",234-397-9,11140-02-6,Not Classified,Notified C&L,1,Not classified:1
81659,"3-chloromethyl-1,2,4-triazolin-5-one",607-678-2,252742-72-6,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;Muta. 2;Carc. 2,Notified C&L,2,H319:1;H341:2;H302:2;H351:2;H314:2;H335:1
81660,Tetraethylammonium hydrogen sulphate,240-899-9,16873-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
81666,"2,2'-[[5-acetamido-4-[(2-chloro-4,6-dinitrophenyl)azo]-2-methoxyphenyl]imino]diethyl diacetate",222-814-7,3618-73-3,Not Classified,REACH registration C&L,17,Not classified:17
81670,Vinyl crotonate,238-930-6,14861-06-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H226:39;H335:38;H315:39
81676,"Corn, flour",271-199-1,68525-86-0,Not Classified,Notified C&L,3,Not classified:3
81678,Norpseudoephedrine hydrochloride,218-446-1,2153-98-2,Acute Tox. 4,Notified C&L,90,H302:90
81680,"reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid",435-440-6,,Eye Dam. 1,Harmonised C&L,0,H318:0
81681,3-methylbutyl isobutyrate,218-078-1,2050-01-3,Flam. Liq. 3,Notified C&L,1502,H226:1502
81682,"Hedychium flavum, ext.",305-088-7,94334-08-4,Not Classified,Notified C&L,1,Not classified:1
81683,"Acetic acid, antimony(3+) salt (3:1)",609-246-9,3643-76-3,,Notified C&L,4,H302:4;H332:4;H411:4
81684,"Phosphoric acid, C12-20-alkyl esters",298-691-9,93821-07-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
81686,3-indoleacetic acid hydrazide,226-672-7,5448-47-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:40;H319:39;H335:39;H315:39;H332:1;H312:1
81692,3-bromobenzophenone,213-808-5,1016-77-9,,Notified C&L,5,H319:5;H335:5;H315:5
81694,"[R-[R*,R*-(E)]]-3,7,11,15-tetramethylhexadec-2-enyl acetate",233-565-9,10236-16-5,Not Classified,Notified C&L,89,Not classified:89
81696,"Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate",224-823-1,4506-71-2,,Notified C&L,5,H319:5;H335:5;H315:5;H312:1;H302:1;H332:1
81698,9H-fluoren-9-yllithium,212-918-0,881-04-9,Skin Corr. 1A,Notified C&L,26,H314:26
81699,"Furandione, telomer with ethylbenzene and (1-methylethyl)benzene",607-996-1,26762-29-8,,Notified C&L,75,Not classified:54;H319:21
81702,Ar-(allyloxy)benzenetrimethanol,264-632-0,64051-40-7,Not Classified,Notified C&L,59,Not classified:59
81704,Disodium (sulphonatothio)acetate,249-615-8,29419-39-4,Acute Tox. 3;Eye Irrit. 2,Notified C&L,83,H319:83;H301:83
81705,"2,2-diethoxyethanol",210-697-5,621-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40;H227:1
81706,1-(1-Methyl-4-piperidinyl)piperazine,607-300-6,23995-88-2,Skin Corr. 1B,Notified C&L,44,H314:43;H319:1;H335:1;H312:1;H302:1;H332:1;H315:1;H318:1
81712,"Oils, mimosa",617-051-5,8031-03-6,Acute Tox. 4;Acute Tox. 3;Aquatic Chronic 3,Notified C&L,138,H302:138;H311:138;H412:138
81714,Boron zinc hydroxide oxide,604-070-9,138265-88-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,254,H410:138;H400:236;H361:124;H411:63;Not classified:16;H319:15
81715,"Aluminum, benzoate C16-18-fatty acids complexes",303-385-6,94166-87-7,Not Classified,REACH registration C&L,73,Not classified:73
81716,Retinyl acetate,204-844-2,127-47-9,Repr. 1B;Aquatic Chronic 4,REACH registration C&L,350,H413:216;H360:198;H361:149;H315:239;H341:2;H350:2;H411:1;Not classified:2;H226:1
81722,Gadolinium orthovanadate,237-113-1,13628-52-9,Not Classified,Notified C&L,2,Not classified:1;H332:1
81724,D-(-)-2-aminobutyric acid,220-084-4,2623-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81725,o-iodobenzylamine hydrochloride,255-777-0,42365-45-7,Eye Dam. 1,Notified C&L,38,H318:38
81726,"Disodium 3-[[4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulphonato-1-anthryl)amino]phenoxy]sulphonyl]benzoate",255-174-2,41011-48-7,Not Classified,Notified C&L,2,Not classified:2
81731,"Fats and Glyceridic oils, Euterpe oleracea",617-812-1,861902-11-6,Not Classified,Notified C&L,2,Not classified:2
81733,Disodium 2-oxoglutarate,206-167-8,305-72-6,Not Classified,REACH registration C&L,2,Not classified:2
81736,"Alcohols, C6-12, ethoxylated",500-475-9,161025-19-0,Eye Dam. 1,Notified C&L,3,H318:3
81737,N-cyclohexylaniline,217-344-4,1821-36-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,76,H302:43;H332:39;H312:39;H317:32;H319:5;H335:5;H315:5;H311:1;H331:1;H301:1
81738,"Alcohols, C10-16, ethoxylated, sulfates, magnesium salts",500-173-7,67762-21-4,Not Classified,Notified C&L,2,Not classified:1;H318:1;H315:1
81743,"Naphthalenesulfonic acid, polymer with formaldehyde, calcium salt",609-392-3,37293-74-6,Not Classified,Notified C&L,117,Not classified:117
81745,"Benzoic acid, 2-chloro-5-iodo-, ethyl ester",608-282-2,289039-54-9,,Notified C&L,2,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
81747,"7-[(4,6-bis{[3-(diethylammonio)propyl]amino}-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(E)-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)diazenyl]naphthalene-2-sulfonate 2-hydroxypropanoate",455-600-9,790240-84-5,Aquatic Chronic 3,REACH registration C&L,40,H412:40
81750,"O,O-bis(methylphenyl) hydrogen dithiophosphate",248-273-7,27157-94-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,1,H311:1;H314:1;H301:1
81751,3-methyl-1-(p-tolyl)-1H-pyrazol-5-amine,263-586-9,62535-60-8,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1
81753,"Shellac, potassium salt",307-772-0,97722-21-9,Not Classified,Notified C&L,1,Not classified:1
81758,Chromic nitrate nonahydrate,616-540-0,7789-02-8,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,74,H319:73;H315:69;H272:74;H302:30;H332:5;H411:1;H317:1
81761,Ethyl heptafluorobutyrate,206-602-1,356-27-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H225:43
81766,"5-(2-bromoacetyl)-1,3-phenylene diacetate",253-193-0,36763-39-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H302:2;H319:3;H315:3;H335:1
81767,Di-tert-butyl azodicarboxylate,212-796-9,870-50-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:49;H335:48;H315:49;Not classified:6;H228:2;H411:1
81768,4-chloro-6-methylpyrimidin-2-ylamine,227-018-3,5600-21-5,,Notified C&L,9,H319:9;H335:8;H315:9
81769,"Acetamide, N,N'-(2,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl)bis-",616-187-2,7510-09-0,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,83,H302:83;H411:83;H318:83
81772,Carbromal,201-046-6,77-65-6,Acute Tox. 4,Notified C&L,1,H302:1
81777,Bis(1-methylethyl) methylphosphonate,215-896-0,1445-75-6,Acute Tox. 4,Notified C&L,76,H302:76;H319:38;H335:5;H315:5
81781,Hydroxyacetone,204-124-8,116-09-6,Flam. Liq. 3,REACH registration C&L,220,H226:65;Not classified:155;H312:3;H332:3
81783,"Benzoic acid, 3-fluoro-, methyl ester",610-262-3,455-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81786,"(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro- 14,17dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carbothioic S-acid",617-081-9,80473-92-3,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,3,H412:2;H317:3
81790,"5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulphonyl)-phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-on",604-158-7,139755-83-2,Eye Irrit. 2,Notified C&L,71,H319:40;H302:32;H412:31;H335:2;H315:2
81793,4-methyl-1-phenylpentan-1-one,218-079-7,2050-07-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
81795,"N,N'-(10,15,16,17-tetrahydro-5,10,15,17-tetraoxo-5H-dinaphtho[2,3-a:2',3'-i]carbazole-4,11-diyl)bis(benzamide)",219-167-8,2379-78-4,Not Classified,Notified C&L,13,Not classified:13
81798,Dialuminium zinc tetraoxide,235-101-0,12068-53-0,Aquatic Chronic 2,REACH registration C&L,33,H411:1;Not classified:32
81799,"Pineapple, ext.",272-839-2,68917-26-0,Flam. Liq. 3,Notified C&L,1388,H226:1311;Not classified:27;H224:25;H225:25
81801,C.I. Acid Brown 236,601-864-7,12217-26-4,Not Classified,Notified C&L,1,Not classified:1
81809,"Charcoal, coconut shell",271-974-4,68647-86-9,Not Classified,REACH registration C&L,63,Not classified:62;H228:1
81812,"2-Butene-1,4-diol, polymer with methyloxirane",600-445-6,103513-08-2,Acute Tox. 4;Skin Irrit. 2,Notified C&L,25,H302:25;H315:25
81813,Gallium telluride,234-690-1,12024-14-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,264,H302:212;H319:208;H335:208;H315:208;H332:56;H301:52
81816,Methyl L-isoleucinate hydrochloride,242-437-1,18598-74-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
81819,"Disodium 2-[[1-(2-chloro-5-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]naphthalene-1-sulphonate",228-815-9,6359-95-1,Not Classified,Notified C&L,9,Not classified:9
81822,Ethyldimethylpropylammonium bromide,283-728-3,84697-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
81824,"Iron(3+) chloride, hexahydrate",600-047-2,10025-77-1,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,110,H302:109;H412:40;H314:55;H318:54;H315:53;H290:25;Not classified:1
81826,Trimethyl citrate,216-449-2,1587-20-8,Not Classified,REACH registration C&L,3,Not classified:3
81827,"cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride",216-906-6,1694-82-2,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0
81829,2-tert-butyl-5-methylanisole,201-827-1,88-40-4,Not Classified,Notified C&L,126,Not classified:88;H302:38;H319:38;H413:38
81832,tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters,430-310-5,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
81834,"3,5-Difluor-4-(2,2-difluorethenyloxy)-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl",619-967-0,197956-59-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
81835,"Sodium α,4-dihydroxy-3-methoxy-α-methylbenzeneethanesulphonate",280-515-7,83682-27-3,Skin Sens. 1,Notified C&L,62,H317:62
81841,"2,5-difluorobenzonitrile",264-753-9,64248-64-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:46;H335:43;H312:43;H302:43;H332:43;H315:46;H311:3;H331:3;H228:1;H301:3
81842,6-chloro-7H-purin-2-ylamine,233-686-7,10310-21-1,Not Classified,Notified C&L,39,Not classified:33;H319:2;H335:3;H315:2;H302:3;H332:2;H312:1;H360:1;H412:1;H350:1;H362:1;H341:1;H318:1
81845,Fluorene,201-695-5,86-73-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,21,H410:11;H400:15;Not classified:3;H411:1;H319:2;H335:2;H315:2;H317:1;H302:1
81848,N-cyclohexylsulphamic acid,202-898-1,100-88-9,Not Classified,REACH registration C&L,28,Not classified:7;H319:20;H315:20;H302:1
81851,2-(2-ethoxyethoxy)ethan(2H)ol,253-502-9,37421-08-2,Acute Tox. 3,Notified C&L,38,H331:38
81854,"1-[4-(phenylthio)phenyl]octane-1,2-dione 2-(O-benzoyloxime)",454-610-0,253585-83-0,Skin Sens. 1,Notified C&L,84,H317:84
81857,"3,3,5-trimethylcyclohexaneacetic acid",221-727-1,3213-73-8,Not Classified,Notified C&L,88,Not classified:88
81860,"Phosphoric acid, C12-14-alkyl esters, compds. with diethanolamine",291-879-1,90506-20-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:3;H315:3;Not classified:1
81864,o-phenylene di(acetate),211-240-2,635-67-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
81869,"(2S,3S,4R)-2-aminooctadecane-1,3,4-triol",439-210-6,554-62-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H410:8;H318:8;H400:8
81870,"(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol",258-611-5,53531-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
81873,Undecan-4-olide,203-225-4,104-67-6,Aquatic Chronic 3,REACH registration C&L,2213,H412:431;Not classified:1536;H411:229;H319:69;H335:56;H315:69
81875,"(chlorophenyl)(chlorotolyl)methane, mixed isomers",400-140-6,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
81877,"diphacinone (ISO);2-diphenylacetylindan-1,3-dione",201-434-5,82-66-6,Acute Tox. 2;STOT RE 1,Harmonised C&L,0,H300:0;H372:0
81879,2-hydroxynaphthalene-1-carbaldehyde [(2-hydroxy-1-naphthyl)methylene]hydrazone,219-210-0,2387-03-3,Aquatic Chronic 2,REACH registration C&L,181,H411:95;Not classified:48;H319:38;H413:38
81881,3-(pyrrol-1-yl)propiononitrile,256-051-6,43036-06-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H312:38;H302:38;H332:38;H315:38
81883,Krypton,231-098-5,7439-90-9,Press. Gas (Comp.),Notified C&L,509,H280:265;H281:244
81885,N-Boc-L-Pyroglutamic acid ethylester,604-450-4,144978-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:1
81888,"1,2-dibromoethylene",208-747-6,540-49-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H315:39;H301:42;H314:3;Not classified:1
81891,"Lignosulfonic acid, ethoxylated, sodium salts",614-669-7,68611-14-3,Eye Irrit. 2;STOT SE 3,Notified C&L,160,H319:160;H335:160;H315:2
81892,"Octane-1,8-diol",211-090-8,629-41-4,,Notified C&L,43,Not classified:41;H302:1;H319:1;H335:1;H315:1;H228:1
81894,"Disodium 4-amino-5-hydroxy-3-(4-nitrophenylazo)naphthalene-2,7-disulphonate",260-178-2,56431-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
81896,"Formamide, N,N'-1,4-phenylenebis-, reaction products with 4-methyl-1,3-benzenediamine and sulfur, leuco derivatives",276-059-3,71838-68-1,Not Classified,REACH registration C&L,39,Not classified:39
81897,6-chloro-1H-indole-2-carboxylic acid,240-799-5,16732-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H302:1
81900,"Cyanoguanidine, polymer with formaldehyde",608-036-4,27026-90-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H302:2;H411:2;H317:2
81904,"3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine",252-091-3,34562-31-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,238,H319:236;H400:7;H302:230;H410:3;H315:236;H335:112;H312:218;H413:55;Not classified:1;H412:1
81906,"Bis(2-aminoethanol), diester with boric acid",244-852-3,22232-01-5,Not Classified,Notified C&L,1,Not classified:1
81916,"Phosphorylase, purine nucleoside",232-857-3,9030-21-1,Resp. Sens. 1,Notified C&L,36,H334:35;Not classified:1
81919,"4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)thio]-N-(3-ethoxypropyl)benzenesulphonamide",286-881-4,85392-23-0,Not Classified,Notified C&L,2,Not classified:2
81922,"N-(3-chloropropyl)-3,4-dimethoxy-N-methylphenethylamine",253-198-8,36770-74-8,,Notified C&L,1,H302:1
81928,Sodium 2-[2-[2-(octylphenoxy)ethoxy]ethoxy]ethanesulphonate,267-791-4,67923-87-9,Not Classified,Notified C&L,5,Not classified:5
81930,Sodium 3-[[4-(benzoylethylamino)-2-methylphenyl]azo]-4-hydroxynaphthalene-1-sulphonate,228-358-5,6245-59-6,Not Classified,REACH registration C&L,24,Not classified:24
81932,3-Chloro-bicyclo[3.2.1]oct-3-en-2-ol,618-327-8,90003-08-0,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,Notified C&L,156,H302:156;H226:156;H318:156
81933,"9-Octadecenoic acid (Z)-, reaction products with triethanolamine",291-755-7,90480-23-2,Not Classified,Notified C&L,25,Not classified:24;H319:1;H315:1
81937,"Fatty acids, olive-oil, Me esters",297-429-0,93572-01-1,Not Classified,Notified C&L,2,Not classified:2
81938,Dipropyl oxalate,210-456-4,615-98-5,Not Classified,Notified C&L,1,Not classified:1
81942,"7-anilino-4-hydroxy-3-[[6-methoxy-4-[(6-sulpho-2,4-xylyl)azo]-m-tolyl]azo]naphthalene-2-sulphonic acid, sodium salt, compound with 2,2',2''-nitrilotriethanol",303-757-8,94213-53-3,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Repr. 2,REACH registration C&L,56,H302:6;H319:6;H361:6;H317:6;Not classified:50
81947,"Exo-2-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)oxy]ethanol",230-364-8,7070-15-7,Not Classified,Notified C&L,140,Not classified:140
81949,Diammonium hexachlorotellurate(2-),240-931-1,16893-14-4,Skin Corr. 1B,Notified C&L,38,H314:38
81951,Morclofone,250-838-8,31848-01-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
81953,Sodium 4-hydroxy-3-[[3-(phenylsulphamoyl)-p-tolyl]azo]naphthalenesulphonate,221-298-0,3058-98-8,Aquatic Chronic 3,Notified C&L,11,H412:10;Not classified:1
81954,Butyl D-glucoside,250-608-7,31387-97-0,Not Classified,Notified C&L,86,Not classified:86
81958,Dimethyl fumarate,210-849-0,624-49-7,Acute Tox. 4,Notified C&L,142,H312:142;H317:51;H319:52;H315:55;H335:10;H411:3;H318:3;H302:1;H332:1;H361:1
81960,Bis-(5-amino-2-hydroxybenzoic acid) sulfate,616-280-8,760108-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
81962,"Hydrocarbons, C5-unsatd.",273-308-8,68956-55-8,Flam. Liq. 1;Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;STOT SE 3;Muta. 1B;Carc. 1A;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,4,H319:4;H335:4;H311:2;H361:4;H372:2;H331:2;H336:4;H304:4;H350:3;H224:4;H400:4;H301:2;H411:4;H340:3;H315:4;H373:1;H312:1;H302:2;H341:1;H351:1;H332:1
81963,2-(tert-butylthio)ethylammonium chloride,262-065-3,60116-77-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
81966,"1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[3-(3,4,5-trimethoxyphenyl)acryloyl]piperazine monomaleate",247-613-1,26328-04-1,Acute Tox. 4,Notified C&L,1,H302:1
81968,4-nitro-1H-benzotriazole,228-579-7,6299-39-4,Muta. 1A;Aquatic Chronic 2,Notified C&L,2,H340:1;H411:2
81969,"1,2-dichloro-4-(trichloromethyl)benzene",235-869-7,13014-24-9,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,6,H302:5;H412:2;H413:3;H335:3;H314:4;H318:1
81970,Pyridoxal,200-630-8,66-72-8,Acute Tox. 4,Notified C&L,38,H302:38
81972,2-cyclohexylcyclohexanone,201-991-4,90-42-6,Aquatic Chronic 2,Notified C&L,258,H411:258
81974,"Cobalt, isooctanoate naphthenate complexes",282-767-3,84418-55-3,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H400:1
81975,Desomorphine,207-045-7,427-00-9,Acute Tox. 4,Notified C&L,38,H302:38
81978,Mebutamate,200-587-5,64-55-1,Acute Tox. 4,Notified C&L,1,H302:1
81980,"Ethyl(phenylethyl)benzene, mono-ar-ethyl derivative",269-971-8,68398-19-6,Not Classified,Notified C&L,5,Not classified:5
81982,3-iodopyridine,214-322-6,1120-90-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48;H312:1;H302:1;H332:1
81985,dibutyltin hydrogen borate,401-040-5,75113-37-0,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H317:0;H318:0;H341:0;H372:0;H312:0;H360:0;H400:0;H302:0;H410:0
81986,"Reaction mass of Di-μ-thio-[{bis(2-ethylhexyl)carbamato-S,S’}oxo molybdenum(V)], Di-μ-thio-[{(2-ethylhexyl)carbamato-S,S’}{(branched ditridecyl)carbamato-S,S’}oxo molybdenum(V)] and Di-μ-thio-[{bis(branched ditridecyl)carbamato-S,S’}oxo molybdenum(V)]",441-570-4,,Skin Irrit. 2,REACH registration C&L,2,H315:2
81989,"4-allyl-2,6-dimethoxyphenol",229-600-2,6627-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,159,H319:159;H335:159;H315:159;H317:38
81992,Propyl nonan-1-oate,229-403-1,6513-03-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
81993,Sulfato de zinc monohydratado,616-096-8,7446-19-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,365,H302:365;H410:364;H318:364;H400:363;H314:25;H315:1
81996,"ethidimuron (ISO);1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea",250-010-6,30043-49-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
81997,m-nitrocinnamic acid,209-104-2,555-68-0,,Notified C&L,5,H319:5;H335:4;H315:5
81998,Samarium (III) chloride hexahydrate,233-797-0,10361-82-7,Skin Irrit. 2,Notified C&L,47,H315:44;H319:6;H335:4;H318:1;H290:1;H317:1;H411:2;Not classified:1
81999,"Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate",218-216-0,2082-79-3,Not Classified,REACH registration C&L,1563,Not classified:1097;H317:307;H319:100;H335:97;H315:102;H413:57;H412:2
82000,"(R)-1,1'-binaphthyl-2,2'-diol compound with (S)-5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole (1:1)",608-073-6,272776-12-2,Not Classified,Notified C&L,2,Not classified:1;H319:1;H412:1;H317:1
82001,"Amines, C12-22-alkyltrimethylenedi-, ethoxylated",603-061-7,125352-08-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,46,H319:46;H411:42;H302:4
82005,"α,α,α-trichlorotoluene;benzotrichloride",202-634-5,98-07-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 1B,Harmonised C&L,0,H335:0;H318:0;H331:0;H350:0;H302:0;H315:0
82009,"4,4,4-trifluoro-1-phenylbutane-1,3-dione",206-307-8,326-06-7,Not Classified,Notified C&L,4,Not classified:1;H319:3;H335:3;H312:2;H302:2;H332:2;H315:3
82013,"8-methoxy-3,4-methylenedioxy-10-nitrophenanthrene-1-carboxylic acid",206-238-3,313-67-7,Acute Tox. 3,Notified C&L,42,H301:42;H341:3;H311:3;H331:3;H351:3;H319:1;H335:1;H350:1;H315:1
82016,2-methylpent-2-en-1-yl acetate,217-416-5,1838-88-6,Flam. Liq. 3,Notified C&L,88,H226:88
82017,"4,4'-dinitrobiphenyl-2-ylamine",257-417-8,51787-75-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
82020,2-methyl-1-pentylpyridinium bromide,402-690-2,148292-41-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0;H312:0
82022,[(2-chlorophenyl)methylene]malononitrile,220-278-9,2698-41-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2B;Acute Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,62,H319:19;H335:19;H317:57;H330:18;H411:18;H400:56;H301:61;H315:19;H334:39;H302:1;H410:1
82024,"2,5-diamino-3,6-dichloro-p-benzoquinone",223-465-3,3908-48-3,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,83,H411:83;H301:83
82027,Erbium trichloride,233-385-0,10138-41-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H335:43;H315:43;Not classified:1;H411:1
82029,"Reaction mass of stereoisomers of 4-METHYLENE-2-(2,2,3-TRIMETHYL-CYCLOPENT-3-ENYLMETHYL)-TETRAHYDRO-PYRAN and; 4-METHYL-6-(2,2,3-TRIMETHYL-CYCLOPENT-3-ENYLMETHYL)-3,6-DIHYDRO-2H-PYRAN and; 4-METHYL-2-(2,2,3-TRIMETHYL-CYCLOPENT-3-ENYLMETHYL)-3,6-DIHYDRO-2H-PYRAN",484-040-8,,Aquatic Chronic 2,REACH registration C&L,2,H411:2
82035,Octadecyl palmitate,220-000-6,2598-99-4,Not Classified,Notified C&L,8,Not classified:8
82040,"(S)-8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid ethylester",605-801-4,177472-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82044,6-amino-1-propyluracil,258-697-4,53681-47-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82047,"Residues, silver-refining",308-309-5,97926-88-0,Not Classified,Notified C&L,1,Not classified:1
82052,3-methylpyrrolidin-2-one,219-865-2,2555-05-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H302:2;H319:2;H335:2;H315:2
82056,Sodium 2-(diethylamino)ethanolate,250-164-4,30381-48-7,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,26,H312:26;H228:26;H302:26;H332:26;H314:26
82057,"Orange, sour, ext.",277-143-2,72968-50-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1788,H317:1699;H304:1710;H411:95;H226:1425;H315:1700;H318:1498;H400:1373;H410:1405;H319:85;Not classified:39;H412:4;H225:1;H332:1;H335:1
82059,Bismuth nitrate pentahydrate,600-076-0,10035-06-0,Skin Irrit. 2,Notified C&L,103,H315:102;H319:47;H335:47;H272:48
82061,(Z)-hex-3-enyl pyruvate,268-703-7,68133-76-6,Not Classified,Notified C&L,89,Not classified:89
82063,"1,5-dimethylhex-4-enylamine",245-016-0,22462-79-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H302:1;H319:1;H335:1;H315:1
82068,"Fatty acids, animal, Bu esters, sulfurized",305-502-6,94581-04-1,Not Classified,Notified C&L,1,Not classified:1
82070,Hexadecyl(2-hydroxyethyl)dimethylammonium dihydrogen phosphate,287-619-1,85563-48-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,135,H318:97;H411:39;H315:135;H400:97;H410:96;H319:38
82071,Butyl hexanoate,210-964-6,626-82-4,Not Classified,Notified C&L,140,Not classified:140
82072,"Benzenediazonium, 2-carboxy-, hydroxide, inner salt, reaction products with formaldehyde-resorcinol condensate and 4-sulfobenzenediazonium hydroxide inner salt, sodium salts",286-251-9,85203-62-9,Not Classified,Notified C&L,2,Not classified:2
82078,"3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid",410-370-9,105488-33-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
82079,"Cyclopenta[c]pyrrole-1-carboxylic acid, 2-[(2S)-2-[[(2S)-2-amino-2-cyclohexylacetyl]amino]-3,3-dimethyl-1-oxobutyl]octahydro-, 1,1-dimethylethyl ester, (1S,3aR,6aS)-",618-869-5,926276-18-8,Skin Sens. 1;STOT RE 2,Notified C&L,1,H373:1;H317:1
82080,"N,N-dimethylmethacrylamide",230-240-3,6976-91-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
82082,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononyl acrylate",224-053-6,4180-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
82083,"Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N-C8-18-branched and linear alkyl, dihydrochlorides",309-301-4,100208-95-5,Not Classified,Notified C&L,6,Not classified:6
82084,"Trisodium 5-amino-3-[[4'-[(6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonate",229-152-8,6420-22-0,,Notified C&L,8,H302:8;H318:8
82085,"(Z)-2-(8-heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethylamine",243-882-4,20565-75-7,Skin Corr. 1C;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,8,H400:8;H411:8;H317:8;H314:8
82093,"Ammonium O,O-dimethyl dithiophosphate",213-922-5,1066-97-3,,Notified C&L,5,H302:4;H319:4;H335:4;H315:4;Not classified:1
82095,Debrisoquine sulphate,209-472-4,581-88-4,Acute Tox. 4,Notified C&L,38,H302:38
82096,(2S)-2-Amino-2-phenylethan-1-ol,606-683-7,20989-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,11,H319:10;H335:9;H315:10;H318:1;H314:1
82097,2-(Trifluoromethyl)-2-hydroxypropionic acid,609-428-8,374-35-6,Skin Corr. 1B,Notified C&L,6,H314:5;H290:1;H318:2;H319:1;H315:1
82098,methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate,406-250-0,72619-32-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
82101,Oleyl acetate,211-759-4,693-80-1,Not Classified,Notified C&L,2,Not classified:2
82107,(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid,431-520-1,64485-90-1,Flam. Sol. 1;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H351:0;H412:0;H228:0
82108,"Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-810-9,68478-30-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
82111,"Amines, tallow alkyl[3-(tetrahydropyrimidinyl)propyl]",296-557-4,92797-22-3,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1;H318:1;H314:1
82122,3-chlorobenzyl alcohol,212-847-5,873-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82124,"Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-",604-855-6,152459-95-5,Muta. 2;Carc. 2;Repr. 1B,REACH registration C&L,9,H351:7;H341:5;H360:5;H362:5;H319:1;H361:3;H315:1;H373:2;H411:2;H302:2
82125,Diisopropyl azodicarboxylate,219-502-8,2446-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,133,H319:81;H373:68;H335:79;H411:78;H315:81;Not classified:53;H351:2;H371:1;H302:1;H332:1
82129,Isoetarine mesilate,230-695-8,7279-75-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
82133,"2,5-dimethylfuran-3(2H)-one",238-365-5,14400-67-0,Acute Tox. 4,Notified C&L,1440,H302:1286;H319:143;H226:154;H315:143
82135,"Gasoline, pyrolysis",278-619-2,77097-78-0,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,8,H373:8;H335:8;H225:8;H361:8;H336:8;H304:8;H315:8
82139,"Tin, melting residues",283-659-9,84696-55-9,Carc. 1B;Aquatic Chronic 2,REACH registration C&L,8,H411:4;H350:4;Not classified:4
82140,2-octyldodecan-1-ol,226-242-9,5333-42-6,Not Classified,REACH registration C&L,366,Not classified:341;H319:25;H315:22;H335:1
82142,Nicotinamide N-oxide,217-859-4,1986-81-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
82144,N-phenylindan-2-amine,251-416-6,33237-72-8,Acute Tox. 4;Skin Irrit. 2,Notified C&L,2,H302:2;H315:2
82145,tebufenpyrad (ISO);N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide,601-585-0,119168-77-3,Acute Tox. 3;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H317:0;H400:0;H301:0;H332:0;H410:0
82147,"cis-Decahydro-1H,6H-3a,5a,8a,10a-tetraazapyrene",616-060-1,74199-16-9,,Notified C&L,5,H319:4;H335:4;H315:5
82149,"Dihydrogen bis[L-glutamato(2-)-N,O1]zincate(2-)",252-309-7,34992-53-5,Not Classified,Notified C&L,1,Not classified:1
82153,Allyl 2-pyridyl ether,227-409-9,5831-77-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38;H301:38
82154,"Potassium 3,6-dichloropyridine-2-carboxylate",261-302-8,58509-83-4,Aquatic Chronic 1,Notified C&L,89,H410:89
82159,"2,5-dimethyl-2-vinylhex-4-enal",260-006-6,56134-05-5,Not Classified,Notified C&L,89,Not classified:89
82161,"Benzoic acid, 4-chloro-2-methyl-",917-372-3,7499-07-2,,Notified C&L,4,H319:4;H335:4;H315:4
82164,"Palmitic acid, diester with 5-hydroxy-6-methylpyridine-3,4-dimethanol",250-520-9,31229-74-0,Not Classified,Notified C&L,1,Not classified:1
82171,"α-hydroxy-1,3-benzodioxole-5-acetic acid",248-628-6,27738-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
82173,"3,5-dichloro-2-hydroxybenzamide",605-840-7,17892-26-1,Not Classified,REACH registration C&L,2,Not classified:2
82174,Tributylaluminium,214-240-0,1116-70-7,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,118,H260:118;H250:118;H314:118;H318:88
82178,"Phosphoric acid, C16-18-alkyl esters, sodium salts",291-914-0,90506-51-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
82179,Bergamot Oil,616-915-9,8007-75-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H317:48;H304:49;H400:46;H226:87;H410:46;H315:49;H208:1;H318:1;H319:2;H411:1;Not classified:1
82184,1-isopropylpiperidin-4-ol,226-944-5,5570-78-5,,Notified C&L,2,H319:2;H335:2;H315:2
82185,potassium (2S)-2-{[(2Z)-4-ethoxy-4-oxobut-2-en-2-yl]amino}propanoate,609-057-1,35052-92-7,Eye Irrit. 2,REACH registration C&L,1,H319:1
82186,"Fatty acids, C8-14, triesters with trimethylolpropane",305-758-9,95009-31-7,Not Classified,REACH registration C&L,2,Not classified:2
82191,Bis(4-fluorophenyl) ketone,206-466-3,345-92-6,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,74,H302:55;H411:55;H319:59;H335:58;H315:59;H332:1
82195,Cyclofenil,220-089-1,2624-43-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H361:1
82199,"Tylosin, phosphate (salt)",215-779-4,1405-53-4,Not Classified,Notified C&L,6,Not classified:2;H319:3;H410:2;H317:4;H334:4;H413:1
82200,"3-amino-1-(2,4,6-trichlorophenyl)-5-pyrazolone",248-358-9,27241-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,195,H319:195;H335:195;H315:195;H302:1
82203,Ajmalicine,207-589-5,483-04-5,Acute Tox. 4,Notified C&L,43,H302:42;H300:1
82209,"1,3,2-dioxathiolane 2,2-dioxide",600-809-4,1072-53-3,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1B;Eye Dam. 1;Carc. 2,REACH registration C&L,22,H318:14;H317:13;H302:17;H351:15;H314:14;H319:3;H335:3;H315:4;Not classified:2;H330:1;H301:2;H341:1;H311:1;H332:1;H412:1
82211,N-ethyl-o(or p)-toluenesulphonamide,232-465-2,8047-99-2,Aquatic Chronic 3,REACH registration C&L,92,H412:4;Not classified:54;H336:33;H319:1;H318:1;H335:1;H315:1
82217,"Tetradecan-1-ol, propoxylated, esters with propionic acid",500-258-9,74775-06-7,Not Classified,REACH registration C&L,59,Not classified:59
82218,"Dinonylnaphthalene-1-sulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",305-300-8,94406-04-9,,Notified C&L,1,Not classified:1
82219,"3-(2-aminoethylamino)propane-1,2-diol",616-325-1,76343-87-8,Acute Tox. 4,Notified C&L,1,H302:1
82221,"Agaricus campestris, ext.",284-539-9,84929-56-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H317:1;H301:1;H332:1;H315:1
82223,"Formaldehyde, oligomeric reaction products with 3,3'-iminodi(propylamine)",500-626-9,161278-35-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,90,H302:90;H312:79;H318:56;H314:90;H332:22;H317:13
82227,"Iron [R-(R*,R*)]-tartrate",220-950-1,2944-65-2,Not Classified,Notified C&L,2,Not classified:2
82228,Iridium hexafluoride,232-024-4,7783-75-7,Met. Corr. 1;Skin Corr. 1B,Notified C&L,1,H290:1;H314:1
82229,"Distillates (petroleum), catalytic reformed depentanizer;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",270-660-4,68475-79-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
82231,"4,8-dimethyl-4,9-decadienal",275-174-6,71077-31-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,121,H317:62;H411:21;H315:62;Not classified:59
82232,"4-Bromo-2,5-difluoroanisole",606-491-3,202865-60-9,,Notified C&L,7,H319:7;H315:7;H335:2
82237,Iron hydroxide oxide yellow,257-098-5,51274-00-1,Not Classified,REACH registration C&L,833,Not classified:831;H318:2;H372:2;H335:2;H315:2
82238,2-hydroxyethyliminodi(acetic acid),202-263-9,93-62-9,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,74,H302:7;H318:7;H319:45;H335:43;H315:44;H314:22
82240,AMBA,427-640-7,,Not Classified,Notified C&L,31,Not classified:31
82244,Jatrorrhizine,222-817-3,3621-38-3,Aquatic Acute 1,Notified C&L,40,H400:38;H302:1;Not classified:1
82246,4'-chloroacetophenone,202-800-7,99-91-2,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,REACH registration C&L,173,H302:142;H319:132;H335:145;H318:40;H330:52;H315:54;H412:28;Not classified:1;H331:1
82247,"3-Thiophenebutanol, 2,5-dihydro-a,a-dimethyl-, 1,1-dioxide",601-262-4,1135-22-4,Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H331:1
82251,Thiophene-3-thiol,231-880-6,7774-73-4,Flam. Liq. 3,Notified C&L,1,H226:1
82252,"7,7-dichlorobicyclo[3.2.0]hept-2-en-6-one",226-165-0,5307-99-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H302:38;H314:38;H319:5;H315:5;H335:1
82255,"2,2,2,o,p'-pentachloroethylidenebisbenzene",212-332-5,789-02-6,Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H372:38;H400:38;H301:41;H351:38;H410:38;H330:3;H311:3;H373:3
82259,Tinidazole,243-014-4,19387-91-8,Acute Tox. 4;Acute Tox. 4;Muta. 2;Carc. 2,Notified C&L,72,H351:71;H332:42;H312:41;H341:40;H361:30;H302:2;H319:1;H335:1;H315:1
82262,"1-[(11'S,13'S)-11'-hydroxy-dodecahydro-13'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-13'-yl]ethanone",611-906-6,59860-75-2,Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H302:1;H413:1;H373:1
82264,trioctylstannane,413-320-4,869-59-0,Skin Irrit. 2;STOT RE 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H372:0;H315:0
82265,Trihydrogen bis[2-hydroxy-5-nitro-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulphonato(3-)]chromate(3-),276-841-4,72796-99-7,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,3,H319:3;H412:3
82267,[2H4]silane,236-899-3,13537-07-0,Press. Gas (Comp.);Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H280:38;H319:38;H332:38;H335:38
82274,"2-Butenoic acid, 3-amino-, 1-methylethyl ester",604-269-0,14205-46-0,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,42,H319:4;H317:2;H331:38;H315:2;H335:1
82277,"Benzeneacetic acid, α-bromo-2-chloro-",604-221-9,141109-25-3,,Notified C&L,4,H314:4
82279,"Eucalyptus maculata citriodora, ext., reaction products with acetone",305-086-6,94334-06-2,Flam. Liq. 3,Notified C&L,52,H226:52
82280,1-[(2-hydroxyethyl)amino]-4-[(3-hydroxypropyl)amino]anthraquinone,266-865-3,67674-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H319:58;H335:57;H315:57;H411:7;H302:5;H311:1
82284,"Oak, Quercus alba, ext.",272-838-7,68917-11-3,Flam. Liq. 2,Notified C&L,1424,H225:1286;Not classified:127;H319:10;H226:11
82285,biphenyl-2-ylamine,201-990-9,90-41-5,Acute Tox. 4;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H351:0;H412:0
82289,Sodium N-choloyltaurinate,205-653-7,145-42-6,Not Classified,Notified C&L,20,Not classified:18;H319:2;H335:1;H315:2
82290,"Glycerides, C14-22 and C16-22-unsatd.",270-310-0,68424-59-9,,Notified C&L,1,Not classified:1
82291,Dialuminium magnesium tetraoxide,235-100-5,12068-51-8,Not Classified,Notified C&L,41,Not classified:37;H319:4;H335:4;H315:4
82294,reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide],420-470-4,,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H315:0
82295,Shale oil bitumen,447-780-2,,Skin Sens. 1;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H373:1;H317:1
82297,Tantalum pentafluoride,232-022-3,7783-71-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:38;H314:46;H302:5;H332:5;H312:5
82304,Insulin (human),234-279-7,11061-68-0,Not Classified,Notified C&L,1,Not classified:1
82306,[(3-chlorophenyl)hydrazono]malononitrile,209-103-7,555-60-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,133,H319:131;H335:131;H311:128;H331:128;H301:133;H315:131
82307,"1,4-dibromo-1,1,2,2-tetrafluorobutane",242-438-7,18599-20-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:39;H312:38;H302:38;H332:38;H315:39
82312,7-hydroxy-3H-phenoxazin-3-one,211-241-8,635-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,155,H319:155;H335:154;H315:155
82313,"2-hydroxy-2,2-diphenylacetamide",225-262-5,4746-87-6,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,38,H302:38;H411:38;H317:38
82315,4-Decyloxy-2-fluorobenzoic acid,600-738-9,106316-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82319,"1,2-diphenoxyethane",203-224-9,104-66-5,Aquatic Chronic 2,REACH registration C&L,4,H411:4
82320,"3,4,5,6-tetrachlorobenzene-1,2-dicarbonitrile",217-783-1,1953-99-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H312:39;H319:1;H400:1;H410:1;H315:1
82321,4-(2-aminoethyl)-2-methoxyphenol,611-267-3,554-52-9,Not Classified,REACH registration C&L,91,Not classified:1;H319:90;H335:1;H315:1
82323,Trisodium phosphate,600-151-8,10101-89-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,548,H319:411;H315:396;H335:257;H318:45;H314:130;Not classified:6
82326,aldicarb (ISO);2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime,204-123-2,116-06-3,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H311:0;H330:0;H400:0;H410:0
82331,Tetrakis(2-hydroxyethyl) orthosilicate,241-598-5,17622-94-5,,Notified C&L,1,H319:1;H335:1;H315:1
82337,"Prop-2-ynyl 2-[4-[(3,5-dichloro-2-pyridyl)oxy]phenoxy]propionate",276-571-7,72280-52-5,Acute Tox. 4;Carc. 2;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H372:89;H361:89;H400:89;H351:89;H332:89;H410:89
82338,"Juniper, Juniperus virginiana, ext.",285-370-3,85085-41-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1453,H317:23;H304:1452;H411:66;H315:21;H410:1384;H400:1384;H302:2;H226:2;H300:1
82346,Sodium isooctadecanoate,264-754-4,64248-79-9,Not Classified,Notified C&L,9,Not classified:9
82348,Tribenoside,233-687-2,10310-32-4,Aquatic Chronic 2,Notified C&L,3,H411:2;Not classified:1
82349,C.I. Acid Brown 126,601-863-1,12217-25-3,Not Classified,Notified C&L,34,Not classified:34
82351,3-methyl-2-oxobutyric acid,212-065-4,759-05-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
82354,"5-(methylthio)-1,3,4-thiadiazole-2(3H)-thione",228-423-8,6264-40-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
82355,Zinc bis(dibenzyldithiocarbamate),238-778-0,14726-36-4,Aquatic Chronic 4,REACH registration C&L,161,H413:37;H410:123;H400:109;Not classified:1
82357,Carnosine,206-169-9,305-84-0,Not Classified,REACH registration C&L,104,Not classified:103;H319:1;H315:1
82358,Bis(C12-C13)alkyl-2-hydroxybutandioate,413-390-6,149144-85-4,Not Classified,Notified C&L,1,Not classified:1
82359,"1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate",429-370-5,220410-74-2,Acute Tox. 4,Harmonised C&L,0,H302:0
82360,Dimethyl(propyl)amine,213-139-9,926-63-6,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,164,H335:139;H318:163;H225:164;H331:140;H302:164;H315:163;H412:23;H332:21;H314:1
82369,Magnesium titanate,234-766-4,12032-30-3,Not Classified,REACH registration C&L,6,Not classified:5;H302:1;H332:1
82370,"Palladium, tris[μ-[(1,2-η:4,5-η)-(1E,4E)-1,5-diphenyl-1,4-pentadien-3-one]]di-",610-654-4,51364-51-3,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,133,H411:125;H317:126;H319:6;H335:5;H315:6;H228:2;H312:1;H302:1;H332:1;Not classified:1
82372,Magnesium metaborate,237-235-5,13703-82-7,Skin Sens. 1B,REACH registration C&L,3,H317:3
82374,Sodium 6-amino-4-hydroxy-5-[[2-(phenylsulphonyl)phenyl]azo]naphthalene-2-sulphonate,228-359-0,6245-60-9,Not Classified,REACH registration C&L,55,Not classified:55
82377,2-methylhex-1-ene,228-041-1,6094-02-6,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,40,H304:40;H225:40
82378,"Trihydrogen [5-amino-4-hydroxy-3-[[2-hydroxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonato(5-)]cuprate(3-)",268-269-9,68039-61-2,,Notified C&L,2,H317:1;Not classified:1
82379,"A mixture of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide; N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide",412-550-2,,Not Classified,Notified C&L,33,Not classified:33
82380,2-[2-(propyn-2-yloxy)ethoxy]ethanol,230-612-5,7218-43-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
82382,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(2-methyl-4-sulphophenyl)azo]naphthalene-2-sulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:4)",254-129-4,38801-07-9,Not Classified,Notified C&L,1,Not classified:1
82383,quintozene (ISO);pentachloronitrobenzene,201-435-0,82-68-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
82385,2-bromo-N-[4-bromo-2-(pyridin-2-ylcarbonyl)phenyl]acetamide,216-905-0,1694-64-0,,Notified C&L,1,H302:1
82389,Lanthanum,231-099-0,7439-91-0,Not Classified,REACH registration C&L,166,Not classified:70;H228:53;H260:46;H319:2;H315:2
82390,3-hydroxy-2-benzopyrone,213-355-3,939-19-5,Acute Tox. 4,Notified C&L,40,H302:40;H319:1;H315:1
82392,Methyl (cyclohexyloxy)acetate,265-840-4,65593-73-9,Not Classified,Notified C&L,1,Not classified:1
82394,"7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid",403-690-5,111298-82-9,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H334:0
82397,"2,4,6-trinitrobenzene-1,3,5-triamine",221-297-5,3058-38-6,Expl. 1.1,REACH registration C&L,5,H201:5;H302:2;H312:2;H332:2
82407,2-methoxyethyl methacrylate,230-241-9,6976-93-8,Repr. 1B,REACH registration C&L,45,H360:4;H317:39;H319:41;H335:39;H315:41
82411,3-methyl-4-phenylbutan-2-ol,260-398-9,56836-93-2,Eye Irrit. 2,REACH registration C&L,106,H319:3;Not classified:103;H412:1
82412,Tributyltin bromide,215-959-2,1461-23-0,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H319:42;H372:42;H312:42;H400:42;H301:42;H410:42;H315:42
82414,"Sulfuric acid, mono-C8-10-alkyl esters, sodium salts",286-718-7,85338-42-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28,H318:28;H315:28
82417,"4-methyl-1,3-dioxane",214-323-1,1120-97-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:42;H335:41;H315:42;H225:45
82419,"Amines, C10-16-alkyldimethyl, N-oxides",274-687-2,70592-80-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,139,H318:138;H410:132;H315:138;H400:137;Not classified:1
82422,Sanguinarine,219-503-3,2447-54-3,Not Classified,Notified C&L,52,Not classified:52
82427,"α,α,α-trifluorotoluene;benzotrifluoride",202-635-0,98-08-8,Flam. Liq. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H225:0
82428,Samarium trinitrate,233-798-6,10361-83-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:2;H335:2;H315:2;H272:3;Not classified:1;H410:1;H318:1;H400:1
82429,"Amines, C10-14-branched and linear alkyl, [1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-)",286-048-5,85186-64-7,Skin Sens. 1B;Repr. 1B;STOT RE 2,Notified C&L,83,H360:83;H317:83;H373:83
82433,4-tert-pentylcyclohexanol,226-311-3,5349-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,130,H319:130;H335:130;H315:130
82435,"4'-fluoro[1,1'-biphenyl]-4-amine",206-306-2,324-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82442,4-acetamidoanilinium chloride,256-052-1,43036-07-3,,Notified C&L,4,H319:4;H335:4;H315:4
82445,"2,6-dichlorobenzenediazonium tetrafluoroborate",206-858-4,387-41-7,Skin Corr. 1B,Notified C&L,38,H314:38
82449,"thiazafluron (ISO);1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea",246-901-4,25366-23-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
82451,Aceprometazine,236-661-9,13461-01-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H318:1;H411:1;H317:1
82455,Trisodium 5-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-8-[[4-(phenylazo)-7-sulphonatonaphthyl]azo]naphthalene-2-sulphonate,229-035-1,6406-87-7,Not Classified,Notified C&L,2,Not classified:2
82463,tert-butyl propionate,208-746-0,540-42-1,Flam. Liq. 3,Harmonised C&L,0,H226:0
82464,"diphenylmethyl (6R,7S)-7-amino-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",611-404-7,56610-72-1,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H317:1;H334:1
82466,Hexyl 2-(ethylideneamino)benzoate,277-145-3,72968-69-5,Not Classified,Notified C&L,113,Not classified:113
82468,"2-(1-aminoanthraquinon-2-yl)anthra[2,3-d]oxazole-5,10-dione",219-168-3,2379-79-5,Not Classified,REACH registration C&L,21,Not classified:20;H319:1;H315:1
82472,Tetraphenylphosphonium tetrafluoroborate,207-044-1,426-79-9,,Notified C&L,4,H319:4;H335:4;H315:4
82475,Dimethyl maleate,210-848-5,624-48-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 2,REACH registration C&L,150,H319:20;H373:3;H335:61;H317:141;H302:150;H314:39;H318:5;H312:5;H315:6;H311:6
82476,"1-Piperidinamine, hydrochloride (1:1)",613-191-6,63234-70-8,,Notified C&L,4,H319:4;H335:4;H315:4
82480,"Hydrocarbons, terpene processing by-products",273-309-3,68956-56-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1737,H319:1475;H317:1678;H304:1679;H411:1628;H226:1698;H315:1695;Not classified:39;H410:15;H400:3;H225:1
82482,"3,3'-dimethyl[1,1'-binaphthalene]-4,4'-diamine",236-069-0,13138-48-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
82489,Digallium trioxide,234-691-7,12024-21-4,Not Classified,Notified C&L,45,Not classified:43;H319:1;H335:1;H315:1;H413:1
82492,"Phosphorylase, maltose",232-856-8,9030-19-7,,Notified C&L,1,H334:1
82496,2-(4-butoxyphenyl)acetamide,222-303-9,3413-59-0,,Notified C&L,1,H302:1
82500,"Pyrrolidinium, 1-butyl-1-methyl-, chloride (1:1)",610-394-1,479500-35-1,Not Classified,Notified C&L,1,Not classified:1
82510,Trioctadecyl phosphite,218-217-6,2082-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
82511,Dibutyl disulphide,211-091-3,629-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;Not classified:2
82513,Gemfibrozil,247-280-2,25812-30-0,Acute Tox. 4;Carc. 2;Repr. 2;Aquatic Chronic 3,REACH registration C&L,131,H302:130;H351:32;H412:1;H361:34;H411:32;Not classified:1;H350:1;H362:1
82515,"1,3-Benzenedimethanamine, reaction products with [[4-(1,1-dimethylethyl)phenoxy]methyl]oxirane",290-608-4,90194-02-8,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H314:1
82519,"4-isothiocyanato-N,N-dimethylaniline",218-360-4,2131-64-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,45,H317:38;H312:38;H302:38;H332:38;H314:44;H330:5;H311:6;H301:6;H331:1;H319:1;H335:1;H315:1
82520,3-methylheptan-4-ol,217-414-4,1838-73-9,Eye Irrit. 2,Notified C&L,38,H319:38
82522,1-(2-methyl-1-oxobut-2-enyl)piperidine,259-204-5,54533-29-8,Not Classified,Notified C&L,88,Not classified:88
82523,Triisooctyl phosphite,246-614-4,25103-12-2,Skin Irrit. 2,Notified C&L,127,H315:125;Not classified:2;H319:1
82525,Guanabenz,225-750-8,5051-62-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,38,H302:38;H361:38;H332:38;H312:38
82529,cyclohexylidene hydroperoxide,220-279-4,2699-11-8,,,0,H302:0;H242:0;H314:0
82530,"2,2-dimethylpropane;neopentane",207-343-7,463-82-1,Press. Gas;Flam. Gas 1;Aquatic Chronic 2,Harmonised C&L,0,H220:0;H411:0;Not classified:0
82533,Sucrose octaacetate,204-772-1,126-14-7,Not Classified,Notified C&L,116,Not classified:116
82536,"Blatta orientalis, ext.",294-757-6,91745-86-7,Flam. Liq. 2,Notified C&L,1,H225:1
82537,(E)-octadec-11-enoic acid,211-758-9,693-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
82539,Citronellyl ethyl oxalate,262-433-3,60788-25-2,Skin Sens. 1,Notified C&L,1519,H317:1286;Not classified:233
82544,Cadmium zinc sulfide yellow,232-466-8,8048-07-5,Not Classified,Notified C&L,44,Not classified:44
82546,"Tricyclo(3.3.1.1'3,7)dec-1-ylmethanol",212-225-3,770-71-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
82562,"Citrus Limon Oil; Extractives And Their Physically Modified Derivatives. Citrus Limonum, Citrus.",616-925-3,8008-56-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,298,H317:230;H304:231;H400:189;H226:269;H410:227;H315:254;H319:10;H411:4;H361:1
82563,"1,3-dioxo-2,3-dihydro-1H-benzo[5,10]anthra[2,1,9-def]isoquinoline-8-sulfonic acid",428-540-6,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1;H315:1;H402:1
82567,2-hydroxybutyronitrile,224-753-1,4476-02-2,Acute Tox. 3;Acute Tox. 1;Acute Tox. 1;Aquatic Acute 1,Notified C&L,94,H310:55;H330:55;H400:55;H301:94;H410:55;H311:39;H331:39;H412:1
82568,5-aminopyrazole-4-carboxamide hemisulphate,248-503-6,27511-79-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,4,H302:3;H332:2;H312:2;H411:1;H319:1;H335:1;H315:1
82570,Ethyl vinyl ether,203-718-4,109-92-2,Flam. Liq. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,681,H336:49;H412:118;H225:179;H319:484;H335:125;Not classified:55;H315:39;H224:7
82572,2-nitro-p-phenylenediamine,226-164-5,5307-14-2,Skin Sens. 1,REACH registration C&L,74,H317:68;H319:13;H335:12;H315:13;H351:7;H341:5;H302:2;H311:1;H331:1;H301:1;H314:1;Not classified:1;H332:1;H312:1
82573,Propyl hexanoate,210-963-0,626-77-7,Not Classified,Notified C&L,136,Not classified:87;H226:46;H319:3;H335:3;H315:3
82576,"4,4'-[(2β,3α,5α,16β,17β)-3,17-bis(acetoxy)androstane-2,16-diyl]bis[1,1-dimethylpiperazinium] dibromide",257-740-4,52212-02-9,Acute Tox. 2;Acute Tox. 4;Acute Tox. 3,Notified C&L,17,H300:16;H312:16;H331:16;H373:1;H301:1
82577,"2-dimethylaminoethanol;N,N-dimethylethanolamine",203-542-8,108-01-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H226:0;H312:0;H302:0;H332:0;H314:0
82581,n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-iodo-4-quinazolinamine,607-200-2,231278-20-9,Aquatic Chronic 4,Notified C&L,1,H413:1
82584,Trimethyl(methylthio)silane,223-466-9,3908-55-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H225:38
82585,Octafluoronaphthalene,206-239-9,313-72-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:48
82586,Methyl 9-octadecenoate,219-559-9,2462-84-2,Not Classified,Notified C&L,4,Not classified:4
82591,"Distillates (Fischer-Tropsch), C8-26, branched and linear",619-568-1,848301-67-7,Not Classified,Notified C&L,35,Not classified:33;H304:2
82592,"2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-8-ol",255-247-9,41175-50-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
82595,"Alcohols, cedarwood-oil",614-632-5,68603-22-5,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,113,H410:113;H400:52;H304:113;H373:88
82601,4-{[(2-Amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid,601-589-2,119-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H302:1
82603,"3,4-dimethoxy-α-methylphenethylamine",204-383-7,120-26-3,Acute Tox. 4,Notified C&L,38,H302:38
82604,Pseudoephedrine,202-018-6,90-82-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,133,H319:133;H335:133;H317:86;H302:133;H315:133;H312:38;H332:38
82605,(S)-(-)-tetrahydro-2-furoic acid,433-770-5,,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H302:1;H314:1
82606,"4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)",418-100-1,172964-15-7,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
82608,"2,2'-[(4-amino-3-nitrophenyl)imino]bisethanol hydrochloride",303-083-4,94158-13-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 1,Notified C&L,47,H319:38;H335:37;H317:44;H372:38;H302:38;H315:38;Not classified:3
82609,3-butylidenephthalide,208-991-3,551-08-6,Acute Tox. 4,Notified C&L,1606,H302:1606
82613,"Furo[3,4-b]furan-2(3H)-one, tetrahydro-4-methoxy-, (3aS,6aR)-",610-510-0,501921-30-8,Not Classified,Notified C&L,12,Not classified:12
82615,Trichromium dicarbide,234-576-1,12012-35-0,Not Classified,REACH registration C&L,24,Not classified:20;H228:4
82619,Carbonylchlorohydrotris(triphenylphosphine)ruthenium,241-051-0,16971-33-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:45;H335:44;H312:40;H302:45;H332:40;H315:45;H413:1
82621,"5-amino-2,6-dioxo-1,2,3,4-tetrahydropyrimidine-4-carboxylic acid",230-514-2,7164-43-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
82625,"cellobiohydrolase, exo-",253-465-9,37329-65-0,Resp. Sens. 1,Harmonised C&L,0,H334:0
82627,"(R,R)-(-)-butane-2,3-diol",246-186-9,24347-58-8,Not Classified,REACH registration C&L,4,Not classified:4
82628,"Fatty acids, tall-oil, mixed esters with pentaerythritol, phthalic anhydride and rosin",295-717-0,92128-24-0,Not Classified,Notified C&L,1,Not classified:1
82629,"Fatty acids, animal, esters with trimethylolpropane",305-501-0,94581-03-0,Not Classified,Notified C&L,1,Not classified:1
82630,pyrolysis oil,929-242-3,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Muta. 1B;Carc. 1A;Repr. 2;STOT RE 1;Aquatic Chronic 3,Notified C&L,2,H372:1;H361:1;H412:1;H304:2;H350:1;H226:2;H340:1;H315:2;H411:1;H332:1;H351:1
82631,2-(7-methoxy-1-naphthyl)ethanamine hydrochloride,604-144-0,139525-77-2,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,3,H302:3;H411:3;H314:3;H318:1
82632,Bromoacetyl chloride,244-790-7,22118-09-8,Skin Corr. 1B;STOT SE 3,Notified C&L,40,H335:39;H314:40;H318:1;H312:1;H302:1;H332:1;H290:1
82633,"2,5-Furandione, dihydro-3-(tetrapropenyl)-, reaction products with isopropanolamine",271-104-3,68515-72-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:59;H315:59
82634,"1,8-bis[(4-methylphenyl)amino]anthraquinone",201-398-0,82-16-6,Not Classified,REACH registration C&L,7,Not classified:7
82636,Butyric anhydride,203-383-4,106-31-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,330,H302:172;H318:69;H314:299;Not classified:21;H319:10;H315:10;H290:1
82638,"Estra-1,3,5(10)-trien-17-one 3-sulphate, compound with piperazine (1:1)",230-696-3,7280-37-7,Acute Tox. 4;Carc. 1A,Notified C&L,62,H302:38;H350:38;H351:24;H360:24;H362:24
82641,"Senna, Cassia auriculata, ext.",307-359-5,97593-53-8,Not Classified,Notified C&L,25,Not classified:25
82645,"Tall oil, polymer with formaldehyde and phenol",614-135-3,67785-03-9,,Notified C&L,1,H319:1;H335:1;H315:1
82647,"Glycerides, C8-10",287-075-5,85409-09-2,Not Classified,Notified C&L,20,Not classified:20
82654,"2,4,6-trinitroresorcinol;styphnic acid",201-436-6,82-71-3,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H201:0;H312:0;H332:0
82656,piperazine hydrochloride,228-042-7,6094-40-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H319:0;H317:0;H412:0;H361:0;H334:0;H315:0
82663,"1,2-Benzenedicarboxylic acid, 1,2-di-2-propen-1-yl ester, polymer with ethyl 2-propenoate and 2-methyl-2-propenoic acid",608-205-2,28411-49-6,Not Classified,Notified C&L,55,Not classified:55
82665,"5-methoxy-1,2,3,4-tetrahydronaphthalen-1-one",251-723-5,33892-75-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82666,"2,2'-oxydi(ethylamine)",220-395-5,2752-17-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,136,H302:95;H411:87;H318:88;H314:136
82667,2-thien-2-ylthiazolidine-4-carboxylic acid,251-055-4,32451-19-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2;H312:2
82673,"Bis[2-[[4-(2,2-dicyanovinyl)-3-methylphenyl]ethylamino]ethyl] adipate",247-301-5,25857-05-0,Not Classified,Notified C&L,9,Not classified:9
82675,Cyclopent-2-en-1-ol,221-725-0,3212-60-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H225:1;H332:1;H315:1
82676,Calcium dihydrogenpyrophosphate,238-933-2,14866-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12,H319:10;H335:10;H315:10;H318:2
82678,"Di-tert-butyl α,α,α',α'-tetramethyl-(p-phenylenedimethylene) diperoxide",220-479-1,2781-00-2,Org. Perox. D;Aquatic Chronic 4,Notified C&L,1,H413:1;H242:1
82681,4-ethyl-2-(8-heptadecenyl)-2-oxazoline-4-methanol,268-820-3,68140-98-7,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,76,H412:4;H317:4;Not classified:72
82683,Tri-μ-carbonylhexacarbonyldiiron,239-359-5,15321-51-4,Flam. Sol. 2;Water-react. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:38;H331:38;H261:38;H228:43;H314:4;H250:1
82688,"5-hydroxydecanoic acid, monoester with glycerol",247-699-0,26446-31-1,Not Classified,Notified C&L,113,Not classified:113
82689,"Pine, Pinus pinea, ext.",290-167-8,90082-76-1,Not Classified,Notified C&L,1,Not classified:1
82690,tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate,431-370-5,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
82694,Triphenylsilane,212-333-0,789-25-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
82697,"(5α)-4,5-epoxy-17-methyl-6-oxomorphinan-3,14-diyl diacetate",264-989-2,64643-76-1,Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
82698,"2,5-dimethylbenzoxazole",227-136-5,5676-58-4,,Notified C&L,6,H319:6;H335:4;H315:6
82701,Paracetamol,203-157-5,103-90-2,Acute Tox. 4,REACH registration C&L,321,H302:313;H412:160;H362:2;H371:7;H319:126;H317:61;H315:127;H335:29;Not classified:7;H341:4;H370:7;H332:9;H373:5;H312:4;H334:2;H372:5;H413:2;H411:2;H316:1;H320:1;H303:1;H351:1
82702,"Gentamicin, sulfate (salt)",215-778-9,1405-41-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,340,H317:334;H334:215;H335:116;H361:29;H319:5;H315:6;H360:6;H261:1;H312:4;H302:5;H332:5;H371:1;H411:1;H373:2;H410:2;H400:2
82703,"Morfinan, 17-(ciclopropilmetil)-4,5-epossi-3,14-diidrossi-17-metil-6-osso-, bromuro, (5a)-",615-932-9,73232-52-7,Acute Tox. 3;Aquatic Acute 1,Notified C&L,55,H400:38;H301:38;H317:16;H312:16;H334:16;H302:17;H332:16;H412:1
82704,"4-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]-5-[[4-(phenylamino)-3-sulphophenyl]azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonic acid, sodium salt",303-476-0,94199-99-2,Aquatic Chronic 3,Notified C&L,442,H412:441;Not classified:1
82709,"methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate",601-679-1,120202-66-6,Skin Corr. 1B;STOT SE 3;Lact.;Aquatic Chronic 2,REACH registration C&L,84,H362:3;H335:58;H314:71;H411:60;H302:21;H290:15;H318:15;H315:7;H319:4;H413:1;H361:1;H371:1;H332:1;H312:1
82710,"3,3-dichloro-2,2-dihydroxycyclohexan-1-one",281-167-9,83878-01-7,Acute Tox. 4,Notified C&L,38,H302:38
82712,"Disodium [[N,N'-ethylenediylbis[N-(carboxylatomethyl)glycinato]](4-)-N,N',O,O',ON,ON']zincate(2-)",237-865-0,14025-21-9,Not Classified,REACH registration C&L,263,Not classified:221;H319:42;H302:1
82713,"Butanedioic acid, disodium salt, hexahydrate",612-073-1,6106-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:43;H335:43;H315:43;Not classified:37
82717,2-chloro-3-hydroxy-p-anisaldehyde,253-627-9,37687-57-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
82724,"Pyrophosphatase, inorganic",232-784-7,9024-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
82728,[No public or meaningful name is available],682-365-1,78201-71-5,Acute Tox. 3;Eye Dam. 1,Notified C&L,1,H318:1;H301:1
82729,"2,2'-dinitrobiphenyl",219-435-4,2436-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H312:1;H302:1;H332:1
82730,"D-arabino-Hexitol, 6-O-α-D-glucopyranosyl-, (2.xi.)-",613-617-0,64519-82-0,Not Classified,Notified C&L,38,Not classified:38
82737,Di-μ-chloro-bis(dicarbonylrhodium),238-540-6,14523-22-9,,Notified C&L,5,H330:4;H301:4;H302:1
82739,Trimethylgallium,215-897-6,1445-79-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,206,H260:113;H250:206;H318:56;H314:206;H261:38;H225:38
82741,fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate,276-696-7,72490-01-8,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H410:0;H400:0
82745,alpha-[butyl(dimethylsilyl)]-omega-[3-(2-{[2- (methacryloyloxy)ethyl]carbamoyloxy}ethoxy) propyl]poly[oxy(dimethyl)silylene],471-170-5,,Not Classified,Notified C&L,1,Not classified:1
82746,"2-(Dicyclohexylphosphanyl)-2',6'-dimethoxybiphenyl",613-838-2,657408-07-6,,Notified C&L,10,H319:8;H335:5;H315:8;H302:5;H317:3;Not classified:1;H312:2;H332:2
82747,"N-[2-[(2,6-dicyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",255-473-8,41642-51-7,Not Classified,REACH registration C&L,27,Not classified:27
82749,"Eucalyptus maculata citriodora, ext., acetylated",305-085-0,94334-05-1,Flam. Liq. 3;Aquatic Chronic 3,Notified C&L,1322,H226:1322;H412:1286
82753,Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate,403-530-4,,Not Classified,REACH registration C&L,56,Not classified:56
82755,Antimony,231-146-5,7440-36-0,Not Classified,REACH registration C&L,660,Not classified:145;H373:52;H412:50;H362:46;H360:46;H351:169;H302:184;H332:208;H411:298;H300:33;H310:33;H413:20;H301:28;H335:5
82756,perfluorooctane sulfonic acid;heptadecafluorooctane-1-sulfonic acid,217-179-8,1763-23-1,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H372:0;H362:0;H360:0;H411:0;H302:0;H351:0;H332:0
82757,Ethyl 4-(phenylmethoxy)-1H-indole-2-carboxylate,248-627-0,27737-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82758,N-methylformanilide,202-262-3,93-61-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,57,H302:50;H412:10;H317:40;H319:8;H335:5;H315:7
82761,"9,10-Anthracenedione, 1-(methylamino)-4-(pentylamino)-, branched and linear",294-187-8,91696-32-1,Not Classified,Notified C&L,32,Not classified:32
82762,Thiophene-2-thiol,231-881-1,7774-74-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,1420,H319:133;H320:1;H312:1366;H302:1370;H332:1370;H315:133;H335:131;Not classified:1;H311:1;H331:1;H301:1
82764,DIPENTENE POLYMER,618-374-4,9003-73-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1410,H319:1373;H315:1373;Not classified:31;H413:6
82771,(1RS)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-4-phenylbutoxy)hexyl]amino]ethanol,618-267-2,89365-50-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H302:1;H319:2;H317:1;H315:2;H412:1
82772,"Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate",222-159-7,3374-05-8,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,43,H302:42;H317:40;H334:40;H351:1;H319:1;H335:1;H332:1;H315:1;H361:1;Not classified:1
82776,4-phenyl-1-azabicyclo[2.2.2]octane,610-607-8,51069-11-5,,Notified C&L,5,H319:5;H335:5;H315:5
82778,"2-nitro-α,α,α-trifluorotoluene",206-855-8,384-22-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:2;H335:2;H311:1;H331:1;H301:1;H315:2;H330:1;H302:1
82788,"2,2'-methylenebis[6-(1-methylcyclohexyl)-p-cresol]",201-044-5,77-62-3,Aquatic Chronic 4,REACH registration C&L,76,H413:75;H319:1;H315:1
82789,"1,2,3,5-tetrahydro-7-methyl-2-thioxopteridin-4,6-dione",230-180-8,6967-57-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
82792,1-chloropropane,208-749-7,540-54-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0;H312:0;H225:0
82795,"Iron, citrate phosphate sodium complexes",286-703-5,85338-28-9,Not Classified,Notified C&L,1,Not classified:1
82798,Antimony pentafluoride,232-021-8,7783-70-2,Aquatic Chronic 3,Notified C&L,105,H412:52;H302:45;H332:39;H411:53;H314:15;H330:8;H311:7;H331:5;H301:7;H318:1
82805,"1,4-bis(1-methylvinyl)benzene",216-515-0,1605-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82806,"N,N'-bis(2-aminoethyl)ethylenediamine dihydrochloride",253-854-3,38260-01-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
82809,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-hydroxy-, polymer with 2,4-diisocyanato-1-methylbenzene",609-378-7,37273-56-6,Resp. Sens. 1,Notified C&L,96,H334:69;H319:41;H317:41
82812,"1,1-dichlorosilacyclopentane",219-299-6,2406-33-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H226:38;H314:38
82813,Mecysteine hydrochloride,242-435-0,18598-63-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;Not classified:1
82814,"Oligomycin A, 12-deoxy-",234-276-0,11052-72-5,Acute Tox. 4,Notified C&L,127,H302:127
82817,Spanish spike oil,616-988-7,8016-78-2,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,130,H226:130;H315:130;H317:91;H341:91;H371:91;H411:91
82818,dipotassium tetrachloroplatinate,233-050-9,10025-99-7,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0;H301:0;H315:0
82819,"Fatty acids, C18 and C18-unsatd., potassium salts",271-976-5,68647-90-5,Eye Irrit. 2,Notified C&L,44,H319:31;H314:13
82820,"5-[[4-(diethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium acetate",281-872-1,84051-83-2,Not Classified,Notified C&L,1,Not classified:1
82821,"3-[(4-nitrophenyl)azo]-5-[(6-sulpho-1-naphthyl)azo]salicylic acid, sodium salt",308-467-5,98072-17-4,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
82824,"Hydrocarbons, C6-C7, n-alkanes, isoalkanes, cyclics, >5% n-hexane",924-168-8,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,5,H373:5;H225:5;H361:5;H336:5;H304:5;H411:5;H315:5
82826,5-hydroxyindole,217-782-6,1953-54-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
82827,"methyl 2-(2-{[(benzyloxy)carbonyl]amino}propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate",922-554-0,,Not Classified,REACH registration C&L,1,Not classified:1
82830,"(2R)-2-{(2R,3S,5S,6R)-6-[(1S,2S,3S,5R)-5-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-2-hydroxy-1,3-dimethyl-4-oxoheptyl]-3,5-dimethyltetrahydro-2H-pyran-2-yl}butanoic acid",611-230-1,55134-13-9,Acute Tox. 2,Notified C&L,40,H300:40;H318:2;H335:1;H315:1;H372:1;H330:1;H411:1
82834,2-Fluor-4-[trans-4-(trans-4-propylcyclohexyl)-cyclohexyl]-phenylboronic acid,917-865-3,,Not Classified,REACH registration C&L,1,Not classified:1
82838,"Decanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol, acrylic acid alkylated (1:2), disodium salts",272-374-5,68815-45-2,Not Classified,Notified C&L,11,Not classified:11
82840,"Liquidambar orientalis, exts., pyrolyzed",309-838-4,101227-15-0,Flam. Liq. 3;Asp. Tox. 1;Skin Mild Irrit. 3;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 2,Notified C&L,1,H316:1;H373:1;H361:1;H304:1;H226:1;H340:1;H350:1
82850,"3-methylcyclohexanol, mixed isomers",209-709-1,591-23-1,Acute Tox. 4,Notified C&L,41,H332:38;H302:3;H315:3;H336:3;H227:1
82853,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with diethylenetriamine, ethoxylated, quaternary salts with dimethyl sulfate",500-354-0,157707-47-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H315:1
82859,"Sodium 4-[[3-(acetylamino)-4-methylphenyl]amino]-1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",274-064-5,69658-24-8,Not Classified,Notified C&L,43,Not classified:43
82864,"4-fluorobenzene-1,3-diamine",228-426-4,6264-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39;H302:1
82865,"N,N-dimethylpropionamide",212-064-9,758-96-3,Acute Tox. 4,Notified C&L,39,H302:39
82866,"dicoumarol;4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)",200-632-9,66-76-2,Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H372:0;H411:0
82867,4-tert-Butylcalix[4]arene,612-010-8,60705-62-6,,Notified C&L,5,H319:5;H335:4;H315:5
82869,Buspirone,253-072-2,36505-84-7,Acute Tox. 3,REACH registration C&L,4,H301:4
82877,1-phenylpyrrole,211-242-3,635-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,195,H319:195;H335:195;H315:195
82879,methyl (±)-lactate,218-449-8,2155-30-8,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H226:0;H335:0
82880,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with 2-piperazin-1-ylethylamine",500-629-5,161278-37-1,,Notified C&L,2,H317:2;H311:1;H412:1;H302:2;H314:2;H312:1;H411:1
82881,"Distillates (petroleum), light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",274-684-6,70592-77-7,Carc. 1B,Harmonised C&L,0,H350:0
82883,"Benzenesulfonic acid, 4-[(2,4-diamino-5-methylphenyl)azo]-, monosodium salt, mixt. with 4,4'-[(2,4-diamino-1,3-phenylene)bis(azo)]bis[benzenesulfonic acid] disodium salt",617-128-3,8062-14-4,Not Classified,Notified C&L,1,Not classified:1
82885,"3,5,6-trichloro-2-pyridone",229-405-2,6515-38-4,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,96,H302:96;H411:96;H318:96
82886,2-(cyanomethyl)benzoic acid,229-602-3,6627-91-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
82888,"N-(1-methylpropyl)-N'-phenylbenzene-1,4-diamine",212-330-4,788-17-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H410:16;H317:16;H400:16
82893,tert-butylbenzene,202-632-4,98-06-6,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,160,H226:141;H315:109;H319:32;H332:36;H331:10;H335:8;Not classified:1;H304:1
82895,"5-Bromo-1,3-dimethyl-2-iodobenzene",606-594-3,206559-43-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
82900,p-tolyl isobutyrate,203-159-6,103-93-5,Not Classified,Notified C&L,1554,Not classified:1554
82904,Benzylcresol,215-543-0,1330-62-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
82907,Tetrafluoroethylene,204-126-9,116-14-3,Flam. Gas 1;Press. Gas (Comp.);Carc. 1B;STOT SE 2,REACH registration C&L,834,H280:267;H220:274;H350:262;H371:232;Not classified:534;H351:1;H373:1
82909,1-(2-chloroethyl)imidazolidin-2-one,219-212-1,2387-20-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82911,Tributyltin chloride,215-958-7,1461-22-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,58,H319:54;H372:58;H312:54;H360:7;H400:56;H301:58;H410:58;H315:58;H317:42;H318:4;H341:4;H311:4;H330:4;Not classified:2
82913,"(S)-3-[3-(tert-butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazole monomaleate",248-111-5,26921-17-5,Acute Tox. 4;Repr. 2,Notified C&L,89,H302:88;H361:82;H372:35;H373:1;Not classified:1;H351:1;H315:1;H360:1;H312:1
82915,Isooctanoic acid,246-617-0,25103-52-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,34,H302:31;H319:30;H318:2;H335:2;H315:2;Not classified:1
82916,Carbimazole,244-854-4,22232-54-8,Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:35;H400:35;H360:35;H373:35;H302:8;H319:8;H317:6;H335:2;H315:1
82922,4-(α-(4-hydroxy-1-naphthyl)benzylidene)naphthalen-1(4H)-one,205-656-3,145-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:59;H335:58;H315:59
82927,nickel diarsenide,235-103-1,12068-61-0,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H372:0;H400:0;H410:0;H350:0
82928,"Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite",305-631-8,94891-31-3,Not Classified,Notified C&L,37,Not classified:37
82930,stigmastane-3-β-ol,243-087-2,19466-47-8,Aquatic Chronic 4,Notified C&L,38,H413:38
82931,"Fatty acids, C12-14, reaction products with diethanolamine",306-325-7,97043-75-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
82932,"Condensation products of 4-methyl-m-phenylene diisocyanate with alcohols, C10-14 (even numbered)",440-930-8,330198-48-6,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H334:1;H413:1;H302:1;H332:1
82933,"Disodium (2S)-2-({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}amino)pentanedioate",604-733-2,150399-23-8,Eye Irrit. 2;STOT SE 3;Muta. 2;Repr. 1B,Notified C&L,15,H319:12;H341:14;H360:14;H335:10;H373:2;H315:4;H372:1;H302:1
82936,"2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine",415-500-8,145963-84-4,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H373:0;H412:0
82938,Ammonium iron bis(sulphate),233-382-4,10138-04-2,Eye Dam. 1,REACH registration C&L,50,H318:5;H319:39;H335:38;H315:38;Not classified:6
82939,"3-(dicocoalkylamino)-1,2-propanediol",482-000-4,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,442,H412:442;H317:442
82940,Triethylvinylsilane,601-065-3,1112-54-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H226:44;H335:39;H315:40
82941,Dipentyl ether,211-756-8,693-65-2,Flam. Liq. 3,Notified C&L,40,H226:40;H411:1;Not classified:1
82946,"1,1-diethoxynonane",259-360-4,54815-13-3,Not Classified,Notified C&L,88,Not classified:88
82947,"(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine",929-011-7,,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H373:2;H317:2;H400:2;H302:2;H332:2;H410:2
82948,Digallium trisulphide,234-692-2,12024-22-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H314:42
82949,"2-Cyano-3-(3,4-dimethoxyphenyl)propanoic acid",611-278-3,55502-61-9,Eye Irrit. 2A,REACH registration C&L,1,H319:1
82953,"3,5-dimethylsalicylic acid",228-356-4,6245-04-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
82956,4-chlorobutyryl chloride,225-059-1,4635-59-0,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 2,REACH registration C&L,136,H302:133;H314:136;H330:129;H318:4;H290:85;H335:2;H331:2;H301:2;H311:1
82958,Ethyl phenoxyacetate,219-867-3,2555-49-9,Eye Irrit. 2,Notified C&L,1401,H319:1287;Not classified:113;H411:1;H335:1;H312:1;H302:1;H332:1;H315:1
82961,"2,5-dichlorobenzenesulphonic acid",201-829-2,88-42-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1;H290:1;H318:1;H314:1
82965,Ethoxydiethylaluminium,216-447-1,1586-92-1,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,101,H260:42;H250:101;H314:101;H318:55;H225:55;H311:55;H331:55;H301:55;H373:4;H336:4;H411:4
82969,Ciprofibrate,257-744-6,52214-84-3,Carc. 1B,Notified C&L,41,H350:38;H302:3;H319:3;H412:1;H351:1
82970,EPOXY / PHENOLIC RESIN,612-377-4,61788-97-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,43,H317:43;H319:43;H411:43;H315:43;H318:1
82971,Bendazac,243-569-2,20187-55-7,Acute Tox. 4,Notified C&L,2,H302:2
82972,"2-methylpenta-1,4-diene",212-109-2,763-30-4,Flam. Liq. 2,Notified C&L,39,H225:39
82975,Calcium titanium trioxide,234-988-1,12049-50-2,Not Classified,REACH registration C&L,19,Not classified:18;H302:1;H332:1
82976,"1,4-dibromopentane",210-967-2,626-87-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:39;H315:44;H302:1;H332:1;H312:1
82978,"Guanosine 2',3',5'-triacetate",230-242-4,6979-94-8,,Notified C&L,1,H302:1;H332:1;H312:1
82981,"4,4'-bis[[4-[(2-hydroxyethyl)amino]-6-(m-sulphoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, sodium salt, compound with 2,2',2''-nitrilotriethanol",302-428-6,94108-91-5,Not Classified,Notified C&L,42,Not classified:42
82983,2-phenylphenol (ISO);biphenyl-2-ol;2-hydroxybiphenyl,201-993-5,90-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H319:0;H335:0;H315:0;H400:0
82985,"3,4-difluorobenzonitrile",264-751-8,64248-62-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H319:48;H335:46;H312:46;H302:46;H332:46;H315:48;H228:2;H311:3;H331:3;H301:3
82988,Cefoxitin,252-641-2,35607-66-0,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H317:1;H334:1;Not classified:2
82989,Ethyl pentafluoropropionate,207-043-6,426-65-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:45;H335:44;H315:45;H225:47
82992,2-naphthylacetic acid,209-475-0,581-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;Not classified:38;H412:1;H301:1
82994,isoeugenol,202-590-7,97-54-1,Skin Sens. 1A,Harmonised C&L,0,H317:0
82996,1-[4-(trifluoromethoxy)phenyl]ethan-1-one,285-066-0,85013-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4;H302:1
82997,Pyridine-2-carbaldehyde oxime,212-849-6,873-69-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,46,H302:7;H412:2;H319:40;H335:39;H315:40
83002,"N,N'-dibenzylethylenediammonium dichloride",222-300-2,3412-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
83004,"1-trimethylsilyl-1,2,4-triazole",242-170-0,18293-54-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43;H225:43
83005,2-(2-phenoxyethoxy)ethanol,203-227-5,104-68-7,Eye Dam. 1,REACH registration C&L,954,H318:144;H319:712;H302:233;Not classified:99
83007,"Echinacea purpurea, ext.",289-808-4,90028-20-9,Not Classified,Notified C&L,10,Not classified:6;H226:4
83011,"1-Bromo-2,3,5-trichlorobenzene",617-194-3,81067-38-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H335:42;H312:38;H302:38;H332:38;H315:43
83012,"2-CHLORO-4,6-DIBROMOANILINE",618-013-0,874-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H302:4
83018,"26-hydroxy-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl stearate",226-312-9,5349-52-0,Not Classified,Notified C&L,2,Not classified:2
83020,"1,1,3-trimethyl-3-phenylindan",223-467-4,3910-35-8,Skin Sens. 1B,Notified C&L,1413,H317:1311;Not classified:101;H319:1;H335:1;H411:1
83021,Decanoic anhydride,218-213-4,2082-76-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
83024,"Dichlorobenzo[rst]phenanthro[10,1,2-cde]pentaphene-9,18-dione",215-380-5,1324-55-6,Not Classified,Notified C&L,21,Not classified:21
83025,2-amino-1-(phenylmethyl)-1H-benzimidazole,256-130-5,43182-10-1,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2,H302:2;H332:1;H314:1;H319:1;H335:1;H315:1
83030,4-fluorobiphenyl,206-304-1,324-74-3,Not Classified,Notified C&L,5,Not classified:3;H319:2;H335:2;H315:2;H312:1;H302:1;H332:1
83032,Carbonyl sulphide,207-340-0,463-58-1,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 3,Notified C&L,229,H280:229;H220:229;H331:229;H319:41;H335:41;H315:41;H336:2
83033,"2,4,8,10-Tetraoxaspiro(5.5)undecane-3,9-diethanol, beta,beta,beta',beta'-tetramethyl-",485-230-3,1455-42-1,Not Classified,REACH registration C&L,3,Not classified:3
83034,Ethyl isonicotinate,216-379-2,1570-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H335:41;H315:42
83037,"Hexa-2,4-diyne-1,6-diol",221-210-0,3031-68-3,Flam. Sol. 1,Notified C&L,43,H228:43
83039,Benalaxyl-M,619-330-7,98243-83-5,Aquatic Chronic 2,Notified C&L,19,H411:19
83040,Lithium potassium titanium oxide,445-620-6,39318-30-4,Not Classified,REACH registration C&L,2,Not classified:2
83041,Sodium 5-aminonaphthalene-2-sulphonate,249-304-7,28907-84-8,Not Classified,Notified C&L,1,Not classified:1
83043,"6-chloro-N,N,N',N'-tetrabutyl-1,3,5-triazine-2,4-diamine",609-724-7,39605-45-3,Skin Sens. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,86,H410:86;H373:86;H317:86;H400:86
83046,2-hydroxy-1-naphthaldehyde,211-902-0,708-06-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2174,H410:2129;H317:119;H400:2167;H319:45;H335:43;H315:45
83051,"2,6,6-trimethylbicyclo[3.1.1]heptane-3-carbaldehyde",262-062-7,60113-43-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,172,H317:108;H411:108;H302:108;H401:1;H315:172;H226:24
83053,1-HYDROXY-7-AZA-BENZOTRIAZOLE,609-760-3,39968-33-7,Expl. 1.4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,162,H302:117;H319:121;H315:162;H204:157;H335:41;H318:41;H301:40;H228:3
83054,"N-[2[2-(dimethylamino) ethoxy]ethyl]-n-methyl-1,3-propanediamine",620-116-0,189253-72-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H318:25;Not classified:25;H317:47;H302:47;H314:47
83056,Methyl L-prolinate hydrochloride,218-363-0,2133-40-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,204,H319:203;H315:203;H335:1;H302:1;H332:1;H312:1
83059,Tungsten,231-143-9,7440-33-7,Flam. Sol. 1;Self-heat. 2,REACH registration C&L,680,H252:411;H228:494;Not classified:186;H319:46;H315:41;H335:7;H413:1
83065,"N,N'-(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[2-[(2,4-dichlorophenyl)azo]-3-oxobutyramide]",227-783-3,5979-28-2,Not Classified,Notified C&L,51,Not classified:46;H350:5
83068,Trioctylamine,214-242-1,1116-76-3,Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,210,H319:178;H372:83;H360:83;H400:102;H410:109;H315:178;H335:54;H411:59;Not classified:2;H413:1
83069,"Hydrocarbons, C4-8",273-305-1,68956-52-5,Acute Tox. 4,Notified C&L,21,H302:16;Not classified:5
83070,"9-HYDROXY-3-(2-HYDROXYETHYL)-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE",605-935-3,181525-38-2,Acute Tox. 4;Muta. 2;Aquatic Chronic 3,REACH registration C&L,1,H302:1;H341:1;H412:1
83071,"Fatty acids, C8-22, reaction products with diethanolamine, ethanolamine, polyethylenepolyamines, polytrimethylenepolyamines and triethanolamine, formates (salts), hydrochlorides",305-756-8,95009-29-3,Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H314:1
83072,nickel dibromide,236-665-0,13462-88-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H341:0;H372:0;H334:0;H360:0;H400:0;H410:0;H350:0
83073,"[1R-(1α,3α,4aα)]-2,3,4,4a,5,6-hexahydro-2,2-dimethyl-1,3-methanonaphthalen-7(1H)-one",270-397-5,68433-81-8,Not Classified,Notified C&L,25,Not classified:25
83074,"Pine, Pinus pinaster, ext.",290-166-2,90082-75-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1558,H317:1547;H304:1547;H411:1;H226:1547;H315:258;H400:1361;H410:1362;Not classified:11
83075,2-phenyl-1H-benzimidazole-5-sulphonic acid,248-502-0,27503-81-7,Not Classified,REACH registration C&L,157,Not classified:139;H319:18;H315:18;H335:4
83077,"Coke (coal), naphtha cracking ethylene manuf. by-product",305-500-5,94581-02-9,Not Classified,Notified C&L,83,Not classified:83
83080,Hyaluronoglucosaminidase,253-464-3,37326-33-3,Resp. Sens. 1,Notified C&L,1,H334:1
83081,2-aminoethyldimethylamine;2-dimethylaminoethylamine,203-541-2,108-00-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H302:0;H314:0;H312:0;H225:0
83084,"2-ethylhexanoic acid, zirconium salt",245-018-1,22464-99-9,Repr. 2,REACH registration C&L,777,H361:180;H315:430;Not classified:145;H319:40;H335:39;H332:20;H413:20;H317:2;H302:1;H226:1
83086,Ethyl hydrogen adipate,210-966-7,626-86-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83088,"Hexanedioic acid, di-C7-9-branched and linear alkyl esters",271-105-9,68515-75-3,Not Classified,Notified C&L,6,Not classified:6
83089,2-bromobutyryl chloride,244-791-2,22118-12-3,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H226:1;H290:1;H318:1;H314:1
83091,"fenamidone (ISO);(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one",605-252-0,161326-34-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
83096,"Dodecane-1,12-diol",227-133-9,5675-51-4,Not Classified,REACH registration C&L,21,Not classified:21
83097,Dihexadecyl peroxodicarbonate,247-611-0,26322-14-5,Org. Perox. F,REACH registration C&L,63,H242:63
83103,Fenspiride,225-751-3,5053-06-5,Acute Tox. 4;Repr. 2;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2;H361:2
83104,N-(2-bromo-4-fluorophenyl)acetamide,600-141-3,1009-22-9,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,46,H302:7;H411:2;H319:43;H335:42;H311:38;H331:38;H301:38;H315:43;Not classified:1
83105,(E)-hex-3-enyl formate,260-442-7,56922-80-6,Flam. Liq. 3,Notified C&L,113,H226:113
83106,Benzyl 3-phenyl-L-alaninate hydrochloride,219-558-3,2462-32-0,Not Classified,Notified C&L,2,Not classified:2
83107,Tetracontane,224-055-7,4181-95-7,Not Classified,Notified C&L,7,Not classified:7
83108,Germanium tetrahydride,231-961-6,7782-65-2,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 2,Notified C&L,185,H280:185;H220:185;H330:185;H302:38
83114,"5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile",425-310-7,77889-90-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
83115,(6-aminohexyl)carbamic acid,205-581-6,143-06-6,Flam. Sol. 2;Eye Irrit. 2,REACH registration C&L,127,H319:121;H228:46;H315:81;H335:5;H318:6
83116,trans-pent-2-ene,211-461-4,646-04-8,Flam. Liq. 1;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,81,H319:44;H335:43;H304:56;H224:62;H315:44;H302:22;H332:22;H225:18;Not classified:1
83120,"2,2',2''-(1,3,5-triazine-2,4,6-triyltriimino)trisethanol",224-538-2,4403-07-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H319:1;H332:1;H312:1
83125,"Benzenesulfonic acid, mono-C7-17-alkyl derivs.",273-228-3,68953-90-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H302:1;H318:1;H314:1
83127,1-bromoundecane,211-757-3,693-67-4,,Notified C&L,5,H319:5;H335:5;H315:5
83132,butyl (2E)-3-[4-amino-3-(methylamino)phenyl]prop-2-enoate,918-878-7,1160838-31-2,Flam. Sol. 2;Self-heat. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H252:1;H335:1;H228:1;H301:1;H315:1
83135,3-Ethoxy-(E)-2-propenoic acid ethyl ester,443-080-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H335:1;H315:1
83136,"Aluminum, 2-(1,3-dihydro-1,3-dioxo-2H-inden-2-ylidene)-1,2-dihydro-6,7-quinolinedisulfonate complexes",305-632-3,94891-32-4,Aquatic Chronic 2,REACH registration C&L,40,H411:2;Not classified:38
83137,Guanidinium phosphate,217-176-1,1763-07-1,Not Classified,Notified C&L,7,Not classified:7
83138,CITRUS AURANTIUM DULCIS OIL,616-926-9,8008-57-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,426,H317:358;H304:361;H400:277;H226:399;H410:307;H315:412;H411:41;H412:1
83139,(2-Mercaptoethyl)pyrazine,609-107-2,35250-53-4,Acute Tox. 3,Notified C&L,1591,H301:1591;H319:43;H335:42;H315:43;H311:1;H331:1
83140,"5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide",428-150-6,113171-13-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
83148,"1,4-Benzenedicarboxylic acid, di-C11-14-isoalkyl esters, C13-rich",605-275-6,162030-42-4,Not Classified,Notified C&L,6,Not classified:6
83150,"Amides, from diethylenetriamine and tall-oil fatty acids, benzyl chloride-quaternized",296-555-3,92797-20-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83151,"trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)",407-580-8,130201-51-3,Eye Dam. 1,Harmonised C&L,0,H318:0
83159,"Disodium 4-[[3,5-bis[(3-amino-4-nitrophenyl)azo]-2,4-dihydroxyphenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",229-324-2,6473-02-5,Not Classified,Notified C&L,3,Not classified:3
83162,"Fatty acids, tall-oil, esters with diethylene glycol",295-716-5,92128-23-9,Not Classified,Notified C&L,4,Not classified:3;H302:1
83163,"Betaines, bis(hydroxyethyl)tallow alkyl",274-845-0,70750-46-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,48,H318:38;H315:47;H319:9;H317:7;H412:7;H400:7;Not classified:1
83165,Sodium 4(-2-hydroxy-1-naphthylazo)naphthalenesulphonate,216-760-3,1658-56-6,Aquatic Chronic 3,REACH registration C&L,2093,H412:19;H319:2073;Not classified:12;H335:8;H315:2
83166,Physostigmine sulphate,200-585-4,64-47-1,Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38
83171,Phenyl(trichloromethyl)mercury,221-960-9,3294-57-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H373:38;H310:38;H330:38;H400:38;H410:38
83176,6-BROMO-HEXANOIC ACID METHYL ESTER,604-307-6,14273-90-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:38;H335:40;H315:40;H319:2;H314:1
83179,"1,3-dicyclohexylurea",219-213-7,2387-23-7,Acute Tox. 4,Notified C&L,53,H302:52;Not classified:1;H361:1
83182,"6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole",615-996-8,73590-58-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4,REACH registration C&L,281,H302:94;H332:93;H312:92;H317:173;H319:120;H335:119;H315:119;H412:46;H341:2;H411:2;H361:1
83183,Hexahydrocyclopenta[c]pyrrol-2(1H)-amine,259-201-9,54528-00-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,4,H318:3;H341:3;H411:3;H302:3;H314:3;H319:1;H335:1;H315:1
83185,Silicristin,251-720-9,33889-69-9,Acute Tox. 4,Notified C&L,39,H302:39
83187,"Turnera diffusa, ext.",283-657-8,84696-52-6,Flam. Liq. 3,Notified C&L,27,H226:26;H225:1
83189,2-({2-[4-(dimethylamino)benzoyloxy]ethyl}(methyl)amino)ethyl 4-(dimethylamino)benzoate,466-080-8,,Not Classified,REACH registration C&L,3,Not classified:3
83191,N-(4-aminophenyl)oxamic acid,203-158-0,103-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
83196,[(butoxymethylethoxy)methylethoxy]propan-1-ol,259-910-3,55934-93-5,Not Classified,REACH registration C&L,232,Not classified:232
83201,"Sulfuric acid, mono-C8-14-alkyl esters, lithium salts",292-217-4,90583-19-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H318:44;H315:43;H335:1;H412:1;H302:1;H317:1
83202,2-naphthyloxyacetic acid,204-380-0,120-23-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,140,H302:140;H319:138;H335:137;H315:138;H312:1;H332:1;H318:1;H317:1
83210,Ethyl 2-Aminothiazole-4-carboxylate,611-074-4,5398-36-7,,Notified C&L,7,H319:7;H335:6;H315:7;H312:1;H302:1;H332:1
83211,tralkoxydim (ISO);2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one,618-075-9,87820-88-0,Acute Tox. 4;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H351:0;H411:0
83212,(S)-2-methylbutylamine,252-307-6,34985-37-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,42,H225:42;H312:38;H302:38;H332:38;H314:42;H334:4
83213,"1-(2,5-dichloro-4-(N-methylsulfamoyl)phenylazo)-2-hydroxy-N-(2-tolyl)-3-naphthamide",400-840-1,,Not Classified,Notified C&L,32,Not classified:32
83214,"Ethene, chloro-, homopolymer, chlorinated",614-692-2,68648-82-8,Not Classified,Notified C&L,6,Not classified:6
83215,"Eriocephalus punctulatus, ext.",305-084-5,94334-04-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,40,H304:40;H411:40;H317:40;H410:4
83220,4-Amino-7-chloroquinoline,601-638-8,1198-40-9,Acute Tox. 3;Eye Irrit. 2,Notified C&L,40,H319:39;H301:39;H341:1;H411:1;H335:1;H315:1
83226,Methylnaphthalenesulphonic acid,255-472-2,41638-59-9,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,29,H319:16;H373:16;H335:16;H411:16;H302:16;Not classified:11;H290:2;H318:2;H314:2
83230,"2-(2,3-dihydro-1-benzofuran-5-yl)acetonitrile",606-348-5,196399-53-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
83234,4-fluoro-4'-methoxybenzophenone,206-464-2,345-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
83235,4-chloro-N-methylpiperidine,226-942-4,5570-77-4,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,61,H226:54;H314:59;H319:4;H412:8;H225:6;H312:6;H331:6;H302:6;H315:2;H335:1
83236,Ethyl laurate,203-386-0,106-33-2,Not Classified,REACH registration C&L,1634,Not classified:1618;H410:16;H400:16
83237,4-bromoisophthalic acid,230-078-3,6939-93-1,,Notified C&L,6,H319:6;H335:5;H315:6
83242,1-benzyl-4-hydroxypiperidine-4-carbonitrile,228-043-2,6094-60-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:44;H335:43;H312:42;H302:42;H332:42;H315:44;H311:1;H331:1;H301:1
83243,"1,2-difluoro-3-methylbenzene",442-630-2,3828-49-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H225:2;H411:1
83251,"5-(difluoromethoxy)-1,3-dihydrobenzimidazole-2-thione",417-780-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H335:2;H315:2;H320:2;Not classified:1;H312:1;H302:1;H332:1
83253,8-aminonaphthalene-1-sulphonic acid,201-437-1,82-75-7,Not Classified,REACH registration C&L,56,Not classified:10;H314:38;H319:8;H335:7;H315:6
83254,Tetrabutylammonium hydroxide,218-147-6,2052-49-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,270,H318:62;H317:10;H302:66;H226:10;H314:195;Not classified:74;H332:55;H312:56;H311:4;H224:4;H301:4;H290:2;H400:1;H411:1;H319:1;H315:1;H336:1;H341:1;H225:1
83256,Sulfacetamide sodium,204-848-4,127-56-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:40;H335:40;H315:40;Not classified:2;H317:1
83259,"Undec-10-enoic acid, ethoxylated",500-170-0,67719-56-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H302:1;H318:1
83261,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)",237-864-5,14025-15-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,372,H302:302;H319:291;Not classified:68;H412:2;H315:2
83263,"4'-cyano[1,1'-biphenyl]-4-yl 4'-heptyl[1,1'-biphenyl]-4-carboxylate",277-064-3,72928-30-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
83264,2-[(1-methylpropyl)amino]ethanol,252-471-9,35265-04-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,6,H335:1;H318:1;H317:1;H330:1;H411:1;H302:1;H314:1;Not classified:5
83266,Terguride,253-624-2,37686-84-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,63,H311:62;H331:62;H301:63;H361:1
83268,"Tris[[1,1'-biphenyl]-2-oxy]phosphine",220-396-0,2752-19-4,Skin Irrit. 2,Notified C&L,1,H315:1
83270,"Aromatic hydrocarbons, C10",918-811-1,1189173-42-9,Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,78,H304:78;H411:78;H336:78
83271,"2',5'-dimethoxyacetophenone",214-858-0,1201-38-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
83272,Diethylphenylphosphine,216-516-6,1605-53-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H315:39;H302:4;H332:4;H312:4
83278,2-hydroxyethyl acrylate,212-454-9,818-61-1,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H400:0;H311:0;H317:0;H314:0
83281,"2,2'-oxybis-ethanol diformate",601-722-4,120570-77-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,89,H302:88;H318:77;H314:88;Not classified:1
83283,"2-chloro-1-(2,5-dimethylphenyl)ethan-1-one",619-866-1,50690-11-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
83284,"Petroleum gases, liquefied;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]",270-704-2,68476-85-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
83285,Methyl L-threoninate,222-158-1,3373-59-9,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,1,H302:1;H317:1
83286,Taurolidine,243-016-5,19388-87-5,Not Classified,Notified C&L,1,Not classified:1
83287,(Z)-dodec-9-enyl acetate,241-054-7,16974-11-1,Aquatic Chronic 1,Notified C&L,89,H410:83;H315:6
83289,4-Methoxycarbonyl-2-methylthiophen-3-yl-ammonium hydrochloride,929-732-7,,Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H314:1
83293,"Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt, hydrate (1:2:2)",612-074-7,6106-24-7,Acute Tox. 4,Notified C&L,95,H302:55;Not classified:40
83294,C.I. REACTIVE RED 136; REAKTIV ROT 136; ROUGE REACTIF 136,404-120-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,11,H319:8;H315:8;Not classified:3
83297,"Amines, N-tallow alkyltrimethylenedi-, diacetates",272-786-5,68911-78-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,4,H318:3;H315:3;H400:4;H302:1;H319:1;H314:1
83298,Terpene resin,618-376-5,9003-74-1,Not Classified,Notified C&L,1,Not classified:1
83299,Neodymium tribromide,236-897-2,13536-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45
83300,"2,6-dichlorobenzothiazole",222-819-4,3622-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41;H312:1;H302:2;H332:1
83308,"Fatty acids, lanolin, distn. residues",293-062-5,91051-12-6,Not Classified,Notified C&L,2,Not classified:2
83309,1-bromo-3-methylbut-2-ene,212-799-5,870-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1333,H319:1286;H335:1286;H315:1286;H226:47;H314:47;H318:3;H330:1;H400:1;H301:1
83310,4-AMINO-3-NITROPYRIDINE,605-505-5,1681-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:44;H319:45;H335:44;H315:45;H312:1;H332:1
83311,Calcium bis[4-[[1-[[(4-methoxyphenyl)amino]carbonyl]-2-oxopropyl]azo]-3-nitrobenzenesulphonate],277-421-3,73385-03-2,Not Classified,Notified C&L,1,Not classified:1
83313,Niobium pentafluoride,232-020-2,7783-68-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,45,H318:38;H312:44;H302:44;H332:44;H314:45
83315,Sodium m-[[4-[[p-[bis(2-hydroxyethyl)amino]phenyl]azo]-1-naphthyl]azo]benzenesulphonate,266-867-4,67674-28-6,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,65,H412:12;H317:12;Not classified:44;H319:9
83318,"Glycerides, C14-20, reaction products with diethylenetriamine",287-077-6,85409-11-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
83320,11-MERCAPTOUNDECANOIC ACID,615-278-4,71310-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
83325,"α-D-Glucopyranoside, α-D-glucopyranosyl, hydrate (1:2)",612-140-5,6138-23-4,Not Classified,Notified C&L,120,Not classified:120
83332,Isobutyldimethoxymethylsilane,242-171-6,18293-82-8,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,1,H226:1;H315:1
83333,disodium tetrachloroplatinate,233-051-4,10026-00-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0;H301:0;H315:0
83334,"Decasodium [[(phosphonatomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",299-048-5,93841-76-0,Not Classified,Notified C&L,1,Not classified:1
83337,Zinc bis[bis(tetrapropylenephenyl)] bis(hydrogen dithiophosphate),234-277-6,11059-65-7,Aquatic Chronic 3,REACH registration C&L,454,H412:8;H360:4;H361:4;H319:446
83340,Sodium p-(3-amino-4-methylbenzamido)benzenesulphonate,275-177-2,71077-34-4,Not Classified,Notified C&L,34,Not classified:34
83345,"5-butyl-1H,3H,5H-pyrimidine-2,4,6-trione",217-781-0,1953-33-9,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
83347,Peppermint oil (Natural oil),616-900-7,8006-90-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,331,H317:271;H411:242;H315:299;H302:29;H319:41;H304:14;H412:9;Not classified:3
83348,"Sodium 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-(phenylazo)-1H-pyrazol-1-yl]benzenesulphonate",228-818-5,6359-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
83357,"1,2-dihydro-1,5-dimethyl-2-(p-tolyl)-3H-pyrazol-3-one",260-175-6,56430-08-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
83359,"9,10-dihydro-9,10-dioxoanthracenediazonium",240-193-0,16048-40-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H351:38;H332:38;H312:38
83360,1-methyl-4-piperidone,215-895-5,1445-73-4,Flam. Liq. 3,REACH registration C&L,77,H226:77;H314:7;H319:5;H335:3;H315:5;Not classified:1;H318:1
83362,4-(4-nitrophenyl)butyric acid,227-019-9,5600-62-4,Acute Tox. 4,Notified C&L,39,H302:39
83363,2-chloro-4-nitrobenzoyl chloride,230-367-4,7073-36-1,,Notified C&L,6,H314:6;H290:1;H318:1
83365,11-[3-(dimethylamino)propyl]-6H-benzo[c][1]benzothiepin-11-ol,604-888-6,1531-85-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2
83367,Isopropenyl methyl ether,204-125-3,116-11-0,Flam. Liq. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,66,H302:66;H412:15;H224:66
83369,"1,1,1-trichloro-3,3,3-trifluoroacetone",212-063-3,758-42-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,1,H330:1;H311:1;H314:1;H301:1
83370,"4-(4-aminophenoxy)-1,2-benzenediamine",228-425-9,6264-66-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
83374,"Benzene, C9-13-alkyl derivs., distn. residues, sulfonated, barium salts",307-592-2,97675-23-5,Not Classified,Notified C&L,441,Not classified:441
83375,Aluminium sulfate hydrate,605-852-2,17927-65-0,Eye Dam. 1,Notified C&L,106,H318:106;H290:23;H335:4;H315:4
83376,"2,9-bis(4-chlorophenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",219-166-2,2379-77-3,Not Classified,REACH registration C&L,18,Not classified:18
83377,Uramustine,200-631-3,66-75-1,Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Carc. 2,Notified C&L,38,H300:38;H335:38;H318:38;H351:38;H315:38
83378,"3,5-dimethylpyridine",209-708-6,591-22-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,193,H318:187;H312:137;H331:96;H301:152;H226:193;H314:92;H335:99;H311:55;H332:95;H315:101;H302:41;H319:6
83379,2-methoxy-1-(2-methoxypropoxy)propane; 2-methoxy-1-[(1-methoxypropan-2-yl)oxy]propane,404-640-5,,Not Classified,REACH registration C&L,247,Not classified:247
83382,"3,3',5,5'-tetramethylbiphenyl-2,2'-diol",607-957-9,26567-10-2,Eye Irrit. 2A,REACH registration C&L,2,H319:2
83383,"1-Decanol, 2-hexyl-, phosphate, potassium salt",254-432-1,39373-89-2,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H411:2
83384,"6-bromo-5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7-ol",251-052-8,32449-41-5,Acute Tox. 4,Notified C&L,1,H312:1
83385,"Tetrasodium 3,3'-[carbonylbis[imino(2-methyl-4,1-phenylene)azo]]bisnaphthalene-1,5-disulphonate",221-728-7,3214-47-9,Not Classified,REACH registration C&L,21,Not classified:20;H317:1;H334:1
83389,Di(tert-butyl)aminyl oxide,219-298-0,2406-25-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H302:38;H226:38;H315:38
83391,Magnesium zirconium trioxide,234-768-5,12032-31-4,Not Classified,Notified C&L,1,Not classified:1
83393,"4,4'-(1-methylethylidene)bis[2,6-dibromo-, polymer with 2-(chloromethyl)oxirane and 4,4'-(1-methylethylidene)bis[phenol]",607-901-3,26265-08-7,Skin Irrit. 2,Notified C&L,123,H315:99;H318:14;H317:15;Not classified:9
83395,4-fluorobenzophenone,206-463-7,345-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
83399,"Fatty acids, C18-unsatd., dimers, polymers with diethylenetriamine, ethylenediamine, sebacic acid and tall-oil fatty acids",614-525-3,68475-96-7,Not Classified,Notified C&L,22,Not classified:22
83404,2-tert-butylcyclohexyl acetate,201-828-7,88-41-5,Aquatic Chronic 2,Notified C&L,2548,H411:2472;H315:93;H319:42;H335:41;Not classified:34;H302:2
83406,2-nitrobenzenesulphonyl chloride,216-907-1,1694-92-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,86,H318:36;H314:53;H302:33;Not classified:2;H335:1;H290:1
83410,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,3-benzenediol",615-108-9,70356-25-1,,Notified C&L,31,Not classified:31
83414,1-(2-thienyl)butan-1-one,226-246-0,5333-83-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
83415,2-(4-chloro-2-methylphenoxy)propionic acid,202-264-4,93-65-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H302:0;H410:0;H315:0
83416,"α,α-diphenylglycine",221-299-6,3060-50-2,Not Classified,Notified C&L,1,Not classified:1
83418,"1,3-dimethyldisiloxane",238-361-3,14396-21-5,Not Classified,Notified C&L,1,Not classified:1
83425,Oftasccine,215-957-1,1461-15-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
83426,Triisooctyl phosphate,246-616-5,25103-23-5,Not Classified,Notified C&L,34,Not classified:34
83427,Astemizole,272-441-9,68844-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H361:1;H302:1
83429,"Trisodium 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulphonato-2-naphthyl]azo]phenyl]amino]-3-sulphonatophenyl]azo]-4-hydroxynaphthalene-2-sulphonate",229-326-3,6473-13-8,Eye Irrit. 2,Notified C&L,194,H319:132;Not classified:48;H320:14;H315:17
83431,Hexaaluminium pentaoxide disilicate,235-102-6,12068-56-3,Not Classified,Notified C&L,1,Not classified:1
83432,2-undecyl-1H-imidazole,240-796-9,16731-68-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H319:78;H335:77;H315:78
83437,Bis(dibenzylidenaceton)palladium(0),608-691-6,32005-36-0,Skin Sens. 1B,Notified C&L,163,H317:159;H319:4;H335:2;H315:4;H312:2;H302:2;H332:2;H228:2;H290:1
83438,"1,5-diamino-4,8-dihydroxyanthraquinone",205-655-8,145-49-3,Eye Irrit. 2,Notified C&L,2,H319:2
83440,1-bromononane,211-755-2,693-58-3,Aquatic Acute 1,Notified C&L,42,H400:41;H319:2;H335:1;H315:2
83443,"Methyl tricyclo[3.3.1.13,7]dec-1-yl ketone",216-761-9,1660-04-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,3,H319:2;H335:2;H413:2;H302:2;H315:2;Not classified:1
83444,LST 7,617-129-9,8062-15-5,Not Classified,Notified C&L,31,Not classified:31
83445,3-chlorovanillin,243-086-7,19463-48-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H335:38;H315:38
83447,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(octadecyloxy)-, ammonium salt (1:1)",611-857-0,59650-73-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
83448,"Distillates (petroleum), vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C",274-685-1,70592-78-8,Carc. 1B,Harmonised C&L,0,H350:0
83449,Aluminium triethanolate,209-105-8,555-75-9,Flam. Sol. 1,REACH registration C&L,52,H228:47;H314:45;Not classified:5;H318:1
83451,"2,3-dihydro-5-nitro-1H-indazol-3-one",262-728-7,61346-19-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
83452,"1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)",617-751-0,85721-33-1,Not Classified,Notified C&L,97,Not classified:56;H412:26;H361:9;H319:6;H410:3;H400:2;H335:2;H317:1;H334:1;H315:2;H411:1
83454,"trans-4-Propyl-trans-4'-trifluoromethyl-(1,1'-bicyclohexyl)",603-728-2,133261-31-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
83455,[2H]benzene,214-321-0,1120-89-4,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1A;STOT RE 1,Notified C&L,38,H319:38;H225:38;H372:38;H304:38;H350:38;H340:38;H315:38
83458,(S)-3-amino-4-(2-naphthylamino)-4-oxobutyric acid,211-243-9,635-91-6,Carc. 2,Notified C&L,39,H351:38;H350:1
83465,Tritylium hexachloroantimonate,216-446-6,1586-91-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,42,H302:42;H332:42;H411:42;H314:4
83469,Praseodymium trinitrate,233-796-5,10361-80-5,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,127,H410:87;H318:87;H400:87;H272:123;H302:122;H315:123;H319:39;H335:39;Not classified:1
83470,(Z)-hex-4-enal,225-058-6,4634-89-3,Flam. Liq. 3,Notified C&L,25,H226:25
83474,2-bromoethanol,208-748-1,540-51-2,,REACH registration C&L,108,H311:104;H331:100;H314:105;H301:104;H341:4;H330:8;H300:4;H310:4;H318:1
83475,"2-(hydroxymethyl)-2-[[(1-oxododecyl)oxy]methyl]propane-1,3-diyl dilaurate",267-449-4,67874-04-8,,Notified C&L,1,Not classified:1
83478,alkali fluorosilicates(Na),240-934-8,16893-85-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H311:0;H331:0;H301:0
83479,"Ethanol, 2,2',2''-nitrilotri-, polymer with 2-methyloxirane",607-888-4,26221-30-7,Not Classified,Notified C&L,5,Not classified:5
83482,"2,6-difluorobenzoic acid",206-856-3,385-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:50;H335:49;H315:50
83483,2-methylpent-1-ene,212-108-7,763-29-1,Flam. Liq. 2,Notified C&L,66,H225:66;H319:22;H335:22;H315:22;H336:1;H304:1
83484,"3,5-difluorobenzonitrile",264-752-3,64248-63-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:45;H335:44;H312:45;H302:45;H332:45;H315:45;H311:2;H331:2;H301:2
83492,"Disodium 2,2'-methylenebis(4-chlorophenolate)",244-853-9,22232-25-3,Eye Irrit. 2,Notified C&L,2,H319:2
83496,Dioctyl carbonate,434-850-2,,Not Classified,REACH registration C&L,91,Not classified:91
83497,Ethyl N-benzyl-3-oxopiperidine-4-carboxylate hydrochloride,258-162-5,52763-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49
83500,trans-β-methylstyrene,212-848-0,873-66-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H335:39;H318:38;H334:38;H304:38;H226:43;H315:40;H332:3;H319:2;H411:1
83501,"Fatty acids, tall-oil, iron salts, basic",271-977-0,68648-06-6,Not Classified,Notified C&L,9,Not classified:9
83502,3-(p-tert-butylphenyl)-2-methylpropanol,259-996-2,56107-04-1,Aquatic Chronic 2,Notified C&L,172,H411:83;Not classified:64;H319:25;H317:25;H412:25;H361:25;H302:25
83503,N-(2-aminoethyl)dodecanamide,233-381-9,10138-02-0,Not Classified,Notified C&L,441,Not classified:441
83505,"2-(3,7-dimethylocta-2,6-dienyl)cyclopentan-1-one",268-706-3,68133-79-9,Skin Irrit. 2,Notified C&L,119,H315:119;H410:2;H400:2
83509,2-nitronaphthalene,209-474-5,581-89-5,Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H350:0
83511,(R)-α-(formyloxy)benzeneacetyl chloride,249-478-4,29169-64-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:42;H314:43;Not classified:1;H290:1
83512,Digallium triselenide,234-693-8,12024-24-7,,Notified C&L,174,H373:174;H330:174;H400:174;H301:174;H410:174
83514,"4-Chloro-2,6-dibromoaniline",618-012-5,874-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H302:5;H311:1;H331:1;H301:1
83516,"2-(1,1-dimethylethoxy)methylethoxypropan-2-ol",422-300-4,,,Notified C&L,9,H319:9
83517,Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate,217-412-3,1838-39-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,7,H302:6;H332:6;H312:6;H319:1;H335:1;H315:1
83519,Calcium bis[4-[[3-[[2-hydroxy-3-[[(4-methoxyphenyl)amino]carbonyl]-1-naphthyl]azo]-4-methylbenzoyl]amino]benzenesulphonate],256-050-0,43035-18-3,Not Classified,REACH registration C&L,42,Not classified:42
83520,(S)-azetidine-2-carboxylic acid,218-362-5,2133-34-8,Not Classified,Notified C&L,3,Not classified:1;H319:2;H335:2;H315:2
83521,"9-Octadecenoic acid (Z)-, sulfated, potassium salts",291-756-2,90480-24-3,Eye Irrit. 2,Notified C&L,1,H319:1
83524,"2,2,6,6-tetramethyl-4-piperidylamine",253-197-2,36768-62-4,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,165,H318:88;H412:77;H302:165;H290:43;H314:161;H319:4;H335:4;H315:4
83525,3-(2-thienyl)acrylic acid,214-402-0,1124-65-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
83529,"Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N-C8-18-branched and linear alkyl",309-300-9,100208-94-4,Not Classified,Notified C&L,1,Not classified:1
83537,Copolymer of epichlorohydrin and diethylentriamine,607-982-5,26658-42-4,Aquatic Chronic 3,Notified C&L,1,H412:1
83538,thiocarbonyl chloride,207-341-6,463-71-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H331:0;H302:0;H315:0
83544,Manganese difluoride,231-960-0,7782-64-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H319:42;H335:42;H312:38;H302:42;H332:42;H315:42
83548,"2,2-dichloroethanol",209-931-9,598-38-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H351:38;H332:38;H312:38
83549,"Butter, distn. lights",294-759-7,91745-88-9,Eye Irrit. 2,Notified C&L,1421,H319:1286;Not classified:135
83552,"Aconitane-3,8,13,14,15-pentol, 1,6,16-trimethoxy-4-(methoxymethyl)-20-methyl-, 8-acetate 14-benzoate, (1α,3α,6α,14α,15α,16β)-",220-397-6,2752-64-9,Acute Tox. 1;Acute Tox. 1,Notified C&L,39,H300:39;H330:39
83554,"2,3-dihydro-4-methyl-1-phenyl-1H-phosphole 1-oxide",211-901-5,707-61-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,45,H319:38;H335:39;H312:39;H302:45;H351:38;H332:39;H315:39;H318:1
83560,Pancreatin,232-468-9,8049-47-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,REACH registration C&L,690,H317:200;H319:680;H315:683;H334:690;H335:112
83561,Sodium 3-hydroxy-4-[(1-hydroxy-2-naphthyl)azo]-7-nitronaphthalene-1-sulphonate,217-250-3,1787-61-7,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,53,H319:42;H412:22;H411:15;H315:11;Not classified:4;H335:6
83562,"Fatty acids, C12-20, reaction products with 3-[[2-[(2-aminoethyl)amino]ethyl]amino]propanenitrile",295-673-2,92113-66-1,Not Classified,Notified C&L,1,Not classified:1
83565,4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate,277-679-7,74050-97-8,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,11,H411:7;H301:7;H302:3;H312:1;Not classified:2;H332:1;H361:1
83571,"L-Phenylalanine, 4-fluoro-",601-248-8,1132-68-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H302:2;H332:2;H312:2;H319:1;H335:1;H315:1;Not classified:1
83572,"Pine, Pinus nigra, ext.",290-165-7,90082-74-9,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1,Notified C&L,273,H226:273;H304:273;H317:273;H400:88;H410:89;H315:2
83573,"Oxirane, (chloromethyl)-, homopolymer, iso-Bu alc.-modified",616-066-4,74232-08-9,Aquatic Chronic 3,Notified C&L,43,H412:43
83574,Citraconic anhydride,210-459-0,616-02-4,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,88,H317:80;H314:78;H334:78;H335:40;H311:49;H318:33;H319:9;H315:9;H331:1;H301:1;H413:1
83576,LANTHANUM STRONTIUM MANGANESE OXIDE,454-770-1,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
83577,"2,5-diamino-4-chlorotoluene",226-162-4,5307-03-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83578,Barite (Ba(SO4)),236-664-5,13462-86-7,Not Classified,Notified C&L,303,Not classified:303
83580,Amobarbital sodium,200-584-9,64-43-7,Acute Tox. 3,Notified C&L,39,H301:39
83581,Dilithium sebacate,242-999-8,19370-86-6,Acute Tox. 4,REACH registration C&L,50,H302:27;Not classified:21;H319:2;H315:2
83585,p-hexylphenol,219-501-2,2446-69-7,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
83586,"Pentane-2,4-dione, monopotassium salt",243-017-0,19393-11-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
83590,2-chloroethyldimethylamine,203-540-7,107-99-3,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,3,H319:3;H317:2;H341:2;H412:2;H301:3;H351:2;H315:3;H335:1;H311:1
83597,"3-butene-1,2,3-tricarboxylic acid",247-612-6,26326-05-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83598,5-methoxy-2-methylbenzoxazole,227-134-4,5676-57-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
83605,"Estra-1,3,5(10)-triene-3,17β-diol 17-(cyclopentanepropionate)",206-237-8,313-06-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,40,H312:38;H360:38;H302:38;H332:38;H350:39;H361:1
83606,"[(1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid – methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate (1:1)",601-680-7,120202-68-8,Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,3,H401:1;H411:1;H318:3
83607,3-(methylthio)propionic acid,211-460-9,646-01-5,,Notified C&L,7,H314:7;H290:1;H318:1
83611,"1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs.",273-227-8,68953-84-4,Skin Sens. 1B;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,68,H410:68;H361:8;H317:68;H400:66;H334:2
83614,Hexadecyl myristate,220-001-1,2599-01-1,Not Classified,Notified C&L,1,Not classified:1
83619,"Linoleic acid, oligomeric reaction products with acrylic acid and tris(2-hydroxyethyl)-1,3,5-triazinetrione",500-257-3,74512-23-5,Not Classified,Notified C&L,71,Not classified:71
83622,"Reaction Mass of (2R)-2-methyl-4-[(1R)-2,2,3-trimethylcyclopent-3-en-1-yl]pent-4-enal and (2S)-2-methyl-4-[(1R)-2,2,3-trimethylcyclopent-3-en-1-yl]pent-4-enal",422-120-6,166432-53-7,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,29,H410:4;H317:29;H400:4;H413:25
83627,Titanium oxide,257-372-4,51745-87-0,Not Classified,Notified C&L,3,Not classified:3
83628,"4-amino-N,N-dimethylbenzylamine",229-033-0,6406-74-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H318:1;H312:1;H302:1;H332:1;H315:1
83631,6-aminopenicillanic acid,208-993-4,551-16-6,Not Classified,REACH registration C&L,70,Not classified:60;H317:8;H334:9;H302:1;H319:2;H315:2;H335:1
83634,"Benzenemethanaminium, N,N-dimethyl-N-octadecyl-, chloride, reaction products with hectorite",305-633-9,94891-33-5,Not Classified,Notified C&L,2,Not classified:2
83635,"1,3-Benzenedimethanamine, N-(2-cyanoethyl) derivs.",290-606-3,90194-00-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,55,H318:55;H317:55;H412:55;H302:55;H332:55;H314:55
83638,"Passionflower, Passiflora incarnata, ext.",277-142-7,72968-47-9,Not Classified,Notified C&L,120,Not classified:117;H226:3;H319:1
83648,"trans-cyclohexane-1,2-diol",215-956-6,1460-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
83652,N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide,416-470-9,170292-97-4,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
83656,"Ar'-isopropyl(1,1'-biphenyl)-4-yl 3-diazo-3,4-dihydro-4-oxonaphthalene-1-sulphonate",257-675-1,52125-43-6,Self-heat. 1,Notified C&L,2,H251:2
83659,Ethyl octanoate,203-385-5,106-32-1,Aquatic Chronic 2,REACH registration C&L,1781,H411:25;Not classified:1662;H315:94
83661,"Quaternary ammonium compounds, coco alkylbis(hydroxyethyl)methyl, chlorides",274-846-6,70750-47-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,190,H318:168;H411:172;H400:186;H302:189;H314:189;H410:16;Not classified:1
83662,"2,6-diamino-5-nitroso-1H-pyrimidin-4-one",219-214-2,2387-48-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H317:38;H302:38;H315:42
83666,Arabinanase,253-463-8,37325-54-5,Resp. Sens. 1,Notified C&L,2,H334:2
83667,[(aminoiminomethyl)thio]acetic acid,231-010-5,7404-50-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H302:41;H318:41;H335:41;H315:41
83672,"Usnea barbata, ext.",283-658-3,84696-53-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,103,H411:89;H317:102;Not classified:1
83673,"8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride",225-752-9,5053-08-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H332:40;H312:40;H412:1
83675,"Lignin, alkali",617-145-6,8068-05-1,Eye Irrit. 2;STOT SE 3,Notified C&L,209,H319:160;H335:158;Not classified:33;H317:17;H315:3
83676,2-ethylimidazole,214-011-5,1072-62-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,147,H302:65;H318:65;H315:125;H319:60;H335:98;Not classified:22
83677,8-anilinonaphthalene-1-sulphonic acid,201-438-7,82-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,14,H319:14;H335:2;H315:3;H302:11
83681,"9H-carbazole-3,6-diamine",201-692-9,86-71-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:38;H318:1;H314:1
83684,"Hexane, 1,6-diisocyanato-, homopolymer, di-Et malonate-and N-(1-methylethyl)-2-propanamine-blocked",606-650-7,208408-04-2,Skin Sens. 1,Notified C&L,90,H317:90
83685,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with diethylenetriamine",500-627-4,161278-36-0,,Notified C&L,1,H302:1;H312:1;H317:1;H314:1
83687,"2,2'-oxybis(ethylamine) hydrochloride",262-435-4,60792-79-2,,Notified C&L,1,H302:1
83689,Glucurolactone,251-053-3,32449-92-6,Not Classified,REACH registration C&L,40,Not classified:15;H302:25
83694,"2(1H)-Quinolinone, 5-[(1R)-2-bromo-1-hydroxyethyl]-8-(phenylmethoxy)-",610-932-5,530084-79-8,Eye Dam. 1,Notified C&L,2,H318:1;H412:1;H317:1
83695,1-isobutoxypropan-2-ol,245-663-9,23436-19-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H226:2;H335:2;H315:2
83699,"Propanenitrile, 3-[[2-(acetyloxy)ethyl][4-[2-(6-nitro-2-benzothiazolyl)diazenyl]phenyl]amino]-",611-614-9,58051-98-2,Not Classified,Notified C&L,4,Not classified:4
83704,"Castor oil, polymd., oxidized",614-490-4,68439-93-0,Not Classified,Notified C&L,5,Not classified:5
83705,4-isopropylphenylacetic acid,224-755-2,4476-28-2,Acute Tox. 4,Notified C&L,43,H302:38;H319:5;H335:5;H315:5
83708,"2,6-dichlorobenzoxazole",222-818-9,3621-82-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,74,H302:73;H319:39;H317:35;H311:35;H400:34;H410:35;H314:35;H315:1;H318:1
83710,"Furo[3,4-b]pyrazine-5,7-dione",225-260-4,4744-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H319:40;H335:40;H315:40
83713,"Petroleum gases, liquefied, sweetened;[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]",270-705-8,68476-86-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
83715,"Amines, N-tallow alkyltripropylenetetra-",272-787-0,68911-79-5,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,11,H335:5;H318:10;H314:11;H373:5;H302:6;H410:6;H400:1
83716,Tantalum disilicide,234-902-2,12039-79-1,Not Classified,Notified C&L,1,Not classified:1
83718,"N,N-dimethylbenzene-1,4-diamine hydrochloride",218-146-0,2052-46-2,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3;Resp. Sens. 1,Notified C&L,40,H300:39;H311:39;H331:39;H334:39;Not classified:1
83724,Methyl 3-bromophenylacetate,604-742-1,150529-73-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
83727,Brofoxine,244-389-7,21440-97-1,Acute Tox. 4;Repr. 2,Notified C&L,1,H302:1;H361:1
83734,Butyl 2-vinyloxyethyl ether,224-172-3,4223-11-4,Flam. Liq. 3;Eye Dam. 1,Notified C&L,38,H226:38;H318:38
83737,Zincite (ZnO),606-554-5,20431-17-8,Not Classified,Notified C&L,1,Not classified:1
83738,"Naphtha (petroleum), light steam-cracked, debenzenized, polymers, hydrogenated",614-305-7,68132-00-3,Not Classified,Notified C&L,137,Not classified:137
83740,2-methoxy-4-prop-1-enylphenyl phenylacetate,204-381-6,120-24-1,Not Classified,Notified C&L,88,Not classified:88
83745,"3,7-dimethylocta-1,6-diene",219-433-3,2436-90-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1610,H317:1389;H304:1572;H400:56;H226:1610;H410:56;H315:1427;H412:245
83747,fluazifop-P-butyl (ISO);butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate,616-669-2,79241-46-6,Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H361:0;H400:0
83751,N-2-naphthyl-L-glutamine,238-542-7,14525-44-1,Carc. 2,Notified C&L,39,H351:38;H350:1
83753,(3-Nitrophenyl)boronic acid,603-734-5,13331-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
83754,"N,N-diethyl-N'-[(8α)-6-methylergolin-8-yl]uronium hydrogen maleate (1:1)",253-625-8,37686-85-4,Repr. 2,Notified C&L,39,H361:39;H302:1;H332:1
83757,Bis(dimethylamino)phosphinic chloride,216-517-1,1605-65-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H318:41;H314:45;H312:1;H302:1;H332:1;H290:1
83759,Trihexylaluminium,214-241-6,1116-73-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,68,H260:68;H250:68;H314:68;H412:8;H361:8;H373:4;H318:55
83760,Oct-1-yne-3-ol,212-455-4,818-72-4,Acute Tox. 4;Aquatic Acute 1,Notified C&L,45,H302:45;H400:40;H311:1;H331:1
83762,(4-(trifluoromethyl)phenyl)boronic acid,603-301-0,128796-39-4,Acute Tox. 4,Notified C&L,49,H302:40;H319:10;H335:8;H315:10;H332:2;H312:1
83764,"3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-dimethano-1H-benz[f]indene",230-512-1,7158-25-0,Skin Sens. 1,REACH registration C&L,89,H317:1;Not classified:88
83765,"Hydrogen bis[benzene-o-diolato(2-)-O,O']borate(1-), compound with N,N'-di-o-tolylguanidine (1:1)",241-053-1,16971-82-7,Acute Tox. 4,Notified C&L,35,H302:35
83766,Potassium palmitate,220-088-6,2624-31-9,Not Classified,Notified C&L,29,Not classified:18;H319:11;H315:11
83767,[No public or meaningful name is available],464-690-9,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H318:1;H411:1;H317:1
83769,"trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)",418-220-4,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
83772,Isoguanine,222-157-6,3373-53-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H319:90;H315:90
83774,2-Chlorobenzoylacetonitrile,609-772-9,40018-25-5,,Notified C&L,7,H302:7;H319:6;H335:5;H315:6;H332:1;H312:1
83776,"(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide",411-000-9,125224-62-6,Skin Sens. 1,Harmonised C&L,0,H317:0
83778,"Iron, acetylacetone 6-methyl-2,4-heptanedione complexes",291-489-1,90412-09-2,Not Classified,REACH registration C&L,2,Not classified:2
83780,"5-Chloro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride",608-031-7,27006-83-3,Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,13,H412:1;H318:1;H314:13;H300:11
83781,Acetatocobalamin,245-019-7,22465-48-1,Carc. 2,Notified C&L,78,H351:38;H373:35;Not classified:5
83782,Ammonium hydrogen 2-sulphobenzoate,230-077-8,6939-89-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
83783,"Fatty acids, C8-22, reaction products with polyethylenepolyamines and polytrimethylenepolyamines, acetates",305-757-3,95009-30-6,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1;H314:1
83784,"1'-(phenylmethyl)-[1,4'-bipiperidine]-4'-carboxamide",217-173-5,1762-50-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H302:1;H332:1;H312:1
83787,"Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with p-phenylenediamine and sodium methoxide",600-736-8,106276-80-6,Not Classified,REACH registration C&L,134,Not classified:134
83788,6-bromopyridin-2-amine,606-385-7,19798-81-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,52,H319:52;H335:51;H312:8;H302:8;H332:8;H315:52
83790,trans-4-Aminocyclohexan-1-ol hydrochloride,610-586-5,50910-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:43;H315:43;H302:1
83797,Methyl 3-hydroxybenzo[b]thiophene-3-carboxylate,236-066-4,13134-76-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
83800,Calcium dipalmitate,208-811-3,542-42-7,,Notified C&L,42,Not classified:42
83802,"4,6-dimethoxysalicylaldehyde",211-904-1,708-76-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
83803,(E)-non-2-enal,242-609-6,18829-56-6,Skin Irrit. 2,Notified C&L,1510,H315:1509;H319:81;H335:45;H226:24;H224:1
83804,1-acetamidocinnamic acid,226-795-6,5469-45-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39
83810,Dimethoxymethane,203-714-2,109-87-5,Flam. Liq. 2,REACH registration C&L,384,H225:379;H302:24;H371:24;H319:177;H335:79;H315:80;H310:33;H317:6;Not classified:5;H336:1
83811,"Tussilago farfara, ext.",283-420-9,84625-50-3,Not Classified,Notified C&L,1,Not classified:1
83818,3-[(methylamino)carbonyl]-5-nitrobenzoic acid,217-788-9,1954-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:2;H335:2;H315:2;Not classified:1
83824,"Disodium 2,5-dichloro-4-(5-hydroxy-3-methyl-4-(sulphophenylazo)pyrazol-1-yl)benzenesulphonate",228-819-0,6359-98-4,Not Classified,REACH registration C&L,2316,Not classified:2296;H319:20;H315:2
83831,3-methylbutyl butyrate,203-380-8,106-27-4,Flam. Liq. 3;Aquatic Chronic 2,REACH registration C&L,1799,H226:1775;H411:23;H412:1741;H319:66;H335:45;H315:66
83833,12-aminododecanoic acid,211-754-7,693-57-2,STOT RE 2,REACH registration C&L,12,H373:12
83836,Digallium tritelluride,234-694-3,12024-27-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,222,H302:222;H332:222
83837,2-methylbutyl hexanoate,220-005-3,2601-13-0,Not Classified,Notified C&L,12,Not classified:11;H226:1
83838,Europium trinitrate,233-380-3,10138-01-9,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H335:40;H315:40;H272:41;Not classified:1;H410:1;H318:1;H400:1
83840,"2,6-dimethyl-3-nitropyridine",239-543-5,15513-52-7,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39;H228:39
83842,Glyceric acid 3-(barium phosphate),245-012-9,22457-55-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H301:1
83844,"5'α(S)-sec-butyl-9,10α-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione",243-089-3,19467-62-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
83848,"Benzene, C9-13-alkyl derivs., distn. residues, sulfonated, calcium salts",307-593-8,97675-24-6,Skin Sens. 1B,REACH registration C&L,889,H317:18;H319:837;H413:33;Not classified:1
83852,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, sodium salt, compd. with 2,2'-iminobis[ethanol] and 2,2',2''-nitrilotris[ethanol]",302-426-5,94108-89-1,Not Classified,Notified C&L,1,Not classified:1
83853,2-methoxy-3-(4-methylpentyl)pyrazine,272-442-4,68844-95-1,Not Classified,Notified C&L,89,Not classified:89
83854,"N,N,N',N'-tetrakis[4-(dibutylamino)phenyl]benzene-1,4-diamine",224-057-8,4182-80-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,35,H319:35;H315:35
83855,Dibismuth dititanium heptaoxide,234-986-0,12048-51-0,Not Classified,Notified C&L,2,Not classified:2
83857,"Gases (petroleum), thermal cracking distn.;Refinery gas;[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-789-6,68478-05-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
83860,Apamin,246-182-7,24345-16-2,,Notified C&L,39,Not classified:38;H302:1;H332:1;H312:1
83861,"Phosphoric acid, mono-C12-15-alkyl esters, disodium salts",309-420-1,100298-67-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83863,Diethyl bromomethylmalonate,249-541-6,29263-94-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:43;H290:1
83865,Glutaryl dichloride,220-711-1,2873-74-7,Acute Tox. 3;Skin Corr. 1B,Notified C&L,43,H314:43;H301:39;H302:4;H290:1;H318:1
83866,Methylseleninic acid,608-183-4,28274-57-9,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H373:39;H331:39;H400:39;H301:39;H410:39;H314:39;H318:1
83871,Sodium (Z)-N-(2-hydroxyethyl)-N-[2-[(1-oxo-9-octadecenyl)amino]ethyl]glycinate,300-070-5,93919-85-8,Not Classified,Notified C&L,2,Not classified:2
83874,"4-methoxy-7-methylfuro[3,2-g]chromen-5-one",201-430-3,82-57-5,Acute Tox. 4,Notified C&L,42,H302:42
83875,"Glycerides, tallow mono-, hydrogenated, acetates",273-612-0,68990-58-9,Not Classified,Notified C&L,22,Not classified:22
83879,"N,N'-dibenzylideneethylenediamine",203-229-6,104-71-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
83887,"1H-Thioxantheno[2,1,9-def]isoquinoline-1,3(2H)-dione, 2-octadecyl-",603-155-8,12671-74-8,Not Classified,Notified C&L,2039,Not classified:2039
83888,Isopropylidenedi-p-phenylene bis(chloroformate),217-970-8,2024-88-6,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,39,H318:39;H311:39;H331:39;H301:39;H314:39
83891,Calcium bis(cyclohexylsulphamate),205-349-4,139-06-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:48;H335:48;H315:48;Not classified:6
83898,2-ethylhexyl acrylate,203-080-7,103-11-7,Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H317:0;H335:0;H315:0
83903,"Naphtha (petroleum), light steam-cracked, debenzenized;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",271-266-5,68527-26-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
83907,"REACTION PRODUCT OF: 3-HYDROXY-5,7-DI-TERT-BUTYLBENZOFURAN-2-ONE WITH O-XYLENE",605-925-9,181314-48-7,Not Classified,Notified C&L,230,Not classified:176;H411:34;H413:20;H317:1;H319:1;H315:1
83908,"(methylstannylidyne)tris(thioethane-1,2-diyl) tris[(9Z,12Z)-octadeca-9,12-dienoate]",273-008-7,68928-40-5,Not Classified,Notified C&L,57,Not classified:56;H373:1;H317:1;H361:1;H400:1;H302:1;H410:1
83913,Dipotassium disulphite,240-795-3,16731-55-8,Eye Dam. 1,REACH registration C&L,1504,H318:164;H335:1385;H315:1293;Not classified:43;H319:11
83915,Tricosane,211-347-4,638-67-5,Not Classified,Notified C&L,93,Not classified:93
83919,"1,2,4(or 1,3,5)-trimethylcyclohex-3-ene-1-carbaldehyde",276-055-1,71832-78-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,233,H319:233;H315:233
83925,Sodium glycinate,227-842-3,6000-44-8,Not Classified,REACH registration C&L,82,Not classified:82
83926,"1,3-dichloro-5-iodobenzene",221-216-3,3032-81-3,,Notified C&L,8,H319:8;H335:7;H315:8;H312:1;H302:1;H332:1
83928,"Biphenyl-3,3',4,4'-tetrayltetraammonium tetrachloride",231-018-9,7411-49-6,Muta. 2;Carc. 1B,Notified C&L,48,H341:47;H350:45;H319:3;H335:3;H351:3;H315:3;H302:2;H332:1;H400:1;H410:1
83929,"Cuprate(5-), [4-[[8-hydroxy-7-[[2-hydroxy-4-[[3-sulfo-4-[2-[2-sulfo-4-[[4-[(4-sulfophenyl)azo]phenyl]-ONN-azoxy]phenyl]ethenyl]phenyl]-NNO-azoxy]phenyl]azo]-6-sulfo-2-naphthalenyl]amino]benzoato(7-)]-, tetrasodium hydrogen",277-519-6,73513-81-2,Not Classified,Notified C&L,14,Not classified:14
83932,Silver phosphate glass,608-534-1,308069-39-8,Not Classified,Notified C&L,117,Not classified:84;H319:32;H410:1;H400:1
83933,"Phosphoric acid, C8-16-alkyl esters, sodium salts",291-910-9,90506-48-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
83935,"Rosin, polymer with formaldehyde",613-866-5,65997-07-1,Not Classified,Notified C&L,7,Not classified:7
83936,"4,5-di-tert-butyl-6-ethoxy-2,2-dimethyl-3,7-dioxa-4-aza-6-phosphanonan-1-oic acid 6-oxide",449-920-8,,Self-react. D;Aquatic Chronic 3,Notified C&L,1,H412:1;H242:1
83945,Bis(diisobutyldithiocarbamato)nickel,239-354-8,15317-78-9,Not Classified,Notified C&L,35,Not classified:35
83950,Ethyl piperidine-2-carboxylate,239-990-6,15862-72-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H226:45;H335:44;H315:45
83953,25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin A1a,601-490-4,117704-25-3,Acute Tox. 4;Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,264,H361:67;H362:68;H400:234;H302:68;H410:264;H301:194;H300:2
83954,"Trisodium 5-[[2,4-dihydroxy-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]phenyl]azo]-4-hydroxy-3-[(4-methoxyphenyl)azo]naphthalene-2,7-disulphonate",302-957-2,94135-86-1,Not Classified,Notified C&L,2,Not classified:2
83955,oxane-4-carbonitrile,610-088-8,4295-99-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
83958,4-fluoro-N-methylaniline,207-294-1,459-59-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:40;H317:39;H318:39;H301:39;H315:40;H319:1;H312:1;H302:1;H332:1;H227:1;H412:1
83961,Pseudoephedrine hydrochloride,206-462-1,345-78-8,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,298,H302:298;H317:178;H335:149;H319:97;H315:97;H332:3;H318:1;H362:1;H336:2
83964,"HEPTANE, BRANCHED, CYCLIC AND LINEAR",610-052-1,426260-76-6,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,99,H225:97;H336:79;H304:79;H411:32;H315:99;H410:37;H400:14;H412:2;H224:2
83968,"Sodium hydrogen [6R-(6α,7β)]-3-(acetoxymethyl)-7-[(5-amino-5-carboxylato-1-oxopentyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",257-093-8,51263-08-2,Skin Sens. 1B;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
83969,"Orange, sweet, Valencia, ext.",307-891-8,97766-30-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,140,H317:130;H304:130;H400:75;H226:130;H410:111;H315:130;H411:19;Not classified:10
83971,"Dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cobaltate(2-)",237-862-4,14025-10-6,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,1,H302:1;H317:1
83976,"Fatty acids, montan-wax, 2-hydroxyethyl esters",270-665-1,68476-05-1,,Notified C&L,83,Not classified:83
83978,Methyl glycinate hydrochloride,227-139-1,5680-79-5,Not Classified,REACH registration C&L,4,Not classified:2;H319:2;H335:2;H315:2
83988,"2-ethylhexyl dihydrogen phosphate, sodium salt",250-443-0,31044-12-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
83990,3-(2-methoxyethoxy)propyl-methyl-bis(trimethylsilyloxy)silane,608-078-3,27306-78-1,Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,537,H319:496;H332:454;H411:484;H312:96;H302:105;H315:94;H412:33;H318:23;H373:23;Not classified:18;H335:1;H330:1
83992,Amantadine sulphate (INNM),250-604-5,31377-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,REACH registration C&L,4,H319:3;H361:3;H335:2;H315:3;H302:1;H412:1
83995,"D-Glucopyranose, oligomeric, C10-16-alkyl glycosides",600-975-8,110615-47-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1107,H318:1103;H315:1103;H319:4;H317:1;H412:1
83996,"N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide",417-530-7,123590-00-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
83997,Umber,235-784-5,12713-03-0,Not Classified,Notified C&L,153,Not classified:153
84000,Rifamide,220-390-8,2750-76-7,Eye Irrit. 2,Notified C&L,1,H319:1
84004,Sultiame,200-511-0,61-56-3,Not Classified,Notified C&L,1,Not classified:1
84006,"Dibutylbis(octadeca-9(Z),12(Z),15(Z)-trienoyloxy)stannane",306-050-2,95873-60-2,Not Classified,Notified C&L,29,Not classified:29
84009,Iododimethylarsine,211-630-2,676-75-5,,Notified C&L,1,H302:1;H310:1
84011,"N,N,N-trimethylanilinium iodide",202-630-3,98-04-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:38;H335:42;H315:43;H319:5;H311:5;H302:4;H331:1;H301:1
84013,"(R*,S*)-(±)-α-2-piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol monohydrochloride",257-412-0,51773-92-3,Acute Tox. 4,Notified C&L,94,H302:93;H319:1;H332:1;H411:1;Not classified:1
84016,"Lubricating oils (petroleum), C",305-595-3,94733-16-1,Carc. 1B,Harmonised C&L,0,H350:0
84017,"pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one",611-516-6,57369-32-1,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
84025,"(9S)-10,11-dihydrocinchonan-9-ol",207-621-8,485-65-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:38;H312:38;H317:1
84027,4-amino-2-methylquinoline,229-604-4,6628-04-2,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,47,H318:1;H411:1;H317:1;H301:1;H319:46;H335:45;H315:46;H302:5
84028,"Balsams, tonka bean",232-460-5,8046-22-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,1451,H302:1451;H412:6;H317:1413;H373:1329;H312:118;H226:36;H361:4
84029,"(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate",402-060-7,108225-03-2,Eye Dam. 1;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H350:0
84032,"Aromatic hydrocarbons, C",309-957-1,101794-75-6,Carc. 1B,Harmonised C&L,0,H350:0
84034,Lead monoxide,215-267-0,1317-36-8,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,759,H372:329;H362:196;H360:748;H400:546;H302:750;H351:394;H332:750;H410:750;H373:420;H361:90;H341:32;H312:14;Not classified:9
84037,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl acetate",259-367-2,54830-99-8,Aquatic Chronic 3,Notified C&L,377,H412:366;Not classified:11;H317:2;H311:2;H301:2;H410:2;H314:2
84039,2-bromo-5-hydroxy-4-methoxybenzaldehyde,426-540-0,2973-59-3,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
84046,Dodecyl nonan-1-oate,241-644-4,17671-26-0,Skin Sens. 1,REACH registration C&L,20,H317:2;Not classified:18
84048,Pentaerythritol tris(3-aziridin-1-ylpropionate),260-568-2,57116-45-7,Eye Irrit. 2;Carc. 2,Notified C&L,75,H319:43;H351:40;H318:27;H335:25;H317:30;H341:27;Not classified:5;H315:3;H412:1;H373:1;H302:1
84049,Inorganic Phosphorus Salt,428-310-5,,Not Classified,REACH registration C&L,43,Not classified:43
84056,"2-[(4-dodecylphenyl)azo]-4-(2,4-xylylazo)resorcinol",269-692-1,68310-04-3,Not Classified,Notified C&L,200,Not classified:200
84058,"2,2,3-trimethylbutane",207-346-3,464-06-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H225:0;H336:0;H304:0;H400:0;H410:0;H315:0
84061,(20R)-20-hydroxypregn-4-en-3-one,205-650-0,145-15-3,,Notified C&L,1,H302:1;H341:1
84062,1-[2-(dimethylamino)-1-(4-phenylmethoxyphenyl)ethyl]cyclohexan-1-ol,618-943-7,93413-61-7,Not Classified,REACH registration C&L,1,Not classified:1
84063,Norgestomet,246-611-8,25092-41-5,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,17,H351:17;H332:17;H360:17;H312:17
84067,Isoheptan-1-ol,257-413-6,51774-11-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,Notified C&L,98,H318:98;H335:98;H315:98
84069,6-chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one,219-163-6,2379-74-0,Not Classified,REACH registration C&L,380,Not classified:340;H410:38;H400:38;H317:1;H319:1;H335:1
84076,Ammonium dihydrogenarsenate,236-667-1,13462-93-6,,Notified C&L,4,H331:4;H400:4;H301:4;H410:4;H350:4
84081,Chloromethyl chloroformate,244-793-3,22128-62-7,Skin Corr. 1B;Acute Tox. 3,Notified C&L,48,H314:48;H331:47;H302:6;H318:2;H311:2;H301:2;H290:2;H330:1
84087,"Amides, from ammonia-ethanolamine reaction by-products and tall-oil fatty acids",271-970-2,68647-75-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H410:1;H315:1
84094,Dimethyl(octadecyl)ammonium acetate,243-377-9,19855-61-9,Not Classified,Notified C&L,1,Not classified:1
84095,"2,4-dimethylcyclohex-3-ene-1-carbaldehyde",268-264-1,68039-49-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,2357,H317:2350;H411:1432;H315:2353;H319:961;H412:919;H410:42;Not classified:5;H226:1;H227:1;H335:1;H312:1;H302:1;H332:1
84096,N-(2-hydroxypropyl)stearamide,252-648-0,35627-96-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
84100,"Fatty acids, C18-unsatd., phosphates",271-708-7,68604-99-9,Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H314:2;H318:1
84105,1-ethyl-3-methyl-1H-imidazolium methanesulfonate (1:1),604-453-0,145022-45-3,Skin Sens. 1B;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,48,H412:42;H317:40;H402:1;H314:7;H290:1;H318:1;H302:2;Not classified:1
84106,1-phenoxypropan-2-ol,212-222-7,770-35-4,Eye Irrit. 2,REACH registration C&L,1425,H319:1255;Not classified:84;H318:83;H226:3
84108,"1,3-dioxolane",211-463-5,646-06-0,Flam. Liq. 2,Harmonised C&L,0,H225:0
84110,4-ethyloctanoic acid,240-560-5,16493-80-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1444,H319:1444;H315:1444;H335:43
84114,"4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium salt trihydrate",601-766-4,121268-17-5,Acute Tox. 4,Notified C&L,89,H302:87;H373:36;H335:46;H318:39;H361:35;H315:45;H319:7;Not classified:2;H411:1;H314:1;H312:2;H332:1
84118,Iron chromite brown spinel,269-069-4,68187-09-7,Not Classified,Notified C&L,51,Not classified:51
84119,"Aframomum meleguη, ext.",291-045-7,90320-21-1,Flam. Liq. 3,Notified C&L,113,H226:113;H317:25;H304:25;H302:25;H410:25;H315:25
84121,Decanoyl chloride,203-938-0,112-13-0,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,95,H290:15;H314:94;H301:31;H302:5;H318:2;Not classified:3
84122,Trimethoxypropylsilane,213-926-7,1067-25-0,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,309,H226:309;H315:218;H319:114;H335:75;H332:48;H336:47;H317:4;Not classified:1;H314:1
84126,"Sodium 3-[(1,5-dihydroxy-2-naphthyl)azo]-4-hydroxybenzenesulphonate",218-145-5,2052-25-7,Not Classified,REACH registration C&L,26,Not classified:8;H412:18
84129,"Amines, C16-18 alkyl, ethoxylated, propoxylated",614-378-5,68213-26-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,47,H302:27;H412:26;H411:20;H301:20;H400:1
84130,"2,4-dichloro-1-iodobenzene",249-938-4,29898-32-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
84133,Octyl heptanoate,225-882-6,5132-75-2,Not Classified,Notified C&L,1,Not classified:1
84138,"Fatty acids, C14-18 and C16-18-unsatd., Me esters, sulfurized",306-517-0,97281-18-0,Not Classified,Notified C&L,441,Not classified:441
84141,"Amides, tall-oil fatty, N,N'-(iminodi-2,1-ethanediyl)bis-, phosphates",288-293-3,85711-34-8,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,220,H317:1;H319:1;H315:220;H318:219
84142,4-anilinobenzenediazonium hydrogen sulphate,224-756-8,4477-28-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1,REACH registration C&L,2,H318:2;H341:2;H400:2;H301:2;H315:2
84145,4-bromophthalic acid,230-183-4,6968-28-1,,Notified C&L,5,H319:5;H335:4;H315:5
84146,"Fatty acids, tall-oil, compds. with N-[3-(dimethylamino)propyl]tall-oil amides",295-714-4,92128-22-8,Skin Corr. 1C;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,62,H400:4;H410:5;H317:59;H314:59;H412:55;Not classified:2
84149,Octadecyl stearate,220-476-5,2778-96-3,Not Classified,REACH registration C&L,231,Not classified:231
84152,Ethyldimethylsilane,212-061-2,758-21-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H225:39
84153,1-ethylvinyl acetate,234-029-7,10500-08-0,Not Classified,Notified C&L,1,Not classified:1
84154,"Naphtha (petroleum), full-range alkylate, butane-contg.;Low boiling point modified naphta;[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C",271-267-0,68527-27-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
84165,Ethyl m-toluate,204-386-3,120-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
84166,"1,1-bis(1,1-dimethylethoxy)-N,N,N-trimethylamine",253-222-7,36805-97-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H226:46;H335:44;H315:46
84167,Tetraoctylammonium bromide,238-936-9,14866-33-2,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,51,H318:2;H315:51;H319:49;H335:47;H312:1;H302:1;H332:1
84168,Ammonium iron(3+) hexakis(cyano-C)ferrate(4-),247-304-1,25869-00-5,Aquatic Chronic 4,REACH registration C&L,261,H413:152;Not classified:99;H412:4;H300:3;H310:3;H330:3;H400:3;H410:3;H411:3
84169,4-iodoaniline,208-743-4,540-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H302:62;H319:61;H335:60;H315:61;H312:8;H332:8;Not classified:2
84170,ALCOHOLS ETHOXYLATED,614-633-0,68603-25-8,Eye Dam. 1,Notified C&L,871,H318:703;Not classified:78;H302:188;H411:96;H319:90;H315:34;H312:14;H335:15;H412:6
84171,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-pentadecafluoronon-1-ene",246-976-3,25431-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
84176,"Solanum dulcamara, ext.",283-655-7,84696-50-4,Flam. Liq. 3,Notified C&L,1,H226:1
84177,Diisopropyl adipate,230-072-0,6938-94-9,Not Classified,REACH registration C&L,263,Not classified:222;H315:38;H400:3
84179,6-methylhept-5-en-2-ol,216-377-1,1569-60-4,Not Classified,Notified C&L,89,Not classified:89
84180,5-amino-3-oxopentanoic acid,226-679-5,5451-09-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,56,H319:56;H315:56;H335:15
84185,4-(2-aminopropyl)phenol,203-152-8,103-86-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
84187,"2,6-dichloroanisole",217-855-2,1984-65-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H302:1;H319:1;H335:1;H315:1;Not classified:1
84188,Dipotassium hexachloroosmate,240-893-6,16871-60-6,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,46,H318:39;H311:40;H331:40;H301:40;H314:41;H302:5;H319:5;H335:5;H315:5;H290:1
84191,4-(ethylnitrosoamino)-4-methylpentan-2-one,226-940-3,5569-45-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Notified C&L,38,H302:38;H332:38;H373:38;H312:38
84197,"dichlorprop-P (ISO);(+)-R-2-(2,4-dichlorophenoxy)propionic acid",403-980-1,15165-67-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H302:0;H318:0;H315:0;H317:0
84207,"Senna, Cassia angustifolia, ext., calcium salt",304-852-7,94280-05-4,Not Classified,Notified C&L,1,Not classified:1
84208,3-methyl-2-oxovaleric acid,215-955-0,1460-34-0,Eye Irrit. 2,Notified C&L,40,H319:40;H315:2;H335:1
84211,NQD-TP-34,432-460-7,,Carc. 2;Aquatic Chronic 4,Notified C&L,1,H351:1;H413:1
84213,"1,3-butylene diacetate",214-244-2,1117-31-3,Not Classified,REACH registration C&L,5,Not classified:5
84215,3-methylanisole,202-893-4,100-84-5,Flam. Liq. 3;Acute Tox. 4,Notified C&L,47,H302:41;H226:47
84221,"2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid",606-162-4,189005-44-5,Not Classified,REACH registration C&L,7,Not classified:4;H319:2;H335:2;H315:2;H302:1
84225,"Formaldehyde, polymer with 2,2'-oxybis[ethanol] and 1,3,5-triazine-2,4,6-triamine",608-779-4,32759-84-5,Skin Sens. 1,Notified C&L,1,H317:1
84226,"3-[(dimethylvinylsilyl)oxy]-1,1,3,5,5-pentamethyl-1,5-divinyltrisiloxane",262-060-6,60111-52-6,Aquatic Chronic 4,Notified C&L,22,H413:22
84228,2-methylprop-2-en-1-ol,208-161-0,513-42-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,72,H319:68;H226:68;H335:67;H315:68;Not classified:4
84236,Nonan-1-ol,205-583-7,143-08-8,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1862,H319:1854;H412:93;H411:1503;H315:266;Not classified:8;H332:6;H335:2
84243,D-N-(4-hydroxyphenyl)glycine,245-247-7,22818-40-2,Not Classified,REACH registration C&L,49,Not classified:2;H319:46;H335:45;H315:46;H302:1
84245,3-Methoxy-2-methyl-1H-pyridin-4-one,616-282-9,76015-11-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
84246,"2,2-dimethoxy-1-methylethylamine",260-717-1,57390-38-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,1,H226:1;H314:1
84250,Nicothiazone,209-108-4,555-90-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
84254,Potassium thioacetate,233-848-7,10387-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1363,H319:1356;H335:1355;H315:1356;Not classified:7
84256,Allantoin,202-592-8,97-59-6,Not Classified,REACH registration C&L,288,Not classified:244;H302:44;H319:1;H332:1;H312:1
84257,(E)-hept-2-enal,242-608-0,18829-55-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Sens. 1,Notified C&L,1645,H302:1645;H226:1256;H311:1256;H317:1255;H332:39;H319:1;H315:1
84258,dimethyldioctadecylammonium hydrogen sulfate,404-050-8,123312-54-9,Eye Irrit. 2;Aquatic Chronic 4,Harmonised C&L,0,H319:0;H413:0
84262,"Decanoic acid, mixed esters with octanoic acid and pentaerythritol",270-472-2,68441-68-9,Not Classified,REACH registration C&L,506,Not classified:506
84269,"N,N-dimethyl-4-(p-tolylazo)aniline",221-135-3,3010-57-9,,Notified C&L,5,H302:5;H332:4;H312:4
84271,"N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide",407-070-5,142859-67-4,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0
84273,1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one,214-405-7,1125-12-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H332:1;H315:1
84277,"Di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide",229-782-3,6731-36-8,Org. Perox. B,REACH registration C&L,251,H241:116;H410:122;H304:83;H242:83;H400:122;H413:52;Not classified:52;H319:18;H335:18;H226:18;H315:18
84278,Triammonium orthophosphate,233-793-9,10361-65-6,Not Classified,Notified C&L,2,Not classified:2
84281,1-benzyl-4-(dimethylamino)piperidine-4-carboxamide,217-174-0,1762-51-2,Acute Tox. 4,Notified C&L,38,H302:38
84283,"Butanoic acid, 2-amino-4-(methylseleno)-, (S)-",608-705-0,3211-76-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H373:93;H331:95;H400:94;H301:95;H410:94;H319:1;H315:1;H311:1
84284,"Mentha longifolia, ext.",290-060-6,90063-99-3,Not Classified,Notified C&L,185,Not classified:184;H319:1;H317:1;H304:1;H411:1;H315:1
84285,"Urea, N-(4-((4-(((cyclohexylamino)carbonyl)amino)phenyl)methyl)phenyl)-N'-octadecyl-",604-940-8,154099-21-5,Aquatic Chronic 2,Notified C&L,24,H411:23;H413:1
84288,"1-Butanamine, 3-methyl-N-(3-methylbutylidene)-",609-128-7,35448-31-8,Flam. Liq. 3,Notified C&L,114,H226:114
84289,"Balsams, Canada, sulfurized",272-834-5,68916-37-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H315:1
84293,2-Bromo-4-chloro-1-iodobenzene,608-682-7,31928-44-6,,Notified C&L,10,H319:10;H335:8;H315:10
84297,"Decyl dihydrogen phosphate, potassium salt",270-390-7,68427-32-7,Acute Tox. 5;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,24,H318:1;H315:4;H303:1;H319:23
84299,"2,2,2-trifluoro-1-(3-fluorophenyl)ethan-1-one",211-903-6,708-64-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H225:39
84301,"Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-788-0,68478-04-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
84303,2-methoxyethanol;ethylene glycol monomethyl ether,203-713-7,109-86-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H312:0;H360:0;H332:0;H302:0;H226:0
84305,Isodecyl acrylate,215-542-5,1330-61-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,727,H319:243;H335:694;H317:589;H411:693;H315:243;Not classified:32;H400:2
84309,3-amino-5-[(methylamino)carbonyl]benzoic acid,217-787-3,1954-96-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
84312,[No public or meaningful name is available],451-700-1,651332-39-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
84313,"Oils, marine",288-321-4,85711-61-1,Not Classified,Notified C&L,1,Not classified:1
84317,"1,2-propanediol-1-acetate",613-080-2,627-69-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H227:1;H335:1;H315:1
84320,"salts of 4,4'-bi-o-toluidine;salts of 3,3'-dimethylbenzidine;salts of o-tolidine",265-294-7,64969-36-4,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H350:0
84324,"4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]-N-(3-ethoxypropyl)benzenesulphonamide",276-602-4,72363-26-9,Not Classified,REACH registration C&L,67,Not classified:59;H317:8;H319:8;H315:8
84328,"4-o-tolylazo-o-toluidine;4-amino-2',3-dimethylazobenzene;fast garnet GBC base;AAT;o-aminoazotoluene",202-591-2,97-56-3,Skin Sens. 1;Carc. 1B,Harmonised C&L,0,H317:0;H350:0
84329,"Oligomycin A, 28-oxo-",234-275-5,11050-94-5,Acute Tox. 4,Notified C&L,39,H302:39
84330,Ethyl hydrogen sebacate,211-753-1,693-55-0,,Notified C&L,4,H319:4;H335:4;H315:4
84332,Selenium tetrachloride,233-053-5,10026-03-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H331:42;H400:42;H301:42;H410:42
84333,"Benzenesulfonic acid, hydroxy-, monosodium salt, reaction products with formaldehyde and 4,4'-sulfonylbis[phenol]",297-283-8,93384-70-4,Not Classified,Notified C&L,4,Not classified:4
84335,"3,7,11-trimethyldodecyn-3-ol",216-510-3,1604-35-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,85,H302:85;H411:84;H400:85;H410:1;H315:1
84337,Benzyltrimethylammonium hydroxide,202-895-5,100-85-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,222,H318:73;H314:221;H224:37;H302:22;H332:22;H312:22;H311:4;H330:4;H301:4;H370:4;Not classified:1
84341,"1-bromo-2,6-difluorobenzene",264-750-2,64248-56-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H226:46;H335:46;H315:47;H302:1
84344,"5,6-dimethyl-1H-benzotriazole",224-058-3,4184-79-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
84345,"Linseed oil, Me ester",285-374-5,85085-45-6,Not Classified,Notified C&L,1,Not classified:1
84351,"6-[(p-tosyl)amino]hexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",301-097-5,93981-14-7,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,18,H412:1;H318:2;Not classified:16
84352,hexafluoropropene;hexafluoropropylene,204-127-4,116-15-4,Press. Gas;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H332:0;H335:0;Not classified:0
84356,"reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)",402-850-1,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
84358,Zinc bis[p-toluenesulphinate],246-181-1,24345-02-6,Aquatic Acute 1,REACH registration C&L,22,H400:4;H319:13;H335:13;H315:13;Not classified:5
84359,"N-(2,4-dinitrophenyl)-L-valine",216-909-2,1694-97-9,Flam. Sol. 1,Notified C&L,1,H228:1
84363,Lysergic acid,201-431-9,82-58-6,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,45,H302:2;H332:2;H341:1;H311:38;H331:38;H301:38;H317:3;Not classified:1
84371,3-phenoxypropionic acid,230-518-4,7170-38-9,,Notified C&L,6,H319:6;H335:5;H315:6
84373,4-(diethylamino)benzonitrile,220-712-7,2873-90-7,,Notified C&L,5,H302:4;H332:4;H312:4;H319:1;H311:1;H331:1;H301:1;H315:1
84374,1-(chlorophenylmethyl)-2-methylbenzene,431-450-1,41870-52-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0
84380,Sodium cyclamate,205-348-9,139-05-9,Not Classified,REACH registration C&L,93,Not classified:41;H302:51;H335:2;H319:1;H351:1;H315:1
84386,Benfotiamine,245-013-4,22457-89-2,Not Classified,Notified C&L,1,Not classified:1
84387,3-amino-4-methoxybenzanilide,204-388-4,120-35-4,Not Classified,REACH registration C&L,41,Not classified:38;H319:3;H335:3;H315:3
84394,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]-, disodium",260-394-7,56819-40-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,162,H410:64;H400:64;H319:83;H226:83;H411:83;H336:83;Not classified:8;H412:5;H413:2
84395,"reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)",432-200-2,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0;H335:0;H315:0
84397,nickel bis(dihydrogen phosphate),242-522-3,18718-11-1,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H372:0;H334:0;H400:0;H410:0;H350:0
84398,"6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine",424-950-4,133949-92-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
84400,"3-hydroxy-2,2-bis(hydroxymethyl)propyl laurate",233-722-1,10332-31-7,,Notified C&L,1,Not classified:1
84401,"Serenoa repens, ext.",290-312-5,90106-85-7,Not Classified,Notified C&L,1,Not classified:1
84403,"1,3-bis(1-isocyanato-1-methylethyl)benzene",220-474-4,2778-42-9,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,162,H319:141;H317:157;H372:56;H334:85;H330:141;H400:141;H410:140;H315:141;H335:84;Not classified:5
84407,(2S-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran,221-217-9,3033-23-6,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,1050,H319:1039;H361:939;H315:1039;H412:62;Not classified:11;H335:1;H317:1;H311:1;H312:1;H331:1;H330:1;H400:1;H301:1;H302:1;H314:1
84415,3-(1H-imidazol-5-yl)pyridine,610-720-2,51746-85-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
84421,Potassium methyl 4-oxidobenzoate,247-464-2,26112-07-2,Not Classified,Notified C&L,3,Not classified:3
84422,"1,3-Isobenzofurandione, polymer with 2,2-dimethyl-1,3-propanediol",611-208-1,54909-13-6,Not Classified,Notified C&L,72,Not classified:71;H319:1;H315:1
84425,Thiamphenicol,239-355-3,15318-45-3,Not Classified,REACH registration C&L,8,Not classified:6;H319:1;H335:1;H317:1;H361:2;H362:1;H315:1
84426,"2,5-dichloro-p-benzoquinone",210-453-8,615-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:57;H335:56;H315:57;H302:5
84428,C.I. Disperse Violet 48,612-891-9,61968-59-0,Not Classified,Notified C&L,3,Not classified:3
84429,Phenylarsonic acid,202-631-9,98-05-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H400:41;H410:45;H331:46;H301:45;H373:4;H300:1;H350:1
84431,"Naphtha (petroleum), hydrodesulfurized light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-178-6,64742-73-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
84442,"Distillates (petroleum), intermediate vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",274-683-0,70592-76-6,Carc. 1B,Harmonised C&L,0,H350:0
84443,Iron sulphide,215-268-6,1317-37-9,Not Classified,REACH registration C&L,93,Not classified:93
84445,"1'-[4-(4-fluorophenyl)-4-oxobutyl][1,4'-bipiperidine]-4'-carboxamide dihydrochloride",219-507-5,2448-68-2,Acute Tox. 4,Notified C&L,49,H302:48;H332:8;H412:7;Not classified:1;H335:1;H312:1;H315:1
84447,(Â±)-Tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate,601-628-3,119738-06-6,Acute Tox. 4;Muta. 2;Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,54,H373:54;H341:54;H360:54;H400:54;H302:54;H410:54
84452,"5,6 beta-Epoxy-7 beta-hydroxy-15 beta,16 beta-methylene-3 beta-pivaloyloxy-5 beta-androstan-17-one",617-351-6,82544-13-6,Aquatic Chronic 2,REACH registration C&L,3,H411:3
84455,"2,4,6-tris(dimethylaminomethyl)phenol",202-013-9,90-72-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0;H315:0
84459,4-fluorobenzaldehyde,207-293-6,459-57-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,71,H302:10;H319:58;H411:9;H226:59;H335:51;H315:54;H413:1
84461,Stearaldehyde,211-346-9,638-66-4,Not Classified,Notified C&L,4,Not classified:2;H319:2;H315:2;H335:1
84466,"Aromatic hydrocarbons, C",309-958-7,101794-76-7,Carc. 1B,Harmonised C&L,0,H350:0
84467,"5-chloro-2-(5-chloro-4,7-dimethyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4,7-dimethylbenzo[b]thiophene-3(2H)-one",219-164-1,2379-75-1,,Notified C&L,12,Not classified:12
84471,"Fatty acids, montan-wax",270-664-6,68476-03-9,Not Classified,Notified C&L,240,Not classified:240
84475,"Gas oils (petroleum), thermal-cracked, hydrodesulfurized;Cracked gasoil",295-411-7,92045-29-9,Carc. 1B,Harmonised C&L,0,H350:0
84476,"1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate",419-430-9,56533-00-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H312:0;H400:0;H302:0;H410:0;H314:0
84481,"Polymyxin B, sulfate (salt)",215-774-7,1405-20-5,Acute Tox. 4,Notified C&L,59,H302:59;H332:3
84482,"Oxobis(pentane-2,4-dionato-O,O')titanium",237-861-9,14024-64-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,45,H319:45;H335:44;H312:39;H302:43;H351:38;H332:39;H315:45
84485,"Trisodium tris[5,6-dihydro-5-(hydroxyimino)-6-oxonaphthalene-2-sulphonato(2-)-N5,O6]ferrate(3-)",243-010-2,19381-50-1,Not Classified,Notified C&L,136,Not classified:131;H319:5;H412:4;H335:1;H315:1
84488,"(3S,6R,9S,12R,15S,18R,21S,24R)-3,9,15,21-Tetraisobutyl-4,6,10,16,18,22-hexamethyl-12,24-bis[4-(4-morpholinyl)benzyl]-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone",604-993-7,155030-63-0,STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,26,H410:26;H372:25;H400:25;H302:2
84495,Dipotassium tetracyanoplatinate,209-236-0,562-76-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H300:39;H310:39;H330:39;H400:39;H410:39
84496,"Neodecanoic acid, 2-oxiranylmethyl ester, reaction products with dodecylbenzenesulfonic acid",600-976-3,110615-48-0,,Notified C&L,1,Not classified:1
84501,"2,5-dimethoxybenzonitrile",226-169-2,5312-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H312:4;H302:4;H332:4;H301:1
84502,"Pregn-4-ene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11β)-",227-843-9,6000-74-4,Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,19,H361:18;H332:16;H312:16;Not classified:1;H373:1
84503,"4-[(2-chlorophenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",229-039-3,6407-74-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H335:38;H400:38;H301:38;H315:38
84504,"2,3-dihydroxypropyl palmitate",208-812-9,542-44-9,Aquatic Chronic 2,Notified C&L,24,H411:18;Not classified:6
84505,"Bromochloro-5,5-dimethylimidazolidine-2,4-dione",251-171-5,32718-18-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,Notified C&L,214,H318:117;H317:172;H400:213;H302:213;H314:207;H272:79;H410:34;H319:7;H335:8;H315:7;H270:4;H332:1
84507,"1-bromo-3,3-dimethylbutan-2-one",226-794-0,5469-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H335:43;H315:44;H318:4;H331:4
84510,"Benzoic acid, 2-(4-(diethylamino)-2-hydroxybenzoyl)-, hexyl ester",443-860-6,302776-68-7,Not Classified,REACH registration C&L,200,Not classified:4;H413:196
84512,Butafosfan,241-341-7,17316-67-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1
84516,Octadecylamine hydrochloride,217-410-2,1838-08-0,,Notified C&L,4,H319:4;H335:4;H315:4
84517,p-[(o-nitrophenyl)amino]phenol,259-132-4,54381-08-7,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,21,H319:14;H400:7;H411:7;H335:6;H312:4;H332:4;H315:6;Not classified:1
84524,Cinchonidine,207-622-3,485-71-2,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,63,H302:51;H317:42;H373:38;H361:39;Not classified:12;H372:1;H412:1
84526,Methyl (4-chloro-2-methylphenoxy)acetate,219-430-7,2436-73-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H312:41;H400:38;H302:41;H332:41;H410:38
84528,N-allylcyclohexylamine,229-603-9,6628-00-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H226:39;H314:39
84529,Pentyl 4-hydroxybenzoate,229-408-9,6521-29-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
84531,"4-trans-Pentyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(2-fluor-4-pentylphenylester)",601-456-9,116903-35-6,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
84535,"Thyme, Thymus vulgaris, ext.",284-535-7,84929-51-1,Flam. Liq. 4;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1763,H227:12;H317:1690;H318:210;H304:1687;H411:1510;H302:1504;H314:1694;H226:1571;Not classified:65;H400:1;H225:2;H315:3;H319:1;H335:1;H361:1
84537,"(±)-β,3,4-trihydroxyphenethylammonium [R-(R*,R*)]-hydrogen tartrate",222-307-0,3414-63-9,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT SE 1,REACH registration C&L,40,H311:2;H330:40;H228:2;H301:2;H370:2;H300:38;H310:38
84538,"Strychnos nux-vomica, ext.",232-461-0,8046-97-7,,Notified C&L,1,H302:1;H225:1
84540,"Origanum heracleoticum, ext.",294-363-4,91721-63-0,Acute Tox. 4;Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,4,H319:3;H317:4;H311:3;H412:4;H304:4;H302:4;H315:4;H318:1
84542,"branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate",427-030-0,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
84546,MILAU,456-870-0,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
84547,Triazolam,249-307-3,28911-01-5,Repr. 1B;Lact.,Notified C&L,188,H360:186;H362:187;H361:1;H336:1;Not classified:1;H373:1
84548,Saponins,232-462-6,8047-15-2,Eye Irrit. 2;STOT SE 3,REACH registration C&L,235,H319:226;H335:225;Not classified:7;H315:6;H312:1;H302:1;H332:1;H317:1
84552,Chlorotriethylplumbane,213-925-1,1067-14-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H373:38;H310:38;H330:38;H360:38;H400:38;H410:38
84558,Potassium linoleate,222-308-6,3414-89-9,Eye Irrit. 2,Notified C&L,24,H319:22;Not classified:2
84560,"Naphthalene-1,3,6-trisulphonic acid",201-690-8,86-66-8,,Notified C&L,33,Not classified:33
84565,"Petrolatum (petroleum), oxidized, ester with ethylene glycol",292-648-8,90669-54-8,Not Classified,Notified C&L,1,Not classified:1
84568,"3,3-dimethylbutan-2-ol",207-347-9,464-07-3,Flam. Liq. 3,Notified C&L,42,H226:42;H319:4;H335:4;H315:4
84569,"etrimfos (ISO);O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate",253-855-9,38260-54-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
84572,"2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride",424-560-4,151257-01-1,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0
84573,Adenosine 5'-(toluene-4-sulphonate),225-883-1,5135-30-8,Not Classified,Notified C&L,7,Not classified:7
84574,2-chloropyrimidine,217-020-2,1722-12-9,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,53,H412:3;H317:7;H319:50;H301:46;H335:5;H315:5;H312:1;H302:1;H332:1
84575,2-nitrobenzamide,210-208-5,610-15-1,,Notified C&L,5,H302:5;H319:4;H335:4;H315:4;H332:1;H312:1
84576,Morphine sulphate,200-582-8,64-31-3,Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,45,H302:42;H351:38;H361:42;H317:4;H331:2;H334:4;H362:2;H301:3;H330:1;H319:2;Not classified:1;H311:1;H336:2;H335:1;H412:1;H315:1
84578,"4,4'-dibromo-2,2',3,3',5,5',6,6'-octafluoro-1,1'-biphenyl",233-847-1,10386-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H335:42;H315:43;H412:4
84580,"Fatty acids, C16-C18 and C18-unsatd., ME esters, epoxidized",605-143-8,158318-67-3,Skin Sens. 1B,REACH registration C&L,85,H317:2;Not classified:83
84581,"Ferrate(1-), [4-[[2-hydroxy-4-(hydroxy-κO)-5-[[2-(hydroxy-κO)-5-nitrophenyl]azo-κN1]phenyl]azo]benzenesulfonato(3-)]-, sodium",604-861-9,152521-14-7,Not Classified,Notified C&L,3,Not classified:3
84583,"1-[[2,5-dimethyl-4-[(2-methylphenyl)azo]phenyl]azo]-2-naphthol",224-757-3,4477-79-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H319:53;H335:53;H315:53;H351:13;H341:13;H317:13;Not classified:5
84587,"2,6-dibromo-p-toluidine",230-182-9,6968-24-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H335:42;H312:43;H302:43;H332:43;H315:43
84590,nickel diiodide,236-666-6,13462-90-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H341:0;H372:0;H334:0;H360:0;H400:0;H410:0;H350:0
84591,Ethylmethylthiambutene,207-128-8,441-61-2,Not Classified,Notified C&L,1,Not classified:1
84592,Dihydrogen bis[2-[[5-(aminosulphonyl)-2-hydroxyphenyl]azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(2-),235-786-6,12715-61-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,35,H319:28;H412:31;H317:4;H413:2;Not classified:1;H315:1
84594,Diethoxydiphenylsilane,219-860-5,2553-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
84595,"Fatty acids, fish-oil, Me esters",271-709-2,68605-02-7,Not Classified,Notified C&L,1,Not classified:1
84596,"Mentha pulegium, ext.",290-061-1,90064-00-9,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1425,H302:1400;H226:1286;H412:1400;H317:1397;H315:25
84598,"N,N-dimethylthioformamide",212-060-7,758-16-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H302:46;H312:46;H319:5;H335:5;H332:4;H315:5;H311:1;H331:1;H301:1
84600,Calcium fumarate (1:1),243-376-3,19855-56-2,Not Classified,Notified C&L,1,Not classified:1
84603,2-ethyl-3-(2-furyl)acrylaldehyde,212-221-1,770-27-4,Acute Tox. 4,Notified C&L,1374,H302:1374
84609,"Sulfuric acid, mono-C12-14-alkyl esters, compds. with triethanolamine",292-216-9,90583-18-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,122,H302:85;H318:122;H412:87;H315:122
84610,tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate,403-760-5,68030-79-5,Skin Sens. 1,Harmonised C&L,0,H317:0
84612,"1,2-ethanediamine, N-(2-aminoethyl)-, polymer with aziridine",600-783-4,106899-94-9,,Notified C&L,474,Not classified:448;H302:26;H319:14;H411:14;H317:12;H318:12;H341:12;H312:11;H334:12;H330:12;H360:12;H315:12;H314:1
84614,3-amino-6-chloro-2-methyl-4-phenylquinazolin-4-ol,608-111-1,27537-87-7,Not Classified,REACH registration C&L,1,Not classified:1
84616,"1-Propanaminium, 3,3',3''-[phosphinylidynetris(oxy)]tris[N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-, N,N',N''-tri-C6-18 acyl derivs. trichlorides",280-518-3,83682-78-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,239,H411:3;H318:3;H400:17;Not classified:222;H410:14
84618,Octyl acetate,203-939-6,112-14-1,Not Classified,REACH registration C&L,1648,Not classified:1646;H319:1;H315:1;H411:1
84621,"1,4,4a,9a-tetrahydroanthraquinone",260-009-2,56136-14-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
84627,4-Fluoro-3-methoxybenzonitrile,607-355-6,243128-37-2,,Notified C&L,11,H302:7;H332:7;H312:7;H319:6;H335:5;H311:3;H331:3;H301:4;H315:6
84629,"1,1'-Biphenyl, 4,4'-bis(trans-4-propylcyclohexyl)-",617-728-5,85600-56-2,,Notified C&L,2,H413:2;Not classified:1
84630,"4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one monohydrochloride",285-687-7,85118-33-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H336:1
84633,"Trisodium 8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo[3,2-b:3',2'-m]triphenodioxazinetrisulphonate",215-383-1,1324-58-9,Not Classified,Notified C&L,13,Not classified:12;H412:1;H317:1
84634,C.I. Acid Green 28,601-866-8,12217-29-7,Not Classified,Notified C&L,2,Not classified:2
84635,"2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane",617-475-0,83558-87-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43;H373:2;H413:3
84639,Propylamine,203-462-3,107-10-8,Flam. Liq. 2;Met. Corr. 1;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,155,H335:105;H318:106;H225:154;H311:150;H331:146;H302:155;H290:87;H314:155;H412:39;H332:5;H312:1;H224:1
84642,"Amides, tall-oil fatty, N,N'-[iminobis(methyl-2,1-ethanediyl)]bis-",288-292-8,85711-33-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
84647,"O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate",410-140-8,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
84648,"Amides, from tall-oil fatty-acids, tetraethylenepentamine and triethylenetetramine",271-971-8,68647-76-7,Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H314:1
84653,Sodium benzenesulphinate,212-842-8,873-55-2,Not Classified,REACH registration C&L,59,Not classified:56;H319:2;H335:2;H315:2;H302:1
84656,Furan-2-propionic acid,213-298-4,935-13-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,200,H318:194;H335:200;H315:200;H319:6
84660,2-phenoxynicotinic acid,252-647-5,35620-71-4,,Notified C&L,4,H319:4;H335:4;H315:4
84662,"Phosphoric acid, C12-14-alkyl esters, sodium salts",291-911-4,90506-49-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:2;Not classified:1
84663,"3-hydroxy-2,2-bis(hydroxymethyl)propyl oleate",233-723-7,10332-32-8,Not Classified,Notified C&L,59,Not classified:59
84666,"Procavia capensis, ext.",308-304-8,97926-84-6,Not Classified,Notified C&L,51,Not classified:26;H226:25
84670,Tetradodecylammonium bromide,238-937-4,14866-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
84673,(17β)-13-Ethyl-17-ethynyl-3-oxogon-4-en-17-yl acetate,604-013-8,13732-69-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;STOT RE 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,3,H317:2;H372:2;H411:3;H302:2;H401:2;H332:2;H315:2;H361:1
84675,"Cyclopropane-1,1-diyldimethanol",609-723-1,39590-81-3,Eye Irrit. 2,REACH registration C&L,44,H319:44;H335:2;H315:2
84679,2-methylpropane-1-thiol,208-162-6,513-44-0,Flam. Liq. 2,Notified C&L,1465,H225:1465;H319:176;H335:175;H315:176;H332:3
84680,Turnbull's blue,247-305-7,25869-98-1,Not Classified,Notified C&L,7,Not classified:7
84682,"2-Propanone, reactionproducts with 5-amino-1,3,3-trimethylcyclohexanemethanamine, reduced",605-041-3,156105-38-3,Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H373:1;H318:1;H317:1;H311:1;H411:1;H314:1
84684,"Spearmint, ext.",283-656-2,84696-51-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1743,H317:1705;H304:1684;H400:1357;H226:1592;H410:1357;H315:1706;H411:163;H302:34;Not classified:13;H412:1
84686,(2S-cis)-(diphenylmethyl)-N-(phenylmethyl)-1-azabicyclo[2.2.2.]octan-3-amine (1-R camphor-10-sulfonate),444-810-6,,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H302:2;H410:1;H318:2;H400:1
84690,"9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium ethyl sulphate",247-906-4,26694-69-9,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,143,H410:143;H318:143;H400:121;H301:121;H302:22
84691,2-methylthiosemicarbazide,230-071-5,6938-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
84692,"2,2-dimethyl-1,3-propanediyl bismethacrylate",217-856-8,1985-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:58;H335:57;H315:58
84693,Halazepam,245-425-4,23092-17-3,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,26,H319:26;H317:26;H412:26;H411:26;H315:26
84694,Cyclohexanethiol,216-378-7,1569-69-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:7;H335:6;H302:46;H226:46;H315:46;H317:1;H331:1;H411:6;H400:1;H332:44;H312:1
84696,"(6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol",619-458-3,99755-59-6,STOT SE 3;Repr. 2;Lact.,Notified C&L,3,H362:3;H361:3;H336:1;H302:2
84699,"Cobalt, acetylacetone 6-methyl-2,4-heptanedione complexes",290-967-7,90294-79-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Carc. 2,REACH registration C&L,2,H302:2;H351:2;H318:2;H317:2
84700,3-ethoxybenzoic acid,210-690-7,621-51-2,,Notified C&L,5,H319:5;H335:5;H315:5
84704,1-chloro-4-(n-propoxy)-5-thioxanthen-10-one,415-890-1,,Not Classified,Notified C&L,2,Not classified:2
84706,"perboric acid, sodium salt, tetrahydrate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm];perboric acid, sodium salt, monohydrate;[containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]",234-390-0,11138-47-9,,,0,H335:0;H318:0;H272:0;H360:0;H302:0
84707,Ammonium α-hydroxy-p-methoxytoluene-α-sulphonate,268-381-8,68083-33-0,Not Classified,Notified C&L,1,Not classified:1
84708,"Fatty acids, C14-18-branched, Bu esters",292-892-5,91002-15-2,Not Classified,Notified C&L,1,Not classified:1
84714,"1,4-dimethyl butanedioate 1,5-dimethyl pentanedioate 1,6-dimethyl hexanedioate",619-131-5,95481-62-2,Acute Tox. 4,Notified C&L,14,H302:14
84721,Praseodymium trichloride,233-794-4,10361-79-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,132,H410:84;H318:85;H400:84;H302:83;H315:85;H319:45;H335:2;Not classified:2;H290:1;H317:1;H411:2
84722,Holmium triiodide,237-470-3,13813-41-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,46,H319:38;H360:38;H335:38;H315:38;H317:7;H334:7;Not classified:1
84723,"5-[[bis(2-hydroxyethyl)amino]carbonyl]-4-hexyl-N,N-bis(2-hydroxyethyl)cyclohex-2-ene-1-octanamide",304-434-4,94266-28-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,7,H318:7;H315:7
84724,α-ethyl-p-methoxybenzyl alcohol,226-315-5,5349-60-0,Acute Tox. 3,Notified C&L,38,H301:38
84725,"2,4,4-trimethylpentene",246-690-9,25167-70-8,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3,Harmonised C&L,0,H336:0;H304:0;H225:0
84727,Disodium tin trioxide,235-030-5,12058-66-1,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,127,H412:2;H318:2;H314:2;H319:125;H335:112;H315:112
84730,2-phenyl-1H-imidazole-4-carboxylic acid,278-701-8,77498-98-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H312:1;H302:1;H332:1;H315:1
84734,"1,4-difluorobenzene",208-742-9,540-36-3,Flam. Liq. 1,Notified C&L,45,H224:33;H225:10;H319:6;H335:2;H315:2;Not classified:1;H226:1
84735,"3,3-bis[(dimethylvinylsilyl)oxy]-1,1,5,5-tetramethyl-1,5-divinyltrisiloxane",262-061-1,60111-54-8,Not Classified,REACH registration C&L,9,Not classified:8;H319:1;H315:1
84740,Palmitamide,211-095-5,629-54-9,Aquatic Chronic 4,Notified C&L,56,H413:38;Not classified:18
84741,"9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-valerate",220-003-2,2600-31-9,STOT RE 2,Notified C&L,2,H373:2;H302:1;H332:1
84744,"Anthracene, 2-ethyl-9,10-dimethoxy-",607-990-9,26708-04-3,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,54,H410:38;H350:38;H400:38;Not classified:14;H332:2
84745,"Lyase, mandelonitrile",232-780-5,9024-43-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,41,H317:38;H334:41
84746,[No public or meaningful name is available],460-170-0,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1;H317:1
84749,(C,402-460-1,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0;H315:0
84752,"6-chloro-1-β,2-β-dihydro-17-hydroxy-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione 17-acetate",207-048-3,427-51-0,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,70,H351:68;H332:45;H312:45;H360:23;H373:19;H361:1;H362:2;H411:2;H302:1;H341:2
84753,Proglumide,229-567-4,6620-60-6,Not Classified,REACH registration C&L,3,Not classified:3
84758,Lauric acid,205-582-1,143-07-7,Eye Dam. 1,REACH registration C&L,2615,H318:1896;H319:668;H315:376;H412:76;Not classified:40;H335:38;H317:22;H411:24
84760,"Solvent naphtha (coal), polymd.",614-306-2,68132-02-5,Not Classified,Notified C&L,5,Not classified:5
84763,Methyl 4-nitrobutyrate,235-866-0,13013-02-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
84766,"[μ-(5-amino-1,3,3-trimethylcyclohexylamine-N:N')]hexafluorodiboron",289-348-4,87788-32-7,Not Classified,Notified C&L,10,Not classified:9;H302:1;H319:1;H313:1;H317:1
84770,"Cyclohexanamine, 4,4'-methylenebis-, reaction products with bisphenol A diglycidyl ether homopolymer",603-357-6,129733-57-9,Not Classified,Notified C&L,25,Not classified:25
84776,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, lithium sodium",287-345-2,85480-64-4,,Notified C&L,35,Not classified:35
84780,3-(p-cumenyl)propionaldehyde,231-885-3,7775-00-0,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1,REACH registration C&L,133,H317:47;H315:27;H400:27;Not classified:62;H361:24
84785,Cycloheptanecarboxylic acid,215-954-5,1460-16-8,STOT SE 3;STOT SE 3,Notified C&L,4,H335:4;H319:1;H315:1
84787,tert-butyl cyanoacetate,214-243-7,1116-98-9,Acute Tox. 4,Notified C&L,46,H302:46;H319:2;H315:2;H227:1
84793,"(1R,11aS)-1-acetyl-11a-methyl-2,3,3a,3b,4,5,6,8,9,11-decahydrospiro[cyclopenta[a]phenanthrene-7,2'-[1,3]dioxolan]-1-yl acetate",607-316-3,240806-31-9,Not Classified,REACH registration C&L,3,Not classified:1;H302:2;H413:2;H360:2
84794,Ammonium thiocyanate,217-175-6,1762-95-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,260,H302:259;H332:257;H312:257;H412:177;H318:11;H400:78;H410:78;Not classified:2;H372:1
84797,3-azaspiro[5.5]undecane hydrochloride,214-404-1,1125-01-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
84799,"Milk, fat, hydrolyzed",277-140-6,72968-43-5,Not Classified,Notified C&L,10,Not classified:10
84802,nickel dinitrate,236-068-5,13138-45-9,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H318:0;H317:0;H272:0;H341:0;H372:0;H334:0;H360:0;H400:0;H350:0;H302:0;H332:0;H410:0;H315:0
84803,1-Bromo-3-chloro-4-iodobenzene,608-683-2,31928-47-9,,Notified C&L,12,H319:11;H335:10;H315:11;H312:4;H302:4;H332:4
84809,2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]benzoxazole-5-sulphonamide,270-393-3,68427-35-0,Not Classified,REACH registration C&L,8,Not classified:7;H412:1
84812,Triacontane,211-349-5,638-68-6,Not Classified,Notified C&L,6,Not classified:6
84817,"Octadecanoic acid, reaction products with diethanolamine and ethanolamine",286-707-7,85338-32-5,Not Classified,Notified C&L,1,Not classified:1
84818,"Licorice, ext.",272-837-1,68916-91-6,Flam. Liq. 3,Notified C&L,1465,H226:1347;Not classified:117;H225:1
84822,Hexyl octanoate,214-247-9,1117-55-1,Not Classified,Notified C&L,282,Not classified:282
84825,4-Bromo-2-fluorobenzylamine hydrochloride,604-577-5,147181-08-6,,Notified C&L,6,H319:5;H335:5;H315:5;H302:1;H332:1;H312:1
84826,2-methyl-4-nitrobenzenediazonium,240-190-4,16047-24-8,,Notified C&L,1,H311:1;H411:1;H331:1;H301:1
84828,diethylamine,203-716-3,109-89-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H225:0;H312:0;H302:0;H332:0;H314:0
84832,Calcium bis[4-[[1-[[(2-chlorophenyl)amino]carbonyl]-2-oxopropyl]azo]-3-nitrobenzenesulphonate],276-057-2,71832-85-4,Not Classified,REACH registration C&L,304,Not classified:301;H413:2;H412:1
84837,4-iodophenol,208-745-5,540-38-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,47,H302:42;H312:42;H314:42;H319:5;H335:4;H315:5;H332:2
84838,4-nitroveratrole,211-906-2,709-09-1,Acute Tox. 4,Notified C&L,42,H302:42
84842,"2,2,8-trimethyl-4H-[1,3]dioxino[4,5-c]pyridine-5-carbaldehyde",922-317-1,6560-65-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2
84846,"2,2'-[[5-acetamido-4-[(2-chloro-4,6-dinitrophenyl)azo]-4-ethoxyphenyl]imino]diethyl diacetate",244-383-4,21429-43-6,Not Classified,Notified C&L,2,Not classified:2
84849,"2,5-dihydroxy-p-benzoquinone",210-454-3,615-94-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:44;H335:43;H312:40;H302:40;H332:40;H315:44
84851,Xanthohumol,614-078-4,6754-58-1,Skin Sens. 1;Aquatic Acute 1,Notified C&L,42,H317:39;H400:39;Not classified:3
84856,"9-Octadecenoic acid (Z)-, reaction products with diethylenetriamine",291-753-6,90480-21-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H410:3;H317:3;H314:3
84857,2-chloro-5-fluorobenzonitrile,260-714-5,57381-56-3,,Notified C&L,5,H319:5;H311:4;H302:4;H332:4;H315:5;H301:1
84858,Mecloralurea,217-786-8,1954-79-6,Acute Tox. 4,Notified C&L,38,H302:38
84862,"fenhexamid (ISO);N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid",422-530-5,126833-17-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
84870,3-methyl-3-butenyl 3-methyl-2-butenoate,277-069-0,72928-35-9,Not Classified,Notified C&L,88,Not classified:88
84873,silicon tetrachloride,233-054-0,10026-04-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H315:0
84876,"2,3-dichloropropiononitrile",220-007-4,2601-89-0,,Notified C&L,4,H300:4
84877,"[(1,1,2,2-tetrafluoroethoxy)methyl]oxirane",287-734-7,85567-21-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:39;H312:38;H332:38;H302:38;H226:38;H315:39
84881,N-cyclohexylpyridin-2-amine,239-541-4,15513-16-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
84883,2-[[2-(diethylamino)ethyl]amino]ethanol,257-091-7,51254-17-2,Eye Irrit. 2,Notified C&L,38,H319:38
84886,Pueraria lobata root extract,607-017-8,223748-08-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H319:31;H315:31
84888,6-ethyl-3-methyloct-5-en-1-ol,247-615-2,26330-64-3,Skin Sens. 1,Notified C&L,246,H317:246;H319:13
84890,"Trisodium [μ-[4-[[4'-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-3-hydroxynaphthalene-2,7-disulphonato(7-)]]dicuprate(3-)",266-354-5,66418-17-5,Eye Irrit. 2;STOT SE 3,Notified C&L,16,H320:13;H335:16;H319:3
84894,2-methyl-1-phenylpropan-2-ol,202-896-0,100-86-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1851,H302:1851;H319:51;H412:50
84895,"1-(2,4-dinitrophenyl)pyridinium chloride",224-059-9,4185-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
84898,"Dimethyl 5,5'-methylenedianthranilate",250-606-6,31383-81-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,31,H317:31;H319:31;H315:31
84902,"Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]",270-787-5,68478-03-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
84903,"Cinnamomum cassia, ext.",284-635-0,84961-46-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1466,H317:1438;H319:1423;H311:21;H315:1437;H312:1412;Not classified:28;H412:14;H302:6;H335:2;H304:1
84909,"Chromate(2-), [1-[(5-chloro-2-hydroxyphenyl)azo]-2-naphthalenolato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-1-naphthalenesulfonato(3-)]-, lithium sodium",287-343-1,85480-62-2,Aquatic Chronic 2,REACH registration C&L,35,H411:35
84911,"Hematite, chromium green black",272-713-7,68909-79-5,Not Classified,REACH registration C&L,142,Not classified:142
84913,Diniobium carbide,234-571-4,12011-99-3,Not Classified,Notified C&L,1,Not classified:1
84919,"2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-(2-sulfo-1-naphthalenyl)diazenyl]-, sodium salt (1:4)",603-092-6,125830-49-1,Not Classified,Notified C&L,4,Not classified:4
84921,"2,5-dichloroanisole",217-852-6,1984-58-3,,Notified C&L,3,H319:2;H335:2;H315:2;H302:1;H332:1;Not classified:1
84922,n.a.,602-660-0,12236-90-7,Not Classified,Notified C&L,9,Not classified:7;H317:1;H411:1
84928,Tetramethylene dimethacrylate,218-218-1,2082-81-7,Skin Sens. 1B,REACH registration C&L,302,H317:192;H319:192;H335:191;H315:192;Not classified:24
84930,"Alcohols, C12-14-secondary, ethoxylated",617-534-0,84133-50-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3670,H318:2687;H315:2248;H319:770;H400:603;Not classified:186;H312:352;H302:511;H332:437;H410:84;H412:116;H335:9;H402:9;H317:1
84931,PV ECHTORANGE P 9025,407-660-2,,Not Classified,Notified C&L,47,Not classified:47
84932,Sulfadoxine,219-504-9,2447-57-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,110,H411:54;H317:66;H319:56;H335:43;H315:56;H334:12;H360:12
84933,"2,2'-[[4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylphenyl]imino]bisethanol",261-309-6,58528-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
84934,"D-glucono-1,5-lactone",202-016-5,90-80-2,Not Classified,REACH registration C&L,209,Not classified:207;H319:2
84935,7-hydroxy-3-(4-methoxyphenyl)-4-benzopyrone,207-623-9,485-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H315:42
84936,"Methanone, [5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)phenyl]phenyl-",609-311-1,36916-19-5,Not Classified,REACH registration C&L,1,Not classified:1
84938,Sodium phenoxide,205-347-3,139-02-6,Skin Corr. 1B,Notified C&L,43,H314:43;H302:4
84939,Sodium N-(2-carboxyethyl)-N-[3-(decyloxy)propyl]-β-alaninate,265-295-2,64972-19-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,78,H319:78;H412:77;H315:15;H317:5
84941,"(S)-(-)-N,alpha-Dimethylbenzylamine",606-240-8,19131-99-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,40,H302:40;H332:40;H312:40;H314:40;H318:1
84942,"1,1,1-TRIFLUORO-2,3-EPOXYPROPANE",609-196-8,359-41-1,,Notified C&L,9,H319:9;H335:9;H225:8;H312:8;H302:8;H332:8;H315:9;H311:1;H331:1;H301:1;H226:1
84946,"9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)",206-232-0,312-93-6,Repr. 2;STOT RE 2,REACH registration C&L,40,H373:1;H361:40;H372:39
84948,3-(hexyloxy)propylamine,240-793-2,16728-61-3,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 1,Notified C&L,22,H302:22;H410:22;H314:22
84958,Sodium dehydrocholate,205-652-1,145-41-5,Not Classified,Notified C&L,1,Not classified:1
84959,(2-hydroxybenzyl)triphenylphosphonium bromide,274-574-8,70340-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
84962,Methyl 2-phenoxyisobutyrate,276-570-1,72278-52-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
84968,reaction mass of: trihexyl citrate;dihexyloctyl citrate;dioctylhexyl citrate;dihexyldecyl citrate,430-290-8,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
84969,Terpin Hidrát,607-392-8,2451-01-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H335:2;H315:4
84976,"Naphthenic oils (petroleum), complex dewaxed heavy;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-179-1,64742-75-2,Carc. 1B,Harmonised C&L,0,H350:0
84977,"1,3,5-tris[3-(trimethoxysilyl)propyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",247-465-8,26115-70-8,Acute Tox. 4,REACH registration C&L,139,H302:47;H319:69;H315:69;H331:46;H301:47;Not classified:23;H335:21;H332:18;H312:18;H330:1
84982,Phenyl phosphorodichloridate,212-220-6,770-12-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,56,H318:10;H272:8;H411:8;H302:14;H314:56;H310:4;H290:1;H335:1
84984,"2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-one",239-992-7,15866-36-1,Not Classified,REACH registration C&L,2,Not classified:2
84985,4-phenoxyphenyl (RS)-2-(2-pyridyloxy) propyl ether,619-166-6,95737-68-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:43;H400:43
84987,O-(1-chloroethyl) S-methyl carbonothioate,700-190-1,91507-67-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H317:1;H314:1
84988,4-fluorobenzylic alcohol,207-292-0,459-56-3,Not Classified,Notified C&L,35,Not classified:31;H319:4;H335:4;H315:4
84993,α-chloro-2-fluorotoluene,206-460-0,345-35-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,50,H226:48;H314:50;H302:1;H332:1;H312:1;H400:1;H410:1;H290:2;H318:1;H319:1
84995,"3,3',5,5'-tetramethylbenzidine",259-364-6,54827-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:53;H335:52;H315:53;H302:7;Not classified:2;H341:1;H351:1;H412:1;H400:1;H410:1
84997,"Linden, Tilia cordata, ext.",284-536-2,84929-52-2,Flam. Liq. 3,Notified C&L,941,H226:900;Not classified:41
84999,Isopropyl oleate,203-935-4,112-11-8,Not Classified,REACH registration C&L,60,Not classified:60
85001,Decan-2-one,211-752-6,693-54-9,Aquatic Chronic 2,Notified C&L,1448,H411:1286;Not classified:162
85003,"Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride",615-280-5,71329-50-5,Not Classified,Notified C&L,58,Not classified:58
85005,Hexadecyl palmitate,309-375-8,100231-74-1,Not Classified,Notified C&L,1,Not classified:1
85008,"Bis(pentane-2,4-dionato-O,O')zinc",237-860-3,14024-63-6,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,327,H319:317;H317:6;H411:6;H400:6;H410:6;H335:216;H315:218;Not classified:9;H302:5;H312:1;H332:1
85009,N-butyl 4-oxopentanoate,218-143-4,2052-15-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,183,H319:92;H315:92;Not classified:91
85010,arsenic,231-148-6,7440-38-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H331:0;H301:0
85011,Troleandomycin,220-392-9,2751-09-9,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H315:1
85013,"methyl (2S)-2-amino-3,3-dimethylbutanoate hydrochloride",613-136-6,63038-27-7,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
85016,1-[1-methyl-1-(6-methyl-7-oxabicyclo[4.1.0]hept-3-yl)ethyl]-7-oxabicyclo[4.1.0]heptane-3-carboxylate,428-600-1,,Skin Sens. 1,Notified C&L,1,H317:1
85017,Tetraacetoxysilane,209-239-7,562-90-3,Skin Corr. 1B,Notified C&L,43,H314:43
85019,"Octane-1,8-diylbis[trichlorosilane]",257-748-8,52217-53-5,,Notified C&L,1,H314:1
85020,"Benzenemethanamine, .alpha.-ethyl-, (S)-",455-040-5,3789-59-1,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,84,H318:84;H411:84;H301:84;H401:1;H290:84;H314:84
85022,2-n-butyl-benzo[d]isothiazol-3-one,420-590-7,4299-07-4,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0;H314:0
85027,"Fats, vegetable, yellow grease",270-663-0,68475-81-0,Not Classified,Notified C&L,26,Not classified:26
85031,"N-(1,1-dimethyl-3-oxobutyl)acrylamide",220-713-2,2873-97-4,Acute Tox. 4;Repr. 2,REACH registration C&L,316,H302:254;H361:154;Not classified:62;H319:4;H335:4;H315:4
85032,"Methyl 1,3-benzodioxole-5-carboxylate",206-309-9,326-56-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
85033,"2,4-dinitrostilbene",219-628-3,2486-13-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
85035,2-hydroxy-3-butenenitrile,227-371-3,5809-59-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H311:1;H331:1;H301:1;H315:1
85036,Ethyl N-acetylglycinate,217-608-9,1906-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85038,"1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride",255-610-1,41994-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85043,"Benzene, diethenyl-, polymer with ethenylbenzene",618-373-9,9003-70-7,Not Classified,Notified C&L,39,Not classified:39
85048,copper(II) oxide,215-269-1,1317-38-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
85050,"Flue gases, ferrous metal, blast furnace",266-001-5,65996-68-1,Flam. Gas 1;Press. Gas (Comp.);Acute Tox. 3;Repr. 1A;STOT RE 1,Notified C&L,29,H220:29;H372:29;H331:28;H280:22;H360:29;H332:1
85053,"Amines, C12-14-tert-alkyl, compds. with 2(3H)-benzothiazolethione",272-782-3,68911-68-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,38,H317:2;H318:2;H400:2;H302:2;H410:2;H315:2;Not classified:36
85057,Sodium 2-propyne-1-sulphonate,259-915-0,55947-46-1,Met. Corr. 1,REACH registration C&L,92,H290:88;Not classified:4
85065,Ethosuximide,201-048-7,77-67-8,Acute Tox. 4,Notified C&L,200,H302:198;H351:2;H341:1;H360:1
85066,Oxazolidine-3-ethanol,243-499-2,20073-50-1,Not Classified,Notified C&L,61,Not classified:56;H319:4;H332:3;H312:3;H315:5;H317:1;H335:2;H318:1;H336:1;H226:1
85067,"Decanoic acid, mixed tetraesters with octanoic acid and oxybis[propanediol]",615-767-2,72480-00-3,Not Classified,Notified C&L,1,Not classified:1
85068,4-benzyl hydrogen N-(tert-butoxycarbonyl)-L-aspartate,231-406-8,7536-58-5,Not Classified,Notified C&L,3,Not classified:3
85069,"3,4-dimethyl-1H-pyrazol-1-ium dihydrogen phosphate",424-640-9,,Acute Tox. 4;Eye Irrit. 2;Repr. 2;STOT RE 2,REACH registration C&L,10,H302:10;H319:10;H373:10;H361:10
85073,"2-methyl-2-[(nitrooxy)methyl]propane-1,3-diyl dinitrate",221-214-2,3032-55-1,Unst. Expl.;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H300:1;H373:1;H310:1;H330:1;H411:1;H200:1
85074,"1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compound with 2-(dimethylamino)ethanol (1:1)",215-898-1,1446-06-6,Not Classified,Notified C&L,2,Not classified:2
85076,Hexyltriethoxysilane,605-940-0,18166-37-5,,Notified C&L,9,H319:5;H315:5;Not classified:4
85077,"5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone monohydrochloride",257-415-7,51781-21-6,Acute Tox. 4,Notified C&L,5,H302:4;H319:2;H361:3;H351:1;Not classified:1
85078,Diethyl N-[4-(methylamino)benzoyl]-L-glutamate,219-161-5,2378-95-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,12,H302:3;H332:3;H312:3;H341:9;H361:9
85081,"Formaldehyde, polymer with 1-piperazineethanamine",618-919-6,93217-98-2,Skin Corr. 1B;Skin Sens. 1,Notified C&L,22,H317:22;H314:22
85087,"N-(2,3-dihydro-1H-inden-2-yl)-N',N'-diethyl-N-phenylpropane-1,3-diamine monohydrochloride",251-418-7,33237-74-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:40;H319:38;H335:38;H315:38;H318:1;H411:1;H317:1
85090,Dodecanedial,253-858-5,38279-34-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85093,Alclofenac,244-795-4,22131-79-9,Acute Tox. 4,Notified C&L,38,H302:38
85094,"Pentanoic acid, 3-methyl-2-oxo-, methyl ester",609-297-7,3682-42-6,Not Classified,Notified C&L,88,Not classified:88
85095,Octyloxirane,219-295-4,2404-44-6,Flam. Liq. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,129,H227:2;H410:2;H315:128;H400:2;H319:43;H335:42;Not classified:1
85096,"Amides, tallow, N-[3-(dimethylamino)propyl], N-oxides",271-972-3,68647-77-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;STOT SE 3;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,22,H335:21;H318:21;H317:20;H411:20;H400:22;H302:20;H314:20;H319:1;H315:2
85097,5-methoxy-1H-benzimidazole,225-502-9,4887-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
85100,tetracarbonylnickel;nickel tetracarbonyl,236-669-2,13463-39-3,Flam. Liq. 2;Acute Tox. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H225:0;H330:0;H360:0;H400:0;H351:0;H410:0
85101,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium perchlorate",245-916-3,23857-51-4,Acute Tox. 4,Notified C&L,1,H302:1
85105,"[S-(R*,R*)]-4,4'-dithiobis[2-aminobutyric] acid",210-962-5,626-72-2,Not Classified,Notified C&L,2,Not classified:2
85106,[No public or meaningful name is available],630-460-3,68915-18-4,Not Classified,Notified C&L,44,Not classified:22;H319:22;H315:22
85109,vinyl acetate,203-545-4,108-05-4,Flam. Liq. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Harmonised C&L,0,H351:0;H332:0;H335:0;H225:0
85110,Argon,231-147-0,7440-37-1,Press. Gas (Comp.),Notified C&L,585,H280:379;H281:213;Not classified:4
85116,"1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane",414-030-0,52667-88-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
85124,"Chromite (Cr2FeO4), conc.",308-539-6,98072-82-3,Not Classified,Notified C&L,34,Not classified:34
85127,Dichloroethylsilane,217-255-0,1789-58-8,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Resp. Sens. 1;STOT SE 3,Notified C&L,41,H335:39;H225:41;H260:40;H334:38;H314:41;H318:3;H312:1;H302:1;H332:1;H261:1
85128,(3R)-(+)-1-(tert-Butoxycarbonyl)-3-aminopyrrolidine,604-556-0,147081-49-0,Acute Tox. 3;Eye Dam. 1,Notified C&L,50,H318:43;H301:41;H319:7;H315:9;H335:3;H302:1;H314:1;H400:1;H410:1;H227:1
85130,Phosphinylidynetrimethanol,213-924-6,1067-12-5,Skin Sens. 1,REACH registration C&L,43,H317:42;H341:14;H350:14;Not classified:1
85132,"Viburnum prunifolium, ext.",284-537-8,84929-54-4,Not Classified,Notified C&L,88,Not classified:88
85133,reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C,407-810-7,,STOT RE 2,Harmonised C&L,0,H373:0
85136,Lutetium oxide,234-764-3,12032-20-1,Not Classified,REACH registration C&L,60,Not classified:14;H319:46;H335:46;H315:46
85139,4-chloro-3-methoxy-2-methylpyridine 1-oxide,602-491-2,122307-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
85141,"Vanilla, tincture",232-463-1,8047-24-3,Skin Sens. 1,Notified C&L,215,H317:139;H226:59;H224:50;H202:25;Not classified:25;H412:25
85146,"Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (1:1), (1R,2S)-",607-827-1,259214-56-7,Not Classified,Notified C&L,1,Not classified:1
85153,(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide,419-800-1,,Skin Sens. 1B,REACH registration C&L,2,H317:2
85154,"Extract residues (coal), creosote oil acid;Wash Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250°C to 280°C (482°F to 536°F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]",310-189-4,122384-77-4,Carc. 1B,Harmonised C&L,0,H350:0
85157,Nonyl acetate,205-585-8,143-13-5,Aquatic Chronic 2,REACH registration C&L,1555,H411:1291;Not classified:264
85158,"N,N'-ethylenebismyristamide",225-884-7,5136-46-9,Not Classified,Notified C&L,7,Not classified:7
85161,"(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid",613-414-7,64013-70-3,Repr. 1B,Notified C&L,66,H360:65;Not classified:1;H302:1;H332:1;H312:1;H315:1
85164,2-(dimethylamino)benzoic acid,210-209-0,610-16-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
85166,2-allyl-p-cresol,229-606-5,6628-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85169,8-bromotheophylline,233-846-6,10381-75-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
85171,Benzoinoxime,207-127-2,441-38-3,Eye Irrit. 2,Notified C&L,61,H319:61
85173,Isopentyl 4-hydroxybenzoate,229-409-4,6521-30-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
85177,Tetramethylammonium bromide,200-581-2,64-20-0,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H300:46;H319:46;H335:45;H315:46;H301:1;Not classified:1
85178,2-ethylhex-2-enoic acid,226-167-1,5309-52-4,Skin Corr. 1B,Notified C&L,39,H314:39
85180,"Silicic acid, aluminum potassium sodium salt",235-787-1,12736-96-8,STOT SE 3,Notified C&L,173,H335:164;H319:48;H315:48;Not classified:9
85183,"Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, sulfate",608-177-1,282102-50-5,Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H341:2;H372:2;H360:2;H400:2;H410:2;H350:2
85184,Methyl nicotinate,202-261-8,93-60-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1621,H319:1606;H315:1596;H335:41;Not classified:15;H317:10;H334:10;H302:2
85190,"4,4',4''-trichlorotrityl alcohol",221-137-4,3010-80-8,,Notified C&L,4,H319:4;H335:4;H315:4
85191,"4,5-dihydro-2,3-dimethylthiazolium iodide",248-116-2,26934-29-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
85194,"Cyclopentanemethanamine, N-methyl-",610-216-2,4492-51-7,Not Classified,Notified C&L,1,Not classified:1
85198,α-methylpiperidine-1-ethanol,213-295-8,934-90-7,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H319:38;H301:38
85202,"4'-fluoro-2,2-dimethoxyacetophenone",407-500-1,21983-80-2,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
85203,Bismuth trinitrate,233-791-8,10361-44-1,Ox. Sol. 2;Eye Dam. 1,REACH registration C&L,214,H319:48;H272:152;H318:89;H315:94;H335:39;Not classified:7;H410:1
85206,"1,3-Benzenediamine, 2-methyl-4,6-bis(methylthio)-",676-676-1,104983-85-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,34,H302:34;H411:33;H317:34;H410:1;H400:1
85213,"1-{[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride",477-080-2,,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,13,H317:2;H334:2;H302:11;H319:11;H335:11;H315:11
85215,Tropine,204-384-2,120-29-6,Acute Tox. 4,REACH registration C&L,18,H302:16;H332:13;H312:3;H301:2;H331:1
85219,Docosyl docosanoate,241-646-5,17671-27-1,Not Classified,REACH registration C&L,199,Not classified:199
85222,"Calcium chloride, dihydrate",600-075-5,10035-04-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,920,H302:623;H319:911;H315:15;Not classified:9;H335:5;H312:5;H332:5
85223,4'-bromoacetanilide,203-154-9,103-88-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H335:46;H315:47;H302:1
85225,"2,3-dichloroanisole",217-853-1,1984-59-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H302:3;H319:2;H335:2;H315:2;H312:1;Not classified:1
85227,3-benzyloxy-p-anisic acid,261-260-0,58452-00-9,,Notified C&L,4,H319:4;H335:4;H315:4
85228,"Scotch broom, ext.",283-653-6,84696-48-0,Not Classified,Notified C&L,37,Not classified:37
85232,Isooctyl mercaptoacetate,246-613-9,25103-09-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,REACH registration C&L,153,H302:115;H317:114;H400:114;H319:38;H412:38;H410:27
85236,"Ceratonia siliqua, ext.",284-634-5,84961-45-5,Not Classified,REACH registration C&L,129,Not classified:128;H317:1
85241,"Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues",272-712-1,68909-77-3,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,130,H319:2;H412:2;H317:84;H318:128;H315:128
85242,"Chromate(2-), [4-[(2-chloro-4-nitrophenyl)azo]-2-[[(2-hydroxy-5-nitrophenyl)imino]methyl]phenolato(2-)][2-hydroxy-3-[(2-hydroxy-1-naphthalenyl)azo]-5-nitrobenzenesulfonato(3-)]-, lithium sodium",287-344-7,85480-63-3,Aquatic Chronic 2,Notified C&L,33,H411:33
85243,Ethyl enantate,203-382-9,106-30-9,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1663,H410:35;H412:34;H400:34;H226:1211;Not classified:417
85250,"Distillates (petroleum), light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-060-4,64741-59-9,Carc. 1B,Harmonised C&L,0,H350:0
85252,2-Bromo-4-nitroimidazole,613-851-3,65902-59-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4;H302:3;H312:1;H332:1
85253,[2-isopropoxyethyl]benzene,268-262-0,68039-47-4,Eye Irrit. 2,Notified C&L,1613,H319:1376;Not classified:237
85254,"2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane",219-863-1,2554-06-5,Not Classified,REACH registration C&L,170,Not classified:49;H319:107;H335:22;H315:22;H413:14
85255,1-naphthyl isothiocyanate,208-990-8,551-06-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H319:41;H335:41;H312:40;H334:41;H301:46;H332:41;H315:41;H330:4;H311:5;H314:4;H331:1
85261,"1,14-dibromotetradecane",253-628-4,37688-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
85267,"Amines, coco alkyl, propionates",295-264-9,91995-05-0,Acute Tox. 4;Skin Corr. 1B,Notified C&L,4,H302:3;H314:3;H318:1;H315:1
85268,"3,7-diaminophenothiazin-5-ium chloride",209-470-3,581-64-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;Not classified:1
85270,"Birch, Betula pubescens, ext.",294-756-0,91745-85-6,Aquatic Chronic 3,Notified C&L,1011,H412:897;Not classified:113;H319:1;H226:1
85272,"(R)-(-)-1,1'-Binaphthalene-2,2'-diyl hydrogen phosphate",609-734-1,39648-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H335:46;H315:46
85276,"Glutens, hydrolyzates, reaction products with lauroyl chloride, sodium salts",500-500-3,161074-67-5,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,4,H318:4;H315:4
85277,Sucrose di(acetate) hexaisobutyrate,204-771-6,126-13-6,Not Classified,Notified C&L,119,Not classified:118;H319:1;H225:1
85278,Ethyl azidoacetate,211-301-3,637-81-0,,Notified C&L,20,H319:20;H226:19;H335:19;H315:20
85280,7-chloroheptane-1-nitrile,245-249-8,22819-91-6,,Notified C&L,4,H302:4;H332:4;H312:4
85283,Ethyl 2-thienylacetate,260-715-0,57382-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85287,"N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine",401-410-6,10357-99-0,Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0;H317:0
85288,Cyclopentylphenylglycolic acid,207-047-8,427-49-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:6;H335:44;H315:45;H318:40;H314:2
85290,(±)-1-(isopropylamino)-3-(naphthyloxy)propan-2-ol,235-867-6,13013-17-7,Acute Tox. 4,REACH registration C&L,2,H302:2
85291,Quaternary ammonium compound,615-921-9,73138-81-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,11,H318:6;H410:6;H315:6;Not classified:5
85293,"Decanoic acid, mixed esters with dipentaerythritol, octanoic acid and valeric acid",270-470-1,68441-66-7,Not Classified,REACH registration C&L,47,Not classified:47
85295,Ethyl isocyanate,203-717-9,109-90-0,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H319:45;H335:45;H225:43;H312:38;H334:45;H301:40;H332:39;H315:45;H330:5;H302:4;H331:2
85297,2-methylvaleric acid,202-594-9,97-61-0,Acute Tox. 5;Acute Tox. 5;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,1510,H313:4;H318:71;H303:4;H314:1475;Not classified:24;H315:11;H319:1;H312:1;H290:1
85298,2-bromomethylnaphthalene,213-359-5,939-26-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,47,H317:42;H314:47;H318:3;H290:2
85299,"Naphthenic acids, compds. with ethanolamine",284-000-8,84776-71-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
85301,m-hydroxybenzonitrile,212-845-4,873-62-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H302:46;H319:46;H335:45;H315:46;H312:2;H332:2
85304,"Oils, vegetable, deodorizer distillates",270-700-0,68476-80-2,Not Classified,REACH registration C&L,122,Not classified:74;H318:32;H314:32;H319:16;H315:16;H412:16
85306,"Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy- 1,2,3-propanetricarboxylate (1:1)",614-707-2,68684-63-9,Muta. 2;Carc. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H341:1;H361:1;H400:1;H351:1;H410:1;H319:1;H335:1;H312:1;H302:2;H332:1;H315:1
85308,Cesium dichlorobromate(1-),237-628-1,13871-03-9,Not Classified,Notified C&L,25,Not classified:25
85311,chlorophenol,246-691-4,25167-80-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H332:0;H312:0;H411:0
85312,"1,4-phenylene diacrylate",229-780-2,6729-79-9,,Notified C&L,1,H319:1;H335:1;H315:1
85314,Benzyl(tetrahydrofuran)lithium,300-546-2,93941-97-0,Not Classified,Notified C&L,25,Not classified:25
85316,"6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 1-bromo-4a,5,9,10,11,12-hexahydro-3-methoxy-, (4aR,8aR)-rel-",605-847-5,179108-06-6,Acute Tox. 4;Skin Sens. 1;Muta. 2;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H317:1;H341:1;H361:1;H412:1;H302:1
85321,4-methyl-1-phenylpentan-2-one,226-316-0,5349-62-2,Flam. Liq. 3,Notified C&L,1373,H226:1286;Not classified:87
85323,Methyl hydrogen sebacate,212-458-0,818-88-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
85325,Bentone SD-3,401-480-8,,Not Classified,Notified C&L,1,Not classified:1
85326,"1-Tridecanol, phosphate",260-396-8,56831-62-0,Acute Tox. 5;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 5,Notified C&L,8,H318:8;H333:8;H303:8;H314:8
85327,"(E,E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one",214-246-3,1117-52-8,Not Classified,Notified C&L,88,Not classified:88
85330,Ethoxylated polyethyleneimine,607-983-0,26658-46-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H302:44;H319:44;H315:44;H411:6;Not classified:2
85333,Manganese bis(dihydrogen phosphate),242-520-2,18718-07-5,Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,35,H319:31;H373:31;H412:31;Not classified:3;H302:1;H411:1
85335,"Balsams, copaiba, sulfurized",272-836-6,68916-78-9,Skin Irrit. 2,Notified C&L,2,H315:2
85340,"Poly(oxy-1,2-ethanediyl), α,α',α'',α'''-[[(2-sulfophenyl)methyliumylidene]bis(4,1-phenylenenitrilodi-2,1-ethanediyl)]tetrakis[ω-hydroxy-, chloride, sodium salt (1:1:1)",618-647-8,9079-33-8,Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2,Notified C&L,1,H319:1;H351:1;H341:1;H317:1
85342,Magnesium methanolate,203-715-8,109-88-6,Flam. Sol. 1;Self-heat. 1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,REACH registration C&L,77,H311:12;H251:4;H331:12;H228:6;H301:12;H370:12;H314:43;H225:32;H318:39;H319:4;H315:4
85351,''bismuth tetroxide'',234-985-5,12048-50-9,Not Classified,Notified C&L,1,Not classified:1
85353,3-Nitrophthalonitrile,610-727-0,51762-67-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H302:46;H319:45;H335:45;H315:45;H332:1;H312:1
85356,3-chloro-4-(3-fluorobenzyloxy)aniline,445-590-4,202197-26-0,Acute Tox. 4;Muta. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H341:0;H400:0;H302:0;H410:0
85357,4-phenylpyridine,213-357-4,939-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:38;H315:40;H302:1;H412:1
85363,C.I. Solvent Red 160,615-022-1,69899-68-9,Not Classified,Notified C&L,185,Not classified:185
85364,Ethyl 2-bromohexanoate,210-455-9,615-96-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,43,H302:43;H314:42;H317:1;H315:1
85368,Piperidine-3-methylamine,245-428-0,23099-21-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H227:1
85370,(carboxylatomethyl)dimethyltetradecylammonium,220-006-9,2601-33-4,Skin Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,276,H361:2;H360:2;H400:2;H410:2;H315:202;H317:146;H318:200;H412:38;H314:41;H319:38;H335:38;Not classified:33
85371,"2,4-dichlorobenzamide",219-505-4,2447-79-2,,Notified C&L,4,H319:4;H335:4;H315:4
85373,Tellurium tetrachloride,233-055-6,10026-07-0,Skin Corr. 1B,Notified C&L,42,H314:42;H302:4
85375,2-methyl-3-pent-2-enylcyclopent-2-enone,234-273-4,11050-62-7,STOT SE 3,Notified C&L,116,H335:61;Not classified:55;H319:1;H315:1
85377,"4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone",410-410-5,54574-82-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
85378,"p-[(2-hydroxy-1-naphthyl)azo]benzenesulphonic acid, compound with methylamine (1:1)",285-151-2,85030-27-9,Not Classified,Notified C&L,83,Not classified:83
85379,Tetramethyltetravinylcyclotetrasiloxane,248-418-4,27342-69-4,Not Classified,Notified C&L,4,Not classified:4
85383,"Fatty acids, C18-unsatd., dimers, polymers with ethylenediamine and tall-oil fatty acids",614-312-5,68139-80-0,Not Classified,Notified C&L,31,Not classified:31
85386,"Diammonium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)",268-018-3,67989-88-2,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,177,H302:154;H315:63;H319:23;Not classified:3
85387,"5-(trifluoromethyl)-4H-1,2,4-triazole-3(2H)-thione",272-137-6,68744-64-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 3,Notified C&L,157,H319:157;H335:157;H312:157;H302:157;H332:157;H315:157
85390,4-Chloro-2-[(2-morpholin-4-yl-ethylimino)-phenyl-methyl]-phenylamine,606-703-4,2109-51-5,Not Classified,REACH registration C&L,2,Not classified:2
85392,6-ethyl-3-methyloct-6-en-1-ol,247-616-8,26330-65-4,Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1559,H319:1324;H317:1558;H315:1
85393,"Leptospermum petersonii, ext.",285-372-4,85085-43-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,60,H317:60;H412:56;H315:60;H319:3;H411:1;H318:1;H302:1
85394,"Polyphosphoric acids, reaction products with diethanolamine, sodium salts",293-459-3,91079-70-8,Not Classified,Notified C&L,3,Not classified:3
85405,Isoundecan-1-ol,257-376-6,51750-47-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,28,H319:28;H411:28
85408,"3-Quinolinecarboxylic acid, 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-, ammonium salt (1:1)",617-221-9,81335-47-9,Not Classified,Notified C&L,83,Not classified:83
85409,6-chloropyridazin-3-amine,226-796-1,5469-69-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H302:42;H319:53;H335:52;H315:53
85413,hexachloroacetone,204-129-5,116-16-5,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
85416,"6,6'-diapo-ψ,ψ-carotenedioic acid",208-810-8,542-40-5,Not Classified,Notified C&L,6,Not classified:6
85420,"α-(5-bromo-2,3-dihydroxy-4-oxo-2,5-cyclohexadienylidene)-α-(5-bromo-2,3,4-trihydroxyphenyl)toluenesulphonic acid",240-632-6,16574-43-9,Aquatic Chronic 2,Notified C&L,1,H411:1
85421,"Chromate(2-), [5-chloro-2-hydroxy-3-[(2-hydroxy-1-naphthalenyl)azo]benzenesulfonato(3-)][4-[(5-chloro-4-nitrophenyl)azo]-2-[[(2-hydroxy-5-nitrophenyl)imino]methyl]phenolato(2-)]-, lithium sodium",287-342-6,85480-61-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:33;H400:33;Not classified:5
85426,"poly(oxy-1,2-ethanediyl), alpha-(((2-ethylhexyl)oxy) hydroxyphosphinyl)-omega-hydroxy-",609-900-3,41205-89-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
85430,"Diethyl hydrogen 2-hydroxypropane-1,2,3-tricarboxylate",250-914-0,32074-56-9,Not Classified,Notified C&L,36,Not classified:36
85432,"Pregna-1,4-diene-3,20-dione, 11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, disodium salt, (11β,16α)-",301-994-1,94087-98-6,Repr. 2;STOT RE 1,Notified C&L,1,H372:1;H361:1
85433,2-[(2-methyl-1-oxoallyl)oxy]ethyl hydrogen 3-chloro-2-hydroxypropylphthalate,259-130-3,54380-33-5,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2;H317:2;H350:2
85435,Hexadecane-1-sulphonyl chloride,254-123-1,38775-38-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:39;H318:38;H314:43
85439,Decyltrimethylammonium bromide,218-219-7,2082-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:44;H315:46
85443,"4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane",269-970-2,68398-18-5,Aquatic Chronic 3,Notified C&L,1409,H412:1286;Not classified:121;H411:1;H317:1;H410:1;H315:1;H400:1
85445,Oxycinchophen,207-624-4,485-89-2,Acute Tox. 4,Notified C&L,6,H302:6
85446,2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE,601-501-2,117976-89-3,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,42,H302:3;H413:2;H319:39;H335:39;H315:39
85447,A mixture of RR and RS isomers of: (2-(2-methoxy-1-methyl)ethoxy)-1-methylethyl acetate; (2-(2-methoxy-2-methyl)ethoxy)-1-methylethyl acetate; (2-(2-methoxy-2-methyl)ethoxy)-2-methylethyl acetate; (2-(2-methoxy-1-methyl)ethoxy)-2-methylethyl acetate,406-880-6,88917-22-0,Not Classified,REACH registration C&L,380,Not classified:112;H302:178;H319:92;H335:90;H315:92
85451,Geranyl butyrate,203-381-3,106-29-6,Not Classified,REACH registration C&L,1699,Not classified:1634;H319:42;H335:42;H315:42;H410:23;H400:23
85453,Disodium cyanodithiocarbamate,205-346-8,138-93-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H332:1;H311:1;H400:1;H301:1
85456,"1-octadecyl-1H-pyrrole-2,5-dione",241-467-2,17450-30-5,Not Classified,Notified C&L,442,Not classified:441;H319:1;H335:1;H315:1
85458,2-methylquinoline-6-sulphonic acid,298-485-9,93805-05-1,Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1
85462,"1-tert-butyl-3,4,5-trimethyl-2,6-dinitrobenzene",205-651-6,145-39-1,Not Classified,Notified C&L,89,Not classified:89
85463,3-propoxypropylamine,240-792-7,16728-59-9,Flam. Liq. 3;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H226:1;H318:1;H314:1
85467,2-(indol-3-yl)ethylamine,200-510-5,61-54-1,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 2,REACH registration C&L,50,H302:1;H401:1;H318:1;H317:1;H319:48;H335:47;H315:48;H301:4;Not classified:1
85469,2-[(4-methylphenyl)sulphonyl]-1-phenylethan-1-one,250-605-0,31378-03-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
85473,[No public or meaningful name is available],473-880-0,,Not Classified,Notified C&L,37,Not classified:37
85475,"disodium tetraborate decahydrate;borax decahydrate;disodium tetraborate pentahydrate;borax pentahydrate;disodium tetraborate, anhydrous;boric acid, disodium salt",215-540-4,1330-43-4,,,0,H360:0
85476,2-methylhept-1-ene,239-993-2,15870-10-7,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,39,H304:39;H225:39
85484,2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid,227-370-8,5809-23-4,,Notified C&L,85,Not classified:83;H319:2;H315:2
85489,"N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-2-propynylamine hydrochloride",241-760-5,17780-75-5,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,154,H332:154;H312:154;H301:154
85491,1-ethylpyrrolidin-2-ylmethylamine,247-466-3,26116-12-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;STOT SE 3,REACH registration C&L,56,H335:53;H312:9;H302:9;H226:54;H314:11;H319:44;H315:45;H334:1;H318:2;H332:1
85492,"Amines, C8-18-alkyl, distn. residues",272-783-9,68911-69-3,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1,Notified C&L,1,H318:1;H373:1;H315:1;H400:1
85493,α-bromo-p-fluorotoluene,207-291-5,459-46-1,Skin Corr. 1B,Notified C&L,49,H314:49;H319:2;H335:1;H290:1;H318:1;H302:1
85498,"Sodium 4-[(2,7-dihydro-3-methyl-2,7-dioxo-3H-dibenz[f,ij]isoquinolin-6-yl)amino]toluene-3-sulphonate",224-759-4,4478-76-6,,Notified C&L,35,Not classified:35
85499,"Fatty Acid Metyl Ester, ethoxylated",605-144-3,158318-69-5,Eye Irrit. 2,Notified C&L,3,H319:3
85501,"potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate",405-680-6,148434-01-9,Self-heat. 2;Aquatic Chronic 2,Harmonised C&L,0,H252:0;H411:0
85502,"N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide",252-529-3,35367-38-5,Acute Tox. 4;Aquatic Acute 1,Notified C&L,288,H312:239;H400:271;H410:82;H332:4;H373:10;H302:1
85510,pyraflufen-ethyl (ISO);2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester,603-347-1,129630-19-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
85511,Butyl salicylate,218-142-9,2052-14-4,Acute Tox. 4,Notified C&L,1584,H302:1584;H319:39;H335:38;H315:39
85514,"Distillates (petroleum), light steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",270-662-5,68475-80-9,Carc. 1B,Harmonised C&L,0,H350:0
85517,"dialifos (ISO);2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate",233-689-3,10311-84-9,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H311:0;H400:0
85519,SBOZ,469-920-1,,Acute Tox. 4;STOT RE 2,Notified C&L,1,H302:1;H373:1
85521,Barium,231-149-1,7440-39-3,Flam. Sol. 1;Water-react. 1;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,416,H318:104;H260:54;H228:29;H301:21;H314:104;H319:224;H335:223;H315:224;H261:312;H302:86;H332:85;Not classified:44;H413:13;H412:2;H411:1
85529,4-amino-3-methylbenzoic acid,219-629-9,2486-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H312:1;H302:1;H332:1
85531,Glycine hydrochloride,227-841-8,6000-43-7,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,11,H318:6;H314:5;Not classified:3;H319:2;H335:2;H315:2
85532,"2,5-dichlorophenol",209-520-4,583-78-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,142,H302:140;H314:128;H319:12;H411:9;H315:12;H335:4;H312:4;Not classified:3
85534,"2-(Dicyclohexylphosphanyl)-2',4',6'-tris(isopropyl)biphenyl",611-387-6,564483-18-7,,Notified C&L,49,Not classified:34;H319:10;H335:9;H315:10;H413:5;H302:4
85536,Trichloro-7-octenylsilane,257-747-2,52217-52-4,,Notified C&L,1,H314:1
85540,Diamminetetrachloroplatinum,240-930-6,16893-05-3,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,38,H318:38;H334:38;H317:38;H301:38
85543,Hafnium nitride,247-282-3,25817-87-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85551,Barium dihydroxide octahydrate,602-490-7,12230-71-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,267,H302:214;H332:214;H318:117;H314:218;Not classified:1
85556,"Bis(ethyl acetoacetato-O1',O3)bis(2-methylpropan-1-olato)titanium",281-161-6,83877-91-2,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,76,H335:14;H318:7;H336:61;H226:76;H315:20;H319:16
85559,Sodium 3-[[4-[(4-ethoxyphenyl)azo]-3-methoxyphenyl]azo]benzenesulphonate,266-247-3,66214-48-0,Not Classified,Notified C&L,1,Not classified:1
85560,gadolinium(III)sulfite trihydrate,456-900-2,51285-81-5,Aquatic Chronic 2,Harmonised C&L,0,H411:0
85562,5-chloro-1H-benzimidazole,225-503-4,4887-82-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,128,H302:128;H318:127;H319:1;H315:1
85563,5-amino-4-cyano-1H-pyrazole-3-acetonitrile,259-299-3,54711-21-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:40;H335:40;H312:40;H302:40;H332:40;H315:40
85564,1-Methyl-3-nitro-guanidine,433-400-2,,Not Classified,Notified C&L,1,Not classified:1
85567,Magnesium bis[didodecylbenzenesulphonate],249-474-2,29152-71-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H302:1;H314:1
85568,"Amides, tallow, hydrogenated, N,N'-ethylenebis-",271-973-9,68647-78-9,Not Classified,Notified C&L,7,Not classified:7
85572,"7-chloro-5-cyclohexyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",217-254-5,1789-33-9,,Notified C&L,1,H302:1;H361:1
85579,"3,3,5,7,7-pentamethyl-1,2,4-trioxepane",455-560-2,,Flam. Liq. 3;Org. Perox. E;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H226:1;H242:1;H412:1
85581,Iron saccharate,232-464-7,8047-67-4,Acute Tox. 3,Notified C&L,4,H301:1;H319:2;H335:2;H315:2;H302:1;H332:1;Not classified:1
85584,Tetraphenylphosphonium bromide,220-393-4,2751-90-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H319:82;H335:48;H315:49;H412:5;H302:6;H312:1;H332:1;H318:1
85588,"Alkenes, C>10 α-, reaction products with maleic anhydride and mono-iso-Pr maleate",278-251-2,75535-27-2,Not Classified,Notified C&L,2,Not classified:2
85593,(diethoxymethoxy)benzene,238-421-9,14444-77-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H319:43;H315:43;H335:4
85594,"diethyl 1-(2,4-dichlorophenyl)-5-methyl-4,5-dihydro-1H-pyrazole-3,5-dicarboxylate",603-923-2,135590-91-9,Aquatic Chronic 2,REACH registration C&L,176,H411:175;Not classified:1
85595,3-methoxypropylamine,226-241-3,5332-73-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,431,H318:98;H317:315;H302:363;H226:376;H314:431;H335:1;H312:1;H412:1;H331:1;H301:1
85597,"4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile",604-075-6,138401-24-8,Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
85603,Pyridinium trifluoroacetate,207-345-8,464-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
85604,"Oxirane, methyl-, polymer with oxirane, mono-2-propenyl ether",618-549-5,9041-33-2,Not Classified,Notified C&L,129,Not classified:119;H319:10;H315:9
85606,Pent-3-en-2-ol,216-376-6,1569-50-2,Flam. Liq. 3,Notified C&L,39,H226:39
85608,Dimethylnaphthalene,249-241-5,28804-88-8,,Notified C&L,46,Not classified:45;H319:1;H335:1;H315:1
85609,"reaction mass of: butan-2-one oxime;syn-O,O'-di(butan-2-one oxime)diethoxysilane",406-930-7,96-29-7,Skin Sens. 1;STOT RE 1;Aquatic Chronic 3,Harmonised C&L,0,H372:0;H412:0;H317:0
85612,Polyoxyethylene (15) hydrogenated tallowmonium chloride,614-363-3,68187-69-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,35,H302:23;H411:23;H319:12;H412:9;H315:12
85615,"Hydrocarbons, C13-C15, n-alkanes, isoalkanes, cyclics, < 2% aromatics",917-488-4,,Asp. Tox. 1,REACH registration C&L,4,H304:4
85618,"2-(chloromethyl)-5-(1,1-dimethylethyl)-m-xylene",243-013-9,19387-83-8,,Notified C&L,2,H302:2
85619,"2,3,4,5,6-pentafluorobenzylic alcohol",207-126-7,440-60-8,Acute Tox. 4,Notified C&L,46,H302:46;H319:6;H315:6;H335:2
85620,"(5R)-5-[(1S)-1,2-Dihydroxyethyl]-4-ethoxy-3-hydroxyfuran-2(5H)-one",617-849-3,86404-04-8,Eye Irrit. 2,REACH registration C&L,74,H319:20;Not classified:54
85623,"1-(4-trans-Pentyl-[1,1-bicyclohexyl]-4-trans-yl)-4-trifluormethoxybenzene",603-778-5,133914-49-5,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
85625,acetic acid … %,200-580-7,64-19-7,Flam. Liq. 3;Skin Corr. 1A,Harmonised C&L,0,H226:0;H314:0
85626,1-nitropropane,203-544-9,108-03-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H226:0;H312:0;H332:0
85627,"L-Mannose, 6-deoxy-, hydrate (1:1)",600-058-2,10030-85-0,Not Classified,Notified C&L,28,Not classified:28
85628,1-ethylpiperazine,226-166-6,5308-25-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,254,H335:131;H318:89;H317:90;H302:208;H226:254;H314:213;H319:41;H315:41;H332:1
85631,"etridiazole (ISO);5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole",219-991-8,2593-15-9,Acute Tox. 4;Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H302:0;H351:0;H410:0
85637,Tris(trimethylsilyl) phosphate,234-028-1,10497-05-9,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,81,H412:1;H318:41;H314:5;H319:40;H335:38;H315:76;H225:42;H226:37;H302:1
85638,N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride,610-414-9,482577-59-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H302:1;H332:1;H315:1
85642,Artemisia Pallens extract,616-970-9,8016-03-3,Asp. Tox. 1,Notified C&L,133,H304:108;H315:26
85650,undecan-2-one; methyl nonyl ketone,203-937-5,112-12-9,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1771,H410:54;H315:21;H400:1435;Not classified:329;H412:36;H411:9
85651,Dehydroabietylamine,215-899-7,1446-61-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:42;H335:41;H315:41;Not classified:7;H314:1
85655,4-[2-piperidinoethoxy]benzoic acid hydrochloride,282-882-9,84449-80-9,Not Classified,REACH registration C&L,6,Not classified:4;H319:2;H335:2;H302:1;H332:1;H315:2
85656,Methyl 3-iodobenzoate,210-570-4,618-91-7,Eye Dam. 1,Notified C&L,40,H318:39;H319:1;H335:2;H315:2
85657,"1-azido-N,N,N',N',N'',N''-hexamethylsilanetriamine",227-015-7,5599-36-0,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H302:38;H314:38;H225:38
85661,"Sulfuric acid, mono-C12-14-alkyl esters, compds. with ethanolamine",292-214-8,90583-16-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,114,H335:84;H318:85;H412:85;H302:84;H315:113;H319:29
85664,"9-Octadecen-1-ol, (9Z)-, mixt. with 1-hexadecanol",616-948-9,8014-52-6,Not Classified,Notified C&L,7,Not classified:7
85666,"Alkenes, ethylene-manuf.-by-product piperylene-cut, polymd.",614-297-5,68131-47-5,Not Classified,Notified C&L,6,Not classified:6
85667,4-methylvaleric acid,211-464-0,646-07-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1598,H319:3;H312:2;H315:42;H311:1592;H318:1375;H314:1555;Not classified:1;H331:1;H301:1;H302:1
85668,"Viscum album, ext.",284-538-3,84929-55-5,Flam. Liq. 3,Notified C&L,2,H226:2
85673,Decane-1-thiol,205-584-2,143-10-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:39;H335:43;H315:40;H400:8;H410:8;H318:13;H314:8;H371:1;Not classified:1
85674,"2,3-dimethylquinoxaline",219-162-0,2379-55-7,Not Classified,Notified C&L,133,Not classified:88;H318:38;H335:43;H315:44;H301:39;H319:6
85676,"α,α,α-trifluoro-o-toluoyl chloride",206-233-6,312-94-7,Met. Corr. 1;Skin Corr. 1C;Skin Sens. 1,REACH registration C&L,49,H290:5;H317:3;H314:49;H319:1;H335:1;H318:1
85678,Polyoxyethylene ester of rosin,617-096-0,8050-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,26,H319:15;H335:15;H315:15;Not classified:11
85680,"Capreomycin, sulfate (salt)",215-776-8,1405-37-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,196,H302:196;H332:196;H360:196;H312:196
85687,4'-methylacetanilide,203-155-4,103-89-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H302:44;H319:43;H335:42;H315:43;H332:1;H312:1
85688,PUVA-50M,443-470-6,,Not Classified,Notified C&L,1,Not classified:1
85689,"[[4-[[4-(anilino)phenyl][4-(phenylimino)-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonic acid",215-385-2,1324-76-1,Not Classified,REACH registration C&L,247,Not classified:64;H411:83;H319:100;H335:99;H315:100
85691,Diethyl phthalimidomalonate,227-138-6,5680-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85693,1-(allyl)pyrrolidine-2-methylamine,247-467-9,26116-13-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;STOT SE 3,Notified C&L,1,H335:1;H312:1;H302:1;H226:1;H314:1
85695,CARDAMOME HE,616-779-0,8000-66-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,177,H411:114;H317:114;H226:48;Not classified:25;H319:7;H315:7;H304:3
85700,"Amides, C12-18 and C18-unsatd., N-(hydroxyethyl), ethoxylated",500-350-9,157707-44-3,Eye Irrit. 2,Notified C&L,90,H319:89;H318:1
85701,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]-, sodium hydrogen",277-515-4,73513-78-7,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1
85706,"Fatty acids, C14-18, iso-Pr esters",274-842-4,70750-32-2,Not Classified,Notified C&L,23,Not classified:23
85707,"2,4-dimethylhepta-2,6-dien-1-ol",279-418-2,80192-56-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85708,Bromocycloheptane,219-294-9,2404-35-5,Aquatic Chronic 2,Notified C&L,38,H411:38
85710,Tridec-2-enal,231-883-2,7774-82-5,Not Classified,Notified C&L,1408,Not classified:1395;H317:13;H315:13
85715,"N*4*-(3-Chloro-4-fluoro-phenyl)-7-[(S)-(tetrahydro-furan-3-yl)oxy]-quinazoline-4,6-diamine",921-874-8,,,Notified C&L,1,Not classified:1
85718,"1,3,5-tri-tert-butylbenzene",215-952-4,1460-02-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H302:1;H332:1;H413:1;H312:1
85720,"Phosphoric acid, C12-18-alkyl esters, sodium salts",291-913-5,90506-50-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,34,H318:34;H315:34
85722,"Aluminium, chloro hydroxy propylene glycol complexes",258-309-3,53026-85-0,Not Classified,Notified C&L,1,Not classified:1
85725,4-methylpiperazine-1-ethylamine,213-296-3,934-98-5,,Notified C&L,7,H314:7
85726,"4-methoxyphenyl-4(5,6-epoxyhexyloxy)benzoate",435-360-1,144447-11-0,Skin Sens. 1,Notified C&L,2,H317:2
85727,"5,6-dihydro-2,4,4,6-tetramethyl4H-1,3-oxazine",248-117-8,26939-18-4,Flam. Liq. 3,Notified C&L,42,H226:42
85729,"3,5-dimethylcyclohex-3-ene-1-carbaldehyde",268-263-6,68039-48-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,151,H317:151;H319:133;H412:120;H315:151;H312:18;H411:31
85732,1-iodo-2-methylpropane,208-160-5,513-38-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,46,H319:46;H335:45;H225:46;H331:39;H315:46;H332:2
85733,3-ethyl-3-methylpentane,213-923-0,1067-08-9,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H225:0;H336:0;H304:0;H400:0;H410:0;H315:0
85736,"Benzothiazole-2(3H)-thione, compound with dibutylamine (1:1)",265-842-5,65605-47-2,Not Classified,Notified C&L,1,Not classified:1
85737,Robenidine hydrochloride,247-307-8,25875-50-7,Acute Tox. 4,Notified C&L,43,H302:41;H410:4;H400:4;H332:1
85738,2-[3-(methylamino)-4-nitrophenoxy]ethanol,261-940-7,59820-63-2,Acute Tox. 4,Notified C&L,7,H302:7
85740,EPOCROS(TM) K,420-750-6,,Not Classified,Notified C&L,1,Not classified:1
85742,Hexadecyltriphenylphosphonium bromide,238-939-5,14866-43-4,,Notified C&L,4,H319:4;H335:4;H315:4
85743,2-chloro-5-iodobenzoic acid,606-224-0,19094-56-5,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,53,H319:11;H317:4;H318:41;H400:41;H301:42;H335:6;H315:7;H302:1;H311:1;H331:1
85744,"4-trans-Propyl-[trans-1,1-bicyclohexyl]-4-carbonic acid-[4-( 4-trans-propylcyclohexyl)-phenylester]",618-105-0,88038-92-0,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
85746,isopropyl propionate,211-300-8,637-78-5,Flam. Liq. 2,Harmonised C&L,0,H225:0
85748,2-hydroxyethyl phenoxyacetate,217-854-7,1984-60-7,Not Classified,Notified C&L,233,Not classified:233
85751,Cyclohexylhydroxylamine hydrochloride,246-612-3,25100-12-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H302:38;H318:38;H335:42;H315:42;H319:4
85753,"3,4-xylylacetaldehyde",272-445-0,68844-97-3,Not Classified,Notified C&L,36,Not classified:36
85757,"reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate",421-480-1,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
85758,Valeranilide,233-603-4,10264-18-3,Acute Tox. 4,Notified C&L,1,H302:1
85765,4-fluoro-4'-(trifluoromethyl)benzophenone,240-633-1,16574-52-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
85766,"Ethanol, 2,2'-oxybis-, reaction products with ammonia, fractionation forecuts",272-711-6,68909-76-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,2,H318:2;H360:2;H411:2;H302:2;H314:2
85768,"Paraffin waxes and Hydrocarbon waxes, oxidized, calcium salts",270-701-6,68476-81-3,Not Classified,Notified C&L,1,Not classified:1
85769,"Tungstate (W12(OH)2O4010-), ammonium, hydrate (1:10:4)",603-462-7,1311-93-9,Not Classified,Notified C&L,1,Not classified:1
85770,Phenyl(tribromomethyl)mercury,221-963-5,3294-60-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H373:38;H310:38;H330:38;H400:38;H410:38
85776,(nitrooxy)oxobismuthine,233-792-3,10361-46-3,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44;H272:44
85782,"diclofop-methyl (ISO);methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate",257-141-8,51338-27-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H317:0;H400:0
85783,"Dioctadecyl 3,3'-dithiobispropionate",229-781-8,6729-96-0,Not Classified,Notified C&L,24,Not classified:24
85784,"3-(4,6-dimethoxy-1,3,5-triazin-2-yl)-7-fluoro-1,3-dihydro-2H-indol-2-one",930-401-4,1383706-71-5,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H317:2
85785,Methyl indoline-2-carboxylate,611-779-7,59040-84-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85788,"4-[(4-ethoxyphenyl)azo]-N,N-diethylaniline",221-136-9,3010-63-7,Aquatic Chronic 4,Notified C&L,38,H413:38
85792,clorofene;chlorophene;2-benzyl-4-chlorophenol,204-385-8,120-32-1,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H373:0;H317:0;H318:0;H361:0;H400:0;H351:0;H332:0;H410:0;H315:0
85793,Tridecane,211-093-4,629-50-5,Asp. Tox. 1,REACH registration C&L,464,H304:438;H319:28;H335:22;H315:28;H336:8;Not classified:2;H413:1
85804,"C18-C50 branched, cyclic and linear hydrocarbons – Distillates",619-569-7,848301-69-9,Asp. Tox. 1,Notified C&L,187,H304:186;Not classified:1
85805,"1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetic acid, compound with N-(p-methoxybenzyl)-N',N'-dimethyl-N-(2-pyridyl)ethane-1,2-diamine (1:1)",260-716-6,57383-74-1,Acute Tox. 3,Notified C&L,2,H301:1;H302:1
85807,"Tall oil, esters with pentaerythritol",298-760-3,93821-73-9,Aquatic Chronic 4,Notified C&L,2,H413:2
85809,"Methyl 2,6-dichloroisonicotinate",255-868-5,42521-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85810,"2,4-dichloro-1-(trichloromethyl)benzene",235-868-1,13014-18-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,45,H319:45;H335:5;H317:2;H412:5;H302:5;H315:6;H413:39
85812,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate",286-175-6,85187-86-6,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H410:2;H400:2;H301:2
85813,3-(TRIMETHYLSILYL)PROPARGYL BROMIDE,609-506-1,38002-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H227:1
85814,1-iodopropane,203-460-2,107-08-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,48,H319:41;H335:40;H341:2;H412:40;H332:46;H351:2;H226:48;H315:41;H302:42;Not classified:1;H331:1
85816,"Decanoic acid, mixed esters with heptanoic acid, octanoic acid and pentaerythritol",270-471-7,68441-67-8,Not Classified,REACH registration C&L,143,Not classified:143
85817,"Diethyl 1,2-cyclopentanedicarboxylate",291-751-5,90474-13-8,Not Classified,REACH registration C&L,1,Not classified:1
85819,Benzyldodecyldimethylammonium bromide,230-698-4,7281-04-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H319:40;H335:39;H315:40;H301:41;H302:29;H400:26;H314:27
85821,"3,4-dihydro-5-methylnaphthalen-1(2H)-one",230-073-6,6939-35-1,Not Classified,Notified C&L,89,Not classified:88;H319:1;H335:1;H315:1
85823,"3,7-dimethyloct-7-ene-1,6-diol",245-015-5,22460-95-3,Skin Irrit. 2;Skin Sens. 1,Notified C&L,126,H317:64;H315:64;Not classified:49;H412:13
85824,Sodium morpholine-4-carbodithioate,212-844-9,873-58-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
85826,"1,2,3,4-tetrahydroquinolin-6-ol",222-153-4,3373-00-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
85829,Cobamamide,237-627-6,13870-90-1,Not Classified,Notified C&L,3,Not classified:3
85835,"3,6,10-trimethylundeca-3,5,9-trien-2-one",214-245-8,1117-41-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,342,H317:342;H319:341;H315:342;H411:83;H410:1;H400:1
85837,"alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol",605-731-4,174607-68-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H335:1;H411:1;H302:1;H332:1;H315:1
85839,"2,6,6-trimethylcyclohex-2-ene-1,4-dione",214-406-2,1125-21-9,Skin Sens. 1,REACH registration C&L,1546,H317:160;H302:1337;Not classified:88;H319:7;H315:7;H335:1;H301:1
85843,tetrabutylammonium butyltriphenylborate,418-080-4,120307-06-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
85845,Hept-3-enyl isobutyrate,267-166-6,67801-45-0,Not Classified,Notified C&L,88,Not classified:88
85846,"Hexasodium 4-amino-3,6-bis[[5-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",268-667-2,68133-24-4,Skin Sens. 1B,REACH registration C&L,34,H317:4;Not classified:16;H320:11;H335:14;H334:14;H319:3
85849,"phenyl glycidyl ether;2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane",204-557-2,122-60-1,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0,H335:0;H317:0;H341:0;H412:0;H350:0;H332:0;H315:0
85854,"Benzoic acid, 4,4'-[[6-[[4-[[(1,1-dimethylethyl)amino]carbonyl]phenyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-, -bis(2-ethylhexyl)ester",604-972-2,154702-15-5,Not Classified,Notified C&L,22,Not classified:11;H413:11
85856,"2H-1-benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-,methyl ester",484-280-3,,Aquatic Chronic 2,REACH registration C&L,2,H411:2
85858,"2-Propanol, 1-amino-, polymer with 2-(2-aminoethoxy)ethanol, 2-aminoethanol and .alpha.-hydro-.omega.-[(1-oxo-2-propenyl)oxy]poly(oxy-1,2-ethanediyl) ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)",611-322-1,558452-37-2,Eye Irrit. 2,Notified C&L,83,H319:83
85859,"3,7-dimethyloct-6-enyl valerate",231-416-2,7540-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,126,H319:126;H335:126;H315:126;H413:38
85860,Triflupromazine,205-673-6,146-54-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,38,H351:38;H311:38;H331:38;H301:38
85862,Octyl formate,203-959-5,112-32-3,Not Classified,Notified C&L,128,Not classified:89;H319:38;H335:38;H315:38;H411:1
85863,Ethacridine lactate,217-408-1,1837-57-6,Not Classified,REACH registration C&L,77,Not classified:2;H319:75;H335:75;H315:75;H411:9;H312:2;H302:2;H332:2
85865,polyurethane,618-449-1,,Not Classified,Notified C&L,2,Not classified:2
85868,trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate,430-280-3,,Skin Sens. 1,Harmonised C&L,0,H317:0
85870,"bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate",415-210-1,160236-81-7,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H302:0;H332:0;H410:0
85871,"3,5-bis(trifluoromethyl)benzamide",244-849-7,22227-26-5,,Notified C&L,5,H319:5;H335:5;H315:5
85872,"9-(diethylamino)spiro[12H-benzo[a]xanthene-12,1'(3'H)-isobenzofuran]-3'-one",247-853-7,26628-47-7,Not Classified,Notified C&L,1,Not classified:1
85873,Tetrapropylammonium chloride,227-375-5,5810-42-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:41
85877,Bromo(p-chlorophenyl)magnesium,212-853-8,873-77-8,Skin Corr. 1B,Notified C&L,70,H314:70;H225:30;H260:1;H318:1
85878,Hydroxytrimethylsilane,213-914-1,1066-40-6,Flam. Liq. 2;Acute Tox. 4,REACH registration C&L,129,H332:31;H225:69;H412:2;Not classified:60
85881,Citicoline,213-580-7,987-78-0,,Notified C&L,1,H319:1;H335:1;H315:1
85882,"Naphthalene-1,4,5,8-tetracarboxylic acid",204-924-7,128-97-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,81,H319:81;H317:42;H315:1
85883,"2,4-diaminobenzenesulphonic acid",201-846-5,88-63-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,59,H317:42;H319:44;H315:44;Not classified:10;H412:4;H411:1;H318:1
85887,Dipotassium phosphonate,236-809-2,13492-26-7,Eye Irrit. 2,REACH registration C&L,264,H319:106;Not classified:136;H302:25;H315:28;H335:5;H320:1;H314:1
85891,"1,2-Benzenediamine, ar-methyl-, reaction products with propylene oxide",918-139-9,1228577-90-9,Eye Irrit. 2,REACH registration C&L,145,H319:145
85893,"Rape oil, Me ester",616-027-1,73891-99-3,Not Classified,Notified C&L,27,Not classified:27
85895,"Benzenesulfonyl chloride, 4-butoxy-",601-287-0,1138-56-3,,Notified C&L,5,H314:5
85896,"Linseed oil, Et ester",273-311-4,68956-59-2,Not Classified,Notified C&L,88,Not classified:88
85897,Cink-szulfát-heptahidrát,616-097-3,7446-20-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,170,H302:111;H410:111;H318:112;H400:110;H319:58;H335:57;H315:58
85902,Gramicidin A,234-259-8,11029-61-1,Acute Tox. 4,Notified C&L,1,H302:1
85903,"2,6-diaminopimelic acid",209-524-6,583-93-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
85904,"(2R)-3-(3,4-Dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]oxy}propanoic acid",606-487-1,20283-92-5,Acute Tox. 3;Aquatic Acute 1,Notified C&L,200,H400:196;H301:196;Not classified:4
85905,"Diethyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate",214-561-6,1149-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
85906,Methyl L-tryptophanate monohydrochloride,231-385-5,7524-52-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85907,6-[[(4-methylphenyl)sulphonyl]amino]hexanoic acid,278-934-5,78521-39-8,Not Classified,REACH registration C&L,484,Not classified:484
85908,2-methyl-2-butenenitrile,224-544-5,4403-61-6,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4,Notified C&L,39,H332:38;H225:39;H301:39;H319:1;H311:1;H331:1;H315:1
85910,"Phosphorous acid, C13-15-alkyl nonylphenyl triesters",296-123-4,92257-34-6,Not Classified,Notified C&L,2,Not classified:1;H410:1;H317:1
85913,(2S)-3-methyl-2-{[(propan-2-yloxy)carbonyl]amino}butanoic acid,604-210-9,140923-27-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
85915,"Methyl 2,4-dichlorophenoxyacetate",217-670-7,1928-38-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H302:41;H410:38;H317:38;H400:38;H332:3;H312:3
85917,"2-(dimethylamino)ethyl [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl succinate, salt with maleic acid (1:2)",258-690-6,53659-00-0,Acute Tox. 4,Notified C&L,1,H302:1
85919,Sodium 2-(4-methoxyphenoxy)propanoate,604-737-4,150436-68-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
85923,Neodymium trihydride,237-610-3,13864-04-5,Pyr. Sol. 1;Water-react. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H260:1;H250:1;H315:1
85926,Aminooxamide,208-213-2,515-96-8,Acute Tox. 3,Notified C&L,40,H301:39;H228:2
85927,"17β-hydroxyestra-4,9,11-trien-3-one 17-acetate",233-432-5,10161-34-9,Repr. 1B,Notified C&L,71,H360:40;H410:28;H351:29;H372:29;H361:30;H302:1;H350:2
85928,"N,N,2-Trimethylpropionamide",606-821-6,21678-37-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
85929,"Fatty acids, C14-18 and C16-18-unsatd., barium salts",305-998-4,95465-85-3,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,54,H302:54;H332:47
85932,Bis(isocyanatomethyl)benzene,247-299-6,25854-16-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,58,H319:58;H335:58;H317:58;H334:58;H315:58;H330:3
85934,1-(p-menth-1-en-6-yl)propan-1-one,250-600-3,31375-17-4,Not Classified,Notified C&L,1399,Not classified:1399
85936,Vanadium oxide (V6O13),601-703-0,12037-42-2,,Notified C&L,4,H302:4;H319:4;H332:4;H335:4
85938,"Hibiscus abelmoschus, ext.",282-891-8,84455-19-6,Self-heat. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1524,H319:98;H252:84;H317:183;H226:1286;Not classified:53;H315:14;H413:1;H412:2;H411:2
85940,"Dichloromethyl(3,3,4,4,5,5,6,6,6-nonafluorohexyl)silane",253-930-6,38436-16-7,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,3,H302:2;H318:2;H314:3
85942,"N,N,N',N'-tetramethylacridin-3,6-yldiamine hydrochloride",200-614-0,65-61-2,Muta. 1A,Notified C&L,117,H340:116;H302:1;H332:1;H312:1;H341:1
85944,"2-(3,5-dimethylhex-3-en-2-yloxy)-2-methylpropyl cyclopropanecarboxylate",700-118-9,676532-44-8,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1310,H411:1310;H317:1310
85946,Caseins,232-555-1,9000-71-9,Not Classified,Notified C&L,423,Not classified:423
85947,2-methoxy-4-propylphenol,220-499-0,2785-87-7,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,1776,H317:1737;H318:54;H335:54;H315:94;H319:1682;H311:40
85948,Lead phosphite,240-176-8,16038-76-9,Not Classified,Notified C&L,1,Not classified:1
85949,"tert-butyl 3,5,5-trimethylperoxyhexanoate",236-050-7,13122-18-4,Org. Perox. D;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,123,H410:50;H242:66;H317:118;H400:100;H315:68;H411:16;Not classified:5
85956,"Purine-2,6-diyldiamine",217-605-2,1904-98-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,49,H319:43;H335:42;H312:43;H302:43;H351:44;H332:43;H315:43;H341:4
85958,"1,1-dichloro-1-nitroethane",209-854-0,594-72-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H311:0;H331:0;H301:0
85961,Tripropyl phosphate,208-151-6,513-08-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:39;H312:39;H302:39;H332:39;H315:39
85973,Octadecylsilane,242-453-9,18623-11-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
85975,Enbucrilate,229-552-2,6606-65-1,Not Classified,REACH registration C&L,18,Not classified:18
85976,"N,N'-hexamethylenebis(cinnamylideneamine)",205-429-9,140-73-8,Skin Irrit. 2;Skin Sens. 1A,REACH registration C&L,5,H317:2;H315:5;H319:3;H335:3
85980,"1-(3,3-diethoxy-2-methylpropyl)-4-(isopropyl)benzene",230-470-4,7149-24-8,Not Classified,Notified C&L,233,Not classified:233
85983,"4'-amino-2',5'-diethoxybenzanilide",204-363-8,120-00-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,42,H319:3;H315:41;H318:38;H335:39;Not classified:1;H301:1
85985,"[1S-(1α,2β,3α,5α)]-[2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]methylamine",260-694-8,57357-85-4,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,84,H318:84;H411:84;H301:1;H401:1;H314:1;H302:83;H315:83
85988,"Hydrocarbons, C",307-758-4,97722-09-3,Carc. 1B,Harmonised C&L,0,H350:0
85993,Phenoxyacetone,210-712-5,621-87-4,Acute Tox. 4,Notified C&L,1,H332:1
85998,"(2S)-1,1,1-trifluoropropan-2-amine hydrochloride",603-062-2,125353-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,159,H319:159;H335:159;H315:159;H302:1
85999,"1,4-bis[(2,6-diethyl-4-methylphenyl)amino]anthraquinone",251-178-3,32724-62-2,Not Classified,REACH registration C&L,125,Not classified:124;H341:1;H317:1
86000,(E)-dodec-2-en-1-al,243-797-2,20407-84-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,544,H317:166;H319:503;H315:506;H400:168;H410:116;H314:38;H413:1
86003,Octan-4-olide,203-208-1,104-50-7,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1783,H412:27;H315:140;Not classified:1643;H319:6;H335:5
86005,"Alkenes, C8-20, mixed with animal fats, sulfurized",295-254-4,91994-96-6,Not Classified,Notified C&L,441,Not classified:441
86008,2-(N-ethyl-m-toluidino)ethanol,202-105-9,91-88-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,73,H302:40;H318:71;H311:33;H412:33;H331:33;H301:33;H319:1;H315:1;Not classified:1
86011,Deferoxamine,200-738-5,70-51-9,Skin Sens. 1,REACH registration C&L,197,H317:3;H302:195;H319:1;H335:1;H341:1;H334:1;H315:1
86012,"chlorpyrifos-methyl (ISO),;O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate",227-011-5,5598-13-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
86015,"2-(2-bromoethyl)-1,3-dioxane",251-716-7,33884-43-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:42;H315:44;H341:2;Not classified:1
86016,Ethyl diphenylcarbamate,210-047-0,603-52-1,Aquatic Chronic 3,REACH registration C&L,3,H412:2;H302:1
86018,Swainsonin,615-797-6,72741-87-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H312:39
86019,"Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-d-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-d-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-d-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-d-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-",250-687-8,31539-05-6,Acute Tox. 1;Eye Irrit. 2;Acute Tox. 1;STOT RE 2,Notified C&L,1,H300:1;H319:1;H373:1;H330:1
86020,"1,1-dimethylcyclopentane",216-673-0,1638-26-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,45,H302:38;H226:38;H225:4;Not classified:3
86021,Rociverine,258-711-9,53716-44-2,Acute Tox. 4,Notified C&L,1,H302:1
86027,"1-methyl-2,6-bis-(2-hydroxyethylamino)benzene",604-688-9,149330-25-6,Skin Sens. 1,Notified C&L,8,H317:5;H412:3;Not classified:2
86028,"Butene, homopolymer (products derived from either/or But-1-ene/But-2-ene)",500-004-7,9003-29-6,Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,1888,H304:391;H315:407;Not classified:879;H413:531;H319:87;H225:26;H331:20
86029,"Isocyanic acid, polymethylenepolyphenylene ester, polymer with 2,2'-iminobis[ethanol] and 4-methyl-1,3-dioxolan-2-one, 2-hydroxyethyl methacrylate-blocked",610-304-0,464177-89-7,,Notified C&L,71,Not classified:71
86030,Blau DYEN 1722,473-110-3,,Not Classified,Notified C&L,1,Not classified:1
86034,N-ethylpyridine-4-methylamine,251-506-5,33403-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:43;H335:42;H315:43;H302:4;H332:3;H312:3;H314:2
86035,Sodium 4-(3-methyl-4-(4-methyl-3-(phenylaminosulphonyl)phenylazo)-5-hydroxypyrazol-1-yl)benzenesulphonate,228-810-1,6359-85-9,Aquatic Chronic 3,REACH registration C&L,19,H412:2;Not classified:17
86036,[4-[cyano(m-tolyl)methyl]phenyl]ammonium chloride,280-698-3,83763-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86038,"2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one",406-480-1,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
86042,"4,4'-methylenedi(cyclohexyl isocyanate);dicyclohexylmethane-4,4'-di-isocyanate",225-863-2,5124-30-1,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H335:0;H317:0;H331:0;H334:0;H315:0
86043,"Lard, sulfonated, sodium salt",293-308-1,91053-43-9,,Notified C&L,39,Not classified:38;H318:1;H315:1
86044,Cyclopropane sulfonamide,604-946-0,154350-29-5,Not Classified,Notified C&L,85,Not classified:42;H302:40;H319:3;H318:1;H228:1
86048,2-bromo-9H-fluorene,214-480-6,1133-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:50;H335:48;H315:50;H302:2;H312:1;H332:1;Not classified:1
86050,"Alcohols, C13-15, branched and linear, ethoxylated",500-337-8,157627-86-6,Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,213,H410:83;H412:160;H400:120;H302:96;H318:96;H319:33;Not classified:1
86051,Butyltriphenylphosphonium chloride,236-443-3,13371-17-0,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,369,H410:16;H318:3;H400:2;H301:148;H302:178;H319:366;H335:365;H315:366;H311:145;H331:145;H411:58;H412:74;H300:1
86052,"6,6-dibutyl-4,4,8,8-tetraethoxy-3,5,7,9-tetraoxa-4,8-disila-6-stannaundecane",289-337-4,87735-26-0,Muta. 2;Repr. 1B;STOT RE 1,Notified C&L,4,H341:4;H360:4;H372:4
86053,Aluminum,618-785-9,91728-14-2,Not Classified,Notified C&L,1,Not classified:1
86054,2-methylheptan-3-one,235-877-0,13019-20-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H226:39;H335:38;H315:38
86057,Cadmium orthophosphate,237-581-7,13847-17-1,,Notified C&L,4,H312:4;H400:4;H302:4;H332:4;H410:4
86058,"Benzoic acid, 2,4-dihydroxy-, copper salt, basic",275-086-8,70983-44-7,,Notified C&L,1,H319:1;H335:1;H315:1;Not classified:1
86060,4-bromo-5-nitroveratrole,256-951-9,51072-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86061,2-nitrobenzoyl chloride,210-206-4,610-14-0,Skin Corr. 1B,Notified C&L,40,H314:40
86067,lithium p-styrenesulfonate,610-257-6,4551-88-6,Skin Sens. 1,Notified C&L,1,H317:1
86070,Diallyl adipate,221-071-6,2998-04-1,Acute Tox. 4,Notified C&L,1,H302:1
86077,"Bis(pentane-2,4-dionato-O,O')manganese",237-858-2,14024-58-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,44,H319:43;H335:42;H312:39;H302:39;H351:43;H332:39;H315:43;Not classified:1
86078,"DIETHYLENE GLYCOL, 1,2-PROPANEDIOL, 1,3-BUTANEDIOL, DIPHENYLMETHANEDIISOCYANATE, POLYMER",642-448-5,155662-82-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,9,H319:9;H335:9;H317:9;H334:9;H332:9;H315:9
86080,"1-ethyl-1,3,3-trimethylindan",262-520-6,60899-29-8,Not Classified,Notified C&L,10,Not classified:10
86082,N-(2-methoxyphenyl)-3-(phosphonooxy)naphthalene-2-carboxamide,283-011-5,84522-15-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86084,"1,4-bis[(2,6-diethylphenyl)amino]anthraquinone",243-630-3,20241-74-1,Not Classified,Notified C&L,1,Not classified:1
86085,Dioctyltin oxide,212-791-1,870-08-6,STOT SE 2,REACH registration C&L,325,H371:23;H410:83;H372:175;H361:225;H413:178;H373:122;H412:18;H319:4;H335:4;H312:4;H332:4;H315:4
86086,"Rennets, microbial",257-760-3,52227-98-2,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H334:1
86088,"1,5-Naphthalenedisulfonic acid, 2-[2-[8-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-, potassium salt (1:5)",603-093-1,125830-50-4,Not Classified,Notified C&L,1,Not classified:1
86089,4-azido-1-fluoro-2-nitrobenzene,248-878-6,28166-06-5,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:38;H301:38;H331:38;H228:38;H319:1;H335:1;H315:1
86090,Gallium tetrachlorogallate,246-338-4,24597-12-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
86092,methyl 3-(bromomethyl)-4-chlorobenzoate,606-914-1,220464-68-6,Skin Corr. 1B,Notified C&L,1,H314:1
86093,"Fatty acids, olive-oil, isodecyl esters",293-080-3,91051-29-5,Not Classified,Notified C&L,1,Not classified:1
86104,"Fatty acids, castor-oil, maleates, sulfonated, trisodium salts",292-873-1,91001-98-8,Not Classified,Notified C&L,1,Not classified:1
86107,Di[(2H3)methyl] sulphide,213-133-6,926-09-0,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H225:38;H302:38;H315:38
86108,"Slags, steelmaking",266-004-1,65996-71-6,Not Classified,REACH registration C&L,70,Not classified:70
86111,Sodium 6-amino-3-[[4-[(4-aminophenyl)azo]-4-methoxy-m-tolyl]azo]-4-hydroxynaphthalene-2-sulphonate,220-955-9,2945-96-2,Acute Tox. 4,Notified C&L,2039,H302:2038;H412:2037;Not classified:1
86112,"6,6-dimethoxy-2,5,5-trimethylhex-2-ene",266-885-2,67674-46-8,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1823,H412:1822;H315:1823;H319:1759
86114,"Alkanes, C7-8-iso-",274-273-1,70024-92-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,9,H225:9;H336:9;H304:9;H411:9;H315:9
86116,1-hydroxy-2-naphthoic acid,201-674-0,86-48-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,146,H302:83;H318:83;H319:51;H335:49;H315:51;Not classified:13
86120,"2,5-Cyclohexadien-1-one, 4-(10H-phenothiazin-3-ylimino)-, S-oxide, reaction products with sodium sulfide (Na2(Sx)) and sulfur, leuco deriv.",288-904-3,85940-16-5,Not Classified,Notified C&L,31,Not classified:31
86123,"disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate",400-380-1,86393-35-3,Skin Sens. 1,Harmonised C&L,0,H317:0
86127,Nicotinaldehyde semicarbazone,236-442-8,13370-80-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
86134,"2-Butenoic acid, 4-oxo-4-phenyl-, ethyl ester (E)-",604-780-9,15121-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34,H317:34;H318:34;H312:34;H400:34;H302:34;H410:34;H315:34
86136,"Triisooctyl benzene-1,2,4-tricarboxylate",248-365-7,27251-75-8,Not Classified,Notified C&L,4,Not classified:4
86138,Bisphenol A diphosphate,605-913-3,181028-79-5,Aquatic Chronic 2,Notified C&L,231,H411:127;Not classified:77;H413:27
86141,4-ethylpyridin-2-amine,251-430-2,33252-32-3,,Notified C&L,4,H319:4;H335:4;H311:4;H302:4;H332:4;H315:4
86142,"N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide",420-210-1,111244-14-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
86144,"[R-(R*,R*)]-N,N'-diallyltartaramide",261-277-3,58477-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H335:50;H315:51
86148,(±)-2-aminododecanoic acid,252-454-6,35237-37-7,Not Classified,Notified C&L,2,Not classified:2
86152,4-ethylbenzaldehyde,225-268-8,4748-78-1,Acute Tox. 4,REACH registration C&L,278,H302:236;H319:42;H335:38;H315:42
86154,[2-(dimethoxymethyl)-1-heptenyl]benzene,202-104-3,91-87-2,Not Classified,Notified C&L,272,Not classified:234;H319:38;H335:38;H315:38
86157,"Di-mu-chloro-bis(hapto-1,5-cyclooctadiene)dirhodium(I)",235-157-6,12092-47-6,Not Classified,REACH registration C&L,131,Not classified:2;H319:128;H317:84;H411:84;H302:84;H315:128;H335:44;H318:1
86158,ethoxylated bis phenol A di-(norbornene carboxylate),412-410-0,32492-61-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
86162,"2-Fluor-4,4'-bis(trans-4-pentylcyclohexyl)-[1,1'-biphenyl]",617-632-3,84816-56-8,Aquatic Chronic 4,Notified C&L,2,H413:2;Not classified:1
86163,"3,5-bis(trifluoromethyl)benzohydrazide",247-462-1,26107-82-4,,Notified C&L,7,H319:7;H335:7;H315:7;H311:1;H331:1;H301:1
86167,Extract Jasmine,617-015-9,8022-96-6,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,161,H411:158;H315:161;H317:24;H410:3;H400:3;H319:1
86171,3-nitro-p-tolualdehyde,250-760-4,31680-07-6,,Notified C&L,5,H319:5;H335:5;H315:5
86175,(+-)-1-(p-((2-Isopropoxyethoxy)methyl)phenoxy)-3-isopropylamino-2-propanol hemifumarate,600-557-5,104344-23-2,Acute Tox. 4,Notified C&L,139,H302:139;H412:15;H361:15;H362:15;H332:4;Not classified:2;H360:1;H312:1;H373:1
86177,[γ-(4-chlorophenyl)-pyridine-2-propyl](dimethyl)ammonium hydrogen (Z)-maleate,219-450-6,2438-32-6,Acute Tox. 3,Notified C&L,140,H301:140;H373:35;H318:46;H311:35;H361:35;H336:35;H317:11;H332:2;H312:2
86178,"Phosphoric acid, esters with castor-oil alcs.",263-102-6,61790-03-2,Not Classified,Notified C&L,1,Not classified:1
86183,"Rubber, chlorinated",618-427-1,9006-03-5,Not Classified,Notified C&L,28,Not classified:28
86184,Cetylpyridinium bromide,205-428-3,140-72-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,49,H319:49;H335:48;H330:42;H413:40;H302:47;H315:49;Not classified:2;H400:2;H301:2;H410:2;H332:1
86186,"Humulus scandens dry purified extract.REACH IUPAC name: Humulus, Humulus scandens, Cannabaceae, aerial part, ethanol/water 1:1 extract.",468-180-7,,Not Classified,REACH registration C&L,2,Not classified:2
86187,(3-methoxyphenyl)acetonitrile,243-428-5,19924-43-7,Not Classified,REACH registration C&L,56,Not classified:1;H319:42;H335:41;H315:42;H330:9;H311:9;H301:16;H412:5
86192,"t-Butyl (2S,2aS,5aR)-1-azabicyclo[3.3.0] oct-2-carboxylate monooxalate salt",478-200-6,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1
86193,Thiazole,206-021-3,288-47-1,Flam. Liq. 2;Acute Tox. 4,Notified C&L,305,H302:305;H225:263;H335:39;H318:39;H226:41;H315:40;H319:5;H332:1
86195,Scandium(3+) perchlorate,237-914-6,14066-05-8,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,42,H314:38;H272:42;H319:4;H335:4;H315:4
86198,4-dimethylaminobenzaldehyde,202-819-0,100-10-7,Not Classified,REACH registration C&L,111,Not classified:11;H412:90;H301:84;H302:14;H319:7;H335:5;H315:7;H312:1
86199,"Butan-2-one O,O',O''-(vinylsilylidyne)trioxime",218-747-8,2224-33-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,678,H317:647;H318:550;H315:539;H301:60;H319:101;H335:64;H373:119;H312:23;H302:24;H332:23;H336:20;H412:7;H400:6;H410:6;H314:2;Not classified:1
86200,"11β,18,21-trihydroxypregn-4-ene-3,20-dione",209-221-9,561-65-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
86202,Disodium 8-(4-methylphenylamino)-5-(4-(3-sulphonatophenylazo)-1-naphthylazo)naphthalenesulphonate,222-554-4,3529-01-9,Not Classified,Notified C&L,15,Not classified:13;H411:2
86204,"1,3-Benzenedimethanamine, reaction products with glycidyl Ph ether",290-610-5,90194-03-9,Not Classified,Notified C&L,22,Not classified:22
86215,Thiophene-3-carbaldehyde,207-865-5,498-62-4,Acute Tox. 4,Notified C&L,45,H302:40;H319:7;H335:6;H315:7;H312:2;H332:2;H227:1;H334:1
86220,"Ethanone, 2-chloro-1-(2-thienyl)-",608-395-7,29683-77-0,,Notified C&L,2,H319:2;H335:2;H302:2;H332:2;H315:2;H312:1
86222,"[1R-(1α,2α,5α)]-2,6,6-trimethylbicyclo[3.1.1]heptane",225-470-6,4863-59-6,Flam. Liq. 3,Notified C&L,38,H226:38
86223,"2-Fluor-4-(4'-trans-propyl-[1,1'-bicyclohexyl]-4-trans-yl)-1-trifluormethoxybenzene",604-042-6,137810-19-6,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
86224,(p-ammoniophenyl)bis(2-hydroxyethyl)ammonium sulphate,259-134-5,54381-16-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,121,H319:121;H317:118;H311:12;H331:12;H411:12;H400:13;H301:110;H410:13;H315:67;H335:12;H302:11;H312:3;H332:3;Not classified:1
86227,"(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)[[]2-(methylsulfonyl)-4-(trifluoromethyl)phenyl]methanone",609-256-3,365400-11-9,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,144,H410:90;H373:106;H400:90;Not classified:38;H411:16
86230,Triethoxy(isobutyl)silane,605-871-6,17980-47-1,Skin Irrit. 2,Notified C&L,60,H315:60;H314:22
86231,Ethyl 3-methylvalerate,227-524-4,5870-68-8,Flam. Liq. 3,Notified C&L,93,H226:93
86233,Digold trisulphide,215-124-2,1303-61-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
86236,N-Phenyl-N-benzyl-N’-(N-methyl)piperidylazine acetate,920-518-9,,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,2,H302:2;H413:2
86237,5-bromo-2-nitropyridine,609-748-8,39856-50-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,54,H319:54;H335:53;H315:54;H312:5;H302:5;H332:1
86240,N-(4-dodecylphenyl)-3-oxobutyramide,281-785-9,84030-15-9,Aquatic Chronic 4,Notified C&L,38,H413:38
86241,Reaction mass of 2-anilino-4-methyl-5-{(E)-[4-nitro-2-(trifluoromethyl)phenyl]diazenyl}-6-[(2-phenylethyl)amino]pyridine-3-carbonitrile and 2-anilino-4-methyl-5-{(E)-[4-nitro-2-(trifluoromethyl)phenyl]diazenyl}-6-[(2-phenylethyl)amino]pyridine-3-carbonitrile and 2-anilino-6-(benzylamino)-5-[(E)-(2-cyano-4-nitrophenyl)diazenyl]-4-methylpyridine-3-carbonitrile and 6-anilino-2-(benzylamino)-5-[(E)-(2-cyano-4-nitrophenyl)diazenyl]-4-methylpyridine-3-carbonitrile and 2-anilino-5-[(E)-(2-cyano-4-nitrophenyl)diazenyl]-4-methyl-6-[(2-phenylethyl)amino]pyridine-3-carbonitrile and 6-anilino-5-[(E)-(2-cyano-4-nitrophenyl)diazenyl]-4-methyl-2-[(2-phenylethyl)amino]pyridine-3-carbonitrile,441-440-7,,Aquatic Chronic 4,Notified C&L,1,H413:1
86242,"5-Ethylpyridine-2,3-dicarboxylic Acid",600-293-0,102268-15-5,,Notified C&L,5,H319:5;H335:4;H315:5
86243,2-BROMO-5-CHLOROANILINE,617-321-2,823-57-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3,H319:3;H312:3;H302:3;H332:3;H315:3
86244,"sodium hypochlorite, solution ... % Cl active",231-668-3,7681-52-9,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H314:0
86246,4-nitrophenyl N-[(phenylmethoxy)carbonyl]glycinate,217-097-2,1738-86-9,Resp. Sens. 1;Aquatic Acute 1,Notified C&L,39,H400:39;H334:39
86247,"Phosphoric acid, butyl ester, branched, compd. with 2-ethyl-N-(2-ethylhexyl)-1-hexanamine",308-859-6,98679-19-7,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H318:2;H314:2
86248,4-Hydroxy-3-mesityl-1-oxaspiro(4.4)non-3-en-2-one,604-634-4,148476-30-6,Aquatic Chronic 2,Notified C&L,194,H411:194
86249,S-(2-furylmethyl) methanethioate,261-563-8,59020-90-5,Acute Tox. 4,Notified C&L,1375,H302:1286;Not classified:89
86252,m-bromobenzenethiol,228-664-9,6320-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:40;H335:40;H315:40;H314:6;H301:5;H311:1;H331:1;H318:1;H312:1;H302:1;H332:1
